id	sid	tid	token	lemma	pos
gsrj-29	1	1	crispr	crispr	PROPN
gsrj-29	1	2	and	and	CCONJ
gsrj-29	1	3	covid-19	covid-19	PROPN
gsrj-29	1	4	:	:	PUNCT
gsrj-29	1	5	lessons	lesson	NOUN
gsrj-29	1	6	learned	learn	VERB
gsrj-29	1	7	to	to	PART
gsrj-29	1	8	prepare	prepare	VERB
gsrj-29	1	9	for	for	ADP
gsrj-29	1	10	the	the	DET
gsrj-29	1	11	next	next	ADJ
gsrj-29	1	12	pathogen	pathogen	NOUN
gsrj-29	1	13	james	james	PROPN
gsrj-29	1	14	m.	m.	PROPN
gsrj-29	1	15	bond	bond	PROPN
gsrj-29	1	16	volume	volume	NOUN
gsrj-29	1	17	two	two	NUM
gsrj-29	1	18	edition	edition	NOUN
gsrj-29	1	19	one	one	NUM
gsrj-29	1	20	fall	fall	NOUN
gsrj-29	1	21	2021	2021	NUM
gsrj-29	1	22	georgetown	georgetown	PROPN
gsrj-29	1	23	scientific	scientific	PROPN
gsrj-29	1	24	research	research	PROPN
gsrj-29	1	25	journal	journal	PROPN
gsrj-29	1	26	24	24	NUM
gsrj-29	1	27	georgetown	georgetown	PROPN
gsrj-29	1	28	scientific	scientific	PROPN
gsrj-29	1	29	research	research	PROPN
gsrj-29	1	30	journal	journal	PROPN
gsrj-29	1	31	crispr	crispr	PROPN
gsrj-29	1	32	and	and	CCONJ
gsrj-29	1	33	covid-19	covid-19	PROPN
gsrj-29	1	34	:	:	PUNCT
gsrj-29	1	35	lessons	lesson	NOUN
gsrj-29	1	36	learned	learn	VERB
gsrj-29	1	37	to	to	PART
gsrj-29	1	38	prepare	prepare	VERB
gsrj-29	1	39	for	for	ADP
gsrj-29	1	40	the	the	DET
gsrj-29	1	41	next	next	ADJ
gsrj-29	1	42	pathogen	pathogen	NOUN
gsrj-29	1	43	james	james	PROPN
gsrj-29	1	44	m.	m.	PROPN
gsrj-29	1	45	bond	bond	PROPN
gsrj-29	1	46	department	department	PROPN
gsrj-29	1	47	of	of	ADP
gsrj-29	1	48	science	science	NOUN
gsrj-29	1	49	,	,	PUNCT
gsrj-29	1	50	technology	technology	NOUN
gsrj-29	1	51	,	,	PUNCT
gsrj-29	1	52	and	and	CCONJ
gsrj-29	1	53	international	international	ADJ
gsrj-29	1	54	affairs	affairs	PROPN
gsrj-29	1	55	,	,	PUNCT
gsrj-29	1	56	georgetown	georgetown	PROPN
gsrj-29	1	57	university	university	PROPN
gsrj-29	1	58	,	,	PUNCT
gsrj-29	1	59	washington	washington	PROPN
gsrj-29	1	60	,	,	PUNCT
gsrj-29	1	61	d.c	d.c	PROPN
gsrj-29	1	62	.	.	PROPN
gsrj-29	1	63	,	,	PUNCT
gsrj-29	1	64	united	united	PROPN
gsrj-29	1	65	states	states	PROPN
gsrj-29	1	66	.	.	PUNCT
gsrj-29	2	1	e	e	X
gsrj-29	2	2	-	-	NOUN
gsrj-29	2	3	mail	mail	NOUN
gsrj-29	2	4	:	:	PUNCT
gsrj-29	2	5	jmb516@georgetown.edu	jmb516@georgetown.edu	PROPN
gsrj-29	2	6	https://doi.org/10.48091/gsr.v2i1.29	https://doi.org/10.48091/gsr.v2i1.29	PROPN
gsrj-29	2	7	abstract	abstract	ADJ
gsrj-29	2	8	crispr	crispr	NOUN
gsrj-29	2	9	-	-	PUNCT
gsrj-29	2	10	cas	cas	NOUN
gsrj-29	2	11	is	be	AUX
gsrj-29	2	12	a	a	DET
gsrj-29	2	13	gene	gene	NOUN
gsrj-29	2	14	editing	edit	VERB
gsrj-29	2	15	technology	technology	NOUN
gsrj-29	2	16	that	that	PRON
gsrj-29	2	17	can	can	AUX
gsrj-29	2	18	strengthen	strengthen	VERB
gsrj-29	2	19	a	a	DET
gsrj-29	2	20	defense	defense	NOUN
gsrj-29	2	21	countermeasure	countermeasure	NOUN
gsrj-29	2	22	against	against	ADP
gsrj-29	2	23	an	an	DET
gsrj-29	2	24	infectious	infectious	ADJ
gsrj-29	2	25	pathogen	pathogen	NOUN
gsrj-29	2	26	and	and	CCONJ
gsrj-29	2	27	can	can	AUX
gsrj-29	2	28	heighten	heighten	VERB
gsrj-29	2	29	the	the	DET
gsrj-29	2	30	attack	attack	NOUN
gsrj-29	2	31	risk	risk	NOUN
gsrj-29	2	32	of	of	ADP
gsrj-29	2	33	an	an	DET
gsrj-29	2	34	engineered	engineer	VERB
gsrj-29	2	35	pathogen	pathogen	NOUN
gsrj-29	2	36	.	.	PUNCT
gsrj-29	3	1	the	the	DET
gsrj-29	3	2	purpose	purpose	NOUN
gsrj-29	3	3	of	of	ADP
gsrj-29	3	4	this	this	DET
gsrj-29	3	5	report	report	NOUN
gsrj-29	3	6	is	be	AUX
gsrj-29	3	7	twofold	twofold	ADJ
gsrj-29	3	8	:	:	PUNCT
gsrj-29	3	9	to	to	PART
gsrj-29	3	10	analyze	analyze	VERB
gsrj-29	3	11	the	the	DET
gsrj-29	3	12	advantages	advantage	NOUN
gsrj-29	3	13	of	of	ADP
gsrj-29	3	14	crispr	crispr	NOUN
gsrj-29	3	15	for	for	ADP
gsrj-29	3	16	participants	participant	NOUN
gsrj-29	3	17	within	within	ADP
gsrj-29	3	18	a	a	DET
gsrj-29	3	19	strategic	strategic	ADJ
gsrj-29	3	20	environment	environment	NOUN
gsrj-29	3	21	,	,	PUNCT
gsrj-29	3	22	such	such	ADJ
gsrj-29	3	23	as	as	ADP
gsrj-29	3	24	rogue	rogue	NOUN
gsrj-29	3	25	,	,	PUNCT
gsrj-29	3	26	non	non	ADJ
gsrj-29	3	27	-	-	ADJ
gsrj-29	3	28	state	state	ADJ
gsrj-29	3	29	attackers	attacker	NOUN
gsrj-29	3	30	and	and	CCONJ
gsrj-29	3	31	defenders	defender	NOUN
gsrj-29	3	32	coordinated	coordinate	VERB
gsrj-29	3	33	between	between	ADP
gsrj-29	3	34	nation	nation	NOUN
gsrj-29	3	35	-	-	PUNCT
gsrj-29	3	36	states	state	NOUN
gsrj-29	3	37	and	and	CCONJ
gsrj-29	3	38	other	other	ADJ
gsrj-29	3	39	entities	entity	NOUN
gsrj-29	3	40	,	,	PUNCT
gsrj-29	3	41	and	and	CCONJ
gsrj-29	3	42	to	to	PART
gsrj-29	3	43	identify	identify	VERB
gsrj-29	3	44	the	the	DET
gsrj-29	3	45	ways	way	NOUN
gsrj-29	3	46	in	in	ADP
gsrj-29	3	47	which	which	PRON
gsrj-29	3	48	crispr	crispr	PROPN
gsrj-29	3	49	configures	configure	VERB
gsrj-29	3	50	a	a	DET
gsrj-29	3	51	defender	defender	NOUN
gsrj-29	3	52	’s	’s	PART
gsrj-29	3	53	countermeasure	countermeasure	NOUN
gsrj-29	3	54	against	against	ADP
gsrj-29	3	55	a	a	DET
gsrj-29	3	56	biological	biological	ADJ
gsrj-29	3	57	event	event	NOUN
gsrj-29	3	58	.	.	PUNCT
gsrj-29	4	1	in	in	ADP
gsrj-29	4	2	its	its	PRON
gsrj-29	4	3	assessment	assessment	NOUN
gsrj-29	4	4	,	,	PUNCT
gsrj-29	4	5	this	this	DET
gsrj-29	4	6	report	report	NOUN
gsrj-29	4	7	utilizes	utilize	VERB
gsrj-29	4	8	the	the	DET
gsrj-29	4	9	case	case	NOUN
gsrj-29	4	10	study	study	NOUN
gsrj-29	4	11	of	of	ADP
gsrj-29	4	12	covid-19	covid-19	PROPN
gsrj-29	4	13	to	to	PART
gsrj-29	4	14	examine	examine	VERB
gsrj-29	4	15	the	the	DET
gsrj-29	4	16	applications	application	NOUN
gsrj-29	4	17	of	of	ADP
gsrj-29	4	18	crisprcas	crisprcas	NOUN
gsrj-29	4	19	systems	system	NOUN
gsrj-29	4	20	to	to	ADP
gsrj-29	4	21	sars	sar	NOUN
gsrj-29	4	22	-	-	PUNCT
gsrj-29	4	23	cov-2	cov-2	NOUN
gsrj-29	4	24	.	.	PUNCT
gsrj-29	5	1	this	this	DET
gsrj-29	5	2	report	report	NOUN
gsrj-29	5	3	finds	find	VERB
gsrj-29	5	4	that	that	SCONJ
gsrj-29	5	5	crispr	crispr	NOUN
gsrj-29	5	6	reduces	reduce	VERB
gsrj-29	5	7	some	some	DET
gsrj-29	5	8	barriers	barrier	NOUN
gsrj-29	5	9	to	to	ADP
gsrj-29	5	10	entry	entry	NOUN
gsrj-29	5	11	and	and	CCONJ
gsrj-29	5	12	exacerbates	exacerbate	VERB
gsrj-29	5	13	the	the	DET
gsrj-29	5	14	possibility	possibility	NOUN
gsrj-29	5	15	for	for	SCONJ
gsrj-29	5	16	malicious	malicious	ADJ
gsrj-29	5	17	non	non	ADJ
gsrj-29	5	18	-	-	ADJ
gsrj-29	5	19	state	state	ADJ
gsrj-29	5	20	attackers	attacker	NOUN
gsrj-29	5	21	to	to	PART
gsrj-29	5	22	engineer	engineer	VERB
gsrj-29	5	23	a	a	DET
gsrj-29	5	24	pathogen	pathogen	NOUN
gsrj-29	5	25	and	and	CCONJ
gsrj-29	5	26	engender	engender	VERB
gsrj-29	5	27	a	a	DET
gsrj-29	5	28	serious	serious	ADJ
gsrj-29	5	29	biological	biological	ADJ
gsrj-29	5	30	event	event	NOUN
gsrj-29	5	31	in	in	ADP
gsrj-29	5	32	the	the	DET
gsrj-29	5	33	very	very	ADV
gsrj-29	5	34	short	short	ADJ
gsrj-29	5	35	-	-	PUNCT
gsrj-29	5	36	term	term	NOUN
gsrj-29	5	37	.	.	PUNCT
gsrj-29	6	1	however	however	ADV
gsrj-29	6	2	,	,	PUNCT
gsrj-29	6	3	key	key	ADJ
gsrj-29	6	4	barriers	barrier	NOUN
gsrj-29	6	5	to	to	ADP
gsrj-29	6	6	entry	entry	NOUN
gsrj-29	6	7	will	will	AUX
gsrj-29	6	8	continue	continue	VERB
gsrj-29	6	9	to	to	PART
gsrj-29	6	10	pose	pose	VERB
gsrj-29	6	11	challenges	challenge	NOUN
gsrj-29	6	12	to	to	ADP
gsrj-29	6	13	attackers	attacker	NOUN
gsrj-29	6	14	comparative	comparative	ADJ
gsrj-29	6	15	to	to	ADP
gsrj-29	6	16	defenders	defender	NOUN
gsrj-29	6	17	.	.	PUNCT
gsrj-29	7	1	in	in	ADP
gsrj-29	7	2	this	this	DET
gsrj-29	7	3	report	report	NOUN
gsrj-29	7	4	,	,	PUNCT
gsrj-29	7	5	“	"	PUNCT
gsrj-29	7	6	attacker	attacker	NOUN
gsrj-29	7	7	”	"	PUNCT
gsrj-29	7	8	refers	refer	VERB
gsrj-29	7	9	to	to	ADP
gsrj-29	7	10	non	non	ADJ
gsrj-29	7	11	-	-	ADJ
gsrj-29	7	12	state	state	ADJ
gsrj-29	7	13	actors	actor	NOUN
gsrj-29	7	14	maliciously	maliciously	ADV
gsrj-29	7	15	using	use	VERB
gsrj-29	7	16	crispr	crispr	NOUN
gsrj-29	7	17	to	to	PART
gsrj-29	7	18	engender	engender	VERB
gsrj-29	7	19	a	a	DET
gsrj-29	7	20	biological	biological	ADJ
gsrj-29	7	21	event	event	NOUN
gsrj-29	7	22	while	while	SCONJ
gsrj-29	7	23	“	"	PUNCT
gsrj-29	7	24	defender	defender	NOUN
gsrj-29	7	25	”	"	PUNCT
gsrj-29	7	26	refers	refer	VERB
gsrj-29	7	27	to	to	ADP
gsrj-29	7	28	coordinated	coordinate	VERB
gsrj-29	7	29	entities	entity	NOUN
gsrj-29	7	30	responding	respond	VERB
gsrj-29	7	31	to	to	ADP
gsrj-29	7	32	biological	biological	ADJ
gsrj-29	7	33	events	event	NOUN
gsrj-29	7	34	,	,	PUNCT
gsrj-29	7	35	whether	whether	SCONJ
gsrj-29	7	36	natural	natural	ADJ
gsrj-29	7	37	or	or	CCONJ
gsrj-29	7	38	deliberate	deliberate	ADJ
gsrj-29	7	39	.	.	PUNCT
gsrj-29	8	1	in	in	ADP
gsrj-29	8	2	the	the	DET
gsrj-29	8	3	shortto	shortto	ADJ
gsrj-29	8	4	mid	mid	PROPN
gsrj-29	8	5	-	-	NOUN
gsrj-29	8	6	term	term	NOUN
gsrj-29	8	7	,	,	PUNCT
gsrj-29	8	8	the	the	DET
gsrj-29	8	9	use	use	NOUN
gsrj-29	8	10	of	of	ADP
gsrj-29	8	11	crispr	crispr	ADJ
gsrj-29	8	12	-	-	PUNCT
gsrj-29	8	13	cas	cas	NOUN
gsrj-29	8	14	systems	system	NOUN
gsrj-29	8	15	in	in	ADP
gsrj-29	8	16	designing	design	VERB
gsrj-29	8	17	a	a	DET
gsrj-29	8	18	countermeasure	countermeasure	NOUN
gsrj-29	8	19	against	against	ADP
gsrj-29	8	20	a	a	DET
gsrj-29	8	21	biological	biological	ADJ
gsrj-29	8	22	event	event	NOUN
gsrj-29	8	23	is	be	AUX
gsrj-29	8	24	to	to	ADP
gsrj-29	8	25	the	the	DET
gsrj-29	8	26	advantage	advantage	NOUN
gsrj-29	8	27	of	of	ADP
gsrj-29	8	28	the	the	DET
gsrj-29	8	29	defender	defender	NOUN
gsrj-29	8	30	.	.	PUNCT
gsrj-29	9	1	crispr	crispr	PROPN
gsrj-29	9	2	offers	offer	VERB
gsrj-29	9	3	more	more	ADV
gsrj-29	9	4	accessible	accessible	ADJ
gsrj-29	9	5	,	,	PUNCT
gsrj-29	9	6	rapid	rapid	ADJ
gsrj-29	9	7	,	,	PUNCT
gsrj-29	9	8	and	and	CCONJ
gsrj-29	9	9	convenient	convenient	ADJ
gsrj-29	9	10	diagnostic	diagnostic	ADJ
gsrj-29	9	11	testing	testing	NOUN
gsrj-29	9	12	;	;	PUNCT
gsrj-29	9	13	a	a	DET
gsrj-29	9	14	quick	quick	ADJ
gsrj-29	9	15	and	and	CCONJ
gsrj-29	9	16	accurate	accurate	ADJ
gsrj-29	9	17	platform	platform	NOUN
gsrj-29	9	18	to	to	PART
gsrj-29	9	19	identify	identify	VERB
gsrj-29	9	20	viral	viral	ADJ
gsrj-29	9	21	vectors	vector	NOUN
gsrj-29	9	22	;	;	PUNCT
gsrj-29	9	23	and	and	CCONJ
gsrj-29	9	24	the	the	DET
gsrj-29	9	25	potential	potential	NOUN
gsrj-29	9	26	for	for	ADP
gsrj-29	9	27	antiviral	antiviral	ADJ
gsrj-29	9	28	therapy	therapy	NOUN
gsrj-29	9	29	.	.	PUNCT
gsrj-29	10	1	through	through	ADP
gsrj-29	10	2	enactment	enactment	NOUN
gsrj-29	10	3	of	of	ADP
gsrj-29	10	4	certain	certain	ADJ
gsrj-29	10	5	policy	policy	NOUN
gsrj-29	10	6	configurations	configuration	NOUN
gsrj-29	10	7	,	,	PUNCT
gsrj-29	10	8	the	the	DET
gsrj-29	10	9	comparative	comparative	ADJ
gsrj-29	10	10	advantage	advantage	NOUN
gsrj-29	10	11	of	of	ADP
gsrj-29	10	12	crispr	crispr	NOUN
gsrj-29	10	13	may	may	AUX
gsrj-29	10	14	decisively	decisively	ADV
gsrj-29	10	15	shift	shift	VERB
gsrj-29	10	16	to	to	ADP
gsrj-29	10	17	the	the	DET
gsrj-29	10	18	defender	defender	NOUN
gsrj-29	10	19	,	,	PUNCT
gsrj-29	10	20	including	include	VERB
gsrj-29	10	21	in	in	ADP
gsrj-29	10	22	the	the	DET
gsrj-29	10	23	very	very	ADV
gsrj-29	10	24	short	short	ADJ
gsrj-29	10	25	-	-	PUNCT
gsrj-29	10	26	term	term	NOUN
gsrj-29	10	27	.	.	PUNCT
gsrj-29	11	1	keywords	keyword	NOUN
gsrj-29	11	2	:	:	PUNCT
gsrj-29	11	3	covid-19	covid-19	PROPN
gsrj-29	11	4	,	,	PUNCT
gsrj-29	11	5	crispr	crispr	ADJ
gsrj-29	11	6	,	,	PUNCT
gsrj-29	11	7	biosecurity	biosecurity	NOUN
gsrj-29	11	8	,	,	PUNCT
gsrj-29	11	9	dual	dual	ADJ
gsrj-29	11	10	-	-	PUNCT
gsrj-29	11	11	use	use	NOUN
gsrj-29	11	12	risk	risk	NOUN
gsrj-29	11	13	technology	technology	NOUN
gsrj-29	11	14	1	1	NUM
gsrj-29	11	15	.	.	PUNCT
gsrj-29	11	16	introduction	introduction	NOUN
gsrj-29	11	17	in	in	ADP
gsrj-29	11	18	december	december	PROPN
gsrj-29	11	19	of	of	ADP
gsrj-29	11	20	2019	2019	NUM
gsrj-29	11	21	,	,	PUNCT
gsrj-29	11	22	a	a	DET
gsrj-29	11	23	novel	novel	ADJ
gsrj-29	11	24	coronavirus	coronavirus	NOUN
gsrj-29	11	25	,	,	PUNCT
gsrj-29	11	26	now	now	ADV
gsrj-29	11	27	known	know	VERB
gsrj-29	11	28	as	as	ADP
gsrj-29	11	29	sars	sar	NOUN
gsrj-29	11	30	-	-	PUNCT
gsrj-29	11	31	cov-2	cov-2	NOUN
gsrj-29	11	32	,	,	PUNCT
gsrj-29	11	33	was	be	AUX
gsrj-29	11	34	identified	identify	VERB
gsrj-29	11	35	in	in	ADP
gsrj-29	11	36	wuhan	wuhan	PROPN
gsrj-29	11	37	,	,	PUNCT
gsrj-29	11	38	china.1	china.1	NOUN
gsrj-29	11	39	the	the	DET
gsrj-29	11	40	disease	disease	NOUN
gsrj-29	11	41	caused	cause	VERB
gsrj-29	11	42	by	by	ADP
gsrj-29	11	43	this	this	DET
gsrj-29	11	44	virus	virus	NOUN
gsrj-29	11	45	–	–	PUNCT
gsrj-29	11	46	coronavirus	coronavirus	NOUN
gsrj-29	11	47	disease	disease	NOUN
gsrj-29	11	48	19	19	NUM
gsrj-29	11	49	(	(	PUNCT
gsrj-29	11	50	covid-19	covid-19	PROPN
gsrj-29	11	51	)	)	PUNCT
gsrj-29	11	52	–	–	PUNCT
gsrj-29	11	53	spread	spread	VERB
gsrj-29	11	54	throughout	throughout	ADP
gsrj-29	11	55	the	the	DET
gsrj-29	11	56	world	world	NOUN
gsrj-29	11	57	and	and	CCONJ
gsrj-29	11	58	was	be	AUX
gsrj-29	11	59	eventually	eventually	ADV
gsrj-29	11	60	characterized	characterize	VERB
gsrj-29	11	61	as	as	ADP
gsrj-29	11	62	a	a	DET
gsrj-29	11	63	pandemic	pandemic	NOUN
gsrj-29	11	64	by	by	ADP
gsrj-29	11	65	the	the	DET
gsrj-29	11	66	world	world	PROPN
gsrj-29	11	67	health	health	PROPN
gsrj-29	11	68	organization	organization	NOUN
gsrj-29	11	69	(	(	PUNCT
gsrj-29	11	70	who).2	who).2	PROPN
gsrj-29	11	71	from	from	ADP
gsrj-29	11	72	the	the	DET
gsrj-29	11	73	first	first	ADJ
gsrj-29	11	74	cases	case	NOUN
gsrj-29	11	75	in	in	ADP
gsrj-29	11	76	china	china	PROPN
gsrj-29	11	77	to	to	ADP
gsrj-29	11	78	the	the	DET
gsrj-29	11	79	ongoing	ongoing	ADJ
gsrj-29	11	80	pandemic	pandemic	NOUN
gsrj-29	11	81	,	,	PUNCT
gsrj-29	11	82	covid-19	covid-19	PROPN
gsrj-29	11	83	has	have	AUX
gsrj-29	11	84	presented	present	VERB
gsrj-29	11	85	major	major	ADJ
gsrj-29	11	86	challenges	challenge	NOUN
gsrj-29	11	87	to	to	ADP
gsrj-29	11	88	economies	economy	NOUN
gsrj-29	11	89	,	,	PUNCT
gsrj-29	11	90	governments	government	NOUN
gsrj-29	11	91	,	,	PUNCT
gsrj-29	11	92	health	health	NOUN
gsrj-29	11	93	systems	system	NOUN
gsrj-29	11	94	,	,	PUNCT
gsrj-29	11	95	and	and	CCONJ
gsrj-29	11	96	communities	community	NOUN
gsrj-29	11	97	everywhere	everywhere	ADV
gsrj-29	11	98	.	.	PUNCT
gsrj-29	12	1	as	as	ADP
gsrj-29	12	2	of	of	ADP
gsrj-29	12	3	august	august	PROPN
gsrj-29	12	4	20th	20th	NOUN
gsrj-29	12	5	,	,	PUNCT
gsrj-29	12	6	2021	2021	NUM
gsrj-29	12	7	,	,	PUNCT
gsrj-29	12	8	over	over	ADP
gsrj-29	12	9	200,000,000	200,000,000	NUM
gsrj-29	12	10	cases	case	NOUN
gsrj-29	12	11	have	have	AUX
gsrj-29	12	12	been	be	AUX
gsrj-29	12	13	reported	report	VERB
gsrj-29	12	14	and	and	CCONJ
gsrj-29	12	15	4,300,000	4,300,000	NUM
gsrj-29	12	16	deaths	death	NOUN
gsrj-29	12	17	have	have	AUX
gsrj-29	12	18	been	be	AUX
gsrj-29	12	19	attributed	attribute	VERB
gsrj-29	12	20	to	to	ADP
gsrj-29	12	21	covid19	covid19	NOUN
gsrj-29	12	22	,	,	PUNCT
gsrj-29	12	23	according	accord	VERB
gsrj-29	12	24	to	to	ADP
gsrj-29	12	25	the	the	DET
gsrj-29	12	26	who.3	who.3	NOUN
gsrj-29	12	27	on	on	ADP
gsrj-29	12	28	december	december	PROPN
gsrj-29	12	29	2	2	NUM
gsrj-29	12	30	,	,	PUNCT
gsrj-29	12	31	2020	2020	NUM
gsrj-29	12	32	,	,	PUNCT
gsrj-29	12	33	the	the	DET
gsrj-29	12	34	first	first	ADJ
gsrj-29	12	35	fully	fully	ADV
gsrj-29	12	36	tested	test	VERB
gsrj-29	12	37	immunization	immunization	NOUN
gsrj-29	12	38	was	be	AUX
gsrj-29	12	39	approved	approve	VERB
gsrj-29	12	40	for	for	SCONJ
gsrj-29	12	41	use.4	use.4	ADJ
gsrj-29	12	42	various	various	ADJ
gsrj-29	12	43	other	other	ADJ
gsrj-29	12	44	tested	test	VERB
gsrj-29	12	45	immunizations	immunization	NOUN
gsrj-29	12	46	were	be	AUX
gsrj-29	12	47	approved	approve	VERB
gsrj-29	12	48	across	across	ADP
gsrj-29	12	49	the	the	DET
gsrj-29	12	50	globe	globe	NOUN
gsrj-29	12	51	shortly	shortly	ADV
gsrj-29	12	52	after	after	ADV
gsrj-29	12	53	.	.	PUNCT
gsrj-29	13	1	at	at	ADP
gsrj-29	13	2	this	this	DET
gsrj-29	13	3	time	time	NOUN
gsrj-29	13	4	,	,	PUNCT
gsrj-29	13	5	around	around	ADP
gsrj-29	13	6	4,850,000,000	4,850,000,000	NUM
gsrj-29	13	7	vaccines	vaccine	NOUN
gsrj-29	13	8	have	have	AUX
gsrj-29	13	9	been	be	AUX
gsrj-29	13	10	administered	administer	VERB
gsrj-29	13	11	,	,	PUNCT
gsrj-29	13	12	25	25	NUM
gsrj-29	13	13	georgetown	georgetown	PROPN
gsrj-29	13	14	scientific	scientific	PROPN
gsrj-29	13	15	research	research	NOUN
gsrj-29	13	16	journal	journal	NOUN
gsrj-29	13	17	according	accord	VERB
gsrj-29	13	18	to	to	ADP
gsrj-29	13	19	the	the	DET
gsrj-29	13	20	center	center	NOUN
gsrj-29	13	21	for	for	ADP
gsrj-29	13	22	systems	system	NOUN
gsrj-29	13	23	science	science	NOUN
gsrj-29	13	24	and	and	CCONJ
gsrj-29	13	25	engineering	engineering	NOUN
gsrj-29	13	26	(	(	PUNCT
gsrj-29	13	27	csse	csse	NOUN
gsrj-29	13	28	)	)	PUNCT
gsrj-29	13	29	at	at	ADP
gsrj-29	13	30	johns	johns	PROPN
gsrj-29	13	31	hopkins	hopkins	PROPN
gsrj-29	13	32	university.5	university.5	PROPN
gsrj-29	13	33	however	however	ADV
gsrj-29	13	34	,	,	PUNCT
gsrj-29	13	35	waves	wave	NOUN
gsrj-29	13	36	of	of	ADP
gsrj-29	13	37	covid-19	covid-19	PROPN
gsrj-29	13	38	cases	case	NOUN
gsrj-29	13	39	continue	continue	VERB
gsrj-29	13	40	to	to	PART
gsrj-29	13	41	rise	rise	VERB
gsrj-29	13	42	in	in	ADP
gsrj-29	13	43	several	several	ADJ
gsrj-29	13	44	countries	country	NOUN
gsrj-29	13	45	,	,	PUNCT
gsrj-29	13	46	especially	especially	ADV
gsrj-29	13	47	due	due	ADJ
gsrj-29	13	48	to	to	ADP
gsrj-29	13	49	highly	highly	ADV
gsrj-29	13	50	transmissible	transmissible	ADJ
gsrj-29	13	51	variants	variant	NOUN
gsrj-29	13	52	and	and	CCONJ
gsrj-29	13	53	insufficient	insufficient	ADJ
gsrj-29	13	54	population	population	NOUN
gsrj-29	13	55	immunity.6	immunity.6	PROPN
gsrj-29	13	56	,	,	PUNCT
gsrj-29	13	57	7	7	NUM
gsrj-29	13	58	furthermore	furthermore	ADV
gsrj-29	13	59	,	,	PUNCT
gsrj-29	13	60	due	due	ADP
gsrj-29	13	61	to	to	ADP
gsrj-29	13	62	an	an	DET
gsrj-29	13	63	immense	immense	ADJ
gsrj-29	13	64	scope	scope	NOUN
gsrj-29	13	65	of	of	ADP
gsrj-29	13	66	global	global	ADJ
gsrj-29	13	67	vaccine	vaccine	NOUN
gsrj-29	13	68	inequity	inequity	NOUN
gsrj-29	13	69	,	,	PUNCT
gsrj-29	13	70	a	a	DET
gsrj-29	13	71	majority	majority	NOUN
gsrj-29	13	72	of	of	ADP
gsrj-29	13	73	lowand	lowand	ADJ
gsrj-29	13	74	lower	lower	ADV
gsrj-29	13	75	-	-	PUNCT
gsrj-29	13	76	middle	middle	ADJ
gsrj-29	13	77	-	-	PUNCT
gsrj-29	13	78	income	income	NOUN
gsrj-29	13	79	countries	country	NOUN
gsrj-29	13	80	may	may	AUX
gsrj-29	13	81	continue	continue	VERB
gsrj-29	13	82	to	to	PART
gsrj-29	13	83	experience	experience	VERB
gsrj-29	13	84	surges	surge	NOUN
gsrj-29	13	85	in	in	ADP
gsrj-29	13	86	covid-19	covid-19	PROPN
gsrj-29	13	87	cases	case	NOUN
gsrj-29	13	88	for	for	ADP
gsrj-29	13	89	years	year	NOUN
gsrj-29	13	90	to	to	PART
gsrj-29	13	91	come.8	come.8	VERB
gsrj-29	13	92	these	these	DET
gsrj-29	13	93	facts	fact	NOUN
gsrj-29	13	94	drive	drive	VERB
gsrj-29	13	95	continued	continue	VERB
gsrj-29	13	96	public	public	ADJ
gsrj-29	13	97	health	health	NOUN
gsrj-29	13	98	measures	measure	NOUN
gsrj-29	13	99	for	for	ADP
gsrj-29	13	100	countries	country	NOUN
gsrj-29	13	101	,	,	PUNCT
gsrj-29	13	102	as	as	SCONJ
gsrj-29	13	103	they	they	PRON
gsrj-29	13	104	denote	denote	VERB
gsrj-29	13	105	that	that	SCONJ
gsrj-29	13	106	the	the	DET
gsrj-29	13	107	covid-19	covid-19	PROPN
gsrj-29	13	108	pandemic	pandemic	NOUN
gsrj-29	13	109	is	be	AUX
gsrj-29	13	110	not	not	PART
gsrj-29	13	111	over	over	ADV
gsrj-29	13	112	.	.	PUNCT
gsrj-29	14	1	the	the	DET
gsrj-29	14	2	imperative	imperative	NOUN
gsrj-29	14	3	to	to	PART
gsrj-29	14	4	constrain	constrain	VERB
gsrj-29	14	5	this	this	DET
gsrj-29	14	6	virus	virus	NOUN
gsrj-29	14	7	motivated	motivated	ADJ
gsrj-29	14	8	countries	country	NOUN
gsrj-29	14	9	to	to	PART
gsrj-29	14	10	take	take	VERB
gsrj-29	14	11	innovative	innovative	ADJ
gsrj-29	14	12	defense	defense	NOUN
gsrj-29	14	13	measures	measure	NOUN
gsrj-29	14	14	against	against	ADP
gsrj-29	14	15	covid-19	covid-19	PROPN
gsrj-29	14	16	.	.	PUNCT
gsrj-29	15	1	among	among	ADP
gsrj-29	15	2	these	these	DET
gsrj-29	15	3	innovative	innovative	ADJ
gsrj-29	15	4	applications	application	NOUN
gsrj-29	15	5	was	be	AUX
gsrj-29	15	6	a	a	DET
gsrj-29	15	7	gene	gene	NOUN
gsrj-29	15	8	editing	edit	VERB
gsrj-29	15	9	technology	technology	NOUN
gsrj-29	15	10	that	that	PRON
gsrj-29	15	11	was	be	AUX
gsrj-29	15	12	discovered	discover	VERB
gsrj-29	15	13	in	in	ADP
gsrj-29	15	14	the	the	DET
gsrj-29	15	15	2010s	2010s	NUM
gsrj-29	15	16	and	and	CCONJ
gsrj-29	15	17	is	be	AUX
gsrj-29	15	18	based	base	VERB
gsrj-29	15	19	on	on	ADP
gsrj-29	15	20	natural	natural	ADJ
gsrj-29	15	21	bacterial	bacterial	ADJ
gsrj-29	15	22	immune	immune	ADJ
gsrj-29	15	23	mechanisms	mechanism	NOUN
gsrj-29	15	24	against	against	ADP
gsrj-29	15	25	viruses	virus	NOUN
gsrj-29	15	26	called	call	VERB
gsrj-29	15	27	crispr	crispr	NOUN
gsrj-29	15	28	-	-	PUNCT
gsrj-29	15	29	cas	cas	NOUN
gsrj-29	15	30	systems.9	systems.9	PROPN
gsrj-29	15	31	the	the	DET
gsrj-29	15	32	systems	system	NOUN
gsrj-29	15	33	are	be	AUX
gsrj-29	15	34	composed	compose	VERB
gsrj-29	15	35	of	of	ADP
gsrj-29	15	36	two	two	NUM
gsrj-29	15	37	components	component	NOUN
gsrj-29	15	38	:	:	PUNCT
gsrj-29	15	39	a	a	DET
gsrj-29	15	40	guide	guide	NOUN
gsrj-29	15	41	rna	rna	NOUN
gsrj-29	15	42	that	that	PRON
gsrj-29	15	43	identifies	identify	VERB
gsrj-29	15	44	a	a	DET
gsrj-29	15	45	target	target	NOUN
gsrj-29	15	46	gene	gene	NOUN
gsrj-29	15	47	and	and	CCONJ
gsrj-29	15	48	a	a	DET
gsrj-29	15	49	crisprassociated	crisprassociate	VERB
gsrj-29	15	50	protein	protein	NOUN
gsrj-29	15	51	that	that	PRON
gsrj-29	15	52	can	can	AUX
gsrj-29	15	53	cut	cut	VERB
gsrj-29	15	54	double	double	ADJ
gsrj-29	15	55	stranded	strand	VERB
gsrj-29	15	56	dna	dna	NOUN
gsrj-29	15	57	,	,	PUNCT
gsrj-29	15	58	allowing	allow	VERB
gsrj-29	15	59	for	for	ADP
gsrj-29	15	60	site	site	NOUN
gsrj-29	15	61	-	-	PUNCT
gsrj-29	15	62	specific	specific	ADJ
gsrj-29	15	63	genome	genome	NOUN
gsrj-29	15	64	modification	modification	NOUN
gsrj-29	15	65	that	that	PRON
gsrj-29	15	66	is	be	AUX
gsrj-29	15	67	quick	quick	ADJ
gsrj-29	15	68	,	,	PUNCT
gsrj-29	15	69	cheap	cheap	ADJ
gsrj-29	15	70	,	,	PUNCT
gsrj-29	15	71	and	and	CCONJ
gsrj-29	15	72	relatively	relatively	ADV
gsrj-29	15	73	user	user	NOUN
gsrj-29	15	74	-	-	PUNCT
gsrj-29	15	75	friendly.10	friendly.10	NOUN
gsrj-29	15	76	researchers	researcher	NOUN
gsrj-29	15	77	are	be	AUX
gsrj-29	15	78	now	now	ADV
gsrj-29	15	79	faced	face	VERB
gsrj-29	15	80	with	with	ADP
gsrj-29	15	81	deciding	decide	VERB
gsrj-29	15	82	how	how	SCONJ
gsrj-29	15	83	best	good	ADJ
gsrj-29	15	84	to	to	PART
gsrj-29	15	85	optimize	optimize	VERB
gsrj-29	15	86	the	the	DET
gsrj-29	15	87	system	system	NOUN
gsrj-29	15	88	for	for	ADP
gsrj-29	15	89	human	human	ADJ
gsrj-29	15	90	applications	application	NOUN
gsrj-29	15	91	,	,	PUNCT
gsrj-29	15	92	and	and	CCONJ
gsrj-29	15	93	the	the	DET
gsrj-29	15	94	covid-19	covid-19	PROPN
gsrj-29	15	95	pandemic	pandemic	NOUN
gsrj-29	15	96	presented	present	VERB
gsrj-29	15	97	a	a	DET
gsrj-29	15	98	myriad	myriad	NOUN
gsrj-29	15	99	of	of	ADP
gsrj-29	15	100	pressing	press	VERB
gsrj-29	15	101	public	public	ADJ
gsrj-29	15	102	health	health	NOUN
gsrj-29	15	103	challenges	challenge	NOUN
gsrj-29	15	104	that	that	PRON
gsrj-29	15	105	crispr	crispr	NOUN
gsrj-29	15	106	could	could	AUX
gsrj-29	15	107	help	help	VERB
gsrj-29	15	108	mitigate	mitigate	VERB
gsrj-29	15	109	.	.	PUNCT
gsrj-29	16	1	simultaneously	simultaneously	ADV
gsrj-29	16	2	,	,	PUNCT
gsrj-29	16	3	crispr	crispr	ADJ
gsrj-29	16	4	gene	gene	NOUN
gsrj-29	16	5	editing	edit	VERB
gsrj-29	16	6	technology	technology	NOUN
gsrj-29	16	7	has	have	VERB
gsrj-29	16	8	the	the	DET
gsrj-29	16	9	potential	potential	NOUN
gsrj-29	16	10	to	to	PART
gsrj-29	16	11	be	be	AUX
gsrj-29	16	12	abused	abuse	VERB
gsrj-29	16	13	for	for	ADP
gsrj-29	16	14	malicious	malicious	ADJ
gsrj-29	16	15	applications	application	NOUN
gsrj-29	16	16	to	to	ADP
gsrj-29	16	17	the	the	DET
gsrj-29	16	18	opposite	opposite	ADJ
gsrj-29	16	19	effect	effect	NOUN
gsrj-29	16	20	of	of	ADP
gsrj-29	16	21	aiding	aid	VERB
gsrj-29	16	22	public	public	ADJ
gsrj-29	16	23	health	health	NOUN
gsrj-29	16	24	responses	response	NOUN
gsrj-29	16	25	.	.	PUNCT
gsrj-29	17	1	specifically	specifically	ADV
gsrj-29	17	2	,	,	PUNCT
gsrj-29	17	3	crispr	crispr	PROPN
gsrj-29	17	4	is	be	AUX
gsrj-29	17	5	often	often	ADV
gsrj-29	17	6	touted	tout	VERB
gsrj-29	17	7	for	for	ADP
gsrj-29	17	8	its	its	PRON
gsrj-29	17	9	comparative	comparative	ADJ
gsrj-29	17	10	ease	ease	NOUN
gsrj-29	17	11	of	of	ADP
gsrj-29	17	12	use	use	NOUN
gsrj-29	17	13	and	and	CCONJ
gsrj-29	17	14	efficiency	efficiency	NOUN
gsrj-29	17	15	in	in	ADP
gsrj-29	17	16	editing	edit	VERB
gsrj-29	17	17	genes,11	genes,11	NOUN
gsrj-29	17	18	which	which	PRON
gsrj-29	17	19	could	could	AUX
gsrj-29	17	20	present	present	VERB
gsrj-29	17	21	the	the	DET
gsrj-29	17	22	opportunity	opportunity	NOUN
gsrj-29	17	23	for	for	ADP
gsrj-29	17	24	malicious	malicious	ADJ
gsrj-29	17	25	attackers	attacker	NOUN
gsrj-29	17	26	to	to	PART
gsrj-29	17	27	genetically	genetically	ADV
gsrj-29	17	28	engineer	engineer	VERB
gsrj-29	17	29	pathogens	pathogen	NOUN
gsrj-29	17	30	into	into	ADP
gsrj-29	17	31	a	a	DET
gsrj-29	17	32	biological	biological	ADJ
gsrj-29	17	33	weapon	weapon	NOUN
gsrj-29	17	34	.	.	PUNCT
gsrj-29	18	1	as	as	SCONJ
gsrj-29	18	2	crispr	crispr	ADJ
gsrj-29	18	3	reduces	reduce	VERB
gsrj-29	18	4	barriers	barrier	NOUN
gsrj-29	18	5	of	of	ADP
gsrj-29	18	6	entry	entry	NOUN
gsrj-29	18	7	due	due	ADP
gsrj-29	18	8	to	to	ADP
gsrj-29	18	9	its	its	PRON
gsrj-29	18	10	low	low	ADJ
gsrj-29	18	11	cost	cost	NOUN
gsrj-29	18	12	and	and	CCONJ
gsrj-29	18	13	ease	ease	NOUN
gsrj-29	18	14	of	of	ADP
gsrj-29	18	15	use	use	NOUN
gsrj-29	18	16	,	,	PUNCT
gsrj-29	18	17	more	more	ADJ
gsrj-29	18	18	attackers	attacker	NOUN
gsrj-29	18	19	could	could	AUX
gsrj-29	18	20	use	use	VERB
gsrj-29	18	21	crispr	crispr	NOUN
gsrj-29	18	22	to	to	PART
gsrj-29	18	23	cause	cause	VERB
gsrj-29	18	24	a	a	DET
gsrj-29	18	25	deliberate	deliberate	ADJ
gsrj-29	18	26	biological	biological	ADJ
gsrj-29	18	27	event	event	NOUN
gsrj-29	18	28	(	(	PUNCT
gsrj-29	18	29	dbe	dbe	PROPN
gsrj-29	18	30	)	)	PUNCT
gsrj-29	18	31	.	.	PUNCT
gsrj-29	19	1	this	this	DET
gsrj-29	19	2	report	report	NOUN
gsrj-29	19	3	will	will	AUX
gsrj-29	19	4	analyze	analyze	VERB
gsrj-29	19	5	the	the	DET
gsrj-29	19	6	advantages	advantage	NOUN
gsrj-29	19	7	crispr	crispr	NOUN
gsrj-29	19	8	holds	hold	VERB
gsrj-29	19	9	for	for	ADP
gsrj-29	19	10	the	the	DET
gsrj-29	19	11	attacker	attacker	NOUN
gsrj-29	19	12	and	and	CCONJ
gsrj-29	19	13	defender	defender	NOUN
gsrj-29	19	14	,	,	PUNCT
gsrj-29	19	15	as	as	ADV
gsrj-29	19	16	well	well	ADV
gsrj-29	19	17	as	as	ADP
gsrj-29	19	18	how	how	SCONJ
gsrj-29	19	19	the	the	DET
gsrj-29	19	20	technology	technology	NOUN
gsrj-29	19	21	can	can	AUX
gsrj-29	19	22	be	be	AUX
gsrj-29	19	23	leveraged	leverage	VERB
gsrj-29	19	24	to	to	PART
gsrj-29	19	25	configure	configure	VERB
gsrj-29	19	26	a	a	DET
gsrj-29	19	27	countermeasure	countermeasure	NOUN
gsrj-29	19	28	against	against	ADP
gsrj-29	19	29	biological	biological	ADJ
gsrj-29	19	30	events	event	NOUN
gsrj-29	19	31	to	to	PART
gsrj-29	19	32	enhance	enhance	VERB
gsrj-29	19	33	global	global	ADJ
gsrj-29	19	34	biopreparedness	biopreparedness	NOUN
gsrj-29	19	35	.	.	PUNCT
gsrj-29	20	1	utilizing	utilize	VERB
gsrj-29	20	2	crispr	crispr	NOUN
gsrj-29	20	3	during	during	ADP
gsrj-29	20	4	the	the	DET
gsrj-29	20	5	covid-19	covid-19	PROPN
gsrj-29	20	6	pandemic	pandemic	NOUN
gsrj-29	20	7	represents	represent	VERB
gsrj-29	20	8	expanded	expand	VERB
gsrj-29	20	9	use	use	NOUN
gsrj-29	20	10	of	of	ADP
gsrj-29	20	11	a	a	DET
gsrj-29	20	12	novel	novel	ADJ
gsrj-29	20	13	technology	technology	NOUN
gsrj-29	20	14	for	for	ADP
gsrj-29	20	15	a	a	DET
gsrj-29	20	16	public	public	ADJ
gsrj-29	20	17	health	health	NOUN
gsrj-29	20	18	crisis	crisis	NOUN
gsrj-29	20	19	.	.	PUNCT
gsrj-29	21	1	this	this	DET
gsrj-29	21	2	report	report	NOUN
gsrj-29	21	3	will	will	AUX
gsrj-29	21	4	begin	begin	VERB
gsrj-29	21	5	by	by	ADP
gsrj-29	21	6	examining	examine	VERB
gsrj-29	21	7	the	the	DET
gsrj-29	21	8	risk	risk	NOUN
gsrj-29	21	9	factors	factor	NOUN
gsrj-29	21	10	that	that	SCONJ
gsrj-29	21	11	malicious	malicious	ADJ
gsrj-29	21	12	non	non	ADJ
gsrj-29	21	13	-	-	ADJ
gsrj-29	21	14	state	state	ADJ
gsrj-29	21	15	attackers	attacker	NOUN
gsrj-29	21	16	utilizing	utilize	VERB
gsrj-29	21	17	crispr	crispr	ADJ
gsrj-29	21	18	and	and	CCONJ
gsrj-29	21	19	other	other	ADJ
gsrj-29	21	20	developing	develop	VERB
gsrj-29	21	21	phenomena	phenomenon	NOUN
gsrj-29	21	22	pose	pose	VERB
gsrj-29	21	23	for	for	ADP
gsrj-29	21	24	the	the	DET
gsrj-29	21	25	strategic	strategic	ADJ
gsrj-29	21	26	environment	environment	NOUN
gsrj-29	21	27	.	.	PUNCT
gsrj-29	22	1	the	the	DET
gsrj-29	22	2	report	report	NOUN
gsrj-29	22	3	will	will	AUX
gsrj-29	22	4	then	then	ADV
gsrj-29	22	5	move	move	VERB
gsrj-29	22	6	to	to	ADP
gsrj-29	22	7	the	the	DET
gsrj-29	22	8	application	application	NOUN
gsrj-29	22	9	of	of	ADP
gsrj-29	22	10	crispr	crispr	NOUN
gsrj-29	22	11	from	from	ADP
gsrj-29	22	12	three	three	NUM
gsrj-29	22	13	principal	principal	ADJ
gsrj-29	22	14	areas	area	NOUN
gsrj-29	22	15	:	:	PUNCT
gsrj-29	22	16	covid-19	covid-19	PROPN
gsrj-29	22	17	diagnostic	diagnostic	ADJ
gsrj-29	22	18	tests	test	NOUN
gsrj-29	22	19	,	,	PUNCT
gsrj-29	22	20	pathogenic	pathogenic	ADJ
gsrj-29	22	21	research	research	NOUN
gsrj-29	22	22	,	,	PUNCT
gsrj-29	22	23	and	and	CCONJ
gsrj-29	22	24	the	the	DET
gsrj-29	22	25	potential	potential	NOUN
gsrj-29	22	26	of	of	ADP
gsrj-29	22	27	antiviral	antiviral	ADJ
gsrj-29	22	28	therapy	therapy	NOUN
gsrj-29	22	29	.	.	PUNCT
gsrj-29	23	1	finally	finally	ADV
gsrj-29	23	2	,	,	PUNCT
gsrj-29	23	3	the	the	DET
gsrj-29	23	4	report	report	NOUN
gsrj-29	23	5	will	will	AUX
gsrj-29	23	6	draw	draw	VERB
gsrj-29	23	7	conclusions	conclusion	NOUN
gsrj-29	23	8	pertaining	pertain	VERB
gsrj-29	23	9	to	to	ADP
gsrj-29	23	10	the	the	DET
gsrj-29	23	11	global	global	ADJ
gsrj-29	23	12	health	health	PROPN
gsrj-29	23	13	strategic	strategic	ADJ
gsrj-29	23	14	environment	environment	NOUN
gsrj-29	23	15	and	and	CCONJ
gsrj-29	23	16	recommend	recommend	VERB
gsrj-29	23	17	policy	policy	NOUN
gsrj-29	23	18	to	to	PART
gsrj-29	23	19	bolster	bolster	VERB
gsrj-29	23	20	global	global	ADJ
gsrj-29	23	21	biopreparedness	biopreparedness	NOUN
gsrj-29	23	22	.	.	PUNCT
gsrj-29	24	1	in	in	ADP
gsrj-29	24	2	this	this	DET
gsrj-29	24	3	report	report	NOUN
gsrj-29	24	4	,	,	PUNCT
gsrj-29	24	5	“	"	PUNCT
gsrj-29	24	6	non	non	ADJ
gsrj-29	24	7	-	-	ADJ
gsrj-29	24	8	state	state	ADJ
gsrj-29	24	9	malicious	malicious	ADJ
gsrj-29	24	10	attacker	attacker	NOUN
gsrj-29	24	11	”	"	PUNCT
gsrj-29	24	12	,	,	PUNCT
gsrj-29	24	13	or	or	CCONJ
gsrj-29	24	14	“	"	PUNCT
gsrj-29	24	15	attacker	attacker	NOUN
gsrj-29	24	16	”	"	PUNCT
gsrj-29	24	17	,	,	PUNCT
gsrj-29	24	18	refers	refer	VERB
gsrj-29	24	19	to	to	ADP
gsrj-29	24	20	rogue	rogue	ADJ
gsrj-29	24	21	groups	group	NOUN
gsrj-29	24	22	or	or	CCONJ
gsrj-29	24	23	individuals	individual	NOUN
gsrj-29	24	24	utilizing	utilize	VERB
gsrj-29	24	25	crispr	crispr	ADJ
gsrj-29	24	26	with	with	ADP
gsrj-29	24	27	malicious	malicious	ADJ
gsrj-29	24	28	intent	intent	NOUN
gsrj-29	24	29	to	to	PART
gsrj-29	24	30	engender	engender	VERB
gsrj-29	24	31	a	a	DET
gsrj-29	24	32	biological	biological	ADJ
gsrj-29	24	33	event	event	NOUN
gsrj-29	24	34	.	.	PUNCT
gsrj-29	25	1	the	the	DET
gsrj-29	25	2	term	term	NOUN
gsrj-29	25	3	“	"	PUNCT
gsrj-29	25	4	biological	biological	ADJ
gsrj-29	25	5	event	event	NOUN
gsrj-29	25	6	”	"	PUNCT
gsrj-29	25	7	refers	refer	VERB
gsrj-29	25	8	to	to	ADP
gsrj-29	25	9	an	an	DET
gsrj-29	25	10	outbreak	outbreak	NOUN
gsrj-29	25	11	of	of	ADP
gsrj-29	25	12	a	a	DET
gsrj-29	25	13	disease	disease	NOUN
gsrj-29	25	14	caused	cause	VERB
gsrj-29	25	15	by	by	ADP
gsrj-29	25	16	a	a	DET
gsrj-29	25	17	pathogen	pathogen	NOUN
gsrj-29	25	18	and	and	CCONJ
gsrj-29	25	19	can	can	AUX
gsrj-29	25	20	be	be	AUX
gsrj-29	25	21	naturally	naturally	ADV
gsrj-29	25	22	occurring	occur	VERB
gsrj-29	25	23	or	or	CCONJ
gsrj-29	25	24	deliberately	deliberately	ADV
gsrj-29	25	25	released.12	released.12	NOUN
gsrj-29	25	26	“	"	PUNCT
gsrj-29	25	27	defender	defender	NOUN
gsrj-29	25	28	”	"	PUNCT
gsrj-29	25	29	refers	refer	VERB
gsrj-29	25	30	to	to	ADP
gsrj-29	25	31	the	the	DET
gsrj-29	25	32	coordinated	coordinated	ADJ
gsrj-29	25	33	entities	entity	NOUN
gsrj-29	25	34	responding	respond	VERB
gsrj-29	25	35	to	to	ADP
gsrj-29	25	36	a	a	DET
gsrj-29	25	37	natural	natural	ADJ
gsrj-29	25	38	or	or	CCONJ
gsrj-29	25	39	deliberate	deliberate	ADJ
gsrj-29	25	40	biological	biological	ADJ
gsrj-29	25	41	event	event	NOUN
gsrj-29	25	42	,	,	PUNCT
gsrj-29	25	43	including	include	VERB
gsrj-29	25	44	,	,	PUNCT
gsrj-29	25	45	but	but	CCONJ
gsrj-29	25	46	not	not	PART
gsrj-29	25	47	limited	limit	VERB
gsrj-29	25	48	to	to	ADP
gsrj-29	25	49	,	,	PUNCT
gsrj-29	25	50	governments	government	NOUN
gsrj-29	25	51	,	,	PUNCT
gsrj-29	25	52	the	the	DET
gsrj-29	25	53	scientific	scientific	ADJ
gsrj-29	25	54	community	community	NOUN
gsrj-29	25	55	,	,	PUNCT
gsrj-29	25	56	institutions	institution	NOUN
gsrj-29	25	57	,	,	PUNCT
gsrj-29	25	58	and	and	CCONJ
gsrj-29	25	59	sectors	sector	NOUN
gsrj-29	25	60	.	.	PUNCT
gsrj-29	26	1	“	"	PUNCT
gsrj-29	26	2	biopreparedness	biopreparedness	NOUN
gsrj-29	26	3	”	"	PUNCT
gsrj-29	26	4	refers	refer	VERB
gsrj-29	26	5	to	to	ADP
gsrj-29	26	6	a	a	DET
gsrj-29	26	7	state	state	NOUN
gsrj-29	26	8	of	of	ADP
gsrj-29	26	9	readiness	readiness	NOUN
gsrj-29	26	10	a	a	DET
gsrj-29	26	11	defender	defender	NOUN
gsrj-29	26	12	builds	build	VERB
gsrj-29	26	13	for	for	ADP
gsrj-29	26	14	potential	potential	ADJ
gsrj-29	26	15	biological	biological	ADJ
gsrj-29	26	16	events.13	events.13	NOUN
gsrj-29	26	17	the	the	DET
gsrj-29	26	18	“	"	PUNCT
gsrj-29	26	19	strategic	strategic	ADJ
gsrj-29	26	20	environment	environment	NOUN
gsrj-29	26	21	”	"	PUNCT
gsrj-29	26	22	is	be	AUX
gsrj-29	26	23	defined	define	VERB
gsrj-29	26	24	as	as	ADP
gsrj-29	26	25	the	the	DET
gsrj-29	26	26	complex	complex	ADJ
gsrj-29	26	27	interaction	interaction	NOUN
gsrj-29	26	28	of	of	ADP
gsrj-29	26	29	entities	entity	NOUN
gsrj-29	26	30	such	such	ADJ
gsrj-29	26	31	as	as	ADP
gsrj-29	26	32	“	"	PUNCT
gsrj-29	26	33	attackers	attacker	NOUN
gsrj-29	26	34	”	"	PUNCT
gsrj-29	26	35	and	and	CCONJ
gsrj-29	26	36	“	"	PUNCT
gsrj-29	26	37	defenders	defender	NOUN
gsrj-29	26	38	”	"	PUNCT
gsrj-29	26	39	amid	amid	ADP
gsrj-29	26	40	dynamic	dynamic	ADJ
gsrj-29	26	41	and	and	CCONJ
gsrj-29	26	42	contradictory	contradictory	ADJ
gsrj-29	26	43	global	global	ADJ
gsrj-29	26	44	forces.14	forces.14	PROPN
gsrj-29	26	45	“	"	PUNCT
gsrj-29	26	46	pathogenic	pathogenic	ADJ
gsrj-29	26	47	surveillance	surveillance	NOUN
gsrj-29	26	48	regime	regime	NOUN
gsrj-29	26	49	”	"	PUNCT
gsrj-29	26	50	refers	refer	VERB
gsrj-29	26	51	to	to	ADP
gsrj-29	26	52	a	a	DET
gsrj-29	26	53	coordinated	coordinated	ADJ
gsrj-29	26	54	program	program	NOUN
gsrj-29	26	55	to	to	PART
gsrj-29	26	56	survey	survey	VERB
gsrj-29	26	57	and	and	CCONJ
gsrj-29	26	58	curtail	curtail	VERB
gsrj-29	26	59	the	the	DET
gsrj-29	26	60	infectious	infectious	ADJ
gsrj-29	26	61	progression	progression	NOUN
gsrj-29	26	62	of	of	ADP
gsrj-29	26	63	a	a	DET
gsrj-29	26	64	pathogen	pathogen	NOUN
gsrj-29	26	65	within	within	ADP
gsrj-29	26	66	a	a	DET
gsrj-29	26	67	society	society	NOUN
gsrj-29	26	68	,	,	PUNCT
gsrj-29	26	69	usually	usually	ADV
gsrj-29	26	70	directed	direct	VERB
gsrj-29	26	71	by	by	ADP
gsrj-29	26	72	a	a	DET
gsrj-29	26	73	government	government	NOUN
gsrj-29	26	74	.	.	PUNCT
gsrj-29	27	1	26	26	NUM
gsrj-29	27	2	georgetown	georgetown	PROPN
gsrj-29	27	3	scientific	scientific	PROPN
gsrj-29	27	4	research	research	NOUN
gsrj-29	27	5	journal	journal	NOUN
gsrj-29	27	6	2	2	NUM
gsrj-29	27	7	.	.	PUNCT
gsrj-29	28	1	anticipating	anticipate	VERB
gsrj-29	28	2	the	the	DET
gsrj-29	28	3	threat	threat	NOUN
gsrj-29	28	4	of	of	ADP
gsrj-29	28	5	crispr	crispr	ADJ
gsrj-29	28	6	engineered	engineer	VERB
gsrj-29	28	7	pathogens	pathogen	NOUN
gsrj-29	28	8	crispr	crispr	NOUN
gsrj-29	28	9	-	-	PUNCT
gsrj-29	28	10	cas	cas	NOUN
gsrj-29	28	11	systems	system	NOUN
gsrj-29	28	12	can	can	AUX
gsrj-29	28	13	be	be	AUX
gsrj-29	28	14	utilized	utilize	VERB
gsrj-29	28	15	to	to	PART
gsrj-29	28	16	delete	delete	VERB
gsrj-29	28	17	genetic	genetic	ADJ
gsrj-29	28	18	sequences	sequence	NOUN
gsrj-29	28	19	,	,	PUNCT
gsrj-29	28	20	add	add	VERB
gsrj-29	28	21	genetic	genetic	ADJ
gsrj-29	28	22	sequences	sequence	NOUN
gsrj-29	28	23	,	,	PUNCT
gsrj-29	28	24	regulate	regulate	VERB
gsrj-29	28	25	expression	expression	NOUN
gsrj-29	28	26	of	of	ADP
gsrj-29	28	27	a	a	DET
gsrj-29	28	28	phenotype	phenotype	NOUN
gsrj-29	28	29	,	,	PUNCT
gsrj-29	28	30	and	and	CCONJ
gsrj-29	28	31	even	even	ADV
gsrj-29	28	32	combine	combine	VERB
gsrj-29	28	33	genetic	genetic	ADJ
gsrj-29	28	34	sequences	sequence	NOUN
gsrj-29	28	35	to	to	PART
gsrj-29	28	36	produce	produce	VERB
gsrj-29	28	37	a	a	DET
gsrj-29	28	38	novel	novel	ADJ
gsrj-29	28	39	expression.15	expression.15	NOUN
gsrj-29	28	40	crispr	crispr	NOUN
gsrj-29	28	41	-	-	PUNCT
gsrj-29	28	42	cas	cas	NOUN
gsrj-29	28	43	systems	system	NOUN
gsrj-29	28	44	are	be	AUX
gsrj-29	28	45	democratized	democratize	VERB
gsrj-29	28	46	for	for	ADP
gsrj-29	28	47	use	use	NOUN
gsrj-29	28	48	,	,	PUNCT
gsrj-29	28	49	as	as	SCONJ
gsrj-29	28	50	gene	gene	NOUN
gsrj-29	28	51	editing	edit	VERB
gsrj-29	28	52	kits	kit	NOUN
gsrj-29	28	53	are	be	AUX
gsrj-29	28	54	commercially	commercially	ADV
gsrj-29	28	55	available	available	ADJ
gsrj-29	28	56	from	from	ADP
gsrj-29	28	57	laboratory	laboratory	NOUN
gsrj-29	28	58	suppliers	supplier	NOUN
gsrj-29	28	59	and	and	CCONJ
gsrj-29	28	60	genome	genome	NOUN
gsrj-29	28	61	engineering	engineering	NOUN
gsrj-29	28	62	companies	company	NOUN
gsrj-29	28	63	and	and	CCONJ
gsrj-29	28	64	are	be	AUX
gsrj-29	28	65	relatively	relatively	ADV
gsrj-29	28	66	inexpensive	inexpensive	ADJ
gsrj-29	28	67	.	.	PUNCT
gsrj-29	29	1	furthermore	furthermore	ADV
gsrj-29	29	2	,	,	PUNCT
gsrj-29	29	3	crispr	crispr	ADJ
gsrj-29	29	4	technologies	technology	NOUN
gsrj-29	29	5	–	–	PUNCT
gsrj-29	29	6	especially	especially	ADV
gsrj-29	29	7	these	these	DET
gsrj-29	29	8	gene	gene	NOUN
gsrj-29	29	9	editing	edit	VERB
gsrj-29	29	10	kits	kit	NOUN
gsrj-29	29	11	–	–	PUNCT
gsrj-29	29	12	are	be	AUX
gsrj-29	29	13	touted	tout	VERB
gsrj-29	29	14	for	for	ADP
gsrj-29	29	15	their	their	PRON
gsrj-29	29	16	easeof	easeof	ADJ
gsrj-29	29	17	-	-	PUNCT
gsrj-29	29	18	use	use	NOUN
gsrj-29	29	19	compared	compare	VERB
gsrj-29	29	20	to	to	ADP
gsrj-29	29	21	other	other	ADJ
gsrj-29	29	22	techniques	technique	NOUN
gsrj-29	29	23	for	for	ADP
gsrj-29	29	24	genomic	genomic	ADJ
gsrj-29	29	25	manipulation.15	manipulation.15	NOUN
gsrj-29	29	26	however	however	ADV
gsrj-29	29	27	,	,	PUNCT
gsrj-29	29	28	the	the	DET
gsrj-29	29	29	same	same	ADJ
gsrj-29	29	30	accessibility	accessibility	NOUN
gsrj-29	29	31	,	,	PUNCT
gsrj-29	29	32	low	low	ADJ
gsrj-29	29	33	cost	cost	NOUN
gsrj-29	29	34	,	,	PUNCT
gsrj-29	29	35	and	and	CCONJ
gsrj-29	29	36	ease	ease	NOUN
gsrj-29	29	37	-	-	PUNCT
gsrj-29	29	38	of	of	ADP
gsrj-29	29	39	-	-	PUNCT
gsrj-29	29	40	use	use	NOUN
gsrj-29	29	41	of	of	ADP
gsrj-29	29	42	crispr	crispr	NOUN
gsrj-29	29	43	-	-	PUNCT
gsrj-29	29	44	cas	cas	NOUN
gsrj-29	29	45	could	could	AUX
gsrj-29	29	46	greatly	greatly	ADV
gsrj-29	29	47	expand	expand	VERB
gsrj-29	29	48	the	the	DET
gsrj-29	29	49	scope	scope	NOUN
gsrj-29	29	50	of	of	ADP
gsrj-29	29	51	potential	potential	ADJ
gsrj-29	29	52	users	user	NOUN
gsrj-29	29	53	.	.	PUNCT
gsrj-29	30	1	in	in	ADP
gsrj-29	30	2	many	many	ADJ
gsrj-29	30	3	ways	way	NOUN
gsrj-29	30	4	,	,	PUNCT
gsrj-29	30	5	it	it	PRON
gsrj-29	30	6	is	be	AUX
gsrj-29	30	7	a	a	DET
gsrj-29	30	8	boon	boon	NOUN
gsrj-29	30	9	for	for	ADP
gsrj-29	30	10	positive	positive	ADJ
gsrj-29	30	11	biological	biological	ADJ
gsrj-29	30	12	applications	application	NOUN
gsrj-29	30	13	,	,	PUNCT
gsrj-29	30	14	and	and	CCONJ
gsrj-29	30	15	research	research	NOUN
gsrj-29	30	16	in	in	ADP
gsrj-29	30	17	the	the	DET
gsrj-29	30	18	field	field	NOUN
gsrj-29	30	19	has	have	AUX
gsrj-29	30	20	flourished	flourish	VERB
gsrj-29	30	21	due	due	ADP
gsrj-29	30	22	to	to	ADP
gsrj-29	30	23	the	the	DET
gsrj-29	30	24	democratization	democratization	NOUN
gsrj-29	30	25	of	of	ADP
gsrj-29	30	26	gene	gene	NOUN
gsrj-29	30	27	editing	editing	NOUN
gsrj-29	30	28	.	.	PUNCT
gsrj-29	31	1	in	in	ADP
gsrj-29	31	2	other	other	ADJ
gsrj-29	31	3	ways	way	NOUN
gsrj-29	31	4	,	,	PUNCT
gsrj-29	31	5	the	the	DET
gsrj-29	31	6	technology	technology	NOUN
gsrj-29	31	7	could	could	AUX
gsrj-29	31	8	pose	pose	VERB
gsrj-29	31	9	a	a	DET
gsrj-29	31	10	biosecurity	biosecurity	NOUN
gsrj-29	31	11	risk	risk	NOUN
gsrj-29	31	12	if	if	SCONJ
gsrj-29	31	13	applied	apply	VERB
gsrj-29	31	14	to	to	ADP
gsrj-29	31	15	malicious	malicious	ADJ
gsrj-29	31	16	genomic	genomic	ADJ
gsrj-29	31	17	engineering	engineering	NOUN
gsrj-29	31	18	,	,	PUNCT
gsrj-29	31	19	rendering	render	VERB
gsrj-29	31	20	it	it	PRON
gsrj-29	31	21	a	a	DET
gsrj-29	31	22	dual	dual	ADJ
gsrj-29	31	23	use	use	NOUN
gsrj-29	31	24	research	research	NOUN
gsrj-29	31	25	of	of	ADP
gsrj-29	31	26	concern	concern	NOUN
gsrj-29	31	27	.	.	PUNCT
gsrj-29	32	1	that	that	PRON
gsrj-29	32	2	is	be	AUX
gsrj-29	32	3	,	,	PUNCT
gsrj-29	32	4	research	research	NOUN
gsrj-29	32	5	that	that	PRON
gsrj-29	32	6	advances	advance	VERB
gsrj-29	32	7	our	our	PRON
gsrj-29	32	8	understanding	understanding	NOUN
gsrj-29	32	9	of	of	ADP
gsrj-29	32	10	crispr	crispr	NOUN
gsrj-29	32	11	-	-	PUNCT
gsrj-29	32	12	cas	cas	NOUN
gsrj-29	32	13	has	have	VERB
gsrj-29	32	14	the	the	DET
gsrj-29	32	15	potential	potential	NOUN
gsrj-29	32	16	to	to	PART
gsrj-29	32	17	be	be	AUX
gsrj-29	32	18	directly	directly	ADV
gsrj-29	32	19	misapplied	misapply	VERB
gsrj-29	32	20	and	and	CCONJ
gsrj-29	32	21	pose	pose	VERB
gsrj-29	32	22	a	a	DET
gsrj-29	32	23	biological	biological	ADJ
gsrj-29	32	24	threat	threat	NOUN
gsrj-29	32	25	.	.	PUNCT
gsrj-29	33	1	regardless	regardless	ADV
gsrj-29	33	2	of	of	ADP
gsrj-29	33	3	the	the	DET
gsrj-29	33	4	numerous	numerous	ADJ
gsrj-29	33	5	positive	positive	ADJ
gsrj-29	33	6	applications	application	NOUN
gsrj-29	33	7	,	,	PUNCT
gsrj-29	33	8	crispr	crispr	PROPN
gsrj-29	33	9	could	could	AUX
gsrj-29	33	10	open	open	VERB
gsrj-29	33	11	the	the	DET
gsrj-29	33	12	door	door	NOUN
gsrj-29	33	13	for	for	SCONJ
gsrj-29	33	14	malicious	malicious	ADJ
gsrj-29	33	15	non	non	ADJ
gsrj-29	33	16	-	-	ADJ
gsrj-29	33	17	state	state	ADJ
gsrj-29	33	18	attackers	attacker	NOUN
gsrj-29	33	19	to	to	PART
gsrj-29	33	20	engineer	engineer	VERB
gsrj-29	33	21	optimized	optimize	VERB
gsrj-29	33	22	pathogenic	pathogenic	ADJ
gsrj-29	33	23	bioweapons	bioweapon	NOUN
gsrj-29	33	24	.	.	PUNCT
gsrj-29	34	1	prior	prior	ADJ
gsrj-29	34	2	genomic	genomic	ADJ
gsrj-29	34	3	manipulation	manipulation	NOUN
gsrj-29	34	4	techniques	technique	NOUN
gsrj-29	34	5	posed	pose	VERB
gsrj-29	34	6	significant	significant	ADJ
gsrj-29	34	7	barriers	barrier	NOUN
gsrj-29	34	8	of	of	ADP
gsrj-29	34	9	entry	entry	NOUN
gsrj-29	34	10	,	,	PUNCT
gsrj-29	34	11	requiring	require	VERB
gsrj-29	34	12	resources	resource	NOUN
gsrj-29	34	13	and	and	CCONJ
gsrj-29	34	14	scientific	scientific	ADJ
gsrj-29	34	15	expertise	expertise	NOUN
gsrj-29	34	16	for	for	ADP
gsrj-29	34	17	performing	perform	VERB
gsrj-29	34	18	expensive	expensive	ADJ
gsrj-29	34	19	and	and	CCONJ
gsrj-29	34	20	complex	complex	ADJ
gsrj-29	34	21	biological	biological	ADJ
gsrj-29	34	22	procedures	procedure	NOUN
gsrj-29	34	23	such	such	ADJ
gsrj-29	34	24	as	as	ADP
gsrj-29	34	25	constructing	construct	VERB
gsrj-29	34	26	zincfinger	zincfinger	NOUN
gsrj-29	34	27	arrays	array	NOUN
gsrj-29	34	28	or	or	CCONJ
gsrj-29	34	29	delivering	deliver	VERB
gsrj-29	34	30	gene	gene	NOUN
gsrj-29	34	31	editing	edit	VERB
gsrj-29	34	32	materials	material	NOUN
gsrj-29	34	33	into	into	ADP
gsrj-29	34	34	cells.16	cells.16	NOUN
gsrj-29	34	35	,	,	PUNCT
gsrj-29	34	36	17	17	NUM
gsrj-29	34	37	crispr	crispr	ADJ
gsrj-29	34	38	-	-	PUNCT
gsrj-29	34	39	cas	cas	NOUN
gsrj-29	34	40	systems	system	NOUN
gsrj-29	34	41	circumvent	circumvent	VERB
gsrj-29	34	42	some	some	PRON
gsrj-29	34	43	of	of	ADP
gsrj-29	34	44	the	the	DET
gsrj-29	34	45	impediments	impediment	NOUN
gsrj-29	34	46	apparent	apparent	ADJ
gsrj-29	34	47	in	in	ADP
gsrj-29	34	48	other	other	ADJ
gsrj-29	34	49	methods	method	NOUN
gsrj-29	34	50	like	like	ADP
gsrj-29	34	51	talens	talen	NOUN
gsrj-29	34	52	(	(	PUNCT
gsrj-29	34	53	transcription	transcription	NOUN
gsrj-29	34	54	activatorlike	activatorlike	NOUN
gsrj-29	34	55	effector	effector	NOUN
gsrj-29	34	56	nucleases	nuclease	NOUN
gsrj-29	34	57	)	)	PUNCT
gsrj-29	34	58	or	or	CCONJ
gsrj-29	34	59	zinc	zinc	NOUN
gsrj-29	34	60	fingers	finger	NOUN
gsrj-29	34	61	.	.	PUNCT
gsrj-29	35	1	in	in	ADP
gsrj-29	35	2	fact	fact	NOUN
gsrj-29	35	3	,	,	PUNCT
gsrj-29	35	4	the	the	DET
gsrj-29	35	5	concerns	concern	NOUN
gsrj-29	35	6	that	that	SCONJ
gsrj-29	35	7	the	the	DET
gsrj-29	35	8	broad	broad	ADJ
gsrj-29	35	9	distribution	distribution	NOUN
gsrj-29	35	10	and	and	CCONJ
gsrj-29	35	11	low	low	ADJ
gsrj-29	35	12	cost	cost	NOUN
gsrj-29	35	13	of	of	ADP
gsrj-29	35	14	the	the	DET
gsrj-29	35	15	technology	technology	NOUN
gsrj-29	35	16	increase	increase	VERB
gsrj-29	35	17	the	the	DET
gsrj-29	35	18	risk	risk	NOUN
gsrj-29	35	19	for	for	ADP
gsrj-29	35	20	deliberate	deliberate	ADJ
gsrj-29	35	21	misuse	misuse	NOUN
gsrj-29	35	22	were	be	AUX
gsrj-29	35	23	stressed	stress	VERB
gsrj-29	35	24	in	in	ADP
gsrj-29	35	25	multiple	multiple	ADJ
gsrj-29	35	26	us	us	PROPN
gsrj-29	35	27	intelligence	intelligence	NOUN
gsrj-29	35	28	community	community	NOUN
gsrj-29	35	29	threat	threat	NOUN
gsrj-29	35	30	assessments.18	assessments.18	PROPN
gsrj-29	35	31	,	,	PUNCT
gsrj-29	35	32	19	19	NUM
gsrj-29	35	33	these	these	DET
gsrj-29	35	34	advances	advance	NOUN
gsrj-29	35	35	in	in	ADP
gsrj-29	35	36	gene	gene	NOUN
gsrj-29	35	37	editing	edit	VERB
gsrj-29	35	38	highlight	highlight	VERB
gsrj-29	35	39	the	the	DET
gsrj-29	35	40	modern	modern	ADJ
gsrj-29	35	41	reality	reality	NOUN
gsrj-29	35	42	that	that	SCONJ
gsrj-29	35	43	the	the	DET
gsrj-29	35	44	tools	tool	NOUN
gsrj-29	35	45	necessary	necessary	ADJ
gsrj-29	35	46	for	for	ADP
gsrj-29	35	47	genetically	genetically	ADV
gsrj-29	35	48	engineering	engineer	VERB
gsrj-29	35	49	a	a	DET
gsrj-29	35	50	dangerous	dangerous	ADJ
gsrj-29	35	51	pathogen	pathogen	NOUN
gsrj-29	35	52	are	be	AUX
gsrj-29	35	53	increasingly	increasingly	ADV
gsrj-29	35	54	available	available	ADJ
gsrj-29	35	55	,	,	PUNCT
gsrj-29	35	56	and	and	CCONJ
gsrj-29	35	57	the	the	DET
gsrj-29	35	58	biosecurity	biosecurity	NOUN
gsrj-29	35	59	risk	risk	NOUN
gsrj-29	35	60	for	for	ADP
gsrj-29	35	61	a	a	DET
gsrj-29	35	62	dbe	dbe	PROPN
gsrj-29	35	63	could	could	AUX
gsrj-29	35	64	be	be	AUX
gsrj-29	35	65	greater	great	ADJ
gsrj-29	35	66	now	now	ADV
gsrj-29	35	67	than	than	ADP
gsrj-29	35	68	ever	ever	ADV
gsrj-29	35	69	before	before	ADV
gsrj-29	35	70	.	.	PUNCT
gsrj-29	36	1	though	though	SCONJ
gsrj-29	36	2	potential	potential	ADJ
gsrj-29	36	3	targets	target	NOUN
gsrj-29	36	4	of	of	ADP
gsrj-29	36	5	maliciously	maliciously	ADV
gsrj-29	36	6	released	release	VERB
gsrj-29	36	7	pathogens	pathogen	NOUN
gsrj-29	36	8	are	be	AUX
gsrj-29	36	9	diverse,20	diverse,20	NOUN
gsrj-29	36	10	for	for	ADP
gsrj-29	36	11	practicality	practicality	NOUN
gsrj-29	36	12	in	in	ADP
gsrj-29	36	13	this	this	DET
gsrj-29	36	14	report	report	NOUN
gsrj-29	36	15	,	,	PUNCT
gsrj-29	36	16	discussion	discussion	NOUN
gsrj-29	36	17	regarding	regard	VERB
gsrj-29	36	18	the	the	DET
gsrj-29	36	19	threat	threat	NOUN
gsrj-29	36	20	of	of	ADP
gsrj-29	36	21	an	an	DET
gsrj-29	36	22	engineered	engineer	VERB
gsrj-29	36	23	pathogen	pathogen	NOUN
gsrj-29	36	24	refers	refer	VERB
gsrj-29	36	25	to	to	ADP
gsrj-29	36	26	that	that	PRON
gsrj-29	36	27	targeting	target	VERB
gsrj-29	36	28	humans	human	NOUN
gsrj-29	36	29	.	.	PUNCT
gsrj-29	37	1	beyond	beyond	ADP
gsrj-29	37	2	the	the	DET
gsrj-29	37	3	reduced	reduce	VERB
gsrj-29	37	4	barrier	barrier	NOUN
gsrj-29	37	5	of	of	ADP
gsrj-29	37	6	entry	entry	NOUN
gsrj-29	37	7	for	for	ADP
gsrj-29	37	8	engineering	engineer	VERB
gsrj-29	37	9	a	a	DET
gsrj-29	37	10	pathogen	pathogen	NOUN
gsrj-29	37	11	,	,	PUNCT
gsrj-29	37	12	the	the	DET
gsrj-29	37	13	attacker	attacker	NOUN
gsrj-29	37	14	may	may	AUX
gsrj-29	37	15	also	also	ADV
gsrj-29	37	16	have	have	VERB
gsrj-29	37	17	certain	certain	ADJ
gsrj-29	37	18	advantages	advantage	NOUN
gsrj-29	37	19	in	in	ADP
gsrj-29	37	20	releasing	release	VERB
gsrj-29	37	21	that	that	DET
gsrj-29	37	22	pathogen	pathogen	NOUN
gsrj-29	37	23	and	and	CCONJ
gsrj-29	37	24	causing	cause	VERB
gsrj-29	37	25	a	a	DET
gsrj-29	37	26	dbe	dbe	NOUN
gsrj-29	37	27	.	.	PUNCT
gsrj-29	38	1	although	although	SCONJ
gsrj-29	38	2	there	there	PRON
gsrj-29	38	3	may	may	AUX
gsrj-29	38	4	be	be	AUX
gsrj-29	38	5	several	several	ADJ
gsrj-29	38	6	similarities	similarity	NOUN
gsrj-29	38	7	between	between	ADP
gsrj-29	38	8	the	the	DET
gsrj-29	38	9	defense	defense	NOUN
gsrj-29	38	10	countermeasure	countermeasure	NOUN
gsrj-29	38	11	against	against	ADP
gsrj-29	38	12	either	either	CCONJ
gsrj-29	38	13	a	a	DET
gsrj-29	38	14	deliberate	deliberate	ADJ
gsrj-29	38	15	or	or	CCONJ
gsrj-29	38	16	natural	natural	ADJ
gsrj-29	38	17	biological	biological	ADJ
gsrj-29	38	18	event	event	NOUN
gsrj-29	38	19	,	,	PUNCT
gsrj-29	38	20	a	a	DET
gsrj-29	38	21	dbe	dbe	PROPN
gsrj-29	38	22	may	may	AUX
gsrj-29	38	23	introduce	introduce	VERB
gsrj-29	38	24	additional	additional	ADJ
gsrj-29	38	25	requirements	requirement	NOUN
gsrj-29	38	26	for	for	ADP
gsrj-29	38	27	several	several	ADJ
gsrj-29	38	28	factors	factor	NOUN
gsrj-29	38	29	,	,	PUNCT
gsrj-29	38	30	from	from	ADP
gsrj-29	38	31	responder	responder	NOUN
gsrj-29	38	32	safety	safety	NOUN
gsrj-29	38	33	to	to	PART
gsrj-29	38	34	attacker	attacker	VERB
gsrj-29	38	35	attribution.21	attribution.21	VERB
gsrj-29	38	36	the	the	DET
gsrj-29	38	37	determination	determination	NOUN
gsrj-29	38	38	of	of	ADP
gsrj-29	38	39	natural	natural	ADJ
gsrj-29	38	40	or	or	CCONJ
gsrj-29	38	41	deliberate	deliberate	ADJ
gsrj-29	38	42	origin	origin	NOUN
gsrj-29	38	43	would	would	AUX
gsrj-29	38	44	presumably	presumably	ADV
gsrj-29	38	45	be	be	AUX
gsrj-29	38	46	made	make	VERB
gsrj-29	38	47	by	by	ADP
gsrj-29	38	48	a	a	DET
gsrj-29	38	49	coordinated	coordinated	ADJ
gsrj-29	38	50	effort	effort	NOUN
gsrj-29	38	51	of	of	ADP
gsrj-29	38	52	stakeholders	stakeholder	NOUN
gsrj-29	38	53	from	from	ADP
gsrj-29	38	54	intelligence	intelligence	NOUN
gsrj-29	38	55	communities	community	NOUN
gsrj-29	38	56	and	and	CCONJ
gsrj-29	38	57	clinical	clinical	ADJ
gsrj-29	38	58	professionals	professional	NOUN
gsrj-29	38	59	with	with	ADP
gsrj-29	38	60	standard	standard	ADJ
gsrj-29	38	61	criteria	criterion	NOUN
gsrj-29	38	62	for	for	ADP
gsrj-29	38	63	assessing	assess	VERB
gsrj-29	38	64	the	the	DET
gsrj-29	38	65	biological	biological	ADJ
gsrj-29	38	66	event.22	event.22	NOUN
gsrj-29	38	67	however	however	ADV
gsrj-29	38	68	,	,	PUNCT
gsrj-29	38	69	upon	upon	SCONJ
gsrj-29	38	70	identification	identification	NOUN
gsrj-29	38	71	of	of	ADP
gsrj-29	38	72	a	a	DET
gsrj-29	38	73	dbe	dbe	NOUN
gsrj-29	38	74	,	,	PUNCT
gsrj-29	38	75	it	it	PRON
gsrj-29	38	76	still	still	ADV
gsrj-29	38	77	may	may	AUX
gsrj-29	38	78	prove	prove	VERB
gsrj-29	38	79	difficult	difficult	ADJ
gsrj-29	38	80	to	to	PART
gsrj-29	38	81	discern	discern	VERB
gsrj-29	38	82	whether	whether	SCONJ
gsrj-29	38	83	this	this	DET
gsrj-29	38	84	intentional	intentional	ADJ
gsrj-29	38	85	release	release	NOUN
gsrj-29	38	86	is	be	AUX
gsrj-29	38	87	a	a	DET
gsrj-29	38	88	wild	wild	ADJ
gsrj-29	38	89	-	-	PUNCT
gsrj-29	38	90	type	type	NOUN
gsrj-29	38	91	or	or	CCONJ
gsrj-29	38	92	genetically	genetically	ADV
gsrj-29	38	93	engineered	engineer	VERB
gsrj-29	38	94	pathogen	pathogen	NOUN
gsrj-29	38	95	,	,	PUNCT
gsrj-29	38	96	which	which	PRON
gsrj-29	38	97	is	be	AUX
gsrj-29	38	98	crucial	crucial	ADJ
gsrj-29	38	99	information	information	NOUN
gsrj-29	38	100	for	for	ADP
gsrj-29	38	101	assessing	assess	VERB
gsrj-29	38	102	pathogenesis	pathogenesis	NOUN
gsrj-29	38	103	due	due	ADP
gsrj-29	38	104	to	to	ADP
gsrj-29	38	105	environment	environment	NOUN
gsrj-29	38	106	and	and	CCONJ
gsrj-29	38	107	natural	natural	ADJ
gsrj-29	38	108	selection	selection	NOUN
gsrj-29	38	109	.	.	PUNCT
gsrj-29	39	1	that	that	PRON
gsrj-29	39	2	is	be	AUX
gsrj-29	39	3	to	to	PART
gsrj-29	39	4	say	say	VERB
gsrj-29	39	5	,	,	PUNCT
gsrj-29	39	6	genetically	genetically	ADV
gsrj-29	39	7	engineered	engineer	VERB
gsrj-29	39	8	pathogens	pathogen	NOUN
gsrj-29	39	9	may	may	AUX
gsrj-29	39	10	experience	experience	VERB
gsrj-29	39	11	a	a	DET
gsrj-29	39	12	comparatively	comparatively	ADV
gsrj-29	39	13	more	more	ADV
gsrj-29	39	14	rapid	rapid	ADJ
gsrj-29	39	15	process	process	NOUN
gsrj-29	39	16	of	of	ADP
gsrj-29	39	17	change	change	NOUN
gsrj-29	39	18	in	in	ADP
gsrj-29	39	19	selecting	selecting	NOUN
gsrj-29	39	20	for	for	ADP
gsrj-29	39	21	new	new	ADJ
gsrj-29	39	22	genes	gene	NOUN
gsrj-29	39	23	that	that	PRON
gsrj-29	39	24	make	make	VERB
gsrj-29	39	25	the	the	DET
gsrj-29	39	26	pathogen	pathogen	NOUN
gsrj-29	39	27	more	more	ADV
gsrj-29	39	28	competitive	competitive	ADJ
gsrj-29	39	29	while	while	SCONJ
gsrj-29	39	30	suppressing	suppress	VERB
gsrj-29	39	31	other	other	ADJ
gsrj-29	39	32	genes	gene	NOUN
gsrj-29	39	33	that	that	PRON
gsrj-29	39	34	are	be	AUX
gsrj-29	39	35	metabolically	metabolically	ADV
gsrj-29	39	36	expensive.23	expensive.23	ADP
gsrj-29	39	37	a	a	DET
gsrj-29	39	38	dynamic	dynamic	ADJ
gsrj-29	39	39	pathogen	pathogen	NOUN
gsrj-29	39	40	like	like	ADP
gsrj-29	39	41	this	this	PRON
gsrj-29	39	42	may	may	AUX
gsrj-29	39	43	confound	confound	VERB
gsrj-29	39	44	an	an	DET
gsrj-29	39	45	efficient	efficient	ADJ
gsrj-29	39	46	countermeasure	countermeasure	NOUN
gsrj-29	39	47	from	from	ADP
gsrj-29	39	48	the	the	DET
gsrj-29	39	49	defender	defender	NOUN
gsrj-29	39	50	.	.	PUNCT
gsrj-29	40	1	furthermore	furthermore	ADV
gsrj-29	40	2	,	,	PUNCT
gsrj-29	40	3	convoluted	convoluted	ADJ
gsrj-29	40	4	dimensions	dimension	NOUN
gsrj-29	40	5	and	and	CCONJ
gsrj-29	40	6	numerous	numerous	ADJ
gsrj-29	40	7	stakeholders	stakeholder	NOUN
gsrj-29	40	8	in	in	ADP
gsrj-29	40	9	a	a	DET
gsrj-29	40	10	public	public	ADJ
gsrj-29	40	11	health	health	NOUN
gsrj-29	40	12	response	response	NOUN
gsrj-29	40	13	may	may	AUX
gsrj-29	40	14	inhibit	inhibit	VERB
gsrj-29	40	15	an	an	DET
gsrj-29	40	16	efficient	efficient	ADJ
gsrj-29	40	17	countermeasure	countermeasure	NOUN
gsrj-29	40	18	by	by	ADP
gsrj-29	40	19	the	the	DET
gsrj-29	40	20	defender	defender	NOUN
gsrj-29	40	21	.	.	PUNCT
gsrj-29	41	1	a	a	DET
gsrj-29	41	2	proactive	proactive	ADJ
gsrj-29	41	3	release	release	NOUN
gsrj-29	41	4	of	of	ADP
gsrj-29	41	5	a	a	DET
gsrj-29	41	6	pathogen	pathogen	NOUN
gsrj-29	41	7	by	by	ADP
gsrj-29	41	8	an	an	DET
gsrj-29	41	9	attacker	attacker	NOUN
gsrj-29	41	10	is	be	AUX
gsrj-29	41	11	fundamentally	fundamentally	ADV
gsrj-29	41	12	less	less	ADV
gsrj-29	41	13	complicated	complicated	ADJ
gsrj-29	41	14	than	than	ADP
gsrj-29	41	15	a	a	DET
gsrj-29	41	16	reactive	reactive	ADJ
gsrj-29	41	17	response	response	NOUN
gsrj-29	41	18	by	by	ADP
gsrj-29	41	19	a	a	DET
gsrj-29	41	20	defender	defender	NOUN
gsrj-29	41	21	.	.	PUNCT
gsrj-29	42	1	27	27	NUM
gsrj-29	42	2	georgetown	georgetown	PROPN
gsrj-29	42	3	scientific	scientific	ADJ
gsrj-29	42	4	research	research	NOUN
gsrj-29	42	5	journal	journal	PROPN
gsrj-29	42	6	understanding	understand	VERB
gsrj-29	42	7	the	the	DET
gsrj-29	42	8	complex	complex	ADJ
gsrj-29	42	9	field	field	NOUN
gsrj-29	42	10	of	of	ADP
gsrj-29	42	11	genetics	genetic	NOUN
gsrj-29	42	12	for	for	ADP
gsrj-29	42	13	beneficial	beneficial	ADJ
gsrj-29	42	14	human	human	ADJ
gsrj-29	42	15	applications	application	NOUN
gsrj-29	42	16	is	be	AUX
gsrj-29	42	17	a	a	DET
gsrj-29	42	18	problem	problem	NOUN
gsrj-29	42	19	facing	face	VERB
gsrj-29	42	20	researchers	researcher	NOUN
gsrj-29	42	21	in	in	ADP
gsrj-29	42	22	crispr	crispr	NOUN
gsrj-29	42	23	for	for	ADP
gsrj-29	42	24	today	today	NOUN
gsrj-29	42	25	.	.	PUNCT
gsrj-29	43	1	from	from	ADP
gsrj-29	43	2	pleiotropic	pleiotropic	ADJ
gsrj-29	43	3	effects	effect	NOUN
gsrj-29	43	4	where	where	SCONJ
gsrj-29	43	5	one	one	NUM
gsrj-29	43	6	gene	gene	NOUN
gsrj-29	43	7	can	can	AUX
gsrj-29	43	8	have	have	VERB
gsrj-29	43	9	multiple	multiple	ADJ
gsrj-29	43	10	expressions	expression	NOUN
gsrj-29	43	11	to	to	ADP
gsrj-29	43	12	epigenetic	epigenetic	ADJ
gsrj-29	43	13	effects	effect	NOUN
gsrj-29	43	14	where	where	SCONJ
gsrj-29	43	15	expression	expression	NOUN
gsrj-29	43	16	is	be	AUX
gsrj-29	43	17	regulated	regulate	VERB
gsrj-29	43	18	by	by	ADP
gsrj-29	43	19	environmental	environmental	ADJ
gsrj-29	43	20	factors	factor	NOUN
gsrj-29	43	21	,	,	PUNCT
gsrj-29	43	22	a	a	DET
gsrj-29	43	23	limitation	limitation	NOUN
gsrj-29	43	24	of	of	ADP
gsrj-29	43	25	crispr	crispr	ADJ
gsrj-29	43	26	gene	gene	NOUN
gsrj-29	43	27	editing	editing	NOUN
gsrj-29	43	28	is	be	AUX
gsrj-29	43	29	scientific	scientific	ADJ
gsrj-29	43	30	understanding	understanding	NOUN
gsrj-29	43	31	of	of	ADP
gsrj-29	43	32	how	how	SCONJ
gsrj-29	43	33	genes	gene	NOUN
gsrj-29	43	34	are	be	AUX
gsrj-29	43	35	associated	associate	VERB
gsrj-29	43	36	with	with	ADP
gsrj-29	43	37	specific	specific	ADJ
gsrj-29	43	38	phenotypic	phenotypic	ADJ
gsrj-29	43	39	expressions	expression	NOUN
gsrj-29	43	40	.	.	PUNCT
gsrj-29	44	1	after	after	ADV
gsrj-29	44	2	all	all	ADV
gsrj-29	44	3	,	,	PUNCT
gsrj-29	44	4	crispr	crispr	PROPN
gsrj-29	44	5	is	be	AUX
gsrj-29	44	6	most	most	ADV
gsrj-29	44	7	often	often	ADV
gsrj-29	44	8	and	and	CCONJ
gsrj-29	44	9	easily	easily	ADV
gsrj-29	44	10	utilized	utilize	VERB
gsrj-29	44	11	in	in	ADP
gsrj-29	44	12	order	order	NOUN
gsrj-29	44	13	to	to	PART
gsrj-29	44	14	silence	silence	VERB
gsrj-29	44	15	genes	gene	NOUN
gsrj-29	44	16	to	to	PART
gsrj-29	44	17	create	create	VERB
gsrj-29	44	18	new	new	ADJ
gsrj-29	44	19	phenotypes	phenotype	NOUN
gsrj-29	44	20	rather	rather	ADV
gsrj-29	44	21	than	than	ADP
gsrj-29	44	22	add	add	VERB
gsrj-29	44	23	genes	gene	NOUN
gsrj-29	44	24	to	to	PART
gsrj-29	44	25	create	create	VERB
gsrj-29	44	26	new	new	ADJ
gsrj-29	44	27	phenotypes	phenotype	NOUN
gsrj-29	44	28	because	because	SCONJ
gsrj-29	44	29	of	of	ADP
gsrj-29	44	30	these	these	DET
gsrj-29	44	31	limitations	limitation	NOUN
gsrj-29	44	32	in	in	ADP
gsrj-29	44	33	scientific	scientific	ADJ
gsrj-29	44	34	understanding	understanding	NOUN
gsrj-29	44	35	.	.	PUNCT
gsrj-29	45	1	furthermore	furthermore	ADV
gsrj-29	45	2	,	,	PUNCT
gsrj-29	45	3	some	some	PRON
gsrj-29	45	4	have	have	AUX
gsrj-29	45	5	cited	cite	VERB
gsrj-29	45	6	the	the	DET
gsrj-29	45	7	fact	fact	NOUN
gsrj-29	45	8	that	that	SCONJ
gsrj-29	45	9	the	the	DET
gsrj-29	45	10	notable	notable	ADJ
gsrj-29	45	11	studies	study	NOUN
gsrj-29	45	12	utilizing	utilize	VERB
gsrj-29	45	13	crispr	crispr	PROPN
gsrj-29	45	14	are	be	AUX
gsrj-29	45	15	conducted	conduct	VERB
gsrj-29	45	16	by	by	ADP
gsrj-29	45	17	the	the	DET
gsrj-29	45	18	most	most	ADV
gsrj-29	45	19	well	well	ADV
gsrj-29	45	20	-	-	PUNCT
gsrj-29	45	21	resourced	resource	VERB
gsrj-29	45	22	and	and	CCONJ
gsrj-29	45	23	important	important	ADJ
gsrj-29	45	24	labs	lab	NOUN
gsrj-29	45	25	,	,	PUNCT
gsrj-29	45	26	suggesting	suggest	VERB
gsrj-29	45	27	that	that	PRON
gsrj-29	45	28	crispr	crispr	NOUN
gsrj-29	45	29	still	still	ADV
gsrj-29	45	30	requires	require	VERB
gsrj-29	45	31	a	a	DET
gsrj-29	45	32	significant	significant	ADJ
gsrj-29	45	33	level	level	NOUN
gsrj-29	45	34	of	of	ADP
gsrj-29	45	35	expertise	expertise	NOUN
gsrj-29	45	36	in	in	ADP
gsrj-29	45	37	order	order	NOUN
gsrj-29	45	38	to	to	PART
gsrj-29	45	39	effectively	effectively	ADV
gsrj-29	45	40	operate	operate	VERB
gsrj-29	45	41	the	the	DET
gsrj-29	45	42	technology	technology	NOUN
gsrj-29	45	43	for	for	ADP
gsrj-29	45	44	complicated	complicated	ADJ
gsrj-29	45	45	uses	use	NOUN
gsrj-29	45	46	.	.	PUNCT
gsrj-29	46	1	24	24	NUM
gsrj-29	46	2	thus	thus	ADV
gsrj-29	46	3	,	,	PUNCT
gsrj-29	46	4	the	the	DET
gsrj-29	46	5	barriers	barrier	NOUN
gsrj-29	46	6	of	of	ADP
gsrj-29	46	7	entry	entry	NOUN
gsrj-29	46	8	of	of	ADP
gsrj-29	46	9	scientific	scientific	ADJ
gsrj-29	46	10	understanding	understanding	NOUN
gsrj-29	46	11	and	and	CCONJ
gsrj-29	46	12	a	a	DET
gsrj-29	46	13	certain	certain	ADJ
gsrj-29	46	14	level	level	NOUN
gsrj-29	46	15	of	of	ADP
gsrj-29	46	16	expertise	expertise	NOUN
gsrj-29	46	17	remains	remain	VERB
gsrj-29	46	18	for	for	ADP
gsrj-29	46	19	attackers	attacker	NOUN
gsrj-29	46	20	.	.	PUNCT
gsrj-29	47	1	as	as	SCONJ
gsrj-29	47	2	a	a	DET
gsrj-29	47	3	genetically	genetically	ADV
gsrj-29	47	4	engineered	engineer	VERB
gsrj-29	47	5	pathogen	pathogen	NOUN
gsrj-29	47	6	is	be	AUX
gsrj-29	47	7	released	release	VERB
gsrj-29	47	8	,	,	PUNCT
gsrj-29	47	9	it	it	PRON
gsrj-29	47	10	may	may	AUX
gsrj-29	47	11	have	have	VERB
gsrj-29	47	12	unpredictable	unpredictable	ADJ
gsrj-29	47	13	and	and	CCONJ
gsrj-29	47	14	unintended	unintended	ADJ
gsrj-29	47	15	effects	effect	NOUN
gsrj-29	47	16	,	,	PUNCT
gsrj-29	47	17	again	again	ADV
gsrj-29	47	18	due	due	ADP
gsrj-29	47	19	to	to	ADP
gsrj-29	47	20	environment	environment	NOUN
gsrj-29	47	21	and	and	CCONJ
gsrj-29	47	22	natural	natural	ADJ
gsrj-29	47	23	selection	selection	NOUN
gsrj-29	47	24	.	.	PUNCT
gsrj-29	48	1	for	for	ADP
gsrj-29	48	2	instance	instance	NOUN
gsrj-29	48	3	,	,	PUNCT
gsrj-29	48	4	an	an	DET
gsrj-29	48	5	optimized	optimize	VERB
gsrj-29	48	6	pathogen	pathogen	NOUN
gsrj-29	48	7	could	could	AUX
gsrj-29	48	8	be	be	AUX
gsrj-29	48	9	engineered	engineer	VERB
gsrj-29	48	10	with	with	ADP
gsrj-29	48	11	the	the	DET
gsrj-29	48	12	intent	intent	NOUN
gsrj-29	48	13	for	for	ADP
gsrj-29	48	14	higher	high	ADJ
gsrj-29	48	15	transmission	transmission	NOUN
gsrj-29	48	16	and	and	CCONJ
gsrj-29	48	17	lethality	lethality	NOUN
gsrj-29	48	18	and	and	CCONJ
gsrj-29	48	19	be	be	AUX
gsrj-29	48	20	presumed	presume	VERB
gsrj-29	48	21	by	by	ADP
gsrj-29	48	22	the	the	DET
gsrj-29	48	23	attacker	attacker	NOUN
gsrj-29	48	24	to	to	PART
gsrj-29	48	25	cause	cause	VERB
gsrj-29	48	26	a	a	DET
gsrj-29	48	27	catastrophic	catastrophic	ADJ
gsrj-29	48	28	dbe	dbe	NOUN
gsrj-29	48	29	yet	yet	ADV
gsrj-29	48	30	perform	perform	VERB
gsrj-29	48	31	unpredictably	unpredictably	ADV
gsrj-29	48	32	when	when	SCONJ
gsrj-29	48	33	released	release	VERB
gsrj-29	48	34	because	because	SCONJ
gsrj-29	48	35	it	it	PRON
gsrj-29	48	36	kills	kill	VERB
gsrj-29	48	37	the	the	DET
gsrj-29	48	38	human	human	ADJ
gsrj-29	48	39	host	host	NOUN
gsrj-29	48	40	too	too	ADV
gsrj-29	48	41	efficiently	efficiently	ADV
gsrj-29	48	42	to	to	PART
gsrj-29	48	43	replicate	replicate	VERB
gsrj-29	48	44	and	and	CCONJ
gsrj-29	48	45	spread.24	spread.24	NOUN
gsrj-29	48	46	this	this	DET
gsrj-29	48	47	theoretical	theoretical	ADJ
gsrj-29	48	48	example	example	NOUN
gsrj-29	48	49	would	would	AUX
gsrj-29	48	50	unintentionally	unintentionally	ADV
gsrj-29	48	51	underperform	underperform	VERB
gsrj-29	48	52	the	the	DET
gsrj-29	48	53	attacker	attacker	NOUN
gsrj-29	48	54	’s	’s	PART
gsrj-29	48	55	goals	goal	NOUN
gsrj-29	48	56	.	.	PUNCT
gsrj-29	49	1	furthermore	furthermore	ADV
gsrj-29	49	2	,	,	PUNCT
gsrj-29	49	3	the	the	DET
gsrj-29	49	4	delivery	delivery	NOUN
gsrj-29	49	5	mechanism	mechanism	NOUN
gsrj-29	49	6	to	to	PART
gsrj-29	49	7	weaponize	weaponize	VERB
gsrj-29	49	8	a	a	DET
gsrj-29	49	9	biological	biological	ADJ
gsrj-29	49	10	agent	agent	NOUN
gsrj-29	49	11	has	have	AUX
gsrj-29	49	12	classically	classically	ADV
gsrj-29	49	13	been	be	AUX
gsrj-29	49	14	a	a	DET
gsrj-29	49	15	limiting	limit	VERB
gsrj-29	49	16	factor	factor	NOUN
gsrj-29	49	17	for	for	ADP
gsrj-29	49	18	malicious	malicious	ADJ
gsrj-29	49	19	use.21	use.21	NOUN
gsrj-29	49	20	(	(	PUNCT
gsrj-29	49	21	p.	p.	NOUN
gsrj-29	49	22	90	90	NUM
gsrj-29	49	23	)	)	PUNCT
gsrj-29	49	24	this	this	PRON
gsrj-29	49	25	too	too	ADV
gsrj-29	49	26	remains	remain	VERB
gsrj-29	49	27	as	as	ADP
gsrj-29	49	28	a	a	DET
gsrj-29	49	29	limiting	limit	VERB
gsrj-29	49	30	barrier	barrier	NOUN
gsrj-29	49	31	of	of	ADP
gsrj-29	49	32	entry	entry	NOUN
gsrj-29	49	33	for	for	ADP
gsrj-29	49	34	contemporary	contemporary	ADJ
gsrj-29	49	35	attackers	attacker	NOUN
gsrj-29	49	36	,	,	PUNCT
gsrj-29	49	37	particularly	particularly	ADV
gsrj-29	49	38	if	if	SCONJ
gsrj-29	49	39	the	the	DET
gsrj-29	49	40	desired	desire	VERB
gsrj-29	49	41	release	release	NOUN
gsrj-29	49	42	is	be	AUX
gsrj-29	49	43	within	within	ADP
gsrj-29	49	44	a	a	DET
gsrj-29	49	45	mass	mass	ADJ
gsrj-29	49	46	population	population	NOUN
gsrj-29	49	47	.	.	PUNCT
gsrj-29	50	1	some	some	DET
gsrj-29	50	2	barriers	barrier	NOUN
gsrj-29	50	3	of	of	ADP
gsrj-29	50	4	entry	entry	NOUN
gsrj-29	50	5	persist	persist	NOUN
gsrj-29	50	6	for	for	ADP
gsrj-29	50	7	the	the	DET
gsrj-29	50	8	attacker	attacker	NOUN
gsrj-29	50	9	.	.	PUNCT
gsrj-29	51	1	even	even	ADV
gsrj-29	51	2	so	so	ADV
gsrj-29	51	3	,	,	PUNCT
gsrj-29	51	4	a	a	DET
gsrj-29	51	5	release	release	NOUN
gsrj-29	51	6	of	of	ADP
gsrj-29	51	7	a	a	DET
gsrj-29	51	8	genetically	genetically	ADV
gsrj-29	51	9	engineered	engineer	VERB
gsrj-29	51	10	pathogen	pathogen	NOUN
gsrj-29	51	11	that	that	PRON
gsrj-29	51	12	exhibits	exhibit	VERB
gsrj-29	51	13	characteristics	characteristic	NOUN
gsrj-29	51	14	unintended	unintended	ADJ
gsrj-29	51	15	by	by	ADP
gsrj-29	51	16	the	the	DET
gsrj-29	51	17	attacker	attacker	NOUN
gsrj-29	51	18	can	can	AUX
gsrj-29	51	19	still	still	ADV
gsrj-29	51	20	be	be	AUX
gsrj-29	51	21	problematic	problematic	ADJ
gsrj-29	51	22	for	for	ADP
gsrj-29	51	23	the	the	DET
gsrj-29	51	24	defender	defender	NOUN
gsrj-29	51	25	.	.	PUNCT
gsrj-29	52	1	if	if	SCONJ
gsrj-29	52	2	the	the	DET
gsrj-29	52	3	attacker	attacker	NOUN
gsrj-29	52	4	can	can	AUX
gsrj-29	52	5	surmount	surmount	VERB
gsrj-29	52	6	these	these	DET
gsrj-29	52	7	barriers	barrier	NOUN
gsrj-29	52	8	of	of	ADP
gsrj-29	52	9	knowledge	knowledge	NOUN
gsrj-29	52	10	and	and	CCONJ
gsrj-29	52	11	delivery	delivery	NOUN
gsrj-29	52	12	,	,	PUNCT
gsrj-29	52	13	while	while	SCONJ
gsrj-29	52	14	harnessing	harness	VERB
gsrj-29	52	15	the	the	DET
gsrj-29	52	16	low	low	ADJ
gsrj-29	52	17	cost	cost	NOUN
gsrj-29	52	18	and	and	CCONJ
gsrj-29	52	19	ease	ease	NOUN
gsrj-29	52	20	of	of	ADP
gsrj-29	52	21	use	use	NOUN
gsrj-29	52	22	of	of	ADP
gsrj-29	52	23	crispr	crispr	NOUN
gsrj-29	52	24	,	,	PUNCT
gsrj-29	52	25	a	a	DET
gsrj-29	52	26	resulting	result	VERB
gsrj-29	52	27	dbe	dbe	PROPN
gsrj-29	52	28	may	may	AUX
gsrj-29	52	29	be	be	AUX
gsrj-29	52	30	devastating	devastating	ADJ
gsrj-29	52	31	to	to	ADP
gsrj-29	52	32	the	the	DET
gsrj-29	52	33	defender	defender	NOUN
gsrj-29	52	34	.	.	PUNCT
gsrj-29	53	1	therefore	therefore	ADV
gsrj-29	53	2	,	,	PUNCT
gsrj-29	53	3	it	it	PRON
gsrj-29	53	4	is	be	AUX
gsrj-29	53	5	critically	critically	ADV
gsrj-29	53	6	important	important	ADJ
gsrj-29	53	7	to	to	PART
gsrj-29	53	8	bolster	bolster	VERB
gsrj-29	53	9	global	global	ADJ
gsrj-29	53	10	biopreparedness	biopreparedness	NOUN
gsrj-29	53	11	in	in	ADP
gsrj-29	53	12	both	both	DET
gsrj-29	53	13	prevention	prevention	NOUN
gsrj-29	53	14	and	and	CCONJ
gsrj-29	53	15	reaction	reaction	NOUN
gsrj-29	53	16	strategies	strategy	NOUN
gsrj-29	53	17	.	.	PUNCT
gsrj-29	54	1	for	for	ADP
gsrj-29	54	2	example	example	NOUN
gsrj-29	54	3	,	,	PUNCT
gsrj-29	54	4	monitoring	monitor	VERB
gsrj-29	54	5	supply	supply	NOUN
gsrj-29	54	6	chains	chain	NOUN
gsrj-29	54	7	of	of	ADP
gsrj-29	54	8	crispr	crispr	ADJ
gsrj-29	54	9	kits	kit	NOUN
gsrj-29	54	10	and	and	CCONJ
gsrj-29	54	11	dangerous	dangerous	ADJ
gsrj-29	54	12	pathogenic	pathogenic	ADJ
gsrj-29	54	13	sequences	sequence	NOUN
gsrj-29	54	14	may	may	AUX
gsrj-29	54	15	be	be	AUX
gsrj-29	54	16	worthwhile	worthwhile	ADJ
gsrj-29	54	17	.	.	PUNCT
gsrj-29	55	1	however	however	ADV
gsrj-29	55	2	,	,	PUNCT
gsrj-29	55	3	it	it	PRON
gsrj-29	55	4	seems	seem	VERB
gsrj-29	55	5	apparent	apparent	ADJ
gsrj-29	55	6	that	that	SCONJ
gsrj-29	55	7	not	not	PART
gsrj-29	55	8	all	all	DET
gsrj-29	55	9	biological	biological	ADJ
gsrj-29	55	10	attacks	attack	NOUN
gsrj-29	55	11	may	may	AUX
gsrj-29	55	12	be	be	AUX
gsrj-29	55	13	preventable	preventable	ADJ
gsrj-29	55	14	due	due	ADP
gsrj-29	55	15	to	to	ADP
gsrj-29	55	16	the	the	DET
gsrj-29	55	17	lowered	lower	VERB
gsrj-29	55	18	barriers	barrier	NOUN
gsrj-29	55	19	of	of	ADP
gsrj-29	55	20	access	access	NOUN
gsrj-29	55	21	to	to	ADP
gsrj-29	55	22	gene	gene	NOUN
gsrj-29	55	23	editing	editing	NOUN
gsrj-29	55	24	as	as	ADV
gsrj-29	55	25	well	well	ADV
gsrj-29	55	26	as	as	ADP
gsrj-29	55	27	the	the	DET
gsrj-29	55	28	difficulty	difficulty	NOUN
gsrj-29	55	29	of	of	ADP
gsrj-29	55	30	surveillance	surveillance	NOUN
gsrj-29	55	31	over	over	ADP
gsrj-29	55	32	genetic	genetic	ADJ
gsrj-29	55	33	and	and	CCONJ
gsrj-29	55	34	crispr	crispr	ADJ
gsrj-29	55	35	materials	material	NOUN
gsrj-29	55	36	.	.	PUNCT
gsrj-29	56	1	thus	thus	ADV
gsrj-29	56	2	,	,	PUNCT
gsrj-29	56	3	for	for	ADP
gsrj-29	56	4	the	the	DET
gsrj-29	56	5	remainder	remainder	NOUN
gsrj-29	56	6	of	of	ADP
gsrj-29	56	7	the	the	DET
gsrj-29	56	8	report	report	NOUN
gsrj-29	56	9	,	,	PUNCT
gsrj-29	56	10	there	there	PRON
gsrj-29	56	11	will	will	AUX
gsrj-29	56	12	be	be	AUX
gsrj-29	56	13	a	a	DET
gsrj-29	56	14	primary	primary	ADJ
gsrj-29	56	15	focus	focus	NOUN
gsrj-29	56	16	on	on	ADP
gsrj-29	56	17	the	the	DET
gsrj-29	56	18	reaction	reaction	NOUN
gsrj-29	56	19	of	of	ADP
gsrj-29	56	20	the	the	DET
gsrj-29	56	21	defender	defender	NOUN
gsrj-29	56	22	,	,	PUNCT
gsrj-29	56	23	but	but	CCONJ
gsrj-29	56	24	this	this	PRON
gsrj-29	56	25	is	be	AUX
gsrj-29	56	26	not	not	PART
gsrj-29	56	27	meant	mean	VERB
gsrj-29	56	28	to	to	PART
gsrj-29	56	29	discount	discount	VERB
gsrj-29	56	30	the	the	DET
gsrj-29	56	31	need	need	NOUN
gsrj-29	56	32	for	for	ADP
gsrj-29	56	33	rethought	rethought	NOUN
gsrj-29	56	34	prevention	prevention	NOUN
gsrj-29	56	35	strategies	strategy	NOUN
gsrj-29	56	36	.	.	PUNCT
gsrj-29	57	1	in	in	ADP
gsrj-29	57	2	the	the	DET
gsrj-29	57	3	instances	instance	NOUN
gsrj-29	57	4	of	of	ADP
gsrj-29	57	5	a	a	DET
gsrj-29	57	6	devastating	devastating	ADJ
gsrj-29	57	7	dbe	dbe	NOUN
gsrj-29	57	8	,	,	PUNCT
gsrj-29	57	9	an	an	DET
gsrj-29	57	10	expeditious	expeditious	ADJ
gsrj-29	57	11	,	,	PUNCT
gsrj-29	57	12	prepared	prepared	ADJ
gsrj-29	57	13	response	response	NOUN
gsrj-29	57	14	to	to	PART
gsrj-29	57	15	contain	contain	VERB
gsrj-29	57	16	the	the	DET
gsrj-29	57	17	spread	spread	NOUN
gsrj-29	57	18	of	of	ADP
gsrj-29	57	19	the	the	DET
gsrj-29	57	20	pathogen	pathogen	NOUN
gsrj-29	57	21	should	should	AUX
gsrj-29	57	22	be	be	AUX
gsrj-29	57	23	a	a	DET
gsrj-29	57	24	foremost	foremost	ADJ
gsrj-29	57	25	consideration	consideration	NOUN
gsrj-29	57	26	.	.	PUNCT
gsrj-29	58	1	3	3	X
gsrj-29	58	2	.	.	X
gsrj-29	58	3	crispr	crispr	ADJ
gsrj-29	58	4	applications	application	NOUN
gsrj-29	58	5	to	to	ADP
gsrj-29	58	6	the	the	DET
gsrj-29	58	7	covid-19	covid-19	PROPN
gsrj-29	58	8	pandemic	pandemic	NOUN
gsrj-29	58	9	this	this	DET
gsrj-29	58	10	report	report	NOUN
gsrj-29	58	11	finds	find	VERB
gsrj-29	58	12	that	that	SCONJ
gsrj-29	58	13	crispr	crispr	NOUN
gsrj-29	58	14	-	-	PUNCT
gsrj-29	58	15	cas	cas	NOUN
gsrj-29	58	16	systems	system	NOUN
gsrj-29	58	17	can	can	AUX
gsrj-29	58	18	be	be	AUX
gsrj-29	58	19	leveraged	leverage	VERB
gsrj-29	58	20	to	to	PART
gsrj-29	58	21	configure	configure	VERB
gsrj-29	58	22	an	an	DET
gsrj-29	58	23	effective	effective	ADJ
gsrj-29	58	24	countermeasure	countermeasure	NOUN
gsrj-29	58	25	against	against	ADP
gsrj-29	58	26	a	a	DET
gsrj-29	58	27	natural	natural	ADJ
gsrj-29	58	28	or	or	CCONJ
gsrj-29	58	29	deliberate	deliberate	ADJ
gsrj-29	58	30	biological	biological	ADJ
gsrj-29	58	31	event	event	NOUN
gsrj-29	58	32	,	,	PUNCT
gsrj-29	58	33	particularly	particularly	ADV
gsrj-29	58	34	in	in	ADP
gsrj-29	58	35	terms	term	NOUN
gsrj-29	58	36	of	of	ADP
gsrj-29	58	37	rapidity	rapidity	NOUN
gsrj-29	58	38	and	and	CCONJ
gsrj-29	58	39	feasibility	feasibility	NOUN
gsrj-29	58	40	of	of	ADP
gsrj-29	58	41	response	response	NOUN
gsrj-29	58	42	.	.	PUNCT
gsrj-29	59	1	in	in	ADP
gsrj-29	59	2	the	the	DET
gsrj-29	59	3	case	case	NOUN
gsrj-29	59	4	study	study	NOUN
gsrj-29	59	5	of	of	ADP
gsrj-29	59	6	crispr	crispr	ADJ
gsrj-29	59	7	use	use	NOUN
gsrj-29	59	8	in	in	ADP
gsrj-29	59	9	the	the	DET
gsrj-29	59	10	covid-19	covid-19	PROPN
gsrj-29	59	11	public	public	ADJ
gsrj-29	59	12	health	health	NOUN
gsrj-29	59	13	response	response	NOUN
gsrj-29	59	14	,	,	PUNCT
gsrj-29	59	15	three	three	NUM
gsrj-29	59	16	principal	principal	ADJ
gsrj-29	59	17	applications	application	NOUN
gsrj-29	59	18	prevail	prevail	VERB
gsrj-29	59	19	:	:	PUNCT
gsrj-29	59	20	diagnostics	diagnostic	NOUN
gsrj-29	59	21	,	,	PUNCT
gsrj-29	59	22	research	research	NOUN
gsrj-29	59	23	,	,	PUNCT
gsrj-29	59	24	and	and	CCONJ
gsrj-29	59	25	potential	potential	ADJ
gsrj-29	59	26	antiviral	antiviral	ADJ
gsrj-29	59	27	therapy	therapy	NOUN
gsrj-29	59	28	.	.	PUNCT
gsrj-29	60	1	crispr	crispr	ADJ
gsrj-29	60	2	diagnostic	diagnostic	ADJ
gsrj-29	60	3	platforms	platform	NOUN
gsrj-29	60	4	can	can	AUX
gsrj-29	60	5	provide	provide	VERB
gsrj-29	60	6	accessible	accessible	ADJ
gsrj-29	60	7	,	,	PUNCT
gsrj-29	60	8	rapid	rapid	ADJ
gsrj-29	60	9	,	,	PUNCT
gsrj-29	60	10	and	and	CCONJ
gsrj-29	60	11	convenient	convenient	ADJ
gsrj-29	60	12	tests	test	NOUN
gsrj-29	60	13	,	,	PUNCT
gsrj-29	60	14	without	without	ADP
gsrj-29	60	15	sacrificing	sacrifice	VERB
gsrj-29	60	16	standards	standard	NOUN
gsrj-29	60	17	of	of	ADP
gsrj-29	60	18	accuracy	accuracy	NOUN
gsrj-29	60	19	.	.	PUNCT
gsrj-29	61	1	crispr	crispr	ADJ
gsrj-29	61	2	-	-	PUNCT
gsrj-29	61	3	cas	cas	NOUN
gsrj-29	61	4	systems	system	NOUN
gsrj-29	61	5	as	as	ADP
gsrj-29	61	6	a	a	DET
gsrj-29	61	7	tool	tool	NOUN
gsrj-29	61	8	for	for	ADP
gsrj-29	61	9	research	research	NOUN
gsrj-29	61	10	can	can	AUX
gsrj-29	61	11	provide	provide	VERB
gsrj-29	61	12	an	an	DET
gsrj-29	61	13	optimized	optimize	VERB
gsrj-29	61	14	platform	platform	NOUN
gsrj-29	61	15	to	to	PART
gsrj-29	61	16	identify	identify	VERB
gsrj-29	61	17	and	and	CCONJ
gsrj-29	61	18	test	test	NOUN
gsrj-29	61	19	vectors	vector	NOUN
gsrj-29	61	20	for	for	ADP
gsrj-29	61	21	countermeasure	countermeasure	NOUN
gsrj-29	61	22	targets	target	NOUN
gsrj-29	61	23	.	.	PUNCT
gsrj-29	62	1	finally	finally	ADV
gsrj-29	62	2	,	,	PUNCT
gsrj-29	62	3	crispr	crispr	NOUN
gsrj-29	62	4	-	-	PUNCT
gsrj-29	62	5	cas	cas	NOUN
gsrj-29	62	6	antiviral	antiviral	PROPN
gsrj-29	62	7	therapy	therapy	NOUN
gsrj-29	62	8	may	may	AUX
gsrj-29	62	9	provide	provide	VERB
gsrj-29	62	10	a	a	DET
gsrj-29	62	11	needed	need	VERB
gsrj-29	62	12	prophylactic	prophylactic	ADJ
gsrj-29	62	13	treatment	treatment	NOUN
gsrj-29	62	14	option	option	NOUN
gsrj-29	62	15	for	for	ADP
gsrj-29	62	16	covid-19	covid-19	PROPN
gsrj-29	62	17	and	and	CCONJ
gsrj-29	62	18	other	other	ADJ
gsrj-29	62	19	current	current	ADJ
gsrj-29	62	20	and	and	CCONJ
gsrj-29	62	21	future	future	ADJ
gsrj-29	62	22	pathogens	pathogen	NOUN
gsrj-29	62	23	.	.	PUNCT
gsrj-29	63	1	28	28	NUM
gsrj-29	63	2	georgetown	georgetown	PROPN
gsrj-29	63	3	scientific	scientific	PROPN
gsrj-29	63	4	research	research	PROPN
gsrj-29	63	5	journal	journal	PROPN
gsrj-29	63	6	3.1	3.1	NUM
gsrj-29	63	7	.	.	PUNCT
gsrj-29	63	8	crispr	crispr	ADJ
gsrj-29	63	9	diagnostic	diagnostic	ADJ
gsrj-29	63	10	platforms	platform	NOUN
gsrj-29	63	11	the	the	DET
gsrj-29	63	12	necessity	necessity	NOUN
gsrj-29	63	13	for	for	ADP
gsrj-29	63	14	testing	testing	NOUN
gsrj-29	63	15	to	to	PART
gsrj-29	63	16	curtail	curtail	VERB
gsrj-29	63	17	the	the	DET
gsrj-29	63	18	spread	spread	NOUN
gsrj-29	63	19	of	of	ADP
gsrj-29	63	20	pandemicand	pandemicand	NOUN
gsrj-29	63	21	epidemic	epidemic	NOUN
gsrj-29	63	22	-	-	PUNCT
gsrj-29	63	23	prone	prone	ADJ
gsrj-29	63	24	diseases	disease	NOUN
gsrj-29	63	25	is	be	AUX
gsrj-29	63	26	of	of	ADP
gsrj-29	63	27	critical	critical	ADJ
gsrj-29	63	28	importance	importance	NOUN
gsrj-29	63	29	for	for	ADP
gsrj-29	63	30	adequate	adequate	ADJ
gsrj-29	63	31	public	public	ADJ
gsrj-29	63	32	health	health	NOUN
gsrj-29	63	33	.	.	PUNCT
gsrj-29	64	1	when	when	SCONJ
gsrj-29	64	2	an	an	DET
gsrj-29	64	3	infectious	infectious	ADJ
gsrj-29	64	4	disease	disease	NOUN
gsrj-29	64	5	begins	begin	VERB
gsrj-29	64	6	to	to	PART
gsrj-29	64	7	spread	spread	VERB
gsrj-29	64	8	,	,	PUNCT
gsrj-29	64	9	rapid	rapid	ADJ
gsrj-29	64	10	steps	step	NOUN
gsrj-29	64	11	must	must	AUX
gsrj-29	64	12	be	be	AUX
gsrj-29	64	13	taken	take	VERB
gsrj-29	64	14	to	to	PART
gsrj-29	64	15	track	track	VERB
gsrj-29	64	16	those	those	PRON
gsrj-29	64	17	infected	infect	VERB
gsrj-29	64	18	in	in	ADP
gsrj-29	64	19	order	order	NOUN
gsrj-29	64	20	to	to	PART
gsrj-29	64	21	protect	protect	VERB
gsrj-29	64	22	those	those	PRON
gsrj-29	64	23	who	who	PRON
gsrj-29	64	24	are	be	AUX
gsrj-29	64	25	not	not	PART
gsrj-29	64	26	.	.	PUNCT
gsrj-29	65	1	numerous	numerous	ADJ
gsrj-29	65	2	pandemics	pandemic	NOUN
gsrj-29	65	3	have	have	AUX
gsrj-29	65	4	emerged	emerge	VERB
gsrj-29	65	5	in	in	ADP
gsrj-29	65	6	the	the	DET
gsrj-29	65	7	past	past	NOUN
gsrj-29	65	8	,	,	PUNCT
gsrj-29	65	9	and	and	CCONJ
gsrj-29	65	10	in	in	ADP
gsrj-29	65	11	every	every	DET
gsrj-29	65	12	instance	instance	NOUN
gsrj-29	65	13	,	,	PUNCT
gsrj-29	65	14	robust	robust	ADJ
gsrj-29	65	15	diagnostic	diagnostic	ADJ
gsrj-29	65	16	testing	testing	NOUN
gsrj-29	65	17	to	to	PART
gsrj-29	65	18	support	support	VERB
gsrj-29	65	19	pathogenic	pathogenic	ADJ
gsrj-29	65	20	surveillance	surveillance	NOUN
gsrj-29	65	21	was	be	AUX
gsrj-29	65	22	necessary.25	necessary.25	NOUN
gsrj-29	65	23	in	in	ADP
gsrj-29	65	24	the	the	DET
gsrj-29	65	25	early	early	ADJ
gsrj-29	65	26	stages	stage	NOUN
gsrj-29	65	27	of	of	ADP
gsrj-29	65	28	confronting	confront	VERB
gsrj-29	65	29	pandemic	pandemic	ADJ
gsrj-29	65	30	diseases	disease	NOUN
gsrj-29	65	31	,	,	PUNCT
gsrj-29	65	32	the	the	DET
gsrj-29	65	33	rapid	rapid	ADJ
gsrj-29	65	34	development	development	NOUN
gsrj-29	65	35	,	,	PUNCT
gsrj-29	65	36	approval	approval	NOUN
gsrj-29	65	37	,	,	PUNCT
gsrj-29	65	38	large	large	ADJ
gsrj-29	65	39	-	-	PUNCT
gsrj-29	65	40	scale	scale	NOUN
gsrj-29	65	41	manufacturing	manufacturing	NOUN
gsrj-29	65	42	,	,	PUNCT
gsrj-29	65	43	and	and	CCONJ
gsrj-29	65	44	deployment	deployment	NOUN
gsrj-29	65	45	of	of	ADP
gsrj-29	65	46	reliable	reliable	ADJ
gsrj-29	65	47	,	,	PUNCT
gsrj-29	65	48	fast	fast	ADJ
gsrj-29	65	49	,	,	PUNCT
gsrj-29	65	50	and	and	CCONJ
gsrj-29	65	51	accessible	accessible	ADJ
gsrj-29	65	52	diagnostic	diagnostic	ADJ
gsrj-29	65	53	tests	test	NOUN
gsrj-29	65	54	remains	remain	VERB
gsrj-29	65	55	of	of	ADP
gsrj-29	65	56	utmost	utmost	ADJ
gsrj-29	65	57	priority	priority	NOUN
gsrj-29	65	58	.	.	PUNCT
gsrj-29	66	1	various	various	ADJ
gsrj-29	66	2	commentators	commentator	NOUN
gsrj-29	66	3	emphasized	emphasize	VERB
gsrj-29	66	4	the	the	DET
gsrj-29	66	5	importance	importance	NOUN
gsrj-29	66	6	of	of	ADP
gsrj-29	66	7	a	a	DET
gsrj-29	66	8	robust	robust	ADJ
gsrj-29	66	9	pathogenic	pathogenic	ADJ
gsrj-29	66	10	surveillance	surveillance	NOUN
gsrj-29	66	11	regime	regime	NOUN
gsrj-29	66	12	during	during	ADP
gsrj-29	66	13	the	the	DET
gsrj-29	66	14	covid-19	covid-19	PROPN
gsrj-29	66	15	response	response	NOUN
gsrj-29	66	16	:	:	PUNCT
gsrj-29	66	17	early	early	ADJ
gsrj-29	66	18	detection	detection	NOUN
gsrj-29	66	19	,	,	PUNCT
gsrj-29	66	20	contact	contact	NOUN
gsrj-29	66	21	tracing	tracing	NOUN
gsrj-29	66	22	,	,	PUNCT
gsrj-29	66	23	and	and	CCONJ
gsrj-29	66	24	isolation	isolation	NOUN
gsrj-29	66	25	of	of	ADP
gsrj-29	66	26	infected	infect	VERB
gsrj-29	66	27	individuals	individual	NOUN
gsrj-29	66	28	for	for	ADP
gsrj-29	66	29	management	management	NOUN
gsrj-29	66	30	of	of	ADP
gsrj-29	66	31	contagious	contagious	ADJ
gsrj-29	66	32	individuals	individual	NOUN
gsrj-29	66	33	to	to	PART
gsrj-29	66	34	limit	limit	VERB
gsrj-29	66	35	their	their	PRON
gsrj-29	66	36	transmission	transmission	NOUN
gsrj-29	66	37	to	to	ADP
gsrj-29	66	38	others	other	NOUN
gsrj-29	66	39	.	.	PUNCT
gsrj-29	67	1	importantly	importantly	ADV
gsrj-29	67	2	,	,	PUNCT
gsrj-29	67	3	this	this	DET
gsrj-29	67	4	strategy	strategy	NOUN
gsrj-29	67	5	would	would	AUX
gsrj-29	67	6	rely	rely	VERB
gsrj-29	67	7	heavily	heavily	ADV
gsrj-29	67	8	on	on	ADP
gsrj-29	67	9	diagnostic	diagnostic	ADJ
gsrj-29	67	10	testing	testing	NOUN
gsrj-29	67	11	,	,	PUNCT
gsrj-29	67	12	particularly	particularly	ADV
gsrj-29	67	13	in	in	ADP
gsrj-29	67	14	early	early	ADJ
gsrj-29	67	15	stages	stage	NOUN
gsrj-29	67	16	to	to	PART
gsrj-29	67	17	prevent	prevent	VERB
gsrj-29	67	18	a	a	DET
gsrj-29	67	19	major	major	ADJ
gsrj-29	67	20	outbreak.26	outbreak.26	NOUN
gsrj-29	67	21	in	in	ADP
gsrj-29	67	22	the	the	DET
gsrj-29	67	23	united	united	PROPN
gsrj-29	67	24	states	states	PROPN
gsrj-29	67	25	,	,	PUNCT
gsrj-29	67	26	the	the	DET
gsrj-29	67	27	average	average	ADJ
gsrj-29	67	28	covid-19	covid-19	PROPN
gsrj-29	67	29	test	test	NOUN
gsrj-29	67	30	sample	sample	NOUN
gsrj-29	67	31	-	-	PUNCT
gsrj-29	67	32	to	to	ADP
gsrj-29	67	33	-	-	PUNCT
gsrj-29	67	34	answer	answer	VERB
gsrj-29	67	35	reporting	reporting	NOUN
gsrj-29	67	36	time	time	NOUN
gsrj-29	67	37	at	at	ADP
gsrj-29	67	38	one	one	NUM
gsrj-29	67	39	point	point	NOUN
gsrj-29	67	40	during	during	ADP
gsrj-29	67	41	the	the	DET
gsrj-29	67	42	pandemic	pandemic	NOUN
gsrj-29	67	43	was	be	AUX
gsrj-29	67	44	4	4	NUM
gsrj-29	67	45	days	day	NOUN
gsrj-29	67	46	–	–	PUNCT
gsrj-29	67	47	–	–	PUNCT
gsrj-29	67	48	far	far	ADV
gsrj-29	67	49	beyond	beyond	ADP
gsrj-29	67	50	what	what	PRON
gsrj-29	67	51	is	be	AUX
gsrj-29	67	52	necessary	necessary	ADJ
gsrj-29	67	53	for	for	ADP
gsrj-29	67	54	contact	contact	NOUN
gsrj-29	67	55	tracing	trace	VERB
gsrj-29	67	56	–	–	PUNCT
gsrj-29	67	57	–	–	PUNCT
gsrj-29	67	58	in	in	ADP
gsrj-29	67	59	part	part	NOUN
gsrj-29	67	60	because	because	SCONJ
gsrj-29	67	61	the	the	DET
gsrj-29	67	62	supply	supply	NOUN
gsrj-29	67	63	chain	chain	NOUN
gsrj-29	67	64	did	do	AUX
gsrj-29	67	65	not	not	PART
gsrj-29	67	66	scale	scale	VERB
gsrj-29	67	67	up	up	ADP
gsrj-29	67	68	capacity	capacity	NOUN
gsrj-29	67	69	for	for	ADP
gsrj-29	67	70	diagnostic	diagnostic	ADJ
gsrj-29	67	71	tests	test	NOUN
gsrj-29	67	72	and	and	CCONJ
gsrj-29	67	73	associated	associate	VERB
gsrj-29	67	74	materials.27	materials.27	PROPN
gsrj-29	67	75	because	because	SCONJ
gsrj-29	67	76	covid-19	covid-19	PROPN
gsrj-29	67	77	could	could	AUX
gsrj-29	67	78	spread	spread	VERB
gsrj-29	67	79	from	from	ADP
gsrj-29	67	80	individual	individual	ADJ
gsrj-29	67	81	to	to	ADP
gsrj-29	67	82	individual	individual	ADJ
gsrj-29	67	83	presymptomatically	presymptomatically	ADV
gsrj-29	67	84	,	,	PUNCT
gsrj-29	67	85	symptomatically	symptomatically	ADV
gsrj-29	67	86	,	,	PUNCT
gsrj-29	67	87	and	and	CCONJ
gsrj-29	67	88	asymptomatically	asymptomatically	ADV
gsrj-29	67	89	,	,	PUNCT
gsrj-29	67	90	some	some	DET
gsrj-29	67	91	studies	study	NOUN
gsrj-29	67	92	even	even	ADV
gsrj-29	67	93	advocated	advocate	VERB
gsrj-29	67	94	for	for	ADP
gsrj-29	67	95	prioritizing	prioritize	VERB
gsrj-29	67	96	test	test	NOUN
gsrj-29	67	97	accessibility	accessibility	NOUN
gsrj-29	67	98	,	,	PUNCT
gsrj-29	67	99	frequency	frequency	NOUN
gsrj-29	67	100	,	,	PUNCT
gsrj-29	67	101	and	and	CCONJ
gsrj-29	67	102	sample	sample	NOUN
gsrj-29	67	103	-	-	PUNCT
gsrj-29	67	104	to	to	ADP
gsrj-29	67	105	-	-	PUNCT
gsrj-29	67	106	answer	answer	VERB
gsrj-29	67	107	reporting	reporting	NOUN
gsrj-29	67	108	time	time	NOUN
gsrj-29	67	109	over	over	ADP
gsrj-29	67	110	accuracy	accuracy	NOUN
gsrj-29	67	111	of	of	ADP
gsrj-29	67	112	positive	positive	ADJ
gsrj-29	67	113	results.28	results.28	NOUN
gsrj-29	67	114	the	the	DET
gsrj-29	67	115	gold	gold	ADJ
gsrj-29	67	116	standard	standard	NOUN
gsrj-29	67	117	for	for	ADP
gsrj-29	67	118	diagnostic	diagnostic	ADJ
gsrj-29	67	119	testing	testing	NOUN
gsrj-29	67	120	of	of	ADP
gsrj-29	67	121	sars	sar	NOUN
gsrj-29	67	122	-	-	PUNCT
gsrj-29	67	123	cov-2	cov-2	PART
gsrj-29	67	124	is	be	AUX
gsrj-29	67	125	the	the	DET
gsrj-29	67	126	real	real	ADJ
gsrj-29	67	127	-	-	PUNCT
gsrj-29	67	128	time	time	NOUN
gsrj-29	67	129	reversetranscription	reversetranscription	NOUN
gsrj-29	67	130	polymerase	polymerase	NOUN
gsrj-29	67	131	chain	chain	NOUN
gsrj-29	67	132	reaction	reaction	NOUN
gsrj-29	67	133	(	(	PUNCT
gsrj-29	67	134	rtpcr	rtpcr	NOUN
gsrj-29	67	135	)	)	PUNCT
gsrj-29	67	136	method.29	method.29	NOUN
gsrj-29	67	137	however	however	ADV
gsrj-29	67	138	,	,	PUNCT
gsrj-29	67	139	this	this	DET
gsrj-29	67	140	method	method	NOUN
gsrj-29	67	141	is	be	AUX
gsrj-29	67	142	not	not	PART
gsrj-29	67	143	without	without	ADP
gsrj-29	67	144	its	its	PRON
gsrj-29	67	145	many	many	ADJ
gsrj-29	67	146	challenges	challenge	NOUN
gsrj-29	67	147	.	.	PUNCT
gsrj-29	68	1	rt	rt	ADJ
gsrj-29	68	2	-	-	PUNCT
gsrj-29	68	3	pcr	pcr	ADJ
gsrj-29	68	4	tests	test	NOUN
gsrj-29	68	5	require	require	VERB
gsrj-29	68	6	specialized	specialized	ADJ
gsrj-29	68	7	and	and	CCONJ
gsrj-29	68	8	expensive	expensive	ADJ
gsrj-29	68	9	equipment	equipment	NOUN
gsrj-29	68	10	,	,	PUNCT
gsrj-29	68	11	a	a	DET
gsrj-29	68	12	complex	complex	ADJ
gsrj-29	68	13	molecular	molecular	ADJ
gsrj-29	68	14	laboratory	laboratory	NOUN
gsrj-29	68	15	,	,	PUNCT
gsrj-29	68	16	and	and	CCONJ
gsrj-29	68	17	highly	highly	ADV
gsrj-29	68	18	trained	train	VERB
gsrj-29	68	19	personnel.30	personnel.30	NOUN
gsrj-29	68	20	comparatively	comparatively	ADV
gsrj-29	68	21	,	,	PUNCT
gsrj-29	68	22	they	they	PRON
gsrj-29	68	23	are	be	AUX
gsrj-29	68	24	laborious	laborious	ADJ
gsrj-29	68	25	and	and	CCONJ
gsrj-29	68	26	expensive	expensive	ADJ
gsrj-29	68	27	tests.31	tests.31	NOUN
gsrj-29	68	28	moreover	moreover	ADV
gsrj-29	68	29	,	,	PUNCT
gsrj-29	68	30	they	they	PRON
gsrj-29	68	31	can	can	AUX
gsrj-29	68	32	produce	produce	VERB
gsrj-29	68	33	false	false	ADJ
gsrj-29	68	34	negative	negative	ADJ
gsrj-29	68	35	results,32	results,32	NOUN
gsrj-29	68	36	may	may	AUX
gsrj-29	68	37	decrease	decrease	VERB
gsrj-29	68	38	in	in	ADP
gsrj-29	68	39	sensitivity	sensitivity	NOUN
gsrj-29	68	40	five	five	NUM
gsrj-29	68	41	days	day	NOUN
gsrj-29	68	42	after	after	ADP
gsrj-29	68	43	onset	onset	NOUN
gsrj-29	68	44	of	of	ADP
gsrj-29	68	45	symptoms,33	symptoms,33	PRON
gsrj-29	68	46	and	and	CCONJ
gsrj-29	68	47	are	be	AUX
gsrj-29	68	48	susceptible	susceptible	ADJ
gsrj-29	68	49	to	to	ADP
gsrj-29	68	50	errors	error	NOUN
gsrj-29	68	51	in	in	ADP
gsrj-29	68	52	sample	sample	NOUN
gsrj-29	68	53	collection.34	collection.34	NOUN
gsrj-29	68	54	other	other	ADJ
gsrj-29	68	55	common	common	ADJ
gsrj-29	68	56	tests	test	NOUN
gsrj-29	68	57	such	such	ADJ
gsrj-29	68	58	as	as	ADP
gsrj-29	68	59	enzyme	enzyme	NOUN
gsrj-29	68	60	-	-	PUNCT
gsrj-29	68	61	linked	link	VERB
gsrj-29	68	62	immunosorbent	immunosorbent	ADJ
gsrj-29	68	63	assays	assay	NOUN
gsrj-29	68	64	(	(	PUNCT
gsrj-29	68	65	elisa	elisa	NOUN
gsrj-29	68	66	)	)	PUNCT
gsrj-29	68	67	and	and	CCONJ
gsrj-29	68	68	rapid	rapid	ADJ
gsrj-29	68	69	antigen	antigen	NOUN
gsrj-29	68	70	and	and	CCONJ
gsrj-29	68	71	antibody	antibody	NOUN
gsrj-29	68	72	tests	test	NOUN
gsrj-29	68	73	are	be	AUX
gsrj-29	68	74	significantly	significantly	ADV
gsrj-29	68	75	cheaper	cheap	ADJ
gsrj-29	68	76	in	in	ADP
gsrj-29	68	77	comparison	comparison	NOUN
gsrj-29	68	78	to	to	ADP
gsrj-29	68	79	the	the	DET
gsrj-29	68	80	gold	gold	NOUN
gsrj-29	68	81	standard	standard	PROPN
gsrj-29	68	82	rt	rt	PROPN
gsrj-29	68	83	-	-	PUNCT
gsrj-29	68	84	pcr	pcr	PROPN
gsrj-29	68	85	test	test	NOUN
gsrj-29	68	86	,	,	PUNCT
gsrj-29	68	87	but	but	CCONJ
gsrj-29	68	88	they	they	PRON
gsrj-29	68	89	suffer	suffer	VERB
gsrj-29	68	90	in	in	ADP
gsrj-29	68	91	terms	term	NOUN
gsrj-29	68	92	of	of	ADP
gsrj-29	68	93	accuracy	accuracy	NOUN
gsrj-29	68	94	and	and	CCONJ
gsrj-29	68	95	exhibit	exhibit	VERB
gsrj-29	68	96	particularly	particularly	ADV
gsrj-29	68	97	low	low	ADJ
gsrj-29	68	98	sensitivity	sensitivity	NOUN
gsrj-29	68	99	in	in	ADP
gsrj-29	68	100	the	the	DET
gsrj-29	68	101	onset	onset	NOUN
gsrj-29	68	102	and	and	CCONJ
gsrj-29	68	103	first	first	ADJ
gsrj-29	68	104	few	few	ADJ
gsrj-29	68	105	days	day	NOUN
gsrj-29	68	106	of	of	ADP
gsrj-29	68	107	illness.35	illness.35	NOUN
gsrj-29	68	108	rapid	rapid	ADJ
gsrj-29	68	109	antigen	antigen	NOUN
gsrj-29	68	110	and	and	CCONJ
gsrj-29	68	111	antibody	antibody	NOUN
gsrj-29	68	112	tests	test	NOUN
gsrj-29	68	113	are	be	AUX
gsrj-29	68	114	advantageous	advantageous	ADJ
gsrj-29	68	115	in	in	ADP
gsrj-29	68	116	accessibility	accessibility	NOUN
gsrj-29	68	117	for	for	ADP
gsrj-29	68	118	point	point	NOUN
gsrj-29	68	119	of	of	ADP
gsrj-29	68	120	care	care	NOUN
gsrj-29	68	121	and	and	CCONJ
gsrj-29	68	122	low	low	ADJ
gsrj-29	68	123	sample	sample	NOUN
gsrj-29	68	124	-	-	PUNCT
gsrj-29	68	125	toanswer	toanswer	NOUN
gsrj-29	68	126	reporting	reporting	NOUN
gsrj-29	68	127	time	time	NOUN
gsrj-29	68	128	(	(	PUNCT
gsrj-29	68	129	20	20	NUM
gsrj-29	68	130	-	-	SYM
gsrj-29	68	131	60	60	NUM
gsrj-29	68	132	minutes	minute	NOUN
gsrj-29	68	133	)	)	PUNCT
gsrj-29	68	134	,	,	PUNCT
gsrj-29	68	135	but	but	CCONJ
gsrj-29	68	136	suffer	suffer	VERB
gsrj-29	68	137	in	in	ADP
gsrj-29	68	138	sensitivity	sensitivity	NOUN
gsrj-29	68	139	at	at	ADP
gsrj-29	68	140	50	50	NUM
gsrj-29	68	141	%	%	NOUN
gsrj-29	68	142	in	in	ADP
gsrj-29	68	143	comparison	comparison	NOUN
gsrj-29	68	144	to	to	ADP
gsrj-29	68	145	rt	rt	NOUN
gsrj-29	68	146	-	-	PUNCT
gsrj-29	68	147	pcr	pcr	NOUN
gsrj-29	68	148	.	.	PUNCT
gsrj-29	69	1	36	36	NUM
gsrj-29	69	2	furthermore	furthermore	ADV
gsrj-29	69	3	,	,	PUNCT
gsrj-29	69	4	such	such	DET
gsrj-29	69	5	an	an	DET
gsrj-29	69	6	unprecedented	unprecedented	ADJ
gsrj-29	69	7	demand	demand	NOUN
gsrj-29	69	8	for	for	ADP
gsrj-29	69	9	diagnostic	diagnostic	ADJ
gsrj-29	69	10	tests	test	NOUN
gsrj-29	69	11	amidst	amidst	ADP
gsrj-29	69	12	the	the	DET
gsrj-29	69	13	covid-19	covid-19	PROPN
gsrj-29	69	14	pandemic	pandemic	NOUN
gsrj-29	69	15	led	lead	VERB
gsrj-29	69	16	to	to	ADP
gsrj-29	69	17	a	a	DET
gsrj-29	69	18	shortage	shortage	NOUN
gsrj-29	69	19	in	in	ADP
gsrj-29	69	20	recommended	recommend	VERB
gsrj-29	69	21	testing	testing	NOUN
gsrj-29	69	22	supply.37	supply.37	VERB
gsrj-29	69	23	these	these	DET
gsrj-29	69	24	limiting	limit	VERB
gsrj-29	69	25	factors	factor	NOUN
gsrj-29	69	26	for	for	ADP
gsrj-29	69	27	the	the	DET
gsrj-29	69	28	gold	gold	NOUN
gsrj-29	69	29	standard	standard	PROPN
gsrj-29	69	30	rt	rt	PROPN
gsrj-29	69	31	-	-	PUNCT
gsrj-29	69	32	pcr	pcr	NOUN
gsrj-29	69	33	test	test	NOUN
gsrj-29	69	34	made	make	VERB
gsrj-29	69	35	it	it	PRON
gsrj-29	69	36	difficult	difficult	ADJ
gsrj-29	69	37	to	to	PART
gsrj-29	69	38	scale	scale	VERB
gsrj-29	69	39	up	up	ADP
gsrj-29	69	40	manufacturing	manufacturing	NOUN
gsrj-29	69	41	to	to	ADP
gsrj-29	69	42	a	a	DET
gsrj-29	69	43	level	level	NOUN
gsrj-29	69	44	concordant	concordant	ADJ
gsrj-29	69	45	with	with	ADP
gsrj-29	69	46	high	high	ADJ
gsrj-29	69	47	demand	demand	NOUN
gsrj-29	69	48	,	,	PUNCT
gsrj-29	69	49	often	often	ADV
gsrj-29	69	50	resulting	result	VERB
gsrj-29	69	51	in	in	ADP
gsrj-29	69	52	test	test	NOUN
gsrj-29	69	53	shortages	shortage	NOUN
gsrj-29	69	54	and	and	CCONJ
gsrj-29	69	55	prolonged	prolonged	ADJ
gsrj-29	69	56	sample	sample	NOUN
gsrj-29	69	57	-	-	PUNCT
gsrj-29	69	58	to	to	ADP
gsrj-29	69	59	-	-	PUNCT
gsrj-29	69	60	answer	answer	VERB
gsrj-29	69	61	reporting	reporting	NOUN
gsrj-29	69	62	time	time	NOUN
gsrj-29	69	63	.	.	PUNCT
gsrj-29	70	1	according	accord	VERB
gsrj-29	70	2	to	to	ADP
gsrj-29	70	3	the	the	DET
gsrj-29	70	4	infectious	infectious	ADJ
gsrj-29	70	5	diseases	disease	NOUN
gsrj-29	70	6	society	society	NOUN
gsrj-29	70	7	of	of	ADP
gsrj-29	70	8	america	america	PROPN
gsrj-29	70	9	,	,	PUNCT
gsrj-29	70	10	test	test	NOUN
gsrj-29	70	11	availability	availability	NOUN
gsrj-29	70	12	and	and	CCONJ
gsrj-29	70	13	a	a	DET
gsrj-29	70	14	sample	sample	NOUN
gsrj-29	70	15	-	-	PUNCT
gsrj-29	70	16	to	to	ADP
gsrj-29	70	17	-	-	PUNCT
gsrj-29	70	18	answer	answer	VERB
gsrj-29	70	19	responding	respond	VERB
gsrj-29	70	20	time	time	NOUN
gsrj-29	70	21	within	within	ADP
gsrj-29	70	22	an	an	DET
gsrj-29	70	23	hour	hour	NOUN
gsrj-29	70	24	are	be	AUX
gsrj-29	70	25	critical	critical	ADJ
gsrj-29	70	26	conditions	condition	NOUN
gsrj-29	70	27	for	for	ADP
gsrj-29	70	28	a	a	DET
gsrj-29	70	29	positive	positive	ADJ
gsrj-29	70	30	bearing	bearing	NOUN
gsrj-29	70	31	on	on	ADP
gsrj-29	70	32	care	care	NOUN
gsrj-29	70	33	and	and	CCONJ
gsrj-29	70	34	disease	disease	NOUN
gsrj-29	70	35	containment.38	containment.38	NOUN
gsrj-29	70	36	in	in	ADP
gsrj-29	70	37	many	many	ADJ
gsrj-29	70	38	cases	case	NOUN
gsrj-29	70	39	,	,	PUNCT
gsrj-29	70	40	diagnostic	diagnostic	ADJ
gsrj-29	70	41	strategies	strategy	NOUN
gsrj-29	70	42	for	for	ADP
gsrj-29	70	43	adequate	adequate	ADJ
gsrj-29	70	44	surveillance	surveillance	NOUN
gsrj-29	70	45	did	do	AUX
gsrj-29	70	46	not	not	PART
gsrj-29	70	47	meet	meet	VERB
gsrj-29	70	48	standards	standard	NOUN
gsrj-29	70	49	for	for	ADP
gsrj-29	70	50	the	the	DET
gsrj-29	70	51	containment	containment	NOUN
gsrj-29	70	52	of	of	ADP
gsrj-29	70	53	covid-19	covid-19	PROPN
gsrj-29	70	54	.	.	PUNCT
gsrj-29	71	1	furthermore	furthermore	ADV
gsrj-29	71	2	,	,	PUNCT
gsrj-29	71	3	gold	gold	NOUN
gsrj-29	71	4	standard	standard	NOUN
gsrj-29	71	5	rt	rt	PROPN
gsrj-29	71	6	-	-	PUNCT
gsrj-29	71	7	pcr	pcr	ADJ
gsrj-29	71	8	tests	test	NOUN
gsrj-29	71	9	do	do	AUX
gsrj-29	71	10	n’t	not	PART
gsrj-29	71	11	have	have	VERB
gsrj-29	71	12	the	the	DET
gsrj-29	71	13	practicality	practicality	NOUN
gsrj-29	71	14	to	to	PART
gsrj-29	71	15	provide	provide	VERB
gsrj-29	71	16	diagnostic	diagnostic	ADJ
gsrj-29	71	17	testing	testing	NOUN
gsrj-29	71	18	to	to	ADP
gsrj-29	71	19	endemic	endemic	ADJ
gsrj-29	71	20	regions	region	NOUN
gsrj-29	71	21	with	with	ADP
gsrj-29	71	22	limited	limited	ADJ
gsrj-29	71	23	resources	resource	NOUN
gsrj-29	71	24	.	.	PUNCT
gsrj-29	72	1	without	without	ADP
gsrj-29	72	2	specialized	specialized	ADJ
gsrj-29	72	3	equipment	equipment	NOUN
gsrj-29	72	4	,	,	PUNCT
gsrj-29	72	5	facilities	facility	NOUN
gsrj-29	72	6	,	,	PUNCT
gsrj-29	72	7	and	and	CCONJ
gsrj-29	72	8	scientists	scientist	NOUN
gsrj-29	72	9	,	,	PUNCT
gsrj-29	72	10	these	these	DET
gsrj-29	72	11	complex	complex	ADJ
gsrj-29	72	12	diagnostic	diagnostic	ADJ
gsrj-29	72	13	methods	method	NOUN
gsrj-29	72	14	become	become	VERB
gsrj-29	72	15	null	null	ADJ
gsrj-29	72	16	.	.	PUNCT
gsrj-29	73	1	however	however	ADV
gsrj-29	73	2	,	,	PUNCT
gsrj-29	73	3	diagnostics	diagnostic	NOUN
gsrj-29	73	4	remain	remain	VERB
gsrj-29	73	5	critical	critical	ADJ
gsrj-29	73	6	to	to	PART
gsrj-29	73	7	limit	limit	VERB
gsrj-29	73	8	the	the	DET
gsrj-29	73	9	disease	disease	NOUN
gsrj-29	73	10	spread	spread	VERB
gsrj-29	73	11	outside	outside	ADV
gsrj-29	73	12	of	of	ADP
gsrj-29	73	13	these	these	DET
gsrj-29	73	14	endemic	endemic	ADJ
gsrj-29	73	15	localities	locality	NOUN
gsrj-29	73	16	and	and	CCONJ
gsrj-29	73	17	prevent	prevent	VERB
gsrj-29	73	18	global	global	ADJ
gsrj-29	73	19	or	or	CCONJ
gsrj-29	73	20	national	national	ADJ
gsrj-29	73	21	outbreak.39	outbreak.39	NOUN
gsrj-29	73	22	yet	yet	ADV
gsrj-29	73	23	,	,	PUNCT
gsrj-29	73	24	countries	country	NOUN
gsrj-29	73	25	face	face	VERB
gsrj-29	73	26	both	both	CCONJ
gsrj-29	73	27	global	global	ADJ
gsrj-29	73	28	and	and	CCONJ
gsrj-29	73	29	national	national	ADJ
gsrj-29	73	30	disparities	disparity	NOUN
gsrj-29	73	31	in	in	ADP
gsrj-29	73	32	relevant	relevant	ADJ
gsrj-29	73	33	resource	resource	NOUN
gsrj-29	73	34	distribution	distribution	NOUN
gsrj-29	73	35	,	,	PUNCT
gsrj-29	73	36	including	include	VERB
gsrj-29	73	37	in	in	ADP
gsrj-29	73	38	diagnostic	diagnostic	ADJ
gsrj-29	73	39	tests	test	NOUN
gsrj-29	73	40	and	and	CCONJ
gsrj-29	73	41	related	relate	VERB
gsrj-29	73	42	29	29	NUM
gsrj-29	73	43	georgetown	georgetown	PROPN
gsrj-29	73	44	scientific	scientific	PROPN
gsrj-29	73	45	research	research	NOUN
gsrj-29	73	46	journal	journal	NOUN
gsrj-29	73	47	infrastructure	infrastructure	NOUN
gsrj-29	73	48	or	or	CCONJ
gsrj-29	73	49	intellectual	intellectual	ADJ
gsrj-29	73	50	property.40	property.40	NOUN
gsrj-29	73	51	the	the	DET
gsrj-29	73	52	need	need	NOUN
gsrj-29	73	53	for	for	ADP
gsrj-29	73	54	a	a	DET
gsrj-29	73	55	sars	sar	NOUN
gsrj-29	73	56	-	-	PUNCT
gsrj-29	73	57	cov-2	cov-2	PART
gsrj-29	73	58	test	test	NOUN
gsrj-29	73	59	that	that	PRON
gsrj-29	73	60	was	be	AUX
gsrj-29	73	61	rapid	rapid	ADJ
gsrj-29	73	62	,	,	PUNCT
gsrj-29	73	63	widely	widely	ADV
gsrj-29	73	64	distributed	distribute	VERB
gsrj-29	73	65	,	,	PUNCT
gsrj-29	73	66	accessible	accessible	ADJ
gsrj-29	73	67	,	,	PUNCT
gsrj-29	73	68	and	and	CCONJ
gsrj-29	73	69	accurate	accurate	ADJ
gsrj-29	73	70	drove	drive	VERB
gsrj-29	73	71	a	a	DET
gsrj-29	73	72	dedicated	dedicated	ADJ
gsrj-29	73	73	effort	effort	NOUN
gsrj-29	73	74	to	to	PART
gsrj-29	73	75	explore	explore	VERB
gsrj-29	73	76	innovative	innovative	ADJ
gsrj-29	73	77	diagnostic	diagnostic	ADJ
gsrj-29	73	78	strategies	strategy	NOUN
gsrj-29	73	79	to	to	PART
gsrj-29	73	80	address	address	VERB
gsrj-29	73	81	the	the	DET
gsrj-29	73	82	covid-19	covid-19	PROPN
gsrj-29	73	83	crisis	crisis	NOUN
gsrj-29	73	84	.	.	PUNCT
gsrj-29	74	1	a	a	DET
gsrj-29	74	2	particularly	particularly	ADV
gsrj-29	74	3	innovative	innovative	ADJ
gsrj-29	74	4	strategy	strategy	NOUN
gsrj-29	74	5	was	be	AUX
gsrj-29	74	6	crispr	crispr	ADJ
gsrj-29	74	7	diagnostics	diagnostic	NOUN
gsrj-29	74	8	,	,	PUNCT
gsrj-29	74	9	which	which	PRON
gsrj-29	74	10	relies	rely	VERB
gsrj-29	74	11	on	on	ADP
gsrj-29	74	12	the	the	DET
gsrj-29	74	13	technology	technology	NOUN
gsrj-29	74	14	’s	’s	PART
gsrj-29	74	15	ability	ability	NOUN
gsrj-29	74	16	to	to	PART
gsrj-29	74	17	locate	locate	VERB
gsrj-29	74	18	specific	specific	ADJ
gsrj-29	74	19	segments	segment	NOUN
gsrj-29	74	20	of	of	ADP
gsrj-29	74	21	viral	viral	ADJ
gsrj-29	74	22	rna	rna	NOUN
gsrj-29	74	23	.	.	PUNCT
gsrj-29	75	1	the	the	DET
gsrj-29	75	2	approach	approach	NOUN
gsrj-29	75	3	was	be	AUX
gsrj-29	75	4	established	establish	VERB
gsrj-29	75	5	in	in	ADP
gsrj-29	75	6	2017	2017	NUM
gsrj-29	75	7	,	,	PUNCT
gsrj-29	75	8	and	and	CCONJ
gsrj-29	75	9	it	it	PRON
gsrj-29	75	10	harnesses	harness	VERB
gsrj-29	75	11	crispr	crispr	ADJ
gsrj-29	75	12	to	to	PART
gsrj-29	75	13	quickly	quickly	ADV
gsrj-29	75	14	pinpoint	pinpoint	VERB
gsrj-29	75	15	and	and	CCONJ
gsrj-29	75	16	tag	tag	VERB
gsrj-29	75	17	pathogenic	pathogenic	ADJ
gsrj-29	75	18	rna	rna	NOUN
gsrj-29	75	19	without	without	ADP
gsrj-29	75	20	rna	rna	NOUN
gsrj-29	75	21	isolation	isolation	NOUN
gsrj-29	75	22	required	require	VERB
gsrj-29	75	23	by	by	ADP
gsrj-29	75	24	rtpcr	rtpcr	ADJ
gsrj-29	75	25	tests	test	NOUN
gsrj-29	75	26	that	that	PRON
gsrj-29	75	27	adds	add	VERB
gsrj-29	75	28	hours	hour	NOUN
gsrj-29	75	29	to	to	ADP
gsrj-29	75	30	the	the	DET
gsrj-29	75	31	process.41	process.41	NOUN
gsrj-29	75	32	,	,	PUNCT
gsrj-29	75	33	42	42	NUM
gsrj-29	75	34	diagnostic	diagnostic	ADJ
gsrj-29	75	35	testing	testing	NOUN
gsrj-29	75	36	platforms	platform	NOUN
gsrj-29	75	37	used	use	VERB
gsrj-29	75	38	this	this	DET
gsrj-29	75	39	strategy	strategy	NOUN
gsrj-29	75	40	to	to	PART
gsrj-29	75	41	deliver	deliver	VERB
gsrj-29	75	42	multiplexed	multiplexed	ADJ
gsrj-29	75	43	and	and	CCONJ
gsrj-29	75	44	accurate	accurate	ADJ
gsrj-29	75	45	detection	detection	NOUN
gsrj-29	75	46	of	of	ADP
gsrj-29	75	47	viral	viral	ADJ
gsrj-29	75	48	presence	presence	NOUN
gsrj-29	75	49	,	,	PUNCT
gsrj-29	75	50	with	with	ADP
gsrj-29	75	51	the	the	DET
gsrj-29	75	52	reporting	reporting	NOUN
gsrj-29	75	53	mechanism	mechanism	NOUN
gsrj-29	75	54	being	be	AUX
gsrj-29	75	55	lateral	lateral	ADJ
gsrj-29	75	56	flow	flow	NOUN
gsrj-29	75	57	for	for	ADP
gsrj-29	75	58	an	an	DET
gsrj-29	75	59	easy	easy	ADJ
gsrj-29	75	60	visual	visual	ADJ
gsrj-29	75	61	readout.43	readout.43	NOUN
gsrj-29	75	62	these	these	DET
gsrj-29	75	63	platforms	platform	NOUN
gsrj-29	75	64	are	be	AUX
gsrj-29	75	65	called	call	VERB
gsrj-29	75	66	“	"	PUNCT
gsrj-29	75	67	sherlock	sherlock	NOUN
gsrj-29	75	68	”	"	PUNCT
gsrj-29	75	69	(	(	PUNCT
gsrj-29	75	70	specific	specific	ADJ
gsrj-29	75	71	high	high	ADJ
gsrj-29	75	72	-	-	PUNCT
gsrj-29	75	73	sensitivity	sensitivity	NOUN
gsrj-29	75	74	enzymatic	enzymatic	ADJ
gsrj-29	75	75	reporter	reporter	NOUN
gsrj-29	75	76	unlocking	unlocking	NOUN
gsrj-29	75	77	)	)	PUNCT
gsrj-29	75	78	and	and	CCONJ
gsrj-29	75	79	“	"	PUNCT
gsrj-29	75	80	detectr	detectr	ADJ
gsrj-29	75	81	”	"	PUNCT
gsrj-29	75	82	(	(	PUNCT
gsrj-29	75	83	dna	dna	NOUN
gsrj-29	75	84	endonuclease	endonuclease	NOUN
gsrj-29	75	85	-	-	PUNCT
gsrj-29	75	86	targeted	target	VERB
gsrj-29	75	87	crispr	crispr	ADJ
gsrj-29	75	88	trans	tran	NOUN
gsrj-29	75	89	reporter).43	reporter).43	PROPN
gsrj-29	75	90	,	,	PUNCT
gsrj-29	75	91	44	44	NUM
gsrj-29	75	92	upon	upon	SCONJ
gsrj-29	75	93	development	development	NOUN
gsrj-29	75	94	,	,	PUNCT
gsrj-29	75	95	the	the	DET
gsrj-29	75	96	diagnostic	diagnostic	ADJ
gsrj-29	75	97	approach	approach	NOUN
gsrj-29	75	98	was	be	AUX
gsrj-29	75	99	discussed	discuss	VERB
gsrj-29	75	100	as	as	ADP
gsrj-29	75	101	a	a	DET
gsrj-29	75	102	revolutionary	revolutionary	ADJ
gsrj-29	75	103	method	method	NOUN
gsrj-29	75	104	to	to	PART
gsrj-29	75	105	limit	limit	VERB
gsrj-29	75	106	disease	disease	NOUN
gsrj-29	75	107	outbreaks	outbreak	NOUN
gsrj-29	75	108	of	of	ADP
gsrj-29	75	109	numerous	numerous	ADJ
gsrj-29	75	110	infectious	infectious	ADJ
gsrj-29	75	111	and	and	CCONJ
gsrj-29	75	112	non	non	ADJ
gsrj-29	75	113	-	-	ADJ
gsrj-29	75	114	infectious	infectious	ADJ
gsrj-29	75	115	diseases	disease	NOUN
gsrj-29	75	116	,	,	PUNCT
gsrj-29	75	117	but	but	CCONJ
gsrj-29	75	118	was	be	AUX
gsrj-29	75	119	never	never	ADV
gsrj-29	75	120	approved	approve	VERB
gsrj-29	75	121	for	for	ADP
gsrj-29	75	122	use.45	use.45	DET
gsrj-29	75	123	the	the	DET
gsrj-29	75	124	covid-19	covid-19	PROPN
gsrj-29	75	125	pandemic	pandemic	NOUN
gsrj-29	75	126	reoriented	reorient	VERB
gsrj-29	75	127	defensive	defensive	ADJ
gsrj-29	75	128	efforts	effort	NOUN
gsrj-29	75	129	within	within	ADP
gsrj-29	75	130	the	the	DET
gsrj-29	75	131	scientific	scientific	ADJ
gsrj-29	75	132	community	community	NOUN
gsrj-29	75	133	towards	towards	ADP
gsrj-29	75	134	the	the	DET
gsrj-29	75	135	common	common	ADJ
gsrj-29	75	136	objective	objective	NOUN
gsrj-29	75	137	to	to	PART
gsrj-29	75	138	end	end	VERB
gsrj-29	75	139	the	the	DET
gsrj-29	75	140	public	public	ADJ
gsrj-29	75	141	health	health	NOUN
gsrj-29	75	142	crisis	crisis	NOUN
gsrj-29	75	143	,	,	PUNCT
gsrj-29	75	144	as	as	SCONJ
gsrj-29	75	145	is	be	AUX
gsrj-29	75	146	the	the	DET
gsrj-29	75	147	case	case	NOUN
gsrj-29	75	148	for	for	ADP
gsrj-29	75	149	the	the	DET
gsrj-29	75	150	efforts	effort	NOUN
gsrj-29	75	151	of	of	ADP
gsrj-29	75	152	sherlock	sherlock	NOUN
gsrj-29	75	153	and	and	CCONJ
gsrj-29	75	154	mammoth	mammoth	ADJ
gsrj-29	75	155	biosciences	bioscience	NOUN
gsrj-29	75	156	.	.	PUNCT
gsrj-29	76	1	these	these	DET
gsrj-29	76	2	companies	company	NOUN
gsrj-29	76	3	emphasized	emphasize	VERB
gsrj-29	76	4	fast	fast	ADJ
gsrj-29	76	5	,	,	PUNCT
gsrj-29	76	6	simple	simple	ADJ
gsrj-29	76	7	,	,	PUNCT
gsrj-29	76	8	and	and	CCONJ
gsrj-29	76	9	accessible	accessible	ADJ
gsrj-29	76	10	diagnostic	diagnostic	ADJ
gsrj-29	76	11	capabilities	capability	NOUN
gsrj-29	76	12	,	,	PUNCT
gsrj-29	76	13	and	and	CCONJ
gsrj-29	76	14	touted	tout	VERB
gsrj-29	76	15	the	the	DET
gsrj-29	76	16	promise	promise	NOUN
gsrj-29	76	17	of	of	ADP
gsrj-29	76	18	their	their	PRON
gsrj-29	76	19	crispr	crispr	ADJ
gsrj-29	76	20	platform	platform	NOUN
gsrj-29	76	21	to	to	PART
gsrj-29	76	22	do	do	VERB
gsrj-29	76	23	so	so	ADV
gsrj-29	76	24	,	,	PUNCT
gsrj-29	76	25	even	even	ADV
gsrj-29	76	26	ceding	cede	VERB
gsrj-29	76	27	bitter	bitter	ADJ
gsrj-29	76	28	patent	patent	NOUN
gsrj-29	76	29	contentions	contention	NOUN
gsrj-29	76	30	for	for	ADP
gsrj-29	76	31	public	public	ADJ
gsrj-29	76	32	health.46	health.46	PROPN
gsrj-29	76	33	thus	thus	ADV
gsrj-29	76	34	,	,	PUNCT
gsrj-29	76	35	sherlock	sherlock	NOUN
gsrj-29	76	36	and	and	CCONJ
gsrj-29	76	37	mammoth	mammoth	ADJ
gsrj-29	76	38	biosciences	bioscience	NOUN
gsrj-29	76	39	adapted	adapt	VERB
gsrj-29	76	40	sherlock	sherlock	NOUN
gsrj-29	76	41	and	and	CCONJ
gsrj-29	76	42	detectr	detectr	ADJ
gsrj-29	76	43	for	for	ADP
gsrj-29	76	44	sars	sars	PROPN
gsrj-29	76	45	-	-	PUNCT
gsrj-29	76	46	cov2.47	cov2.47	PROPN
gsrj-29	76	47	,	,	PUNCT
gsrj-29	76	48	48	48	NUM
gsrj-29	76	49	,	,	PUNCT
gsrj-29	76	50	in	in	ADP
gsrj-29	76	51	march	march	PROPN
gsrj-29	76	52	2020	2020	NUM
gsrj-29	76	53	,	,	PUNCT
gsrj-29	76	54	sherlock	sherlock	PROPN
gsrj-29	76	55	made	make	VERB
gsrj-29	76	56	history	history	NOUN
gsrj-29	76	57	with	with	ADP
gsrj-29	76	58	the	the	DET
gsrj-29	76	59	first	first	ADJ
gsrj-29	76	60	fda	fda	PROPN
gsrj-29	76	61	authorized	authorize	VERB
gsrj-29	76	62	use	use	NOUN
gsrj-29	76	63	of	of	ADP
gsrj-29	76	64	crispr	crispr	NOUN
gsrj-29	76	65	in	in	ADP
gsrj-29	76	66	a	a	DET
gsrj-29	76	67	diagnostic	diagnostic	ADJ
gsrj-29	76	68	application	application	NOUN
gsrj-29	76	69	,	,	PUNCT
gsrj-29	76	70	and	and	CCONJ
gsrj-29	76	71	was	be	AUX
gsrj-29	76	72	soon	soon	ADV
gsrj-29	76	73	followed	follow	VERB
gsrj-29	76	74	by	by	ADP
gsrj-29	76	75	mammoth.49	mammoth.49	NOUN
gsrj-29	76	76	,	,	PUNCT
gsrj-29	76	77	50	50	NUM
gsrj-29	76	78	when	when	SCONJ
gsrj-29	76	79	compared	compare	VERB
gsrj-29	76	80	with	with	ADP
gsrj-29	76	81	the	the	DET
gsrj-29	76	82	gold	gold	ADJ
gsrj-29	76	83	standard	standard	NOUN
gsrj-29	76	84	rtpcr	rtpcr	ADJ
gsrj-29	76	85	tests	test	NOUN
gsrj-29	76	86	,	,	PUNCT
gsrj-29	76	87	crispr	crispr	ADJ
gsrj-29	76	88	diagnostic	diagnostic	ADJ
gsrj-29	76	89	platforms	platform	NOUN
gsrj-29	76	90	were	be	AUX
gsrj-29	76	91	successful	successful	ADJ
gsrj-29	76	92	in	in	ADP
gsrj-29	76	93	offering	offer	VERB
gsrj-29	76	94	several	several	ADJ
gsrj-29	76	95	advantages	advantage	NOUN
gsrj-29	76	96	.	.	PUNCT
gsrj-29	77	1	these	these	DET
gsrj-29	77	2	advantages	advantage	NOUN
gsrj-29	77	3	did	do	AUX
gsrj-29	77	4	not	not	PART
gsrj-29	77	5	sacrifice	sacrifice	VERB
gsrj-29	77	6	accuracy	accuracy	NOUN
gsrj-29	77	7	.	.	PUNCT
gsrj-29	78	1	the	the	DET
gsrj-29	78	2	sherlock	sherlock	NOUN
gsrj-29	78	3	adaptation	adaptation	NOUN
gsrj-29	78	4	for	for	ADP
gsrj-29	78	5	sars	sar	NOUN
gsrj-29	78	6	-	-	PUNCT
gsrj-29	78	7	cov-2	cov-2	NUM
gsrj-29	78	8	is	be	AUX
gsrj-29	78	9	said	say	VERB
gsrj-29	78	10	to	to	PART
gsrj-29	78	11	take	take	VERB
gsrj-29	78	12	an	an	DET
gsrj-29	78	13	hour	hour	NOUN
gsrj-29	78	14	with	with	ADP
gsrj-29	78	15	results	result	NOUN
gsrj-29	78	16	that	that	PRON
gsrj-29	78	17	are	be	AUX
gsrj-29	78	18	100	100	NUM
gsrj-29	78	19	%	%	NOUN
gsrj-29	78	20	concordant	concordant	ADJ
gsrj-29	78	21	with	with	ADP
gsrj-29	78	22	the	the	DET
gsrj-29	78	23	gold	gold	ADJ
gsrj-29	78	24	standard	standard	PROPN
gsrj-29	78	25	rt	rt	PROPN
gsrj-29	78	26	-	-	PUNCT
gsrj-29	78	27	pcr	pcr	ADJ
gsrj-29	78	28	tests	test	NOUN
gsrj-29	78	29	in	in	ADP
gsrj-29	78	30	terms	term	NOUN
gsrj-29	78	31	of	of	ADP
gsrj-29	78	32	sensitivity	sensitivity	NOUN
gsrj-29	78	33	and	and	CCONJ
gsrj-29	78	34	specificity.51	specificity.51	NOUN
gsrj-29	78	35	the	the	DET
gsrj-29	78	36	detectr	detectr	ADJ
gsrj-29	78	37	adaptation	adaptation	NOUN
gsrj-29	78	38	for	for	ADP
gsrj-29	78	39	sars	sar	NOUN
gsrj-29	78	40	-	-	PUNCT
gsrj-29	78	41	cov-2	cov-2	NUM
gsrj-29	78	42	is	be	AUX
gsrj-29	78	43	said	say	VERB
gsrj-29	78	44	to	to	PART
gsrj-29	78	45	be	be	AUX
gsrj-29	78	46	an	an	DET
gsrj-29	78	47	even	even	ADV
gsrj-29	78	48	faster	fast	ADJ
gsrj-29	78	49	sample	sample	NOUN
gsrj-29	78	50	-	-	PUNCT
gsrj-29	78	51	to	to	ADP
gsrj-29	78	52	-	-	PUNCT
gsrj-29	78	53	answer	answer	VERB
gsrj-29	78	54	alternative	alternative	NOUN
gsrj-29	78	55	to	to	ADP
gsrj-29	78	56	the	the	DET
gsrj-29	78	57	gold	gold	NOUN
gsrj-29	78	58	standard	standard	PROPN
gsrj-29	78	59	rt	rt	PROPN
gsrj-29	78	60	-	-	PUNCT
gsrj-29	78	61	pcr	pcr	ADJ
gsrj-29	78	62	tests	test	NOUN
gsrj-29	78	63	,	,	PUNCT
gsrj-29	78	64	yet	yet	CCONJ
gsrj-29	78	65	still	still	ADV
gsrj-29	78	66	comparable	comparable	ADJ
gsrj-29	78	67	in	in	ADP
gsrj-29	78	68	terms	term	NOUN
gsrj-29	78	69	of	of	ADP
gsrj-29	78	70	accuracy	accuracy	NOUN
gsrj-29	78	71	at	at	ADP
gsrj-29	78	72	95	95	NUM
gsrj-29	78	73	%	%	NOUN
gsrj-29	78	74	positive	positive	ADJ
gsrj-29	78	75	predictive	predictive	ADJ
gsrj-29	78	76	agreement	agreement	NOUN
gsrj-29	78	77	and	and	CCONJ
gsrj-29	78	78	100	100	NUM
gsrj-29	78	79	%	%	NOUN
gsrj-29	78	80	negative	negative	ADJ
gsrj-29	78	81	predictive	predictive	ADJ
gsrj-29	78	82	agreement.48	agreement.48	PROPN
gsrj-29	78	83	both	both	CCONJ
gsrj-29	78	84	sherlock	sherlock	NOUN
gsrj-29	78	85	and	and	CCONJ
gsrj-29	78	86	detectr	detectr	ADJ
gsrj-29	78	87	exhibit	exhibit	NOUN
gsrj-29	78	88	accessibility	accessibility	NOUN
gsrj-29	78	89	with	with	ADP
gsrj-29	78	90	ease	ease	NOUN
gsrj-29	78	91	-	-	PUNCT
gsrj-29	78	92	of	of	ADP
gsrj-29	78	93	-	-	PUNCT
gsrj-29	78	94	use	use	NOUN
gsrj-29	78	95	qualities	quality	NOUN
gsrj-29	78	96	such	such	ADJ
gsrj-29	78	97	as	as	ADP
gsrj-29	78	98	visual	visual	ADJ
gsrj-29	78	99	readouts	readout	NOUN
gsrj-29	78	100	that	that	PRON
gsrj-29	78	101	are	be	AUX
gsrj-29	78	102	converted	convert	VERB
gsrj-29	78	103	from	from	ADP
gsrj-29	78	104	crispr	crispr	ADJ
gsrj-29	78	105	activity.52	activity.52	NOUN
gsrj-29	78	106	furthermore	furthermore	ADV
gsrj-29	78	107	,	,	PUNCT
gsrj-29	78	108	neither	neither	DET
gsrj-29	78	109	test	test	NOUN
gsrj-29	78	110	requires	require	VERB
gsrj-29	78	111	complicated	complicated	ADJ
gsrj-29	78	112	processing	processing	NOUN
gsrj-29	78	113	through	through	ADP
gsrj-29	78	114	specialized	specialized	ADJ
gsrj-29	78	115	equipment.53	equipment.53	NOUN
gsrj-29	78	116	because	because	SCONJ
gsrj-29	78	117	of	of	ADP
gsrj-29	78	118	this	this	DET
gsrj-29	78	119	profound	profound	ADJ
gsrj-29	78	120	accessibility	accessibility	NOUN
gsrj-29	78	121	,	,	PUNCT
gsrj-29	78	122	these	these	DET
gsrj-29	78	123	diagnostic	diagnostic	ADJ
gsrj-29	78	124	platforms	platform	NOUN
gsrj-29	78	125	are	be	AUX
gsrj-29	78	126	also	also	ADV
gsrj-29	78	127	promising	promise	VERB
gsrj-29	78	128	for	for	ADP
gsrj-29	78	129	important	important	ADJ
gsrj-29	78	130	point	point	NOUN
gsrj-29	78	131	-	-	PUNCT
gsrj-29	78	132	of	of	ADP
gsrj-29	78	133	-	-	PUNCT
gsrj-29	78	134	care	care	NOUN
gsrj-29	78	135	testing	testing	NOUN
gsrj-29	78	136	for	for	ADP
gsrj-29	78	137	sars	sar	NOUN
gsrj-29	78	138	-	-	PUNCT
gsrj-29	78	139	cov-2	cov-2	NOUN
gsrj-29	78	140	,	,	PUNCT
gsrj-29	78	141	although	although	SCONJ
gsrj-29	78	142	they	they	PRON
gsrj-29	78	143	currently	currently	ADV
gsrj-29	78	144	lack	lack	VERB
gsrj-29	78	145	bureaucratic	bureaucratic	ADJ
gsrj-29	78	146	authorization	authorization	NOUN
gsrj-29	78	147	outside	outside	ADP
gsrj-29	78	148	of	of	ADP
gsrj-29	78	149	laboratory	laboratory	NOUN
gsrj-29	78	150	settings.48	settings.48	PROPN
gsrj-29	78	151	,	,	PUNCT
gsrj-29	78	152	54	54	NUM
gsrj-29	78	153	these	these	DET
gsrj-29	78	154	crispr	crispr	ADJ
gsrj-29	78	155	diagnostic	diagnostic	ADJ
gsrj-29	78	156	platforms	platform	NOUN
gsrj-29	78	157	continue	continue	VERB
gsrj-29	78	158	to	to	PART
gsrj-29	78	159	be	be	AUX
gsrj-29	78	160	promising	promise	VERB
gsrj-29	78	161	with	with	ADP
gsrj-29	78	162	each	each	DET
gsrj-29	78	163	development	development	NOUN
gsrj-29	78	164	.	.	PUNCT
gsrj-29	79	1	led	lead	VERB
gsrj-29	79	2	by	by	ADP
gsrj-29	79	3	crispr	crispr	ADJ
gsrj-29	79	4	co	co	NOUN
gsrj-29	79	5	-	-	NOUN
gsrj-29	79	6	inventor	inventor	ADJ
gsrj-29	79	7	jennifer	jennifer	PROPN
gsrj-29	79	8	doudna	doudna	PROPN
gsrj-29	79	9	,	,	PUNCT
gsrj-29	79	10	one	one	NUM
gsrj-29	79	11	research	research	NOUN
gsrj-29	79	12	team	team	NOUN
gsrj-29	79	13	has	have	AUX
gsrj-29	79	14	recently	recently	ADV
gsrj-29	79	15	developed	develop	VERB
gsrj-29	79	16	a	a	DET
gsrj-29	79	17	crispr	crispr	NOUN
gsrj-29	79	18	based	base	VERB
gsrj-29	79	19	diagnostic	diagnostic	ADJ
gsrj-29	79	20	approach	approach	NOUN
gsrj-29	79	21	that	that	PRON
gsrj-29	79	22	can	can	AUX
gsrj-29	79	23	detect	detect	VERB
gsrj-29	79	24	sarscov-2	sarscov-2	NOUN
gsrj-29	79	25	using	use	VERB
gsrj-29	79	26	only	only	ADV
gsrj-29	79	27	a	a	DET
gsrj-29	79	28	crispr	crispr	ADJ
gsrj-29	79	29	solution	solution	NOUN
gsrj-29	79	30	and	and	CCONJ
gsrj-29	79	31	a	a	DET
gsrj-29	79	32	mobile	mobile	ADJ
gsrj-29	79	33	phone.55	phone.55	NOUN
gsrj-29	79	34	the	the	DET
gsrj-29	79	35	tests	test	NOUN
gsrj-29	79	36	mix	mix	VERB
gsrj-29	79	37	a	a	DET
gsrj-29	79	38	saliva	saliva	NOUN
gsrj-29	79	39	sample	sample	NOUN
gsrj-29	79	40	with	with	ADP
gsrj-29	79	41	a	a	DET
gsrj-29	79	42	chemical	chemical	ADJ
gsrj-29	79	43	solution	solution	NOUN
gsrj-29	79	44	that	that	PRON
gsrj-29	79	45	allows	allow	VERB
gsrj-29	79	46	the	the	DET
gsrj-29	79	47	crispr	crispr	ADJ
gsrj-29	79	48	-	-	PUNCT
gsrj-29	79	49	cas	cas	NOUN
gsrj-29	79	50	system	system	NOUN
gsrj-29	79	51	to	to	PART
gsrj-29	79	52	identify	identify	VERB
gsrj-29	79	53	and	and	CCONJ
gsrj-29	79	54	cut	cut	VERB
gsrj-29	79	55	a	a	DET
gsrj-29	79	56	sequence	sequence	NOUN
gsrj-29	79	57	of	of	ADP
gsrj-29	79	58	sarscov-2	sarscov-2	NUM
gsrj-29	79	59	,	,	PUNCT
gsrj-29	79	60	then	then	ADV
gsrj-29	79	61	emit	emit	VERB
gsrj-29	79	62	a	a	DET
gsrj-29	79	63	glow	glow	NOUN
gsrj-29	79	64	strong	strong	ADJ
gsrj-29	79	65	enough	enough	ADV
gsrj-29	79	66	for	for	ADP
gsrj-29	79	67	a	a	DET
gsrj-29	79	68	smartphone	smartphone	NOUN
gsrj-29	79	69	to	to	ADP
gsrj-29	79	70	detect.56	detect.56	NOUN
gsrj-29	79	71	thus	thus	ADV
gsrj-29	79	72	,	,	PUNCT
gsrj-29	79	73	the	the	DET
gsrj-29	79	74	test	test	NOUN
gsrj-29	79	75	is	be	AUX
gsrj-29	79	76	not	not	PART
gsrj-29	79	77	only	only	ADV
gsrj-29	79	78	capable	capable	ADJ
gsrj-29	79	79	of	of	ADP
gsrj-29	79	80	reporting	report	VERB
gsrj-29	79	81	a	a	DET
gsrj-29	79	82	positive	positive	ADJ
gsrj-29	79	83	or	or	CCONJ
gsrj-29	79	84	negative	negative	ADJ
gsrj-29	79	85	result	result	NOUN
gsrj-29	79	86	,	,	PUNCT
gsrj-29	79	87	but	but	CCONJ
gsrj-29	79	88	also	also	ADV
gsrj-29	79	89	a	a	DET
gsrj-29	79	90	quantitative	quantitative	ADJ
gsrj-29	79	91	estimation	estimation	NOUN
gsrj-29	79	92	of	of	ADP
gsrj-29	79	93	the	the	DET
gsrj-29	79	94	viral	viral	ADJ
gsrj-29	79	95	load	load	NOUN
gsrj-29	79	96	by	by	ADP
gsrj-29	79	97	measuring	measure	VERB
gsrj-29	79	98	the	the	DET
gsrj-29	79	99	amount	amount	NOUN
gsrj-29	79	100	of	of	ADP
gsrj-29	79	101	sars	sar	NOUN
gsrj-29	79	102	-	-	PUNCT
gsrj-29	79	103	cov-2	cov-2	NOUN
gsrj-29	79	104	rna.57	rna.57	ADJ
gsrj-29	79	105	advances	advance	NOUN
gsrj-29	79	106	like	like	ADP
gsrj-29	79	107	these	these	DET
gsrj-29	79	108	aim	aim	NOUN
gsrj-29	79	109	to	to	PART
gsrj-29	79	110	bring	bring	VERB
gsrj-29	79	111	the	the	DET
gsrj-29	79	112	user	user	NOUN
gsrj-29	79	113	interface	interface	NOUN
gsrj-29	79	114	even	even	ADV
gsrj-29	79	115	closer	close	ADV
gsrj-29	79	116	to	to	ADP
gsrj-29	79	117	patients	patient	NOUN
gsrj-29	79	118	and	and	CCONJ
gsrj-29	79	119	practitioners	practitioner	NOUN
gsrj-29	79	120	to	to	PART
gsrj-29	79	121	fill	fill	VERB
gsrj-29	79	122	the	the	DET
gsrj-29	79	123	gaps	gap	NOUN
gsrj-29	79	124	in	in	ADP
gsrj-29	79	125	diagnostic	diagnostic	ADJ
gsrj-29	79	126	testing	testing	NOUN
gsrj-29	79	127	by	by	ADP
gsrj-29	79	128	making	make	VERB
gsrj-29	79	129	diagnosis	diagnosis	NOUN
gsrj-29	79	130	user	user	NOUN
gsrj-29	79	131	-	-	PUNCT
gsrj-29	79	132	friendly	friendly	ADJ
gsrj-29	79	133	,	,	PUNCT
gsrj-29	79	134	inexpensive	inexpensive	ADJ
gsrj-29	79	135	,	,	PUNCT
gsrj-29	79	136	and	and	CCONJ
gsrj-29	79	137	portable	portable	ADJ
gsrj-29	79	138	.	.	PUNCT
gsrj-29	80	1	crispr	crispr	ADJ
gsrj-29	80	2	diagnostic	diagnostic	ADJ
gsrj-29	80	3	platforms	platform	NOUN
gsrj-29	80	4	underscored	underscore	VERB
gsrj-29	80	5	notable	notable	ADJ
gsrj-29	80	6	lessons	lesson	NOUN
gsrj-29	80	7	learned	learn	VERB
gsrj-29	80	8	in	in	ADP
gsrj-29	80	9	how	how	SCONJ
gsrj-29	80	10	crispr	crispr	ADJ
gsrj-29	80	11	technologies	technology	NOUN
gsrj-29	80	12	can	can	AUX
gsrj-29	80	13	be	be	AUX
gsrj-29	80	14	harnessed	harness	VERB
gsrj-29	80	15	to	to	PART
gsrj-29	80	16	aid	aid	VERB
gsrj-29	80	17	current	current	ADJ
gsrj-29	80	18	and	and	CCONJ
gsrj-29	80	19	30	30	NUM
gsrj-29	80	20	georgetown	georgetown	PROPN
gsrj-29	80	21	scientific	scientific	PROPN
gsrj-29	80	22	research	research	PROPN
gsrj-29	80	23	journal	journal	PROPN
gsrj-29	80	24	future	future	ADJ
gsrj-29	80	25	public	public	ADJ
gsrj-29	80	26	health	health	NOUN
gsrj-29	80	27	responses	response	NOUN
gsrj-29	80	28	.	.	PUNCT
gsrj-29	81	1	crispr	crispr	ADJ
gsrj-29	81	2	diagnostic	diagnostic	ADJ
gsrj-29	81	3	platforms	platform	NOUN
gsrj-29	81	4	can	can	AUX
gsrj-29	81	5	provide	provide	VERB
gsrj-29	81	6	tests	test	NOUN
gsrj-29	81	7	that	that	PRON
gsrj-29	81	8	are	be	AUX
gsrj-29	81	9	more	more	ADV
gsrj-29	81	10	accessible	accessible	ADJ
gsrj-29	81	11	in	in	ADP
gsrj-29	81	12	terms	term	NOUN
gsrj-29	81	13	of	of	ADP
gsrj-29	81	14	ease	ease	NOUN
gsrj-29	81	15	of	of	ADP
gsrj-29	81	16	use	use	NOUN
gsrj-29	81	17	and	and	CCONJ
gsrj-29	81	18	cost	cost	NOUN
gsrj-29	81	19	,	,	PUNCT
gsrj-29	81	20	rapid	rapid	ADJ
gsrj-29	81	21	in	in	ADP
gsrj-29	81	22	terms	term	NOUN
gsrj-29	81	23	of	of	ADP
gsrj-29	81	24	sample	sample	NOUN
gsrj-29	81	25	-	-	PUNCT
gsrj-29	81	26	to	to	ADP
gsrj-29	81	27	-	-	PUNCT
gsrj-29	81	28	answer	answer	VERB
gsrj-29	81	29	reporting	reporting	NOUN
gsrj-29	81	30	time	time	NOUN
gsrj-29	81	31	,	,	PUNCT
gsrj-29	81	32	and	and	CCONJ
gsrj-29	81	33	convenient	convenient	ADJ
gsrj-29	81	34	in	in	ADP
gsrj-29	81	35	terms	term	NOUN
gsrj-29	81	36	of	of	ADP
gsrj-29	81	37	point	point	NOUN
gsrj-29	81	38	-	-	PUNCT
gsrj-29	81	39	of	of	ADP
gsrj-29	81	40	-	-	PUNCT
gsrj-29	81	41	care	care	NOUN
gsrj-29	81	42	,	,	PUNCT
gsrj-29	81	43	all	all	ADV
gsrj-29	81	44	without	without	ADP
gsrj-29	81	45	sacrificing	sacrifice	VERB
gsrj-29	81	46	specificity	specificity	NOUN
gsrj-29	81	47	or	or	CCONJ
gsrj-29	81	48	sensitivity	sensitivity	NOUN
gsrj-29	81	49	.	.	PUNCT
gsrj-29	82	1	moreover	moreover	ADV
gsrj-29	82	2	,	,	PUNCT
gsrj-29	82	3	crispr	crispr	PROPN
gsrj-29	82	4	’s	’s	PART
gsrj-29	82	5	diagnostic	diagnostic	ADJ
gsrj-29	82	6	potential	potential	NOUN
gsrj-29	82	7	to	to	PART
gsrj-29	82	8	provide	provide	VERB
gsrj-29	82	9	unprecedented	unprecedented	ADJ
gsrj-29	82	10	accessibility	accessibility	NOUN
gsrj-29	82	11	is	be	AUX
gsrj-29	82	12	actively	actively	ADV
gsrj-29	82	13	being	be	AUX
gsrj-29	82	14	discussed	discuss	VERB
gsrj-29	82	15	,	,	PUNCT
gsrj-29	82	16	including	include	VERB
gsrj-29	82	17	over	over	ADP
gsrj-29	82	18	-	-	PUNCT
gsrj-29	82	19	the	the	DET
gsrj-29	82	20	-	-	PUNCT
gsrj-29	82	21	counter	counter	NOUN
gsrj-29	82	22	crispr	crispr	NOUN
gsrj-29	82	23	-	-	PUNCT
gsrj-29	82	24	based	base	VERB
gsrj-29	82	25	tests	test	NOUN
gsrj-29	82	26	for	for	ADP
gsrj-29	82	27	diseases	disease	NOUN
gsrj-29	82	28	such	such	ADJ
gsrj-29	82	29	as	as	ADP
gsrj-29	82	30	covid19	covid19	NOUN
gsrj-29	82	31	,	,	PUNCT
gsrj-29	82	32	hpv	hpv	PROPN
gsrj-29	82	33	,	,	PUNCT
gsrj-29	82	34	hiv	hiv	PROPN
gsrj-29	82	35	,	,	PUNCT
gsrj-29	82	36	malaria	malaria	NOUN
gsrj-29	82	37	,	,	PUNCT
gsrj-29	82	38	zika	zika	X
gsrj-29	82	39	,	,	PUNCT
gsrj-29	82	40	tuberculosis	tuberculosis	NOUN
gsrj-29	82	41	,	,	PUNCT
gsrj-29	82	42	dengue	dengue	NOUN
gsrj-29	82	43	,	,	PUNCT
gsrj-29	82	44	and	and	CCONJ
gsrj-29	82	45	even	even	ADV
gsrj-29	82	46	cancer	cancer	NOUN
gsrj-29	82	47	.	.	PUNCT
gsrj-29	83	1	58	58	NUM
gsrj-29	83	2	,	,	PUNCT
gsrj-29	83	3	59	59	NUM
gsrj-29	83	4	crispr	crispr	NOUN
gsrj-29	83	5	is	be	AUX
gsrj-29	83	6	naturally	naturally	ADV
gsrj-29	83	7	multiplexed	multiplexed	ADJ
gsrj-29	83	8	,	,	PUNCT
gsrj-29	83	9	meaning	mean	VERB
gsrj-29	83	10	that	that	SCONJ
gsrj-29	83	11	it	it	PRON
gsrj-29	83	12	has	have	VERB
gsrj-29	83	13	high	high	ADJ
gsrj-29	83	14	potential	potential	NOUN
gsrj-29	83	15	for	for	ADP
gsrj-29	83	16	providing	provide	VERB
gsrj-29	83	17	a	a	DET
gsrj-29	83	18	test	test	NOUN
gsrj-29	83	19	that	that	PRON
gsrj-29	83	20	detects	detect	VERB
gsrj-29	83	21	multiple	multiple	ADJ
gsrj-29	83	22	diseases	disease	NOUN
gsrj-29	83	23	at	at	ADP
gsrj-29	83	24	once.60	once.60	PROPN
gsrj-29	83	25	clearly	clearly	ADV
gsrj-29	83	26	,	,	PUNCT
gsrj-29	83	27	crispr	crispr	PROPN
gsrj-29	83	28	can	can	AUX
gsrj-29	83	29	support	support	VERB
gsrj-29	83	30	pathogenic	pathogenic	ADJ
gsrj-29	83	31	surveillance	surveillance	NOUN
gsrj-29	83	32	regimes	regime	NOUN
gsrj-29	83	33	by	by	ADP
gsrj-29	83	34	providing	provide	VERB
gsrj-29	83	35	more	more	ADV
gsrj-29	83	36	efficient	efficient	ADJ
gsrj-29	83	37	avenues	avenue	NOUN
gsrj-29	83	38	for	for	ADP
gsrj-29	83	39	identification	identification	NOUN
gsrj-29	83	40	of	of	ADP
gsrj-29	83	41	infected	infected	ADJ
gsrj-29	83	42	individuals	individual	NOUN
gsrj-29	83	43	,	,	PUNCT
gsrj-29	83	44	thereby	thereby	ADV
gsrj-29	83	45	optimizing	optimize	VERB
gsrj-29	83	46	contact	contact	NOUN
gsrj-29	83	47	tracing	tracing	NOUN
gsrj-29	83	48	and	and	CCONJ
gsrj-29	83	49	disease	disease	NOUN
gsrj-29	83	50	management	management	NOUN
gsrj-29	83	51	efforts	effort	NOUN
gsrj-29	83	52	.	.	PUNCT
gsrj-29	84	1	these	these	DET
gsrj-29	84	2	factors	factor	NOUN
gsrj-29	84	3	by	by	ADP
gsrj-29	84	4	which	which	PRON
gsrj-29	84	5	crispr	crispr	NOUN
gsrj-29	84	6	can	can	AUX
gsrj-29	84	7	augment	augment	VERB
gsrj-29	84	8	the	the	DET
gsrj-29	84	9	standards	standard	NOUN
gsrj-29	84	10	of	of	ADP
gsrj-29	84	11	diagnostic	diagnostic	ADJ
gsrj-29	84	12	testing	testing	NOUN
gsrj-29	84	13	are	be	AUX
gsrj-29	84	14	all	all	PRON
gsrj-29	84	15	policy	policy	NOUN
gsrj-29	84	16	relevant	relevant	ADJ
gsrj-29	84	17	.	.	PUNCT
gsrj-29	85	1	crispr	crispr	PROPN
gsrj-29	85	2	diagnostic	diagnostic	ADJ
gsrj-29	85	3	testing	testing	NOUN
gsrj-29	85	4	is	be	AUX
gsrj-29	85	5	rapid	rapid	ADJ
gsrj-29	85	6	,	,	PUNCT
gsrj-29	85	7	simple	simple	ADJ
gsrj-29	85	8	,	,	PUNCT
gsrj-29	85	9	and	and	CCONJ
gsrj-29	85	10	cost	cost	NOUN
gsrj-29	85	11	-	-	PUNCT
gsrj-29	85	12	effective	effective	ADJ
gsrj-29	85	13	enough	enough	ADV
gsrj-29	85	14	to	to	PART
gsrj-29	85	15	concur	concur	VERB
gsrj-29	85	16	with	with	ADP
gsrj-29	85	17	a	a	DET
gsrj-29	85	18	timeline	timeline	NOUN
gsrj-29	85	19	relevant	relevant	ADJ
gsrj-29	85	20	to	to	ADP
gsrj-29	85	21	public	public	ADJ
gsrj-29	85	22	health	health	NOUN
gsrj-29	85	23	.	.	PUNCT
gsrj-29	86	1	whereas	whereas	SCONJ
gsrj-29	86	2	gold	gold	NOUN
gsrj-29	86	3	standard	standard	PROPN
gsrj-29	86	4	rt	rt	PROPN
gsrj-29	86	5	-	-	PUNCT
gsrj-29	86	6	pcr	pcr	NOUN
gsrj-29	86	7	sample	sample	NOUN
gsrj-29	86	8	-	-	PUNCT
gsrj-29	86	9	to	to	ADP
gsrj-29	86	10	-	-	PUNCT
gsrj-29	86	11	answer	answer	NOUN
gsrj-29	86	12	reporting	reporting	NOUN
gsrj-29	86	13	time	time	NOUN
gsrj-29	86	14	delays	delay	NOUN
gsrj-29	86	15	were	be	AUX
gsrj-29	86	16	largely	largely	ADV
gsrj-29	86	17	due	due	ADJ
gsrj-29	86	18	to	to	PART
gsrj-29	86	19	supply	supply	VERB
gsrj-29	86	20	chain	chain	NOUN
gsrj-29	86	21	issues	issue	NOUN
gsrj-29	86	22	for	for	ADP
gsrj-29	86	23	complicated	complicated	ADJ
gsrj-29	86	24	materials	material	NOUN
gsrj-29	86	25	and	and	CCONJ
gsrj-29	86	26	procedural	procedural	ADJ
gsrj-29	86	27	issues	issue	NOUN
gsrj-29	86	28	for	for	ADP
gsrj-29	86	29	complicated	complicated	ADJ
gsrj-29	86	30	processes	process	NOUN
gsrj-29	86	31	,	,	PUNCT
gsrj-29	86	32	crispr	crispr	ADJ
gsrj-29	86	33	tests	test	NOUN
gsrj-29	86	34	can	can	AUX
gsrj-29	86	35	help	help	VERB
gsrj-29	86	36	limit	limit	VERB
gsrj-29	86	37	pathogenic	pathogenic	ADJ
gsrj-29	86	38	spread	spread	NOUN
gsrj-29	86	39	and	and	CCONJ
gsrj-29	86	40	optimize	optimize	VERB
gsrj-29	86	41	contact	contact	NOUN
gsrj-29	86	42	tracing	trace	VERB
gsrj-29	86	43	by	by	ADP
gsrj-29	86	44	offering	offer	VERB
gsrj-29	86	45	in	in	ADP
gsrj-29	86	46	-	-	PUNCT
gsrj-29	86	47	clinic	clinic	NOUN
gsrj-29	86	48	results	result	NOUN
gsrj-29	86	49	.	.	PUNCT
gsrj-29	87	1	it	it	PRON
gsrj-29	87	2	is	be	AUX
gsrj-29	87	3	perhaps	perhaps	ADV
gsrj-29	87	4	equally	equally	ADV
gsrj-29	87	5	important	important	ADJ
gsrj-29	87	6	that	that	SCONJ
gsrj-29	87	7	detection	detection	NOUN
gsrj-29	87	8	methods	method	NOUN
gsrj-29	87	9	prioritize	prioritize	VERB
gsrj-29	87	10	point	point	NOUN
gsrj-29	87	11	of	of	ADP
gsrj-29	87	12	care	care	NOUN
gsrj-29	87	13	and	and	CCONJ
gsrj-29	87	14	accessibility	accessibility	NOUN
gsrj-29	87	15	so	so	SCONJ
gsrj-29	87	16	that	that	SCONJ
gsrj-29	87	17	testing	testing	NOUN
gsrj-29	87	18	strategies	strategy	NOUN
gsrj-29	87	19	can	can	AUX
gsrj-29	87	20	feasibly	feasibly	ADV
gsrj-29	87	21	extend	extend	VERB
gsrj-29	87	22	to	to	AUX
gsrj-29	87	23	lowand	lowand	VERB
gsrj-29	87	24	lower	lower	ADV
gsrj-29	87	25	-	-	PUNCT
gsrj-29	87	26	middle	middle	ADJ
gsrj-29	87	27	-	-	PUNCT
gsrj-29	87	28	income	income	NOUN
gsrj-29	87	29	countries	country	NOUN
gsrj-29	87	30	,	,	PUNCT
gsrj-29	87	31	remote	remote	ADJ
gsrj-29	87	32	communities	community	NOUN
gsrj-29	87	33	that	that	PRON
gsrj-29	87	34	are	be	AUX
gsrj-29	87	35	hours	hour	NOUN
gsrj-29	87	36	away	away	ADV
gsrj-29	87	37	from	from	ADP
gsrj-29	87	38	the	the	DET
gsrj-29	87	39	nearest	near	ADJ
gsrj-29	87	40	health	health	NOUN
gsrj-29	87	41	provider	provider	NOUN
gsrj-29	87	42	,	,	PUNCT
gsrj-29	87	43	and	and	CCONJ
gsrj-29	87	44	any	any	DET
gsrj-29	87	45	other	other	ADJ
gsrj-29	87	46	locality	locality	NOUN
gsrj-29	87	47	with	with	ADP
gsrj-29	87	48	limited	limited	ADJ
gsrj-29	87	49	resources	resource	NOUN
gsrj-29	87	50	or	or	CCONJ
gsrj-29	87	51	lack	lack	NOUN
gsrj-29	87	52	of	of	ADP
gsrj-29	87	53	required	required	ADJ
gsrj-29	87	54	equipment	equipment	NOUN
gsrj-29	87	55	.	.	PUNCT
gsrj-29	88	1	this	this	DET
gsrj-29	88	2	accessibility	accessibility	NOUN
gsrj-29	88	3	factor	factor	NOUN
gsrj-29	88	4	of	of	ADP
gsrj-29	88	5	crispr	crispr	NOUN
gsrj-29	88	6	is	be	AUX
gsrj-29	88	7	extremely	extremely	ADV
gsrj-29	88	8	policy	policy	NOUN
gsrj-29	88	9	relevant	relevant	ADJ
gsrj-29	88	10	to	to	PART
gsrj-29	88	11	prevent	prevent	VERB
gsrj-29	88	12	pathogenic	pathogenic	ADJ
gsrj-29	88	13	spread	spread	VERB
gsrj-29	88	14	out	out	ADP
gsrj-29	88	15	of	of	ADP
gsrj-29	88	16	endemic	endemic	ADJ
gsrj-29	88	17	regions	region	NOUN
gsrj-29	88	18	by	by	ADP
gsrj-29	88	19	both	both	PRON
gsrj-29	88	20	limiting	limit	VERB
gsrj-29	88	21	the	the	DET
gsrj-29	88	22	outbreak	outbreak	NOUN
gsrj-29	88	23	within	within	ADP
gsrj-29	88	24	these	these	DET
gsrj-29	88	25	regions	region	NOUN
gsrj-29	88	26	and	and	CCONJ
gsrj-29	88	27	reducing	reduce	VERB
gsrj-29	88	28	the	the	DET
gsrj-29	88	29	need	need	NOUN
gsrj-29	88	30	to	to	PART
gsrj-29	88	31	travel	travel	VERB
gsrj-29	88	32	outside	outside	ADP
gsrj-29	88	33	of	of	ADP
gsrj-29	88	34	these	these	DET
gsrj-29	88	35	regions	region	NOUN
gsrj-29	88	36	.	.	PUNCT
gsrj-29	89	1	the	the	DET
gsrj-29	89	2	low	low	ADJ
gsrj-29	89	3	$	$	SYM
gsrj-29	89	4	1	1	NUM
gsrj-29	89	5	-	-	SYM
gsrj-29	89	6	2	2	NUM
gsrj-29	89	7	cost	cost	NOUN
gsrj-29	89	8	per	per	ADP
gsrj-29	89	9	test	test	NOUN
gsrj-29	89	10	would	would	AUX
gsrj-29	89	11	be	be	AUX
gsrj-29	89	12	feasible	feasible	ADJ
gsrj-29	89	13	for	for	ADP
gsrj-29	89	14	consumers	consumer	NOUN
gsrj-29	89	15	and	and	CCONJ
gsrj-29	89	16	national	national	ADJ
gsrj-29	89	17	testing	testing	NOUN
gsrj-29	89	18	programs	program	NOUN
gsrj-29	89	19	,	,	PUNCT
gsrj-29	89	20	expanding	expand	VERB
gsrj-29	89	21	testing	testing	NOUN
gsrj-29	89	22	capacity	capacity	NOUN
gsrj-29	89	23	in	in	ADP
gsrj-29	89	24	economic	economic	ADJ
gsrj-29	89	25	terms.61	terms.61	NOUN
gsrj-29	89	26	crispr	crispr	NOUN
gsrj-29	89	27	-	-	PUNCT
gsrj-29	89	28	based	base	VERB
gsrj-29	89	29	diagnostics	diagnostic	NOUN
gsrj-29	89	30	have	have	AUX
gsrj-29	89	31	not	not	PART
gsrj-29	89	32	been	be	AUX
gsrj-29	89	33	in	in	ADP
gsrj-29	89	34	effect	effect	NOUN
gsrj-29	89	35	for	for	ADP
gsrj-29	89	36	long	long	ADJ
gsrj-29	89	37	–	–	PUNCT
gsrj-29	89	38	–	–	PUNCT
gsrj-29	89	39	the	the	DET
gsrj-29	89	40	first	first	ADJ
gsrj-29	89	41	authorized	authorize	VERB
gsrj-29	89	42	use	use	NOUN
gsrj-29	89	43	of	of	ADP
gsrj-29	89	44	a	a	DET
gsrj-29	89	45	crispr	crispr	ADJ
gsrj-29	89	46	test	test	NOUN
gsrj-29	89	47	was	be	AUX
gsrj-29	89	48	in	in	ADP
gsrj-29	89	49	march	march	PROPN
gsrj-29	89	50	2020	2020	NUM
gsrj-29	89	51	.	.	PUNCT
gsrj-29	90	1	this	this	DET
gsrj-29	90	2	fact	fact	NOUN
gsrj-29	90	3	necessitates	necessitate	VERB
gsrj-29	90	4	more	more	ADJ
gsrj-29	90	5	studies	study	NOUN
gsrj-29	90	6	concerning	concern	VERB
gsrj-29	90	7	the	the	DET
gsrj-29	90	8	trade	trade	NOUN
gsrj-29	90	9	-	-	PUNCT
gsrj-29	90	10	off	off	NOUN
gsrj-29	90	11	between	between	ADP
gsrj-29	90	12	crispr	crispr	ADJ
gsrj-29	90	13	diagnostic	diagnostic	ADJ
gsrj-29	90	14	testing	testing	NOUN
gsrj-29	90	15	and	and	CCONJ
gsrj-29	90	16	alternatives	alternative	NOUN
gsrj-29	90	17	like	like	ADP
gsrj-29	90	18	gold	gold	NOUN
gsrj-29	90	19	standard	standard	PROPN
gsrj-29	90	20	rt	rt	PROPN
gsrj-29	90	21	-	-	PUNCT
gsrj-29	90	22	pcr	pcr	ADJ
gsrj-29	90	23	tests	test	NOUN
gsrj-29	90	24	,	,	PUNCT
gsrj-29	90	25	particularly	particularly	ADV
gsrj-29	90	26	in	in	ADP
gsrj-29	90	27	terms	term	NOUN
gsrj-29	90	28	of	of	ADP
gsrj-29	90	29	sensitivity	sensitivity	NOUN
gsrj-29	90	30	and	and	CCONJ
gsrj-29	90	31	specificity	specificity	NOUN
gsrj-29	90	32	.	.	PUNCT
gsrj-29	91	1	however	however	ADV
gsrj-29	91	2	,	,	PUNCT
gsrj-29	91	3	the	the	DET
gsrj-29	91	4	initial	initial	ADJ
gsrj-29	91	5	application	application	NOUN
gsrj-29	91	6	of	of	ADP
gsrj-29	91	7	crispr	crispr	NOUN
gsrj-29	91	8	for	for	ADP
gsrj-29	91	9	diagnostic	diagnostic	ADJ
gsrj-29	91	10	purposes	purpose	NOUN
gsrj-29	91	11	in	in	ADP
gsrj-29	91	12	the	the	DET
gsrj-29	91	13	covid-19	covid-19	PROPN
gsrj-29	91	14	pandemic	pandemic	NOUN
gsrj-29	91	15	is	be	AUX
gsrj-29	91	16	promising	promise	VERB
gsrj-29	91	17	.	.	PUNCT
gsrj-29	92	1	the	the	DET
gsrj-29	92	2	faster	fast	ADJ
gsrj-29	92	3	,	,	PUNCT
gsrj-29	92	4	more	more	ADV
gsrj-29	92	5	accurate	accurate	ADJ
gsrj-29	92	6	,	,	PUNCT
gsrj-29	92	7	more	more	ADV
gsrj-29	92	8	accessible	accessible	ADJ
gsrj-29	92	9	,	,	PUNCT
gsrj-29	92	10	easier	easy	ADJ
gsrj-29	92	11	,	,	PUNCT
gsrj-29	92	12	and	and	CCONJ
gsrj-29	92	13	cheaper	cheap	ADJ
gsrj-29	92	14	diagnostic	diagnostic	ADJ
gsrj-29	92	15	potential	potential	NOUN
gsrj-29	92	16	of	of	ADP
gsrj-29	92	17	crispr	crispr	NOUN
gsrj-29	92	18	could	could	AUX
gsrj-29	92	19	improve	improve	VERB
gsrj-29	92	20	the	the	DET
gsrj-29	92	21	pathogenic	pathogenic	ADJ
gsrj-29	92	22	surveillance	surveillance	NOUN
gsrj-29	92	23	of	of	ADP
gsrj-29	92	24	the	the	DET
gsrj-29	92	25	covid-19	covid-19	PROPN
gsrj-29	92	26	pandemic	pandemic	NOUN
gsrj-29	92	27	and	and	CCONJ
gsrj-29	92	28	be	be	AUX
gsrj-29	92	29	a	a	DET
gsrj-29	92	30	boon	boon	NOUN
gsrj-29	92	31	for	for	ADP
gsrj-29	92	32	global	global	ADJ
gsrj-29	92	33	biopreparedness	biopreparedness	NOUN
gsrj-29	92	34	and	and	CCONJ
gsrj-29	92	35	confrontation	confrontation	NOUN
gsrj-29	92	36	of	of	ADP
gsrj-29	92	37	diseases	disease	NOUN
gsrj-29	92	38	.	.	PUNCT
gsrj-29	93	1	3.2	3.2	NUM
gsrj-29	93	2	.	.	X
gsrj-29	93	3	crispr	crispr	PROPN
gsrj-29	93	4	assisted	assist	VERB
gsrj-29	93	5	research	research	NOUN
gsrj-29	93	6	the	the	DET
gsrj-29	93	7	necessity	necessity	NOUN
gsrj-29	93	8	for	for	ADP
gsrj-29	93	9	rapid	rapid	ADJ
gsrj-29	93	10	research	research	NOUN
gsrj-29	93	11	on	on	ADP
gsrj-29	93	12	sars	sar	NOUN
gsrj-29	93	13	-	-	PUNCT
gsrj-29	93	14	cov2	cov2	PROPN
gsrj-29	93	15	facilitated	facilitate	VERB
gsrj-29	93	16	by	by	ADP
gsrj-29	93	17	crispr	crispr	ADJ
gsrj-29	93	18	-	-	PUNCT
gsrj-29	93	19	cas	cas	NOUN
gsrj-29	93	20	systems	system	NOUN
gsrj-29	93	21	enabled	enable	VERB
gsrj-29	93	22	quicker	quick	ADJ
gsrj-29	93	23	development	development	NOUN
gsrj-29	93	24	rates	rate	NOUN
gsrj-29	93	25	for	for	ADP
gsrj-29	93	26	public	public	ADJ
gsrj-29	93	27	health	health	NOUN
gsrj-29	93	28	countermeasures	countermeasure	NOUN
gsrj-29	93	29	against	against	ADP
gsrj-29	93	30	infectious	infectious	ADJ
gsrj-29	93	31	pathogens	pathogen	NOUN
gsrj-29	93	32	.	.	PUNCT
gsrj-29	94	1	crispr	crispr	NOUN
gsrj-29	94	2	-	-	PUNCT
gsrj-29	94	3	cas	cas	NOUN
gsrj-29	94	4	assisted	assist	VERB
gsrj-29	94	5	screening	screening	NOUN
gsrj-29	94	6	is	be	AUX
gsrj-29	94	7	a	a	DET
gsrj-29	94	8	process	process	NOUN
gsrj-29	94	9	by	by	ADP
gsrj-29	94	10	which	which	PRON
gsrj-29	94	11	researchers	researcher	NOUN
gsrj-29	94	12	can	can	AUX
gsrj-29	94	13	inhibit	inhibit	VERB
gsrj-29	94	14	certain	certain	ADJ
gsrj-29	94	15	genetic	genetic	ADJ
gsrj-29	94	16	functions	function	NOUN
gsrj-29	94	17	in	in	ADP
gsrj-29	94	18	order	order	NOUN
gsrj-29	94	19	to	to	PART
gsrj-29	94	20	find	find	VERB
gsrj-29	94	21	the	the	DET
gsrj-29	94	22	equivalent	equivalent	NOUN
gsrj-29	94	23	of	of	ADP
gsrj-29	94	24	a	a	DET
gsrj-29	94	25	few	few	ADJ
gsrj-29	94	26	needles	needle	NOUN
gsrj-29	94	27	in	in	ADP
gsrj-29	94	28	a	a	DET
gsrj-29	94	29	haystack	haystack	NOUN
gsrj-29	94	30	of	of	ADP
gsrj-29	94	31	a	a	DET
gsrj-29	94	32	complex	complex	ADJ
gsrj-29	94	33	genome	genome	NOUN
gsrj-29	94	34	.	.	PUNCT
gsrj-29	95	1	researchers	researcher	NOUN
gsrj-29	95	2	often	often	ADV
gsrj-29	95	3	use	use	VERB
gsrj-29	95	4	this	this	DET
gsrj-29	95	5	crispr	crispr	ADJ
gsrj-29	95	6	“	"	PUNCT
gsrj-29	95	7	knock	knock	VERB
gsrj-29	95	8	-	-	PUNCT
gsrj-29	95	9	out	out	ADP
gsrj-29	95	10	”	"	PUNCT
gsrj-29	95	11	technique	technique	NOUN
gsrj-29	95	12	in	in	ADP
gsrj-29	95	13	order	order	NOUN
gsrj-29	95	14	to	to	PART
gsrj-29	95	15	identify	identify	VERB
gsrj-29	95	16	the	the	DET
gsrj-29	95	17	effect	effect	NOUN
gsrj-29	95	18	of	of	ADP
gsrj-29	95	19	key	key	ADJ
gsrj-29	95	20	genes	gene	NOUN
gsrj-29	95	21	.	.	PUNCT
gsrj-29	96	1	researchers	researcher	NOUN
gsrj-29	96	2	can	can	AUX
gsrj-29	96	3	also	also	ADV
gsrj-29	96	4	elicit	elicit	VERB
gsrj-29	96	5	gain	gain	NOUN
gsrj-29	96	6	of	of	ADP
gsrj-29	96	7	function	function	NOUN
gsrj-29	96	8	by	by	ADP
gsrj-29	96	9	inserting	insert	VERB
gsrj-29	96	10	a	a	DET
gsrj-29	96	11	genetic	genetic	ADJ
gsrj-29	96	12	sequence	sequence	NOUN
gsrj-29	96	13	that	that	PRON
gsrj-29	96	14	the	the	DET
gsrj-29	96	15	dna	dna	PROPN
gsrj-29	96	16	repair	repair	NOUN
gsrj-29	96	17	mechanisms	mechanism	NOUN
gsrj-29	96	18	can	can	AUX
gsrj-29	96	19	utilize	utilize	VERB
gsrj-29	96	20	as	as	ADP
gsrj-29	96	21	a	a	DET
gsrj-29	96	22	template	template	NOUN
gsrj-29	96	23	when	when	SCONJ
gsrj-29	96	24	repairing	repair	VERB
gsrj-29	96	25	the	the	DET
gsrj-29	96	26	cuts	cut	NOUN
gsrj-29	96	27	made	make	VERB
gsrj-29	96	28	by	by	ADP
gsrj-29	96	29	the	the	DET
gsrj-29	96	30	cas	cas	PROPN
gsrj-29	96	31	proteins	protein	NOUN
gsrj-29	96	32	.	.	PUNCT
gsrj-29	97	1	these	these	DET
gsrj-29	97	2	crispr	crispr	ADJ
gsrj-29	97	3	“	"	PUNCT
gsrj-29	97	4	knock	knock	VERB
gsrj-29	97	5	-	-	PUNCT
gsrj-29	97	6	in	in	ADP
gsrj-29	97	7	”	"	PUNCT
gsrj-29	97	8	techniques	technique	NOUN
gsrj-29	97	9	can	can	AUX
gsrj-29	97	10	be	be	AUX
gsrj-29	97	11	utilized	utilize	VERB
gsrj-29	97	12	,	,	PUNCT
gsrj-29	97	13	for	for	ADP
gsrj-29	97	14	instance	instance	NOUN
gsrj-29	97	15	,	,	PUNCT
gsrj-29	97	16	to	to	PART
gsrj-29	97	17	make	make	VERB
gsrj-29	97	18	experimental	experimental	ADJ
gsrj-29	97	19	procedures	procedure	NOUN
gsrj-29	97	20	more	more	ADV
gsrj-29	97	21	applicable	applicable	ADJ
gsrj-29	97	22	to	to	ADP
gsrj-29	97	23	a	a	DET
gsrj-29	97	24	desired	desire	VERB
gsrj-29	97	25	target	target	NOUN
gsrj-29	97	26	.	.	PUNCT
gsrj-29	98	1	during	during	ADP
gsrj-29	98	2	the	the	DET
gsrj-29	98	3	covid-19	covid-19	PROPN
gsrj-29	98	4	pandemic	pandemic	NOUN
gsrj-29	98	5	,	,	PUNCT
gsrj-29	98	6	these	these	DET
gsrj-29	98	7	research	research	NOUN
gsrj-29	98	8	techniques	technique	NOUN
gsrj-29	98	9	were	be	AUX
gsrj-29	98	10	heavily	heavily	ADV
gsrj-29	98	11	utilized	utilize	VERB
gsrj-29	98	12	to	to	PART
gsrj-29	98	13	better	well	ADV
gsrj-29	98	14	understand	understand	VERB
gsrj-29	98	15	sars	sar	NOUN
gsrj-29	98	16	-	-	PUNCT
gsrj-29	98	17	cov-2	cov-2	NOUN
gsrj-29	98	18	,	,	PUNCT
gsrj-29	98	19	ultimately	ultimately	ADV
gsrj-29	98	20	in	in	ADP
gsrj-29	98	21	order	order	NOUN
gsrj-29	98	22	to	to	PART
gsrj-29	98	23	develop	develop	VERB
gsrj-29	98	24	and	and	CCONJ
gsrj-29	98	25	test	test	NOUN
gsrj-29	98	26	disease	disease	NOUN
gsrj-29	98	27	countermeasures	countermeasure	NOUN
gsrj-29	98	28	.	.	PUNCT
gsrj-29	99	1	numerous	numerous	ADJ
gsrj-29	99	2	genome	genome	NOUN
gsrj-29	99	3	-	-	PUNCT
gsrj-29	99	4	wide	wide	ADJ
gsrj-29	99	5	crispr	crispr	NOUN
gsrj-29	99	6	screening	screening	NOUN
gsrj-29	99	7	tests	test	NOUN
gsrj-29	99	8	31	31	NUM
gsrj-29	99	9	georgetown	georgetown	PROPN
gsrj-29	99	10	scientific	scientific	ADJ
gsrj-29	99	11	research	research	NOUN
gsrj-29	99	12	journal	journal	NOUN
gsrj-29	99	13	for	for	ADP
gsrj-29	99	14	sars	sar	NOUN
gsrj-29	99	15	-	-	PUNCT
gsrj-29	99	16	cov-2	cov-2	NUM
gsrj-29	99	17	were	be	AUX
gsrj-29	99	18	conducted	conduct	VERB
gsrj-29	99	19	in	in	ADP
gsrj-29	99	20	order	order	NOUN
gsrj-29	99	21	to	to	PART
gsrj-29	99	22	better	well	ADV
gsrj-29	99	23	understand	understand	VERB
gsrj-29	99	24	how	how	SCONJ
gsrj-29	99	25	the	the	DET
gsrj-29	99	26	virus	virus	NOUN
gsrj-29	99	27	infected	infect	VERB
gsrj-29	99	28	human	human	ADJ
gsrj-29	99	29	cells.62	cells.62	NOUN
gsrj-29	99	30	,	,	PUNCT
gsrj-29	99	31	63	63	NUM
gsrj-29	99	32	,	,	PUNCT
gsrj-29	99	33	64	64	NUM
gsrj-29	99	34	some	some	PRON
gsrj-29	99	35	of	of	ADP
gsrj-29	99	36	these	these	DET
gsrj-29	99	37	tests	test	NOUN
gsrj-29	99	38	sought	seek	VERB
gsrj-29	99	39	to	to	PART
gsrj-29	99	40	identify	identify	VERB
gsrj-29	99	41	host	host	NOUN
gsrj-29	99	42	factors	factor	NOUN
gsrj-29	99	43	required	require	VERB
gsrj-29	99	44	for	for	ADP
gsrj-29	99	45	sars	sar	NOUN
gsrj-29	99	46	-	-	PUNCT
gsrj-29	99	47	cov-2	cov-2	NOUN
gsrj-29	99	48	entry	entry	NOUN
gsrj-29	99	49	with	with	ADP
gsrj-29	99	50	the	the	DET
gsrj-29	99	51	intent	intent	NOUN
gsrj-29	99	52	to	to	PART
gsrj-29	99	53	establish	establish	VERB
gsrj-29	99	54	covid-19	covid-19	PROPN
gsrj-29	99	55	countermeasures	countermeasure	NOUN
gsrj-29	99	56	that	that	SCONJ
gsrj-29	99	57	prophylactically	prophylactically	ADV
gsrj-29	99	58	or	or	CCONJ
gsrj-29	99	59	therapeutically	therapeutically	ADV
gsrj-29	99	60	targeted	target	VERB
gsrj-29	99	61	the	the	DET
gsrj-29	99	62	human	human	ADJ
gsrj-29	99	63	cell	cell	NOUN
gsrj-29	99	64	.	.	PUNCT
gsrj-29	100	1	other	other	ADJ
gsrj-29	100	2	crispr	crispr	ADJ
gsrj-29	100	3	screening	screening	NOUN
gsrj-29	100	4	tests	test	NOUN
gsrj-29	100	5	sought	seek	VERB
gsrj-29	100	6	to	to	PART
gsrj-29	100	7	identify	identify	VERB
gsrj-29	100	8	viral	viral	ADJ
gsrj-29	100	9	vectors	vector	NOUN
gsrj-29	100	10	with	with	ADP
gsrj-29	100	11	the	the	DET
gsrj-29	100	12	intent	intent	NOUN
gsrj-29	100	13	to	to	PART
gsrj-29	100	14	establish	establish	VERB
gsrj-29	100	15	potential	potential	ADJ
gsrj-29	100	16	targets	target	NOUN
gsrj-29	100	17	on	on	ADP
gsrj-29	100	18	the	the	DET
gsrj-29	100	19	virus	virus	NOUN
gsrj-29	100	20	to	to	PART
gsrj-29	100	21	inhibit	inhibit	VERB
gsrj-29	100	22	its	its	PRON
gsrj-29	100	23	replication	replication	NOUN
gsrj-29	100	24	.	.	PUNCT
gsrj-29	101	1	for	for	ADP
gsrj-29	101	2	instance	instance	NOUN
gsrj-29	101	3	,	,	PUNCT
gsrj-29	101	4	researchers	researcher	NOUN
gsrj-29	101	5	discovered	discover	VERB
gsrj-29	101	6	both	both	PRON
gsrj-29	101	7	key	key	ADJ
gsrj-29	101	8	host	host	NOUN
gsrj-29	101	9	and	and	CCONJ
gsrj-29	101	10	viral	viral	ADJ
gsrj-29	101	11	factors	factor	NOUN
gsrj-29	101	12	that	that	PRON
gsrj-29	101	13	modulate	modulate	VERB
gsrj-29	101	14	sars	sar	NOUN
gsrj-29	101	15	-	-	PUNCT
gsrj-29	101	16	cov-2	cov-2	NOUN
gsrj-29	101	17	entry	entry	NOUN
gsrj-29	101	18	into	into	ADP
gsrj-29	101	19	a	a	DET
gsrj-29	101	20	human	human	ADJ
gsrj-29	101	21	cell	cell	NOUN
gsrj-29	101	22	like	like	ADP
gsrj-29	101	23	the	the	DET
gsrj-29	101	24	important	important	ADJ
gsrj-29	101	25	human	human	ADJ
gsrj-29	101	26	ace2	ace2	NOUN
gsrj-29	101	27	receptor	receptor	NOUN
gsrj-29	101	28	or	or	CCONJ
gsrj-29	101	29	the	the	DET
gsrj-29	101	30	s1	s1	NOUN
gsrj-29	101	31	/	/	SYM
gsrj-29	101	32	s2	s2	NOUN
gsrj-29	101	33	boundary	boundary	NOUN
gsrj-29	101	34	of	of	ADP
gsrj-29	101	35	the	the	DET
gsrj-29	101	36	sarscov-2	sarscov-2	NUM
gsrj-29	101	37	spike	spike	ADJ
gsrj-29	101	38	protein.65	protein.65	NOUN
gsrj-29	101	39	for	for	ADP
gsrj-29	101	40	the	the	DET
gsrj-29	101	41	purposes	purpose	NOUN
gsrj-29	101	42	of	of	ADP
gsrj-29	101	43	this	this	DET
gsrj-29	101	44	report	report	NOUN
gsrj-29	101	45	,	,	PUNCT
gsrj-29	101	46	understanding	understand	VERB
gsrj-29	101	47	the	the	DET
gsrj-29	101	48	terminology	terminology	NOUN
gsrj-29	101	49	and	and	CCONJ
gsrj-29	101	50	complex	complex	ADJ
gsrj-29	101	51	biology	biology	NOUN
gsrj-29	101	52	behind	behind	ADP
gsrj-29	101	53	these	these	DET
gsrj-29	101	54	factors	factor	NOUN
gsrj-29	101	55	is	be	AUX
gsrj-29	101	56	less	less	ADV
gsrj-29	101	57	important	important	ADJ
gsrj-29	101	58	than	than	ADP
gsrj-29	101	59	understanding	understand	VERB
gsrj-29	101	60	the	the	DET
gsrj-29	101	61	use	use	NOUN
gsrj-29	101	62	of	of	ADP
gsrj-29	101	63	crispr	crispr	NOUN
gsrj-29	101	64	in	in	ADP
gsrj-29	101	65	discovering	discover	VERB
gsrj-29	101	66	them	they	PRON
gsrj-29	101	67	.	.	PUNCT
gsrj-29	102	1	for	for	ADP
gsrj-29	102	2	sars	sar	NOUN
gsrj-29	102	3	-	-	PUNCT
gsrj-29	102	4	cov-2	cov-2	NOUN
gsrj-29	102	5	research	research	NOUN
gsrj-29	102	6	,	,	PUNCT
gsrj-29	102	7	crispr	crispr	ADJ
gsrj-29	102	8	screening	screening	NOUN
gsrj-29	102	9	techniques	technique	NOUN
gsrj-29	102	10	were	be	AUX
gsrj-29	102	11	notably	notably	ADV
gsrj-29	102	12	utilized	utilize	VERB
gsrj-29	102	13	for	for	ADP
gsrj-29	102	14	the	the	DET
gsrj-29	102	15	background	background	NOUN
gsrj-29	102	16	of	of	ADP
gsrj-29	102	17	prophylactic	prophylactic	ADJ
gsrj-29	102	18	and	and	CCONJ
gsrj-29	102	19	therapeutic	therapeutic	ADJ
gsrj-29	102	20	treatment	treatment	NOUN
gsrj-29	102	21	strategies	strategy	NOUN
gsrj-29	102	22	by	by	ADP
gsrj-29	102	23	identifying	identify	VERB
gsrj-29	102	24	factors	factor	NOUN
gsrj-29	102	25	that	that	SCONJ
gsrj-29	102	26	sars	sar	NOUN
gsrj-29	102	27	-	-	PUNCT
gsrj-29	102	28	cov-2	cov-2	PART
gsrj-29	102	29	relies	rely	VERB
gsrj-29	102	30	upon	upon	SCONJ
gsrj-29	102	31	for	for	ADP
gsrj-29	102	32	its	its	PRON
gsrj-29	102	33	replication	replication	NOUN
gsrj-29	102	34	.	.	PUNCT
gsrj-29	103	1	furthermore	furthermore	ADV
gsrj-29	103	2	,	,	PUNCT
gsrj-29	103	3	researchers	researcher	NOUN
gsrj-29	103	4	utilized	utilize	VERB
gsrj-29	103	5	a	a	DET
gsrj-29	103	6	crispr	crispr	ADJ
gsrj-29	103	7	“	"	PUNCT
gsrj-29	103	8	knock	knock	VERB
gsrj-29	103	9	-	-	PUNCT
gsrj-29	103	10	in	in	ADP
gsrj-29	103	11	”	"	PUNCT
gsrj-29	103	12	technique	technique	NOUN
gsrj-29	103	13	to	to	PART
gsrj-29	103	14	safely	safely	ADV
gsrj-29	103	15	apply	apply	VERB
gsrj-29	103	16	clinical	clinical	ADJ
gsrj-29	103	17	evaluation	evaluation	NOUN
gsrj-29	103	18	to	to	ADP
gsrj-29	103	19	experimental	experimental	ADJ
gsrj-29	103	20	trials	trial	NOUN
gsrj-29	103	21	.	.	PUNCT
gsrj-29	104	1	in	in	ADP
gsrj-29	104	2	one	one	NUM
gsrj-29	104	3	study	study	NOUN
gsrj-29	104	4	conducted	conduct	VERB
gsrj-29	104	5	by	by	ADP
gsrj-29	104	6	sun	sun	PROPN
gsrj-29	104	7	et	et	PROPN
gsrj-29	104	8	al	al	PROPN
gsrj-29	104	9	.	.	PROPN
gsrj-29	104	10	,	,	PUNCT
gsrj-29	104	11	researchers	researcher	NOUN
gsrj-29	104	12	effectively	effectively	ADV
gsrj-29	104	13	humanized	humanize	VERB
gsrj-29	104	14	a	a	DET
gsrj-29	104	15	mouse	mouse	NOUN
gsrj-29	104	16	by	by	ADP
gsrj-29	104	17	inserting	insert	VERB
gsrj-29	104	18	the	the	DET
gsrj-29	104	19	gene	gene	NOUN
gsrj-29	104	20	for	for	ADP
gsrj-29	104	21	the	the	DET
gsrj-29	104	22	host	host	NOUN
gsrj-29	104	23	factor	factor	NOUN
gsrj-29	104	24	that	that	PRON
gsrj-29	104	25	allows	allow	VERB
gsrj-29	104	26	sars	sar	NOUN
gsrj-29	104	27	-	-	PUNCT
gsrj-29	104	28	cov-2	cov-2	NOUN
gsrj-29	104	29	to	to	PART
gsrj-29	104	30	enter	enter	VERB
gsrj-29	104	31	into	into	ADP
gsrj-29	104	32	a	a	DET
gsrj-29	104	33	human	human	ADJ
gsrj-29	104	34	cell	cell	NOUN
gsrj-29	104	35	,	,	PUNCT
gsrj-29	104	36	the	the	DET
gsrj-29	104	37	ace2	ace2	PROPN
gsrj-29	104	38	receptor.66	receptor.66	NOUN
gsrj-29	104	39	by	by	ADP
gsrj-29	104	40	eliciting	elicit	VERB
gsrj-29	104	41	a	a	DET
gsrj-29	104	42	gain	gain	NOUN
gsrj-29	104	43	of	of	ADP
gsrj-29	104	44	function	function	NOUN
gsrj-29	104	45	outcome	outcome	NOUN
gsrj-29	104	46	that	that	PRON
gsrj-29	104	47	allowed	allow	VERB
gsrj-29	104	48	a	a	DET
gsrj-29	104	49	mouse	mouse	NOUN
gsrj-29	104	50	to	to	PART
gsrj-29	104	51	become	become	AUX
gsrj-29	104	52	infected	infect	VERB
gsrj-29	104	53	by	by	ADP
gsrj-29	104	54	covid-19	covid-19	PROPN
gsrj-29	104	55	,	,	PUNCT
gsrj-29	104	56	these	these	DET
gsrj-29	104	57	researchers	researcher	NOUN
gsrj-29	104	58	created	create	VERB
gsrj-29	104	59	a	a	DET
gsrj-29	104	60	tool	tool	NOUN
gsrj-29	104	61	that	that	PRON
gsrj-29	104	62	could	could	AUX
gsrj-29	104	63	be	be	AUX
gsrj-29	104	64	used	use	VERB
gsrj-29	104	65	to	to	PART
gsrj-29	104	66	evaluate	evaluate	VERB
gsrj-29	104	67	the	the	DET
gsrj-29	104	68	effectiveness	effectiveness	NOUN
gsrj-29	104	69	of	of	ADP
gsrj-29	104	70	covid-19	covid-19	PROPN
gsrj-29	104	71	vaccines	vaccine	NOUN
gsrj-29	104	72	and	and	CCONJ
gsrj-29	104	73	therapeutic	therapeutic	ADJ
gsrj-29	104	74	treatments	treatment	NOUN
gsrj-29	104	75	in	in	ADP
gsrj-29	104	76	clinical	clinical	ADJ
gsrj-29	104	77	trials	trial	NOUN
gsrj-29	104	78	on	on	ADP
gsrj-29	104	79	nonhuman	nonhuman	ADJ
gsrj-29	104	80	subjects	subject	NOUN
gsrj-29	104	81	.	.	PUNCT
gsrj-29	105	1	the	the	DET
gsrj-29	105	2	mouse	mouse	NOUN
gsrj-29	105	3	could	could	AUX
gsrj-29	105	4	then	then	ADV
gsrj-29	105	5	be	be	AUX
gsrj-29	105	6	treated	treat	VERB
gsrj-29	105	7	with	with	ADP
gsrj-29	105	8	a	a	DET
gsrj-29	105	9	vaccine	vaccine	NOUN
gsrj-29	105	10	,	,	PUNCT
gsrj-29	105	11	therapy	therapy	NOUN
gsrj-29	105	12	,	,	PUNCT
gsrj-29	105	13	or	or	CCONJ
gsrj-29	105	14	drug	drug	NOUN
gsrj-29	105	15	that	that	PRON
gsrj-29	105	16	could	could	AUX
gsrj-29	105	17	not	not	PART
gsrj-29	105	18	yet	yet	ADV
gsrj-29	105	19	be	be	AUX
gsrj-29	105	20	ethically	ethically	ADV
gsrj-29	105	21	tried	try	VERB
gsrj-29	105	22	on	on	ADP
gsrj-29	105	23	human	human	ADJ
gsrj-29	105	24	subjects	subject	NOUN
gsrj-29	105	25	.	.	PUNCT
gsrj-29	106	1	in	in	ADP
gsrj-29	106	2	the	the	DET
gsrj-29	106	3	need	need	NOUN
gsrj-29	106	4	for	for	ADP
gsrj-29	106	5	rapid	rapid	ADJ
gsrj-29	106	6	development	development	NOUN
gsrj-29	106	7	and	and	CCONJ
gsrj-29	106	8	evaluation	evaluation	NOUN
gsrj-29	106	9	of	of	ADP
gsrj-29	106	10	humantargeted	humantargete	VERB
gsrj-29	106	11	prophylactic	prophylactic	ADJ
gsrj-29	106	12	and	and	CCONJ
gsrj-29	106	13	therapeutic	therapeutic	ADJ
gsrj-29	106	14	countermeasures	countermeasure	NOUN
gsrj-29	106	15	to	to	ADP
gsrj-29	106	16	a	a	DET
gsrj-29	106	17	pathogen	pathogen	NOUN
gsrj-29	106	18	,	,	PUNCT
gsrj-29	106	19	this	this	PRON
gsrj-29	106	20	is	be	AUX
gsrj-29	106	21	a	a	DET
gsrj-29	106	22	crucial	crucial	ADJ
gsrj-29	106	23	step	step	NOUN
gsrj-29	106	24	to	to	PART
gsrj-29	106	25	optimize	optimize	VERB
gsrj-29	106	26	procedure	procedure	NOUN
gsrj-29	106	27	.	.	PUNCT
gsrj-29	107	1	this	this	DET
gsrj-29	107	2	research	research	NOUN
gsrj-29	107	3	is	be	AUX
gsrj-29	107	4	the	the	DET
gsrj-29	107	5	necessary	necessary	ADJ
gsrj-29	107	6	background	background	NOUN
gsrj-29	107	7	to	to	PART
gsrj-29	107	8	continue	continue	VERB
gsrj-29	107	9	developing	develop	VERB
gsrj-29	107	10	and	and	CCONJ
gsrj-29	107	11	evaluating	evaluate	VERB
gsrj-29	107	12	covid-19	covid-19	PROPN
gsrj-29	107	13	therapeutic	therapeutic	ADJ
gsrj-29	107	14	,	,	PUNCT
gsrj-29	107	15	vaccine	vaccine	NOUN
gsrj-29	107	16	,	,	PUNCT
gsrj-29	107	17	and	and	CCONJ
gsrj-29	107	18	drug	drug	NOUN
gsrj-29	107	19	candidates	candidate	NOUN
gsrj-29	107	20	in	in	ADP
gsrj-29	107	21	clinical	clinical	ADJ
gsrj-29	107	22	trials	trial	NOUN
gsrj-29	107	23	.	.	PUNCT
gsrj-29	108	1	the	the	DET
gsrj-29	108	2	development	development	NOUN
gsrj-29	108	3	of	of	ADP
gsrj-29	108	4	these	these	DET
gsrj-29	108	5	countermeasures	countermeasure	NOUN
gsrj-29	108	6	remains	remain	VERB
gsrj-29	108	7	crucial	crucial	ADJ
gsrj-29	108	8	as	as	SCONJ
gsrj-29	108	9	nations	nation	NOUN
gsrj-29	108	10	must	must	AUX
gsrj-29	108	11	continue	continue	VERB
gsrj-29	108	12	to	to	PART
gsrj-29	108	13	cope	cope	VERB
gsrj-29	108	14	with	with	ADP
gsrj-29	108	15	covid-19	covid-19	PROPN
gsrj-29	108	16	cases	case	NOUN
gsrj-29	108	17	.	.	PUNCT
gsrj-29	109	1	beyond	beyond	ADP
gsrj-29	109	2	the	the	DET
gsrj-29	109	3	application	application	NOUN
gsrj-29	109	4	of	of	ADP
gsrj-29	109	5	covid-19	covid-19	PROPN
gsrj-29	109	6	,	,	PUNCT
gsrj-29	109	7	crispr	crispr	PROPN
gsrj-29	109	8	can	can	AUX
gsrj-29	109	9	be	be	AUX
gsrj-29	109	10	utilized	utilize	VERB
gsrj-29	109	11	to	to	PART
gsrj-29	109	12	identify	identify	VERB
gsrj-29	109	13	factors	factor	NOUN
gsrj-29	109	14	upon	upon	SCONJ
gsrj-29	109	15	which	which	PRON
gsrj-29	109	16	any	any	DET
gsrj-29	109	17	pathogen	pathogen	NOUN
gsrj-29	109	18	relies	rely	VERB
gsrj-29	109	19	for	for	ADP
gsrj-29	109	20	replication	replication	NOUN
gsrj-29	109	21	with	with	ADP
gsrj-29	109	22	these	these	DET
gsrj-29	109	23	experimental	experimental	ADJ
gsrj-29	109	24	techniques	technique	NOUN
gsrj-29	109	25	.	.	PUNCT
gsrj-29	110	1	in	in	ADP
gsrj-29	110	2	fact	fact	NOUN
gsrj-29	110	3	,	,	PUNCT
gsrj-29	110	4	researchers	researcher	NOUN
gsrj-29	110	5	are	be	AUX
gsrj-29	110	6	now	now	ADV
gsrj-29	110	7	identifying	identify	VERB
gsrj-29	110	8	viral	viral	ADJ
gsrj-29	110	9	and	and	CCONJ
gsrj-29	110	10	host	host	NOUN
gsrj-29	110	11	factors	factor	NOUN
gsrj-29	110	12	to	to	PART
gsrj-29	110	13	target	target	VERB
gsrj-29	110	14	for	for	ADP
gsrj-29	110	15	other	other	ADJ
gsrj-29	110	16	critical	critical	ADJ
gsrj-29	110	17	diseases	disease	NOUN
gsrj-29	110	18	–	–	PUNCT
gsrj-29	110	19	–	–	PUNCT
gsrj-29	110	20	such	such	ADJ
gsrj-29	110	21	as	as	ADP
gsrj-29	110	22	hiv	hiv	PROPN
gsrj-29	110	23	or	or	CCONJ
gsrj-29	110	24	malaria	malaria	NOUN
gsrj-29	110	25	–	–	PUNCT
gsrj-29	110	26	–	–	PUNCT
gsrj-29	110	27	and	and	CCONJ
gsrj-29	110	28	discussing	discuss	VERB
gsrj-29	110	29	the	the	DET
gsrj-29	110	30	potential	potential	NOUN
gsrj-29	110	31	of	of	ADP
gsrj-29	110	32	novel	novel	ADJ
gsrj-29	110	33	countermeasures	countermeasure	NOUN
gsrj-29	110	34	for	for	ADP
gsrj-29	110	35	these	these	DET
gsrj-29	110	36	pathogens	pathogen	NOUN
gsrj-29	110	37	as	as	ADP
gsrj-29	110	38	well.67	well.67	NOUN
gsrj-29	110	39	,	,	PUNCT
gsrj-29	110	40	68	68	NUM
gsrj-29	110	41	crispr	crispr	ADJ
gsrj-29	110	42	-	-	PUNCT
gsrj-29	110	43	cas	cas	NOUN
gsrj-29	110	44	systems	system	NOUN
gsrj-29	110	45	are	be	AUX
gsrj-29	110	46	clearly	clearly	ADV
gsrj-29	110	47	a	a	DET
gsrj-29	110	48	promising	promising	ADJ
gsrj-29	110	49	research	research	NOUN
gsrj-29	110	50	tool	tool	NOUN
gsrj-29	110	51	that	that	PRON
gsrj-29	110	52	can	can	AUX
gsrj-29	110	53	provide	provide	VERB
gsrj-29	110	54	an	an	DET
gsrj-29	110	55	efficient	efficient	ADJ
gsrj-29	110	56	and	and	CCONJ
gsrj-29	110	57	accurate	accurate	ADJ
gsrj-29	110	58	platform	platform	NOUN
gsrj-29	110	59	to	to	PART
gsrj-29	110	60	identify	identify	VERB
gsrj-29	110	61	and	and	CCONJ
gsrj-29	110	62	test	test	VERB
gsrj-29	110	63	viral	viral	ADJ
gsrj-29	110	64	vectors	vector	NOUN
gsrj-29	110	65	for	for	ADP
gsrj-29	110	66	needed	need	VERB
gsrj-29	110	67	antiviral	antiviral	ADJ
gsrj-29	110	68	therapeutic	therapeutic	ADJ
gsrj-29	110	69	,	,	PUNCT
gsrj-29	110	70	vaccine	vaccine	NOUN
gsrj-29	110	71	,	,	PUNCT
gsrj-29	110	72	and	and	CCONJ
gsrj-29	110	73	drug	drug	NOUN
gsrj-29	110	74	targets	target	NOUN
gsrj-29	110	75	.	.	PUNCT
gsrj-29	111	1	this	this	DET
gsrj-29	111	2	tool	tool	NOUN
gsrj-29	111	3	can	can	AUX
gsrj-29	111	4	be	be	AUX
gsrj-29	111	5	utilized	utilize	VERB
gsrj-29	111	6	to	to	PART
gsrj-29	111	7	optimize	optimize	VERB
gsrj-29	111	8	the	the	DET
gsrj-29	111	9	configuration	configuration	NOUN
gsrj-29	111	10	of	of	ADP
gsrj-29	111	11	a	a	DET
gsrj-29	111	12	countermeasure	countermeasure	NOUN
gsrj-29	111	13	against	against	ADP
gsrj-29	111	14	an	an	DET
gsrj-29	111	15	emerging	emerge	VERB
gsrj-29	111	16	pathogen	pathogen	NOUN
gsrj-29	111	17	and	and	CCONJ
gsrj-29	111	18	mitigate	mitigate	VERB
gsrj-29	111	19	its	its	PRON
gsrj-29	111	20	pathogenesis	pathogenesis	NOUN
gsrj-29	111	21	.	.	PUNCT
gsrj-29	112	1	3.3	3.3	NUM
gsrj-29	112	2	.	.	PUNCT
gsrj-29	113	1	crispr	crispr	ADJ
gsrj-29	113	2	therapeutic	therapeutic	ADJ
gsrj-29	113	3	treatment	treatment	NOUN
gsrj-29	113	4	crispr	crispr	NOUN
gsrj-29	113	5	therapy	therapy	NOUN
gsrj-29	113	6	can	can	AUX
gsrj-29	113	7	potentially	potentially	ADV
gsrj-29	113	8	provide	provide	VERB
gsrj-29	113	9	an	an	DET
gsrj-29	113	10	important	important	ADJ
gsrj-29	113	11	countermeasure	countermeasure	NOUN
gsrj-29	113	12	opportunity	opportunity	NOUN
gsrj-29	113	13	for	for	ADP
gsrj-29	113	14	covid-19	covid-19	PROPN
gsrj-29	113	15	,	,	PUNCT
gsrj-29	113	16	as	as	ADV
gsrj-29	113	17	well	well	ADV
gsrj-29	113	18	as	as	ADP
gsrj-29	113	19	the	the	DET
gsrj-29	113	20	ability	ability	NOUN
gsrj-29	113	21	to	to	PART
gsrj-29	113	22	reconfigure	reconfigure	VERB
gsrj-29	113	23	treatment	treatment	NOUN
gsrj-29	113	24	for	for	ADP
gsrj-29	113	25	other	other	ADJ
gsrj-29	113	26	persistent	persistent	ADJ
gsrj-29	113	27	and	and	CCONJ
gsrj-29	113	28	emergent	emergent	ADJ
gsrj-29	113	29	diseases	disease	NOUN
gsrj-29	113	30	.	.	PUNCT
gsrj-29	114	1	since	since	SCONJ
gsrj-29	114	2	december	december	PROPN
gsrj-29	114	3	2020	2020	NUM
gsrj-29	114	4	,	,	PUNCT
gsrj-29	114	5	vaccines	vaccine	NOUN
gsrj-29	114	6	have	have	AUX
gsrj-29	114	7	been	be	AUX
gsrj-29	114	8	approved	approve	VERB
gsrj-29	114	9	and	and	CCONJ
gsrj-29	114	10	rolled	roll	VERB
gsrj-29	114	11	-	-	PUNCT
gsrj-29	114	12	out	out	NOUN
gsrj-29	114	13	across	across	ADP
gsrj-29	114	14	the	the	DET
gsrj-29	114	15	world	world	NOUN
gsrj-29	114	16	in	in	ADP
gsrj-29	114	17	an	an	DET
gsrj-29	114	18	effort	effort	NOUN
gsrj-29	114	19	to	to	PART
gsrj-29	114	20	control	control	VERB
gsrj-29	114	21	the	the	DET
gsrj-29	114	22	pandemic.69	pandemic.69	NOUN
gsrj-29	114	23	however	however	ADV
gsrj-29	114	24	,	,	PUNCT
gsrj-29	114	25	the	the	DET
gsrj-29	114	26	mutation	mutation	NOUN
gsrj-29	114	27	rate	rate	NOUN
gsrj-29	114	28	of	of	ADP
gsrj-29	114	29	sars	sar	NOUN
gsrj-29	114	30	-	-	PUNCT
gsrj-29	114	31	cov-2	cov-2	NUM
gsrj-29	114	32	is	be	AUX
gsrj-29	114	33	relatively	relatively	ADV
gsrj-29	114	34	high	high	ADJ
gsrj-29	114	35	,	,	PUNCT
gsrj-29	114	36	and	and	CCONJ
gsrj-29	114	37	each	each	DET
gsrj-29	114	38	variant	variant	NOUN
gsrj-29	114	39	poses	pose	VERB
gsrj-29	114	40	new	new	ADJ
gsrj-29	114	41	challenges	challenge	NOUN
gsrj-29	114	42	.	.	PUNCT
gsrj-29	115	1	human	human	ADJ
gsrj-29	115	2	behavior	behavior	NOUN
gsrj-29	115	3	,	,	PUNCT
gsrj-29	115	4	motivation	motivation	NOUN
gsrj-29	115	5	,	,	PUNCT
gsrj-29	115	6	and	and	CCONJ
gsrj-29	115	7	culture	culture	NOUN
gsrj-29	115	8	continue	continue	VERB
gsrj-29	115	9	to	to	PART
gsrj-29	115	10	be	be	AUX
gsrj-29	115	11	essential	essential	ADJ
gsrj-29	115	12	for	for	ADP
gsrj-29	115	13	effective	effective	ADJ
gsrj-29	115	14	pandemic	pandemic	ADJ
gsrj-29	115	15	recovery	recovery	NOUN
gsrj-29	115	16	.	.	PUNCT
gsrj-29	116	1	given	give	VERB
gsrj-29	116	2	broad	broad	ADJ
gsrj-29	116	3	societal	societal	ADJ
gsrj-29	116	4	challenges	challenge	NOUN
gsrj-29	116	5	such	such	ADJ
gsrj-29	116	6	as	as	ADP
gsrj-29	116	7	vaccine	vaccine	NOUN
gsrj-29	116	8	hesitancy	hesitancy	NOUN
gsrj-29	116	9	and	and	CCONJ
gsrj-29	116	10	vaccine	vaccine	NOUN
gsrj-29	116	11	inequity	inequity	NOUN
gsrj-29	116	12	,	,	PUNCT
gsrj-29	116	13	as	as	ADV
gsrj-29	116	14	well	well	ADV
gsrj-29	116	15	as	as	ADP
gsrj-29	116	16	the	the	DET
gsrj-29	116	17	fact	fact	NOUN
gsrj-29	116	18	that	that	SCONJ
gsrj-29	116	19	vaccinated	vaccinated	ADJ
gsrj-29	116	20	people	people	NOUN
gsrj-29	116	21	can	can	AUX
gsrj-29	116	22	still	still	ADV
gsrj-29	116	23	be	be	AUX
gsrj-29	116	24	infected	infect	VERB
gsrj-29	116	25	and	and	CCONJ
gsrj-29	116	26	spread	spread	VERB
gsrj-29	116	27	covid-19	covid-19	PROPN
gsrj-29	116	28	,	,	PUNCT
gsrj-29	116	29	the	the	DET
gsrj-29	116	30	pandemic	pandemic	NOUN
gsrj-29	116	31	will	will	AUX
gsrj-29	116	32	persist	persist	VERB
gsrj-29	116	33	globally.70	globally.70	NOUN
gsrj-29	116	34	,	,	PUNCT
gsrj-29	116	35	71	71	NUM
gsrj-29	116	36	as	as	SCONJ
gsrj-29	116	37	the	the	DET
gsrj-29	116	38	world	world	NOUN
gsrj-29	116	39	has	have	AUX
gsrj-29	116	40	seen	see	VERB
gsrj-29	116	41	,	,	PUNCT
gsrj-29	116	42	an	an	DET
gsrj-29	116	43	outbreak	outbreak	NOUN
gsrj-29	116	44	of	of	ADP
gsrj-29	116	45	covid19	covid19	NOUN
gsrj-29	116	46	anywhere	anywhere	ADV
gsrj-29	116	47	threatens	threaten	VERB
gsrj-29	116	48	to	to	PART
gsrj-29	116	49	increase	increase	VERB
gsrj-29	116	50	the	the	DET
gsrj-29	116	51	case	case	NOUN
gsrj-29	116	52	rate	rate	NOUN
gsrj-29	116	53	32	32	NUM
gsrj-29	116	54	georgetown	georgetown	PROPN
gsrj-29	116	55	scientific	scientific	PROPN
gsrj-29	116	56	research	research	PROPN
gsrj-29	116	57	journal	journal	PROPN
gsrj-29	116	58	everywhere	everywhere	ADV
gsrj-29	116	59	.	.	PUNCT
gsrj-29	117	1	thus	thus	ADV
gsrj-29	117	2	,	,	PUNCT
gsrj-29	117	3	there	there	PRON
gsrj-29	117	4	is	be	VERB
gsrj-29	117	5	a	a	DET
gsrj-29	117	6	persistent	persistent	ADJ
gsrj-29	117	7	need	need	NOUN
gsrj-29	117	8	for	for	ADP
gsrj-29	117	9	covid-19	covid-19	PROPN
gsrj-29	117	10	treatment	treatment	NOUN
gsrj-29	117	11	options	option	NOUN
gsrj-29	117	12	as	as	SCONJ
gsrj-29	117	13	the	the	DET
gsrj-29	117	14	pandemic	pandemic	NOUN
gsrj-29	117	15	continues	continue	VERB
gsrj-29	117	16	.	.	PUNCT
gsrj-29	118	1	this	this	DET
gsrj-29	118	2	need	need	NOUN
gsrj-29	118	3	can	can	AUX
gsrj-29	118	4	potentially	potentially	ADV
gsrj-29	118	5	be	be	AUX
gsrj-29	118	6	filled	fill	VERB
gsrj-29	118	7	by	by	ADP
gsrj-29	118	8	crispr	crispr	ADJ
gsrj-29	118	9	therapeutic	therapeutic	ADJ
gsrj-29	118	10	treatment	treatment	NOUN
gsrj-29	118	11	for	for	ADP
gsrj-29	118	12	sars	sar	NOUN
gsrj-29	118	13	-	-	PUNCT
gsrj-29	118	14	cov-2	cov-2	NOUN
gsrj-29	118	15	.	.	PUNCT
gsrj-29	118	16	applying	apply	VERB
gsrj-29	118	17	crispr	crispr	ADJ
gsrj-29	118	18	-	-	PUNCT
gsrj-29	118	19	cas	cas	NOUN
gsrj-29	118	20	systems	system	NOUN
gsrj-29	118	21	as	as	ADP
gsrj-29	118	22	a	a	DET
gsrj-29	118	23	countermeasure	countermeasure	NOUN
gsrj-29	118	24	to	to	ADP
gsrj-29	118	25	covid-19	covid-19	PROPN
gsrj-29	118	26	has	have	AUX
gsrj-29	118	27	demonstrated	demonstrate	VERB
gsrj-29	118	28	promising	promising	ADJ
gsrj-29	118	29	initial	initial	ADJ
gsrj-29	118	30	evaluations	evaluation	NOUN
gsrj-29	118	31	,	,	PUNCT
gsrj-29	118	32	although	although	SCONJ
gsrj-29	118	33	the	the	DET
gsrj-29	118	34	novel	novel	ADJ
gsrj-29	118	35	therapeutic	therapeutic	ADJ
gsrj-29	118	36	option	option	NOUN
gsrj-29	118	37	has	have	AUX
gsrj-29	118	38	received	receive	VERB
gsrj-29	118	39	comparatively	comparatively	ADV
gsrj-29	118	40	less	less	ADJ
gsrj-29	118	41	attention	attention	NOUN
gsrj-29	118	42	than	than	SCONJ
gsrj-29	118	43	other	other	ADJ
gsrj-29	118	44	therapeutic	therapeutic	ADJ
gsrj-29	118	45	options.72	options.72	NOUN
gsrj-29	118	46	one	one	NUM
gsrj-29	118	47	group	group	NOUN
gsrj-29	118	48	of	of	ADP
gsrj-29	118	49	stanford	stanford	PROPN
gsrj-29	118	50	-	-	PUNCT
gsrj-29	118	51	based	base	VERB
gsrj-29	118	52	crispr	crispr	ADJ
gsrj-29	118	53	researchers	researcher	NOUN
gsrj-29	118	54	have	have	AUX
gsrj-29	118	55	developed	develop	VERB
gsrj-29	118	56	a	a	DET
gsrj-29	118	57	crispr	crispr	ADJ
gsrj-29	118	58	facilitated	facilitate	VERB
gsrj-29	118	59	therapeutic	therapeutic	ADJ
gsrj-29	118	60	approach	approach	NOUN
gsrj-29	118	61	called	call	VERB
gsrj-29	118	62	prophylactic	prophylactic	ADJ
gsrj-29	118	63	antiviral	antiviral	ADJ
gsrj-29	118	64	crispr	crispr	NOUN
gsrj-29	118	65	in	in	ADP
gsrj-29	118	66	human	human	ADJ
gsrj-29	118	67	cells	cell	NOUN
gsrj-29	118	68	(	(	PUNCT
gsrj-29	118	69	pac	pac	NOUN
gsrj-29	118	70	-	-	NOUN
gsrj-29	118	71	man	man	NOUN
gsrj-29	118	72	)	)	PUNCT
gsrj-29	118	73	that	that	PRON
gsrj-29	118	74	can	can	AUX
gsrj-29	118	75	effectively	effectively	ADV
gsrj-29	118	76	degrade	degrade	VERB
gsrj-29	118	77	rna	rna	NOUN
gsrj-29	118	78	from	from	ADP
gsrj-29	118	79	sars	sar	NOUN
gsrj-29	118	80	-	-	PUNCT
gsrj-29	118	81	cov-2	cov-2	NOUN
gsrj-29	118	82	in	in	ADP
gsrj-29	118	83	human	human	ADJ
gsrj-29	118	84	cells.73	cells.73	NOUN
gsrj-29	118	85	a	a	DET
gsrj-29	118	86	significant	significant	ADJ
gsrj-29	118	87	challenge	challenge	NOUN
gsrj-29	118	88	for	for	ADP
gsrj-29	118	89	the	the	DET
gsrj-29	118	90	stanford	stanford	PROPN
gsrj-29	118	91	team	team	NOUN
gsrj-29	118	92	is	be	AUX
gsrj-29	118	93	finding	find	VERB
gsrj-29	118	94	a	a	DET
gsrj-29	118	95	delivery	delivery	NOUN
gsrj-29	118	96	mechanism	mechanism	NOUN
gsrj-29	118	97	for	for	ADP
gsrj-29	118	98	the	the	DET
gsrj-29	118	99	pacman	pacman	PROPN
gsrj-29	118	100	approach	approach	NOUN
gsrj-29	118	101	,	,	PUNCT
gsrj-29	118	102	most	most	ADV
gsrj-29	118	103	effectively	effectively	ADV
gsrj-29	118	104	targeting	target	VERB
gsrj-29	118	105	epithelial	epithelial	ADJ
gsrj-29	118	106	cells	cell	NOUN
gsrj-29	118	107	in	in	ADP
gsrj-29	118	108	the	the	DET
gsrj-29	118	109	lung	lung	NOUN
gsrj-29	118	110	where	where	SCONJ
gsrj-29	118	111	the	the	DET
gsrj-29	118	112	virus	virus	NOUN
gsrj-29	118	113	inflicts	inflict	VERB
gsrj-29	118	114	the	the	DET
gsrj-29	118	115	most	most	ADJ
gsrj-29	118	116	damage	damage	NOUN
gsrj-29	118	117	.	.	PUNCT
gsrj-29	119	1	if	if	SCONJ
gsrj-29	119	2	this	this	DET
gsrj-29	119	3	barrier	barrier	NOUN
gsrj-29	119	4	is	be	AUX
gsrj-29	119	5	overcome	overcome	VERB
gsrj-29	119	6	,	,	PUNCT
gsrj-29	119	7	the	the	DET
gsrj-29	119	8	team	team	NOUN
gsrj-29	119	9	believes	believe	VERB
gsrj-29	119	10	that	that	SCONJ
gsrj-29	119	11	the	the	DET
gsrj-29	119	12	pac	pac	PROPN
gsrj-29	119	13	-	-	PUNCT
gsrj-29	119	14	man	man	NOUN
gsrj-29	119	15	approach	approach	NOUN
gsrj-29	119	16	can	can	AUX
gsrj-29	119	17	be	be	AUX
gsrj-29	119	18	utilized	utilize	VERB
gsrj-29	119	19	as	as	ADP
gsrj-29	119	20	a	a	DET
gsrj-29	119	21	countermeasure	countermeasure	NOUN
gsrj-29	119	22	to	to	ADP
gsrj-29	119	23	all	all	DET
gsrj-29	119	24	coronaviruses	coronaviruse	NOUN
gsrj-29	119	25	and	and	CCONJ
gsrj-29	119	26	emerging	emerge	VERB
gsrj-29	119	27	variants	variant	NOUN
gsrj-29	119	28	of	of	ADP
gsrj-29	119	29	sars	sar	NOUN
gsrj-29	119	30	-	-	PUNCT
gsrj-29	119	31	cov-2	cov-2	NOUN
gsrj-29	119	32	.	.	PUNCT
gsrj-29	120	1	in	in	ADP
gsrj-29	120	2	the	the	DET
gsrj-29	120	3	same	same	ADJ
gsrj-29	120	4	study	study	NOUN
gsrj-29	120	5	,	,	PUNCT
gsrj-29	120	6	the	the	DET
gsrj-29	120	7	approach	approach	NOUN
gsrj-29	120	8	was	be	AUX
gsrj-29	120	9	found	find	VERB
gsrj-29	120	10	to	to	PART
gsrj-29	120	11	demonstrate	demonstrate	VERB
gsrj-29	120	12	effectiveness	effectiveness	NOUN
gsrj-29	120	13	in	in	ADP
gsrj-29	120	14	degrading	degrade	VERB
gsrj-29	120	15	rna	rna	NOUN
gsrj-29	120	16	from	from	ADP
gsrj-29	120	17	influenza	influenza	NOUN
gsrj-29	120	18	in	in	ADP
gsrj-29	120	19	human	human	ADJ
gsrj-29	120	20	cells	cell	NOUN
gsrj-29	120	21	.	.	PUNCT
gsrj-29	121	1	another	another	DET
gsrj-29	121	2	group	group	NOUN
gsrj-29	121	3	of	of	ADP
gsrj-29	121	4	crispr	crispr	ADJ
gsrj-29	121	5	researchers	researcher	NOUN
gsrj-29	121	6	utilized	utilize	VERB
gsrj-29	121	7	a	a	DET
gsrj-29	121	8	highly	highly	ADV
gsrj-29	121	9	reprogrammable	reprogrammable	ADJ
gsrj-29	121	10	crispr	crispr	ADJ
gsrj-29	121	11	-	-	PUNCT
gsrj-29	121	12	cas	cas	NOUN
gsrj-29	121	13	system	system	NOUN
gsrj-29	121	14	to	to	PART
gsrj-29	121	15	target	target	VERB
gsrj-29	121	16	sars	sar	NOUN
gsrj-29	121	17	-	-	PUNCT
gsrj-29	121	18	cov-2	cov-2	PART
gsrj-29	121	19	transcripts	transcript	NOUN
gsrj-29	121	20	that	that	PRON
gsrj-29	121	21	code	code	NOUN
gsrj-29	121	22	for	for	ADP
gsrj-29	121	23	specific	specific	ADJ
gsrj-29	121	24	proteins	protein	NOUN
gsrj-29	121	25	like	like	ADP
gsrj-29	121	26	the	the	DET
gsrj-29	121	27	spike	spike	ADJ
gsrj-29	121	28	protein.74	protein.74	NOUN
gsrj-29	121	29	as	as	SCONJ
gsrj-29	121	30	mentioned	mention	VERB
gsrj-29	121	31	,	,	PUNCT
gsrj-29	121	32	the	the	DET
gsrj-29	121	33	spike	spike	ADJ
gsrj-29	121	34	protein	protein	NOUN
gsrj-29	121	35	on	on	ADP
gsrj-29	121	36	coronaviruses	coronaviruse	NOUN
gsrj-29	121	37	was	be	AUX
gsrj-29	121	38	identified	identify	VERB
gsrj-29	121	39	by	by	ADP
gsrj-29	121	40	crispr	crispr	ADJ
gsrj-29	121	41	knock	knock	NOUN
gsrj-29	121	42	-	-	PUNCT
gsrj-29	121	43	out	out	ADP
gsrj-29	121	44	techniques	technique	NOUN
gsrj-29	121	45	to	to	PART
gsrj-29	121	46	be	be	AUX
gsrj-29	121	47	integral	integral	ADJ
gsrj-29	121	48	for	for	ADP
gsrj-29	121	49	latching	latch	VERB
gsrj-29	121	50	onto	onto	ADP
gsrj-29	121	51	and	and	CCONJ
gsrj-29	121	52	infecting	infect	VERB
gsrj-29	121	53	the	the	DET
gsrj-29	121	54	human	human	ADJ
gsrj-29	121	55	cell	cell	NOUN
gsrj-29	121	56	.	.	PUNCT
gsrj-29	122	1	ultimately	ultimately	ADV
gsrj-29	122	2	,	,	PUNCT
gsrj-29	122	3	the	the	DET
gsrj-29	122	4	reprogrammable	reprogrammable	ADJ
gsrj-29	122	5	crisprcas	crisprcas	NOUN
gsrj-29	122	6	system	system	NOUN
gsrj-29	122	7	demonstrated	demonstrate	VERB
gsrj-29	122	8	a	a	DET
gsrj-29	122	9	high	high	ADJ
gsrj-29	122	10	degree	degree	NOUN
gsrj-29	122	11	of	of	ADP
gsrj-29	122	12	effectiveness	effectiveness	NOUN
gsrj-29	122	13	,	,	PUNCT
gsrj-29	122	14	with	with	ADP
gsrj-29	122	15	greater	great	ADJ
gsrj-29	122	16	than	than	ADP
gsrj-29	122	17	98	98	NUM
gsrj-29	122	18	%	%	NOUN
gsrj-29	122	19	efficiency	efficiency	NOUN
gsrj-29	122	20	in	in	ADP
gsrj-29	122	21	silencing	silence	VERB
gsrj-29	122	22	these	these	DET
gsrj-29	122	23	regions	region	NOUN
gsrj-29	122	24	of	of	ADP
gsrj-29	122	25	viral	viral	ADJ
gsrj-29	122	26	transcript	transcript	NOUN
gsrj-29	122	27	.	.	PUNCT
gsrj-29	123	1	notably	notably	ADV
gsrj-29	123	2	,	,	PUNCT
gsrj-29	123	3	the	the	DET
gsrj-29	123	4	group	group	NOUN
gsrj-29	123	5	expressed	express	VERB
gsrj-29	123	6	concern	concern	NOUN
gsrj-29	123	7	for	for	ADP
gsrj-29	123	8	emerging	emerge	VERB
gsrj-29	123	9	variants	variant	NOUN
gsrj-29	123	10	of	of	ADP
gsrj-29	123	11	sars	sar	NOUN
gsrj-29	123	12	-	-	PUNCT
gsrj-29	123	13	cov-2	cov-2	NOUN
gsrj-29	123	14	and	and	CCONJ
gsrj-29	123	15	the	the	DET
gsrj-29	123	16	propensity	propensity	NOUN
gsrj-29	123	17	of	of	ADP
gsrj-29	123	18	sarscov-2	sarscov-2	NUM
gsrj-29	123	19	to	to	PART
gsrj-29	123	20	escape	escape	VERB
gsrj-29	123	21	from	from	ADP
gsrj-29	123	22	host	host	NOUN
gsrj-29	123	23	immunity	immunity	NOUN
gsrj-29	123	24	.	.	PUNCT
gsrj-29	124	1	the	the	DET
gsrj-29	124	2	reprogrammable	reprogrammable	ADJ
gsrj-29	124	3	nature	nature	NOUN
gsrj-29	124	4	of	of	ADP
gsrj-29	124	5	this	this	DET
gsrj-29	124	6	crispr	crispr	ADJ
gsrj-29	124	7	approach	approach	NOUN
gsrj-29	124	8	is	be	AUX
gsrj-29	124	9	a	a	DET
gsrj-29	124	10	vital	vital	ADJ
gsrj-29	124	11	countermeasure	countermeasure	NOUN
gsrj-29	124	12	for	for	ADP
gsrj-29	124	13	emerging	emerge	VERB
gsrj-29	124	14	strains	strain	NOUN
gsrj-29	124	15	of	of	ADP
gsrj-29	124	16	sars	sar	NOUN
gsrj-29	124	17	-	-	PUNCT
gsrj-29	124	18	cov-2	cov-2	NOUN
gsrj-29	124	19	,	,	PUNCT
gsrj-29	124	20	but	but	CCONJ
gsrj-29	124	21	also	also	ADV
gsrj-29	124	22	for	for	ADP
gsrj-29	124	23	the	the	DET
gsrj-29	124	24	system	system	NOUN
gsrj-29	124	25	’s	’s	PART
gsrj-29	124	26	adaptability	adaptability	NOUN
gsrj-29	124	27	to	to	ADP
gsrj-29	124	28	future	future	ADJ
gsrj-29	124	29	emerging	emerge	VERB
gsrj-29	124	30	pathogens	pathogen	NOUN
gsrj-29	124	31	.	.	PUNCT
gsrj-29	125	1	either	either	CCONJ
gsrj-29	125	2	the	the	DET
gsrj-29	125	3	pac	pac	PROPN
gsrj-29	125	4	-	-	ADJ
gsrj-29	125	5	man	man	NOUN
gsrj-29	125	6	approach	approach	NOUN
gsrj-29	125	7	or	or	CCONJ
gsrj-29	125	8	the	the	DET
gsrj-29	125	9	reprogrammable	reprogrammable	ADJ
gsrj-29	125	10	crispr	crispr	ADJ
gsrj-29	125	11	-	-	PUNCT
gsrj-29	125	12	cas	cas	NOUN
gsrj-29	125	13	system	system	NOUN
gsrj-29	125	14	can	can	AUX
gsrj-29	125	15	effectively	effectively	ADV
gsrj-29	125	16	deactivate	deactivate	VERB
gsrj-29	125	17	sars	sar	NOUN
gsrj-29	125	18	-	-	PUNCT
gsrj-29	125	19	cov-2	cov-2	NOUN
gsrj-29	125	20	replication	replication	NOUN
gsrj-29	125	21	cycles	cycle	NOUN
gsrj-29	125	22	.	.	PUNCT
gsrj-29	126	1	it	it	PRON
gsrj-29	126	2	should	should	AUX
gsrj-29	126	3	be	be	AUX
gsrj-29	126	4	noted	note	VERB
gsrj-29	126	5	that	that	SCONJ
gsrj-29	126	6	crispr	crispr	NOUN
gsrj-29	126	7	-	-	PUNCT
gsrj-29	126	8	cas	cas	NOUN
gsrj-29	126	9	therapeutic	therapeutic	ADJ
gsrj-29	126	10	treatment	treatment	NOUN
gsrj-29	126	11	is	be	AUX
gsrj-29	126	12	subject	subject	ADJ
gsrj-29	126	13	to	to	ADP
gsrj-29	126	14	significant	significant	ADJ
gsrj-29	126	15	ethical	ethical	ADJ
gsrj-29	126	16	considerations	consideration	NOUN
gsrj-29	126	17	.	.	PUNCT
gsrj-29	127	1	crispr	crispr	ADJ
gsrj-29	127	2	-	-	PUNCT
gsrj-29	127	3	cas	cas	NOUN
gsrj-29	127	4	systems	system	NOUN
gsrj-29	127	5	recently	recently	ADV
gsrj-29	127	6	brought	bring	VERB
gsrj-29	127	7	discussion	discussion	NOUN
gsrj-29	127	8	of	of	ADP
gsrj-29	127	9	gene	gene	NOUN
gsrj-29	127	10	therapy	therapy	NOUN
gsrj-29	127	11	back	back	ADV
gsrj-29	127	12	into	into	ADP
gsrj-29	127	13	the	the	DET
gsrj-29	127	14	limelight	limelight	NOUN
gsrj-29	127	15	after	after	SCONJ
gsrj-29	127	16	tragic	tragic	ADJ
gsrj-29	127	17	setbacks	setback	NOUN
gsrj-29	127	18	related	relate	VERB
gsrj-29	127	19	to	to	ADP
gsrj-29	127	20	other	other	ADJ
gsrj-29	127	21	prior	prior	ADJ
gsrj-29	127	22	gene	gene	NOUN
gsrj-29	127	23	therapy	therapy	NOUN
gsrj-29	127	24	techniques.75	techniques.75	ADV
gsrj-29	127	25	however	however	ADV
gsrj-29	127	26	,	,	PUNCT
gsrj-29	127	27	opportunities	opportunity	NOUN
gsrj-29	127	28	associated	associate	VERB
gsrj-29	127	29	with	with	ADP
gsrj-29	127	30	crispr	crispr	ADJ
gsrj-29	127	31	-	-	PUNCT
gsrj-29	127	32	cas	cas	NOUN
gsrj-29	127	33	systems	system	NOUN
gsrj-29	127	34	are	be	AUX
gsrj-29	127	35	not	not	PART
gsrj-29	127	36	without	without	ADP
gsrj-29	127	37	ethical	ethical	ADJ
gsrj-29	127	38	concerns	concern	NOUN
gsrj-29	127	39	as	as	ADV
gsrj-29	127	40	well	well	ADV
gsrj-29	127	41	.	.	PUNCT
gsrj-29	128	1	this	this	PRON
gsrj-29	128	2	is	be	AUX
gsrj-29	128	3	especially	especially	ADV
gsrj-29	128	4	true	true	ADJ
gsrj-29	128	5	regarding	regard	VERB
gsrj-29	128	6	crispr	crispr	PROPN
gsrj-29	128	7	germline	germline	NOUN
gsrj-29	128	8	therapy	therapy	NOUN
gsrj-29	128	9	that	that	PRON
gsrj-29	128	10	causes	cause	VERB
gsrj-29	128	11	genetic	genetic	ADJ
gsrj-29	128	12	changes	change	NOUN
gsrj-29	128	13	at	at	ADP
gsrj-29	128	14	an	an	DET
gsrj-29	128	15	early	early	ADJ
gsrj-29	128	16	age	age	NOUN
gsrj-29	128	17	in	in	ADP
gsrj-29	128	18	all	all	DET
gsrj-29	128	19	cells	cell	NOUN
gsrj-29	128	20	,	,	PUNCT
gsrj-29	128	21	therefore	therefore	ADV
gsrj-29	128	22	driving	drive	VERB
gsrj-29	128	23	through	through	ADP
gsrj-29	128	24	generations	generation	NOUN
gsrj-29	128	25	via	via	ADP
gsrj-29	128	26	inheritance	inheritance	NOUN
gsrj-29	128	27	.	.	PUNCT
gsrj-29	129	1	somatic	somatic	ADJ
gsrj-29	129	2	gene	gene	NOUN
gsrj-29	129	3	therapy	therapy	NOUN
gsrj-29	129	4	through	through	ADP
gsrj-29	129	5	crispr	crispr	NOUN
gsrj-29	129	6	,	,	PUNCT
gsrj-29	129	7	on	on	ADP
gsrj-29	129	8	the	the	DET
gsrj-29	129	9	other	other	ADJ
gsrj-29	129	10	hand	hand	NOUN
gsrj-29	129	11	,	,	PUNCT
gsrj-29	129	12	causes	cause	VERB
gsrj-29	129	13	genetic	genetic	ADJ
gsrj-29	129	14	changes	change	NOUN
gsrj-29	129	15	in	in	ADP
gsrj-29	129	16	only	only	ADJ
gsrj-29	129	17	certain	certain	ADJ
gsrj-29	129	18	cells	cell	NOUN
gsrj-29	129	19	,	,	PUNCT
gsrj-29	129	20	but	but	CCONJ
gsrj-29	129	21	still	still	ADV
gsrj-29	129	22	some	some	DET
gsrj-29	129	23	commentators	commentator	NOUN
gsrj-29	129	24	remain	remain	VERB
gsrj-29	129	25	skeptical	skeptical	ADJ
gsrj-29	129	26	and	and	CCONJ
gsrj-29	129	27	stipulate	stipulate	VERB
gsrj-29	129	28	that	that	SCONJ
gsrj-29	129	29	ethical	ethical	ADJ
gsrj-29	129	30	distinctions	distinction	NOUN
gsrj-29	129	31	between	between	ADP
gsrj-29	129	32	somatic	somatic	ADJ
gsrj-29	129	33	editing	editing	NOUN
gsrj-29	129	34	and	and	CCONJ
gsrj-29	129	35	the	the	DET
gsrj-29	129	36	more	more	ADV
gsrj-29	129	37	controversial	controversial	ADJ
gsrj-29	129	38	germline	germline	NOUN
gsrj-29	129	39	editing	editing	NOUN
gsrj-29	129	40	are	be	AUX
gsrj-29	129	41	not	not	PART
gsrj-29	129	42	as	as	ADV
gsrj-29	129	43	clear	clear	ADJ
gsrj-29	129	44	cut	cut	NOUN
gsrj-29	129	45	as	as	ADP
gsrj-29	129	46	they	they	PRON
gsrj-29	129	47	seem.76	seem.76	PROPN
gsrj-29	129	48	furthermore	furthermore	ADV
gsrj-29	129	49	,	,	PUNCT
gsrj-29	129	50	due	due	ADP
gsrj-29	129	51	to	to	ADP
gsrj-29	129	52	research	research	NOUN
gsrj-29	129	53	and	and	CCONJ
gsrj-29	129	54	development	development	NOUN
gsrj-29	129	55	costs	cost	NOUN
gsrj-29	129	56	,	,	PUNCT
gsrj-29	129	57	crispr	crispr	ADJ
gsrj-29	129	58	gene	gene	NOUN
gsrj-29	129	59	therapy	therapy	NOUN
gsrj-29	129	60	is	be	AUX
gsrj-29	129	61	likely	likely	ADJ
gsrj-29	129	62	to	to	PART
gsrj-29	129	63	be	be	AUX
gsrj-29	129	64	restrictively	restrictively	ADV
gsrj-29	129	65	expensive	expensive	ADJ
gsrj-29	129	66	to	to	PART
gsrj-29	129	67	lower	lower	VERB
gsrj-29	129	68	income	income	NOUN
gsrj-29	129	69	individuals.77	individuals.77	NOUN
gsrj-29	129	70	there	there	PRON
gsrj-29	129	71	is	be	VERB
gsrj-29	129	72	also	also	ADV
gsrj-29	129	73	significant	significant	ADJ
gsrj-29	129	74	concern	concern	NOUN
gsrj-29	129	75	for	for	ADP
gsrj-29	129	76	limitations	limitation	NOUN
gsrj-29	129	77	to	to	PART
gsrj-29	129	78	crispr	crispr	VERB
gsrj-29	129	79	like	like	ADP
gsrj-29	129	80	off	off	ADP
gsrj-29	129	81	-	-	PUNCT
gsrj-29	129	82	target	target	NOUN
gsrj-29	129	83	effects	effect	NOUN
gsrj-29	129	84	–	–	PUNCT
gsrj-29	129	85	–	–	PUNCT
gsrj-29	129	86	where	where	SCONJ
gsrj-29	129	87	the	the	DET
gsrj-29	129	88	system	system	NOUN
gsrj-29	129	89	cuts	cut	VERB
gsrj-29	129	90	and	and	CCONJ
gsrj-29	129	91	replaces	replace	VERB
gsrj-29	129	92	an	an	DET
gsrj-29	129	93	unintended	unintended	ADJ
gsrj-29	129	94	sequence	sequence	NOUN
gsrj-29	129	95	and	and	CCONJ
gsrj-29	129	96	has	have	VERB
gsrj-29	129	97	unpredictable	unpredictable	ADJ
gsrj-29	129	98	effects	effect	NOUN
gsrj-29	129	99	.	.	PUNCT
gsrj-29	130	1	other	other	ADJ
gsrj-29	130	2	limitations	limitation	NOUN
gsrj-29	130	3	include	include	VERB
gsrj-29	130	4	dna	dna	NOUN
gsrj-29	130	5	-	-	PUNCT
gsrj-29	130	6	damage	damage	NOUN
gsrj-29	130	7	toxicity	toxicity	NOUN
gsrj-29	130	8	,	,	PUNCT
gsrj-29	130	9	where	where	SCONJ
gsrj-29	130	10	the	the	DET
gsrj-29	130	11	editing	editing	NOUN
gsrj-29	130	12	may	may	AUX
gsrj-29	130	13	trigger	trigger	VERB
gsrj-29	130	14	effects	effect	NOUN
gsrj-29	130	15	like	like	ADP
gsrj-29	130	16	early	early	ADJ
gsrj-29	130	17	cell	cell	NOUN
gsrj-29	130	18	death	death	NOUN
gsrj-29	130	19	,	,	PUNCT
gsrj-29	130	20	or	or	CCONJ
gsrj-29	130	21	immunotoxicity	immunotoxicity	NOUN
gsrj-29	130	22	,	,	PUNCT
gsrj-29	130	23	where	where	SCONJ
gsrj-29	130	24	the	the	DET
gsrj-29	130	25	cells	cell	NOUN
gsrj-29	130	26	may	may	AUX
gsrj-29	130	27	build	build	VERB
gsrj-29	130	28	immunity	immunity	NOUN
gsrj-29	130	29	against	against	ADP
gsrj-29	130	30	the	the	DET
gsrj-29	130	31	therapeutic	therapeutic	ADJ
gsrj-29	130	32	treatment.78	treatment.78	PROPN
gsrj-29	130	33	these	these	DET
gsrj-29	130	34	limitations	limitation	NOUN
gsrj-29	130	35	are	be	AUX
gsrj-29	130	36	especially	especially	ADV
gsrj-29	130	37	of	of	ADP
gsrj-29	130	38	concern	concern	NOUN
gsrj-29	130	39	if	if	SCONJ
gsrj-29	130	40	the	the	DET
gsrj-29	130	41	therapeutic	therapeutic	ADJ
gsrj-29	130	42	target	target	NOUN
gsrj-29	130	43	is	be	AUX
gsrj-29	130	44	the	the	DET
gsrj-29	130	45	human	human	ADJ
gsrj-29	130	46	cell	cell	NOUN
gsrj-29	130	47	.	.	PUNCT
gsrj-29	131	1	crispr	crispr	ADJ
gsrj-29	131	2	-	-	PUNCT
gsrj-29	131	3	cas	cas	NOUN
gsrj-29	131	4	systems	system	NOUN
gsrj-29	131	5	are	be	AUX
gsrj-29	131	6	known	know	VERB
gsrj-29	131	7	to	to	PART
gsrj-29	131	8	be	be	AUX
gsrj-29	131	9	naturally	naturally	ADV
gsrj-29	131	10	occurring	occur	VERB
gsrj-29	131	11	in	in	ADP
gsrj-29	131	12	bacteria	bacteria	NOUN
gsrj-29	131	13	with	with	ADP
gsrj-29	131	14	the	the	DET
gsrj-29	131	15	purpose	purpose	NOUN
gsrj-29	131	16	of	of	ADP
gsrj-29	131	17	deleting	delete	VERB
gsrj-29	131	18	rna	rna	NOUN
gsrj-29	131	19	from	from	ADP
gsrj-29	131	20	an	an	DET
gsrj-29	131	21	infectious	infectious	ADJ
gsrj-29	131	22	virus	virus	NOUN
gsrj-29	131	23	that	that	PRON
gsrj-29	131	24	hijacks	hijack	VERB
gsrj-29	131	25	cell	cell	NOUN
gsrj-29	131	26	functions	function	NOUN
gsrj-29	131	27	.	.	PUNCT
gsrj-29	132	1	these	these	DET
gsrj-29	132	2	systems	system	NOUN
gsrj-29	132	3	can	can	AUX
gsrj-29	132	4	be	be	AUX
gsrj-29	132	5	therapeutically	therapeutically	ADV
gsrj-29	132	6	leveraged	leverage	VERB
gsrj-29	132	7	for	for	ADP
gsrj-29	132	8	somatic	somatic	ADJ
gsrj-29	132	9	gene	gene	NOUN
gsrj-29	132	10	editing	edit	VERB
gsrj-29	132	11	in	in	ADP
gsrj-29	132	12	human	human	ADJ
gsrj-29	132	13	cells	cell	NOUN
gsrj-29	132	14	for	for	ADP
gsrj-29	132	15	the	the	DET
gsrj-29	132	16	same	same	ADJ
gsrj-29	132	17	purpose	purpose	NOUN
gsrj-29	132	18	.	.	PUNCT
gsrj-29	133	1	beyond	beyond	ADP
gsrj-29	133	2	the	the	DET
gsrj-29	133	3	potential	potential	NOUN
gsrj-29	133	4	of	of	ADP
gsrj-29	133	5	these	these	DET
gsrj-29	133	6	systems	system	NOUN
gsrj-29	133	7	for	for	ADP
gsrj-29	133	8	this	this	DET
gsrj-29	133	9	pandemic	pandemic	ADJ
gsrj-29	133	10	,	,	PUNCT
gsrj-29	133	11	33	33	NUM
gsrj-29	133	12	georgetown	georgetown	PROPN
gsrj-29	133	13	scientific	scientific	PROPN
gsrj-29	133	14	research	research	NOUN
gsrj-29	133	15	journal	journal	NOUN
gsrj-29	133	16	crispr	crispr	NOUN
gsrj-29	133	17	-	-	PUNCT
gsrj-29	133	18	cas	cas	NOUN
gsrj-29	133	19	systems	system	NOUN
gsrj-29	133	20	can	can	AUX
gsrj-29	133	21	be	be	AUX
gsrj-29	133	22	applied	apply	VERB
gsrj-29	133	23	to	to	ADP
gsrj-29	133	24	persistent	persistent	ADJ
gsrj-29	133	25	pathogens	pathogen	NOUN
gsrj-29	133	26	like	like	ADP
gsrj-29	133	27	hiv.79	hiv.79	NOUN
gsrj-29	133	28	before	before	ADP
gsrj-29	133	29	broad	broad	ADJ
gsrj-29	133	30	application	application	NOUN
gsrj-29	133	31	of	of	ADP
gsrj-29	133	32	crispr	crispr	ADJ
gsrj-29	133	33	therapies	therapy	NOUN
gsrj-29	133	34	to	to	ADP
gsrj-29	133	35	any	any	DET
gsrj-29	133	36	disease	disease	NOUN
gsrj-29	133	37	,	,	PUNCT
gsrj-29	133	38	careful	careful	ADJ
gsrj-29	133	39	ethical	ethical	ADJ
gsrj-29	133	40	considerations	consideration	NOUN
gsrj-29	133	41	and	and	CCONJ
gsrj-29	133	42	clinical	clinical	ADJ
gsrj-29	133	43	trials	trial	NOUN
gsrj-29	133	44	must	must	AUX
gsrj-29	133	45	be	be	AUX
gsrj-29	133	46	carried	carry	VERB
gsrj-29	133	47	out	out	ADP
gsrj-29	133	48	.	.	PUNCT
gsrj-29	134	1	thus	thus	ADV
gsrj-29	134	2	,	,	PUNCT
gsrj-29	134	3	crispr	crispr	ADJ
gsrj-29	134	4	antiviral	antiviral	ADJ
gsrj-29	134	5	therapies	therapy	NOUN
gsrj-29	134	6	have	have	AUX
gsrj-29	134	7	not	not	PART
gsrj-29	134	8	yet	yet	ADV
gsrj-29	134	9	been	be	AUX
gsrj-29	134	10	clinically	clinically	ADV
gsrj-29	134	11	applied	apply	VERB
gsrj-29	134	12	as	as	ADP
gsrj-29	134	13	a	a	DET
gsrj-29	134	14	countermeasure	countermeasure	NOUN
gsrj-29	134	15	against	against	ADP
gsrj-29	134	16	covid-19.80	covid-19.80	PROPN
gsrj-29	134	17	nonetheless	nonetheless	ADV
gsrj-29	134	18	,	,	PUNCT
gsrj-29	134	19	the	the	DET
gsrj-29	134	20	pandemic	pandemic	ADJ
gsrj-29	134	21	persists	persist	NOUN
gsrj-29	134	22	and	and	CCONJ
gsrj-29	134	23	there	there	PRON
gsrj-29	134	24	remains	remain	VERB
gsrj-29	134	25	great	great	ADJ
gsrj-29	134	26	potential	potential	NOUN
gsrj-29	134	27	:	:	PUNCT
gsrj-29	134	28	crispr	crispr	ADJ
gsrj-29	134	29	-	-	PUNCT
gsrj-29	134	30	cas	cas	NOUN
gsrj-29	134	31	systems	system	NOUN
gsrj-29	134	32	can	can	AUX
gsrj-29	134	33	provide	provide	VERB
gsrj-29	134	34	a	a	DET
gsrj-29	134	35	therapeutic	therapeutic	ADJ
gsrj-29	134	36	treatment	treatment	NOUN
gsrj-29	134	37	for	for	ADP
gsrj-29	134	38	sars	sar	NOUN
gsrj-29	134	39	-	-	PUNCT
gsrj-29	134	40	cov-2	cov-2	NOUN
gsrj-29	134	41	and	and	CCONJ
gsrj-29	134	42	emerging	emerge	VERB
gsrj-29	134	43	variants	variant	NOUN
gsrj-29	134	44	,	,	PUNCT
gsrj-29	134	45	setting	set	VERB
gsrj-29	134	46	the	the	DET
gsrj-29	134	47	stage	stage	NOUN
gsrj-29	134	48	for	for	ADP
gsrj-29	134	49	an	an	DET
gsrj-29	134	50	important	important	ADJ
gsrj-29	134	51	reprogrammable	reprogrammable	ADJ
gsrj-29	134	52	countermeasure	countermeasure	NOUN
gsrj-29	134	53	for	for	ADP
gsrj-29	134	54	future	future	ADJ
gsrj-29	134	55	pathogens	pathogen	NOUN
gsrj-29	134	56	.	.	PUNCT
gsrj-29	135	1	4	4	X
gsrj-29	135	2	.	.	X
gsrj-29	135	3	the	the	DET
gsrj-29	135	4	role	role	NOUN
gsrj-29	135	5	of	of	ADP
gsrj-29	135	6	crispr	crispr	NOUN
gsrj-29	135	7	in	in	ADP
gsrj-29	135	8	the	the	DET
gsrj-29	135	9	strategic	strategic	ADJ
gsrj-29	135	10	environment	environment	NOUN
gsrj-29	135	11	crispr	crispr	NOUN
gsrj-29	135	12	democratizes	democratize	VERB
gsrj-29	135	13	gene	gene	NOUN
gsrj-29	135	14	editing	edit	VERB
gsrj-29	135	15	in	in	ADP
gsrj-29	135	16	terms	term	NOUN
gsrj-29	135	17	of	of	ADP
gsrj-29	135	18	ease	ease	NOUN
gsrj-29	135	19	-	-	PUNCT
gsrj-29	135	20	of	of	ADP
gsrj-29	135	21	-	-	PUNCT
gsrj-29	135	22	use	use	NOUN
gsrj-29	135	23	,	,	PUNCT
gsrj-29	135	24	cost	cost	NOUN
gsrj-29	135	25	,	,	PUNCT
gsrj-29	135	26	and	and	CCONJ
gsrj-29	135	27	commercial	commercial	ADJ
gsrj-29	135	28	accessibility	accessibility	NOUN
gsrj-29	135	29	.	.	PUNCT
gsrj-29	136	1	it	it	PRON
gsrj-29	136	2	is	be	AUX
gsrj-29	136	3	therefore	therefore	ADV
gsrj-29	136	4	possible	possible	ADJ
gsrj-29	136	5	for	for	SCONJ
gsrj-29	136	6	malicious	malicious	ADJ
gsrj-29	136	7	non	non	ADJ
gsrj-29	136	8	-	-	ADJ
gsrj-29	136	9	state	state	ADJ
gsrj-29	136	10	attackers	attacker	NOUN
gsrj-29	136	11	to	to	PART
gsrj-29	136	12	engineer	engineer	VERB
gsrj-29	136	13	a	a	DET
gsrj-29	136	14	dangerous	dangerous	ADJ
gsrj-29	136	15	pathogen	pathogen	NOUN
gsrj-29	136	16	and	and	CCONJ
gsrj-29	136	17	cause	cause	VERB
gsrj-29	136	18	a	a	DET
gsrj-29	136	19	dbe	dbe	NOUN
gsrj-29	136	20	.	.	PUNCT
gsrj-29	137	1	some	some	DET
gsrj-29	137	2	barriers	barrier	NOUN
gsrj-29	137	3	to	to	ADP
gsrj-29	137	4	access	access	NOUN
gsrj-29	137	5	remain	remain	VERB
gsrj-29	137	6	for	for	ADP
gsrj-29	137	7	the	the	DET
gsrj-29	137	8	attacker	attacker	NOUN
gsrj-29	137	9	,	,	PUNCT
gsrj-29	137	10	including	include	VERB
gsrj-29	137	11	scientific	scientific	ADJ
gsrj-29	137	12	knowledge	knowledge	NOUN
gsrj-29	137	13	in	in	ADP
gsrj-29	137	14	the	the	DET
gsrj-29	137	15	field	field	NOUN
gsrj-29	137	16	of	of	ADP
gsrj-29	137	17	genetics	genetic	NOUN
gsrj-29	137	18	and	and	CCONJ
gsrj-29	137	19	mechanism	mechanism	NOUN
gsrj-29	137	20	of	of	ADP
gsrj-29	137	21	delivering	deliver	VERB
gsrj-29	137	22	an	an	DET
gsrj-29	137	23	engineered	engineer	VERB
gsrj-29	137	24	pathogen	pathogen	NOUN
gsrj-29	137	25	.	.	PUNCT
gsrj-29	138	1	nonetheless	nonetheless	ADV
gsrj-29	138	2	,	,	PUNCT
gsrj-29	138	3	the	the	DET
gsrj-29	138	4	first	first	ADJ
gsrj-29	138	5	-	-	PUNCT
gsrj-29	138	6	mover	mover	NOUN
gsrj-29	138	7	advantage	advantage	NOUN
gsrj-29	138	8	is	be	AUX
gsrj-29	138	9	prominent	prominent	ADJ
gsrj-29	138	10	as	as	SCONJ
gsrj-29	138	11	it	it	PRON
gsrj-29	138	12	is	be	AUX
gsrj-29	138	13	far	far	ADV
gsrj-29	138	14	less	less	ADV
gsrj-29	138	15	complicated	complicated	ADJ
gsrj-29	138	16	to	to	PART
gsrj-29	138	17	release	release	VERB
gsrj-29	138	18	a	a	DET
gsrj-29	138	19	pathogen	pathogen	NOUN
gsrj-29	138	20	than	than	SCONJ
gsrj-29	138	21	to	to	PART
gsrj-29	138	22	contain	contain	VERB
gsrj-29	138	23	it	it	PRON
gsrj-29	138	24	.	.	PUNCT
gsrj-29	139	1	unintended	unintended	ADJ
gsrj-29	139	2	effects	effect	NOUN
gsrj-29	139	3	caused	cause	VERB
gsrj-29	139	4	by	by	ADP
gsrj-29	139	5	a	a	DET
gsrj-29	139	6	lack	lack	NOUN
gsrj-29	139	7	of	of	ADP
gsrj-29	139	8	scientific	scientific	ADJ
gsrj-29	139	9	knowledge	knowledge	NOUN
gsrj-29	139	10	when	when	SCONJ
gsrj-29	139	11	engineering	engineer	VERB
gsrj-29	139	12	a	a	DET
gsrj-29	139	13	pathogen	pathogen	NOUN
gsrj-29	139	14	may	may	AUX
gsrj-29	139	15	be	be	AUX
gsrj-29	139	16	irrelevant	irrelevant	ADJ
gsrj-29	139	17	and	and	CCONJ
gsrj-29	139	18	still	still	ADV
gsrj-29	139	19	drive	drive	VERB
gsrj-29	139	20	disease	disease	NOUN
gsrj-29	139	21	through	through	ADP
gsrj-29	139	22	society	society	NOUN
gsrj-29	139	23	.	.	PUNCT
gsrj-29	140	1	further	far	ADV
gsrj-29	140	2	,	,	PUNCT
gsrj-29	140	3	the	the	DET
gsrj-29	140	4	complexity	complexity	NOUN
gsrj-29	140	5	of	of	ADP
gsrj-29	140	6	an	an	DET
gsrj-29	140	7	efficient	efficient	ADJ
gsrj-29	140	8	and	and	CCONJ
gsrj-29	140	9	coordinated	coordinated	ADJ
gsrj-29	140	10	defense	defense	NOUN
gsrj-29	140	11	response	response	NOUN
gsrj-29	140	12	with	with	ADP
gsrj-29	140	13	varied	varied	ADJ
gsrj-29	140	14	stakeholders	stakeholder	NOUN
gsrj-29	140	15	contributes	contribute	VERB
gsrj-29	140	16	to	to	ADP
gsrj-29	140	17	containment	containment	NOUN
gsrj-29	140	18	difficulties	difficulty	NOUN
gsrj-29	140	19	.	.	PUNCT
gsrj-29	141	1	this	this	DET
gsrj-29	141	2	comparative	comparative	ADJ
gsrj-29	141	3	ease	ease	NOUN
gsrj-29	141	4	of	of	ADP
gsrj-29	141	5	release	release	NOUN
gsrj-29	141	6	relative	relative	ADJ
gsrj-29	141	7	to	to	ADP
gsrj-29	141	8	containment	containment	NOUN
gsrj-29	141	9	is	be	AUX
gsrj-29	141	10	a	a	DET
gsrj-29	141	11	key	key	ADJ
gsrj-29	141	12	asset	asset	NOUN
gsrj-29	141	13	for	for	ADP
gsrj-29	141	14	the	the	DET
gsrj-29	141	15	attacker	attacker	NOUN
gsrj-29	141	16	and	and	CCONJ
gsrj-29	141	17	gives	give	VERB
gsrj-29	141	18	the	the	DET
gsrj-29	141	19	crispr	crispr	ADJ
gsrj-29	141	20	advantage	advantage	NOUN
gsrj-29	141	21	to	to	ADP
gsrj-29	141	22	the	the	DET
gsrj-29	141	23	attacker	attacker	NOUN
gsrj-29	141	24	in	in	ADP
gsrj-29	141	25	the	the	DET
gsrj-29	141	26	very	very	ADV
gsrj-29	141	27	short	short	ADJ
gsrj-29	141	28	-	-	PUNCT
gsrj-29	141	29	term	term	NOUN
gsrj-29	141	30	engineering	engineering	NOUN
gsrj-29	141	31	phase	phase	NOUN
gsrj-29	141	32	and	and	CCONJ
gsrj-29	141	33	immediately	immediately	ADV
gsrj-29	141	34	following	follow	VERB
gsrj-29	141	35	release	release	NOUN
gsrj-29	141	36	.	.	PUNCT
gsrj-29	142	1	in	in	ADP
gsrj-29	142	2	the	the	DET
gsrj-29	142	3	countermeasure	countermeasure	NOUN
gsrj-29	142	4	response	response	NOUN
gsrj-29	142	5	to	to	ADP
gsrj-29	142	6	a	a	DET
gsrj-29	142	7	pathogen	pathogen	NOUN
gsrj-29	142	8	,	,	PUNCT
gsrj-29	142	9	efficiency	efficiency	NOUN
gsrj-29	142	10	and	and	CCONJ
gsrj-29	142	11	rapidity	rapidity	NOUN
gsrj-29	142	12	are	be	AUX
gsrj-29	142	13	key	key	ADJ
gsrj-29	142	14	to	to	AUX
gsrj-29	142	15	containment	containment	VERB
gsrj-29	142	16	.	.	PUNCT
gsrj-29	143	1	this	this	DET
gsrj-29	143	2	report	report	NOUN
gsrj-29	143	3	finds	find	VERB
gsrj-29	143	4	that	that	PRON
gsrj-29	143	5	crispr	crispr	NOUN
gsrj-29	143	6	can	can	AUX
gsrj-29	143	7	be	be	AUX
gsrj-29	143	8	leveraged	leverage	VERB
gsrj-29	143	9	to	to	PART
gsrj-29	143	10	rapidly	rapidly	ADV
gsrj-29	143	11	configure	configure	VERB
gsrj-29	143	12	this	this	DET
gsrj-29	143	13	defense	defense	NOUN
gsrj-29	143	14	countermeasure	countermeasure	NOUN
gsrj-29	143	15	.	.	PUNCT
gsrj-29	144	1	crispr	crispr	ADJ
gsrj-29	144	2	diagnostic	diagnostic	ADJ
gsrj-29	144	3	tests	test	NOUN
gsrj-29	144	4	offer	offer	VERB
gsrj-29	144	5	certain	certain	ADJ
gsrj-29	144	6	advantages	advantage	NOUN
gsrj-29	144	7	over	over	ADP
gsrj-29	144	8	gold	gold	NOUN
gsrj-29	144	9	standard	standard	ADJ
gsrj-29	144	10	rt	rt	PROPN
gsrj-29	144	11	-	-	PUNCT
gsrj-29	144	12	pcr	pcr	ADJ
gsrj-29	144	13	tests	test	NOUN
gsrj-29	144	14	,	,	PUNCT
gsrj-29	144	15	including	include	VERB
gsrj-29	144	16	accessibility	accessibility	NOUN
gsrj-29	144	17	,	,	PUNCT
gsrj-29	144	18	sample	sample	NOUN
gsrj-29	144	19	-	-	PUNCT
gsrj-29	144	20	to	to	ADP
gsrj-29	144	21	-	-	PUNCT
gsrj-29	144	22	answer	answer	VERB
gsrj-29	144	23	reporting	reporting	NOUN
gsrj-29	144	24	time	time	NOUN
gsrj-29	144	25	,	,	PUNCT
gsrj-29	144	26	and	and	CCONJ
gsrj-29	144	27	convenience	convenience	NOUN
gsrj-29	144	28	.	.	PUNCT
gsrj-29	145	1	these	these	DET
gsrj-29	145	2	tests	test	NOUN
gsrj-29	145	3	are	be	AUX
gsrj-29	145	4	of	of	ADP
gsrj-29	145	5	critical	critical	ADJ
gsrj-29	145	6	importance	importance	NOUN
gsrj-29	145	7	for	for	ADP
gsrj-29	145	8	a	a	DET
gsrj-29	145	9	pathogenic	pathogenic	ADJ
gsrj-29	145	10	surveillance	surveillance	NOUN
gsrj-29	145	11	regime	regime	NOUN
gsrj-29	145	12	to	to	PART
gsrj-29	145	13	efficiently	efficiently	ADV
gsrj-29	145	14	and	and	CCONJ
gsrj-29	145	15	rapidly	rapidly	ADV
gsrj-29	145	16	contain	contain	VERB
gsrj-29	145	17	the	the	DET
gsrj-29	145	18	spread	spread	NOUN
gsrj-29	145	19	.	.	PUNCT
gsrj-29	146	1	crispr	crispr	ADJ
gsrj-29	146	2	tests	test	NOUN
gsrj-29	146	3	are	be	AUX
gsrj-29	146	4	a	a	DET
gsrj-29	146	5	key	key	ADJ
gsrj-29	146	6	asset	asset	NOUN
gsrj-29	146	7	for	for	ADP
gsrj-29	146	8	the	the	DET
gsrj-29	146	9	defender	defender	NOUN
gsrj-29	146	10	–	–	PUNCT
gsrj-29	146	11	especially	especially	ADV
gsrj-29	146	12	in	in	ADP
gsrj-29	146	13	initial	initial	ADJ
gsrj-29	146	14	outbreak	outbreak	NOUN
gsrj-29	146	15	stages	stage	NOUN
gsrj-29	146	16	–	–	PUNCT
gsrj-29	146	17	and	and	CCONJ
gsrj-29	146	18	can	can	AUX
gsrj-29	146	19	be	be	AUX
gsrj-29	146	20	leveraged	leverage	VERB
gsrj-29	146	21	further	far	ADV
gsrj-29	146	22	to	to	PART
gsrj-29	146	23	enhance	enhance	VERB
gsrj-29	146	24	the	the	DET
gsrj-29	146	25	defense	defense	NOUN
gsrj-29	146	26	advantage	advantage	NOUN
gsrj-29	146	27	of	of	ADP
gsrj-29	146	28	crispr	crispr	NOUN
gsrj-29	146	29	in	in	ADP
gsrj-29	146	30	the	the	DET
gsrj-29	146	31	short	short	ADJ
gsrj-29	146	32	term	term	NOUN
gsrj-29	146	33	.	.	PUNCT
gsrj-29	147	1	crispr	crispr	PROPN
gsrj-29	147	2	offers	offer	VERB
gsrj-29	147	3	a	a	DET
gsrj-29	147	4	platform	platform	NOUN
gsrj-29	147	5	to	to	PART
gsrj-29	147	6	identify	identify	VERB
gsrj-29	147	7	and	and	CCONJ
gsrj-29	147	8	test	test	VERB
gsrj-29	147	9	viral	viral	ADJ
gsrj-29	147	10	vectors	vector	NOUN
gsrj-29	147	11	,	,	PUNCT
gsrj-29	147	12	aiding	aid	VERB
gsrj-29	147	13	the	the	DET
gsrj-29	147	14	configuration	configuration	NOUN
gsrj-29	147	15	of	of	ADP
gsrj-29	147	16	countermeasures	countermeasure	NOUN
gsrj-29	147	17	like	like	ADP
gsrj-29	147	18	vaccines	vaccine	NOUN
gsrj-29	147	19	and	and	CCONJ
gsrj-29	147	20	treatments	treatment	NOUN
gsrj-29	147	21	.	.	PUNCT
gsrj-29	148	1	this	this	DET
gsrj-29	148	2	efficient	efficient	ADJ
gsrj-29	148	3	platform	platform	NOUN
gsrj-29	148	4	is	be	AUX
gsrj-29	148	5	to	to	ADP
gsrj-29	148	6	the	the	DET
gsrj-29	148	7	advantage	advantage	NOUN
gsrj-29	148	8	of	of	ADP
gsrj-29	148	9	the	the	DET
gsrj-29	148	10	defender	defender	NOUN
gsrj-29	148	11	in	in	ADP
gsrj-29	148	12	the	the	DET
gsrj-29	148	13	shortto	shortto	PROPN
gsrj-29	148	14	midterm	midterm	NOUN
gsrj-29	148	15	.	.	PUNCT
gsrj-29	149	1	finally	finally	ADV
gsrj-29	149	2	,	,	PUNCT
gsrj-29	149	3	crispr	crispr	PROPN
gsrj-29	149	4	offers	offer	VERB
gsrj-29	149	5	the	the	DET
gsrj-29	149	6	potential	potential	ADJ
gsrj-29	149	7	development	development	NOUN
gsrj-29	149	8	of	of	ADP
gsrj-29	149	9	therapeutic	therapeutic	ADJ
gsrj-29	149	10	treatment	treatment	NOUN
gsrj-29	149	11	options	option	NOUN
gsrj-29	149	12	for	for	ADP
gsrj-29	149	13	the	the	DET
gsrj-29	149	14	defender	defender	NOUN
gsrj-29	149	15	’s	’s	PART
gsrj-29	149	16	long	long	ADJ
gsrj-29	149	17	-	-	PUNCT
gsrj-29	149	18	term	term	NOUN
gsrj-29	149	19	countermeasure	countermeasure	NOUN
gsrj-29	149	20	strategy	strategy	NOUN
gsrj-29	149	21	since	since	SCONJ
gsrj-29	149	22	diseases	disease	NOUN
gsrj-29	149	23	are	be	AUX
gsrj-29	149	24	n’t	not	PART
gsrj-29	149	25	just	just	ADV
gsrj-29	149	26	eradicated	eradicate	VERB
gsrj-29	149	27	.	.	PUNCT
gsrj-29	150	1	crispr	crispr	PROPN
gsrj-29	150	2	can	can	AUX
gsrj-29	150	3	also	also	ADV
gsrj-29	150	4	test	test	VERB
gsrj-29	150	5	the	the	DET
gsrj-29	150	6	effectiveness	effectiveness	NOUN
gsrj-29	150	7	of	of	ADP
gsrj-29	150	8	these	these	DET
gsrj-29	150	9	long	long	ADJ
gsrj-29	150	10	-	-	PUNCT
gsrj-29	150	11	term	term	NOUN
gsrj-29	150	12	therapeutic	therapeutic	ADJ
gsrj-29	150	13	treatments	treatment	NOUN
gsrj-29	150	14	.	.	PUNCT
gsrj-29	151	1	therefore	therefore	ADV
gsrj-29	151	2	,	,	PUNCT
gsrj-29	151	3	this	this	DET
gsrj-29	151	4	report	report	NOUN
gsrj-29	151	5	concludes	conclude	VERB
gsrj-29	151	6	that	that	SCONJ
gsrj-29	151	7	the	the	DET
gsrj-29	151	8	decreased	decrease	VERB
gsrj-29	151	9	barrier	barrier	NOUN
gsrj-29	151	10	to	to	PART
gsrj-29	151	11	access	access	VERB
gsrj-29	151	12	for	for	ADP
gsrj-29	151	13	malicious	malicious	ADJ
gsrj-29	151	14	actors	actor	NOUN
gsrj-29	151	15	to	to	PART
gsrj-29	151	16	engineer	engineer	VERB
gsrj-29	151	17	a	a	DET
gsrj-29	151	18	pathogen	pathogen	NOUN
gsrj-29	151	19	renders	render	VERB
gsrj-29	151	20	crispr	crispr	ADJ
gsrj-29	151	21	more	more	ADV
gsrj-29	151	22	advantageous	advantageous	ADJ
gsrj-29	151	23	to	to	ADP
gsrj-29	151	24	a	a	DET
gsrj-29	151	25	malicious	malicious	ADJ
gsrj-29	151	26	,	,	PUNCT
gsrj-29	151	27	non	non	ADJ
gsrj-29	151	28	-	-	ADJ
gsrj-29	151	29	state	state	ADJ
gsrj-29	151	30	actor	actor	NOUN
gsrj-29	151	31	in	in	ADP
gsrj-29	151	32	the	the	DET
gsrj-29	151	33	very	very	ADV
gsrj-29	151	34	short	short	ADJ
gsrj-29	151	35	-	-	PUNCT
gsrj-29	151	36	term	term	NOUN
gsrj-29	151	37	.	.	PUNCT
gsrj-29	152	1	however	however	ADV
gsrj-29	152	2	,	,	PUNCT
gsrj-29	152	3	the	the	DET
gsrj-29	152	4	remaining	remain	VERB
gsrj-29	152	5	barriers	barrier	NOUN
gsrj-29	152	6	for	for	ADP
gsrj-29	152	7	the	the	DET
gsrj-29	152	8	attacker	attacker	NOUN
gsrj-29	152	9	and	and	CCONJ
gsrj-29	152	10	the	the	DET
gsrj-29	152	11	crispr	crispr	ADJ
gsrj-29	152	12	defense	defense	NOUN
gsrj-29	152	13	applications	application	NOUN
gsrj-29	152	14	against	against	ADP
gsrj-29	152	15	said	say	VERB
gsrj-29	152	16	pathogen	pathogen	NOUN
gsrj-29	152	17	suggest	suggest	VERB
gsrj-29	152	18	a	a	DET
gsrj-29	152	19	net	net	ADJ
gsrj-29	152	20	positive	positive	NOUN
gsrj-29	152	21	for	for	ADP
gsrj-29	152	22	the	the	DET
gsrj-29	152	23	defender	defender	NOUN
gsrj-29	152	24	in	in	ADP
gsrj-29	152	25	the	the	DET
gsrj-29	152	26	shortto	shortto	ADJ
gsrj-29	152	27	mid	mid	ADJ
gsrj-29	152	28	-	-	NOUN
gsrj-29	152	29	term	term	NOUN
gsrj-29	152	30	and	and	CCONJ
gsrj-29	152	31	long	long	ADJ
gsrj-29	152	32	-	-	PUNCT
gsrj-29	152	33	term	term	NOUN
gsrj-29	152	34	response	response	NOUN
gsrj-29	152	35	.	.	PUNCT
gsrj-29	153	1	the	the	DET
gsrj-29	153	2	shortto	shortto	ADJ
gsrj-29	153	3	mid	mid	ADJ
gsrj-29	153	4	-	-	ADJ
gsrj-29	153	5	term	term	ADJ
gsrj-29	153	6	response	response	NOUN
gsrj-29	153	7	refers	refer	VERB
gsrj-29	153	8	to	to	ADP
gsrj-29	153	9	the	the	DET
gsrj-29	153	10	direct	direct	ADJ
gsrj-29	153	11	response	response	NOUN
gsrj-29	153	12	to	to	ADP
gsrj-29	153	13	a	a	DET
gsrj-29	153	14	biological	biological	ADJ
gsrj-29	153	15	event	event	NOUN
gsrj-29	153	16	that	that	PRON
gsrj-29	153	17	can	can	AUX
gsrj-29	153	18	last	last	VERB
gsrj-29	153	19	months	month	NOUN
gsrj-29	153	20	to	to	ADP
gsrj-29	153	21	a	a	DET
gsrj-29	153	22	few	few	ADJ
gsrj-29	153	23	years	year	NOUN
gsrj-29	153	24	after	after	SCONJ
gsrj-29	153	25	first	first	ADJ
gsrj-29	153	26	cases	case	NOUN
gsrj-29	153	27	are	be	AUX
gsrj-29	153	28	identified	identify	VERB
gsrj-29	153	29	;	;	PUNCT
gsrj-29	153	30	the	the	DET
gsrj-29	153	31	long	long	ADJ
gsrj-29	153	32	-	-	PUNCT
gsrj-29	153	33	term	term	NOUN
gsrj-29	153	34	response	response	NOUN
gsrj-29	153	35	refers	refer	VERB
gsrj-29	153	36	to	to	ADP
gsrj-29	153	37	the	the	DET
gsrj-29	153	38	several	several	ADJ
gsrj-29	153	39	yearto	yearto	NUM
gsrj-29	153	40	decade	decade	NOUN
gsrj-29	153	41	-	-	PUNCT
gsrj-29	153	42	long	long	ADJ
gsrj-29	153	43	biological	biological	ADJ
gsrj-29	153	44	preparation	preparation	NOUN
gsrj-29	153	45	efforts	effort	NOUN
gsrj-29	153	46	from	from	ADP
gsrj-29	153	47	the	the	DET
gsrj-29	153	48	defender	defender	NOUN
gsrj-29	153	49	.	.	PUNCT
gsrj-29	154	1	with	with	ADP
gsrj-29	154	2	increased	increase	VERB
gsrj-29	154	3	research	research	NOUN
gsrj-29	154	4	and	and	CCONJ
gsrj-29	154	5	development	development	NOUN
gsrj-29	154	6	(	(	PUNCT
gsrj-29	154	7	r&d	r&d	NOUN
gsrj-29	154	8	)	)	PUNCT
gsrj-29	154	9	,	,	PUNCT
gsrj-29	154	10	applied	apply	VERB
gsrj-29	154	11	use	use	NOUN
gsrj-29	154	12	,	,	PUNCT
gsrj-29	154	13	and	and	CCONJ
gsrj-29	154	14	normalization	normalization	NOUN
gsrj-29	154	15	of	of	ADP
gsrj-29	154	16	crispr	crispr	NOUN
gsrj-29	154	17	,	,	PUNCT
gsrj-29	154	18	this	this	DET
gsrj-29	154	19	net	net	ADJ
gsrj-29	154	20	positive	positive	NOUN
gsrj-29	154	21	can	can	AUX
gsrj-29	154	22	only	only	ADV
gsrj-29	154	23	improve	improve	VERB
gsrj-29	154	24	for	for	ADP
gsrj-29	154	25	the	the	DET
gsrj-29	154	26	defender	defender	NOUN
gsrj-29	154	27	.	.	PUNCT
gsrj-29	155	1	through	through	ADP
gsrj-29	155	2	development	development	NOUN
gsrj-29	155	3	of	of	ADP
gsrj-29	155	4	policies	policy	NOUN
gsrj-29	155	5	that	that	PRON
gsrj-29	155	6	optimize	optimize	VERB
gsrj-29	155	7	crispr	crispr	NOUN
gsrj-29	155	8	for	for	ADP
gsrj-29	155	9	rapid	rapid	ADJ
gsrj-29	155	10	defense	defense	NOUN
gsrj-29	155	11	applications	application	NOUN
gsrj-29	155	12	,	,	PUNCT
gsrj-29	155	13	the	the	DET
gsrj-29	155	14	comparative	comparative	ADJ
gsrj-29	155	15	advantage	advantage	NOUN
gsrj-29	155	16	of	of	ADP
gsrj-29	155	17	crispr	crispr	NOUN
gsrj-29	155	18	may	may	AUX
gsrj-29	155	19	decisively	decisively	ADV
gsrj-29	155	20	shift	shift	VERB
gsrj-29	155	21	from	from	ADP
gsrj-29	155	22	the	the	DET
gsrj-29	155	23	attacker	attacker	NOUN
gsrj-29	155	24	to	to	ADP
gsrj-29	155	25	the	the	DET
gsrj-29	155	26	defender	defender	NOUN
gsrj-29	155	27	in	in	ADP
gsrj-29	155	28	the	the	DET
gsrj-29	155	29	very	very	ADV
gsrj-29	155	30	short	short	ADJ
gsrj-29	155	31	-	-	PUNCT
gsrj-29	155	32	term	term	NOUN
gsrj-29	155	33	as	as	ADV
gsrj-29	155	34	well	well	ADV
gsrj-29	155	35	.	.	PUNCT
gsrj-29	156	1	34	34	NUM
gsrj-29	156	2	georgetown	georgetown	PROPN
gsrj-29	156	3	scientific	scientific	PROPN
gsrj-29	156	4	research	research	PROPN
gsrj-29	156	5	journal	journal	NOUN
gsrj-29	156	6	5	5	NUM
gsrj-29	156	7	.	.	PUNCT
gsrj-29	156	8	policy	policy	NOUN
gsrj-29	156	9	recommendations	recommendation	NOUN
gsrj-29	156	10	accordingly	accordingly	ADV
gsrj-29	156	11	,	,	PUNCT
gsrj-29	156	12	this	this	DET
gsrj-29	156	13	report	report	NOUN
gsrj-29	156	14	recommends	recommend	VERB
gsrj-29	156	15	four	four	NUM
gsrj-29	156	16	policy	policy	NOUN
gsrj-29	156	17	changes	change	NOUN
gsrj-29	156	18	:	:	PUNCT
gsrj-29	156	19	1	1	X
gsrj-29	156	20	.	.	X
gsrj-29	157	1	r&d	r&d	NOUN
gsrj-29	157	2	of	of	ADP
gsrj-29	157	3	crispr	crispr	NOUN
gsrj-29	157	4	to	to	PART
gsrj-29	157	5	break	break	VERB
gsrj-29	157	6	down	down	ADP
gsrj-29	157	7	limitations	limitation	NOUN
gsrj-29	157	8	and	and	CCONJ
gsrj-29	157	9	build	build	VERB
gsrj-29	157	10	up	up	ADP
gsrj-29	157	11	social	social	ADJ
gsrj-29	157	12	norms	norm	NOUN
gsrj-29	157	13	,	,	PUNCT
gsrj-29	157	14	2	2	X
gsrj-29	157	15	.	.	PUNCT
gsrj-29	158	1	the	the	DET
gsrj-29	158	2	creation	creation	NOUN
gsrj-29	158	3	of	of	ADP
gsrj-29	158	4	an	an	DET
gsrj-29	158	5	international	international	ADJ
gsrj-29	158	6	platform	platform	NOUN
gsrj-29	158	7	to	to	PART
gsrj-29	158	8	promote	promote	VERB
gsrj-29	158	9	information	information	NOUN
gsrj-29	158	10	sharing	sharing	NOUN
gsrj-29	158	11	,	,	PUNCT
gsrj-29	158	12	3	3	X
gsrj-29	158	13	.	.	X
gsrj-29	158	14	investment	investment	NOUN
gsrj-29	158	15	in	in	ADP
gsrj-29	158	16	a	a	DET
gsrj-29	158	17	manufacturing	manufacturing	NOUN
gsrj-29	158	18	sector	sector	NOUN
gsrj-29	158	19	for	for	ADP
gsrj-29	158	20	ready	ready	ADJ
gsrj-29	158	21	crispr	crispr	ADJ
gsrj-29	158	22	diagnostic	diagnostic	ADJ
gsrj-29	158	23	testing	testing	NOUN
gsrj-29	158	24	,	,	PUNCT
gsrj-29	158	25	and	and	CCONJ
gsrj-29	158	26	4	4	X
gsrj-29	158	27	.	.	X
gsrj-29	159	1	deployment	deployment	NOUN
gsrj-29	159	2	of	of	ADP
gsrj-29	159	3	crispr	crispr	ADJ
gsrj-29	159	4	diagnostic	diagnostic	ADJ
gsrj-29	159	5	tests	test	NOUN
gsrj-29	159	6	to	to	ADP
gsrj-29	159	7	endemic	endemic	ADJ
gsrj-29	159	8	regions	region	NOUN
gsrj-29	159	9	upon	upon	SCONJ
gsrj-29	159	10	outbreak	outbreak	NOUN
gsrj-29	159	11	.	.	PUNCT
gsrj-29	160	1	these	these	DET
gsrj-29	160	2	policy	policy	NOUN
gsrj-29	160	3	recommendations	recommendation	NOUN
gsrj-29	160	4	are	be	AUX
gsrj-29	160	5	not	not	PART
gsrj-29	160	6	intended	intend	VERB
gsrj-29	160	7	to	to	PART
gsrj-29	160	8	be	be	AUX
gsrj-29	160	9	comprehensive	comprehensive	ADJ
gsrj-29	160	10	.	.	PUNCT
gsrj-29	161	1	rather	rather	ADV
gsrj-29	161	2	the	the	DET
gsrj-29	161	3	emphasis	emphasis	NOUN
gsrj-29	161	4	of	of	ADP
gsrj-29	161	5	this	this	DET
gsrj-29	161	6	report	report	NOUN
gsrj-29	161	7	is	be	AUX
gsrj-29	161	8	to	to	PART
gsrj-29	161	9	identify	identify	VERB
gsrj-29	161	10	some	some	DET
gsrj-29	161	11	lessons	lesson	NOUN
gsrj-29	161	12	learned	learn	VERB
gsrj-29	161	13	from	from	ADP
gsrj-29	161	14	the	the	DET
gsrj-29	161	15	applications	application	NOUN
gsrj-29	161	16	of	of	ADP
gsrj-29	161	17	crispr	crispr	NOUN
gsrj-29	161	18	during	during	ADP
gsrj-29	161	19	the	the	DET
gsrj-29	161	20	covid-19	covid-19	PROPN
gsrj-29	161	21	pandemic	pandemic	NOUN
gsrj-29	161	22	as	as	ADP
gsrj-29	161	23	a	a	DET
gsrj-29	161	24	prompt	prompt	NOUN
gsrj-29	161	25	for	for	ADP
gsrj-29	161	26	a	a	DET
gsrj-29	161	27	rethought	rethought	ADJ
gsrj-29	161	28	biopreparedness	biopreparedness	NOUN
gsrj-29	161	29	strategy	strategy	NOUN
gsrj-29	161	30	for	for	ADP
gsrj-29	161	31	an	an	DET
gsrj-29	161	32	evolving	evolve	VERB
gsrj-29	161	33	global	global	ADJ
gsrj-29	161	34	health	health	NOUN
gsrj-29	161	35	strategic	strategic	ADJ
gsrj-29	161	36	environment	environment	NOUN
gsrj-29	161	37	.	.	PUNCT
gsrj-29	162	1	crispr	crispr	ADJ
gsrj-29	162	2	-	-	PUNCT
gsrj-29	162	3	cas	cas	NOUN
gsrj-29	162	4	systems	system	NOUN
gsrj-29	162	5	have	have	VERB
gsrj-29	162	6	several	several	ADJ
gsrj-29	162	7	technical	technical	ADJ
gsrj-29	162	8	limitations	limitation	NOUN
gsrj-29	162	9	that	that	PRON
gsrj-29	162	10	include	include	VERB
gsrj-29	162	11	possible	possible	ADJ
gsrj-29	162	12	off	off	ADP
gsrj-29	162	13	-	-	PUNCT
gsrj-29	162	14	target	target	NOUN
gsrj-29	162	15	effects	effect	NOUN
gsrj-29	162	16	,	,	PUNCT
gsrj-29	162	17	immunotoxicity	immunotoxicity	NOUN
gsrj-29	162	18	,	,	PUNCT
gsrj-29	162	19	and	and	CCONJ
gsrj-29	162	20	dna	dna	NOUN
gsrj-29	162	21	-	-	PUNCT
gsrj-29	162	22	damage	damage	NOUN
gsrj-29	162	23	toxicity	toxicity	NOUN
gsrj-29	162	24	.	.	PUNCT
gsrj-29	163	1	these	these	DET
gsrj-29	163	2	limitations	limitation	NOUN
gsrj-29	163	3	engender	engender	VERB
gsrj-29	163	4	social	social	ADJ
gsrj-29	163	5	hesitancy	hesitancy	NOUN
gsrj-29	163	6	due	due	ADP
gsrj-29	163	7	to	to	ADP
gsrj-29	163	8	reasonable	reasonable	ADJ
gsrj-29	163	9	ethical	ethical	ADJ
gsrj-29	163	10	concerns	concern	NOUN
gsrj-29	163	11	,	,	PUNCT
gsrj-29	163	12	ultimately	ultimately	ADV
gsrj-29	163	13	curtailing	curtail	VERB
gsrj-29	163	14	the	the	DET
gsrj-29	163	15	defender	defender	NOUN
gsrj-29	163	16	’s	’s	PART
gsrj-29	163	17	ability	ability	NOUN
gsrj-29	163	18	to	to	PART
gsrj-29	163	19	configure	configure	VERB
gsrj-29	163	20	a	a	DET
gsrj-29	163	21	prepared	prepared	ADJ
gsrj-29	163	22	and	and	CCONJ
gsrj-29	163	23	rapid	rapid	ADJ
gsrj-29	163	24	public	public	ADJ
gsrj-29	163	25	health	health	NOUN
gsrj-29	163	26	response	response	NOUN
gsrj-29	163	27	to	to	ADP
gsrj-29	163	28	a	a	DET
gsrj-29	163	29	pathogen	pathogen	NOUN
gsrj-29	163	30	.	.	PUNCT
gsrj-29	164	1	in	in	ADP
gsrj-29	164	2	order	order	NOUN
gsrj-29	164	3	for	for	SCONJ
gsrj-29	164	4	crispr	crispr	NOUN
gsrj-29	164	5	to	to	PART
gsrj-29	164	6	be	be	AUX
gsrj-29	164	7	applied	apply	VERB
gsrj-29	164	8	to	to	ADP
gsrj-29	164	9	biopreparedness	biopreparedness	NOUN
gsrj-29	164	10	and	and	CCONJ
gsrj-29	164	11	biosafety	biosafety	NOUN
gsrj-29	164	12	on	on	ADP
gsrj-29	164	13	a	a	DET
gsrj-29	164	14	needed	need	VERB
gsrj-29	164	15	broader	broad	ADJ
gsrj-29	164	16	scale	scale	NOUN
gsrj-29	164	17	,	,	PUNCT
gsrj-29	164	18	limitations	limitation	NOUN
gsrj-29	164	19	and	and	CCONJ
gsrj-29	164	20	associated	associated	ADJ
gsrj-29	164	21	hesitancy	hesitancy	NOUN
gsrj-29	164	22	must	must	AUX
gsrj-29	164	23	be	be	AUX
gsrj-29	164	24	addressed	address	VERB
gsrj-29	164	25	.	.	PUNCT
gsrj-29	165	1	thus	thus	ADV
gsrj-29	165	2	,	,	PUNCT
gsrj-29	165	3	the	the	DET
gsrj-29	165	4	first	first	ADJ
gsrj-29	165	5	recommendation	recommendation	NOUN
gsrj-29	165	6	in	in	ADP
gsrj-29	165	7	this	this	DET
gsrj-29	165	8	report	report	NOUN
gsrj-29	165	9	is	be	AUX
gsrj-29	165	10	increased	increase	VERB
gsrj-29	165	11	r&d	r&d	NOUN
gsrj-29	165	12	funding	funding	NOUN
gsrj-29	165	13	and	and	CCONJ
gsrj-29	165	14	efforts	effort	NOUN
gsrj-29	165	15	to	to	PART
gsrj-29	165	16	break	break	VERB
gsrj-29	165	17	down	down	ADP
gsrj-29	165	18	limitations	limitation	NOUN
gsrj-29	165	19	regarding	regard	VERB
gsrj-29	165	20	crispr	crispr	NOUN
gsrj-29	165	21	.	.	PUNCT
gsrj-29	166	1	mounting	mount	VERB
gsrj-29	166	2	use	use	NOUN
gsrj-29	166	3	of	of	ADP
gsrj-29	166	4	the	the	DET
gsrj-29	166	5	technology	technology	NOUN
gsrj-29	166	6	after	after	SCONJ
gsrj-29	166	7	limitations	limitation	NOUN
gsrj-29	166	8	are	be	AUX
gsrj-29	166	9	addressed	address	VERB
gsrj-29	166	10	will	will	AUX
gsrj-29	166	11	build	build	VERB
gsrj-29	166	12	social	social	ADJ
gsrj-29	166	13	norms	norm	NOUN
gsrj-29	166	14	around	around	ADP
gsrj-29	166	15	crispr	crispr	NOUN
gsrj-29	166	16	and	and	CCONJ
gsrj-29	166	17	mitigate	mitigate	VERB
gsrj-29	166	18	public	public	ADJ
gsrj-29	166	19	hesitancy	hesitancy	NOUN
gsrj-29	166	20	for	for	ADP
gsrj-29	166	21	safe	safe	ADJ
gsrj-29	166	22	applications	application	NOUN
gsrj-29	166	23	.	.	PUNCT
gsrj-29	167	1	one	one	NUM
gsrj-29	167	2	notable	notable	ADJ
gsrj-29	167	3	enabling	enable	VERB
gsrj-29	167	4	factor	factor	NOUN
gsrj-29	167	5	for	for	ADP
gsrj-29	167	6	the	the	DET
gsrj-29	167	7	recent	recent	ADJ
gsrj-29	167	8	applications	application	NOUN
gsrj-29	167	9	of	of	ADP
gsrj-29	167	10	crispr	crispr	NOUN
gsrj-29	167	11	was	be	AUX
gsrj-29	167	12	the	the	DET
gsrj-29	167	13	decision	decision	NOUN
gsrj-29	167	14	to	to	PART
gsrj-29	167	15	put	put	VERB
gsrj-29	167	16	patents	patent	NOUN
gsrj-29	167	17	aside	aside	ADV
gsrj-29	167	18	to	to	PART
gsrj-29	167	19	aid	aid	VERB
gsrj-29	167	20	the	the	DET
gsrj-29	167	21	effort	effort	NOUN
gsrj-29	167	22	to	to	PART
gsrj-29	167	23	contain	contain	VERB
gsrj-29	167	24	covid19.44	covid19.44	NOUN
gsrj-29	167	25	this	this	DET
gsrj-29	167	26	decision	decision	NOUN
gsrj-29	167	27	seems	seem	VERB
gsrj-29	167	28	to	to	PART
gsrj-29	167	29	signify	signify	VERB
gsrj-29	167	30	that	that	SCONJ
gsrj-29	167	31	lessened	lessen	VERB
gsrj-29	167	32	resources	resource	NOUN
gsrj-29	167	33	devoted	devote	VERB
gsrj-29	167	34	to	to	ADP
gsrj-29	167	35	court	court	NOUN
gsrj-29	167	36	fights	fight	NOUN
gsrj-29	167	37	along	along	ADP
gsrj-29	167	38	with	with	ADP
gsrj-29	167	39	the	the	DET
gsrj-29	167	40	information	information	NOUN
gsrj-29	167	41	sharing	share	VERB
gsrj-29	167	42	for	for	ADP
gsrj-29	167	43	a	a	DET
gsrj-29	167	44	common	common	ADJ
gsrj-29	167	45	cause	cause	NOUN
gsrj-29	167	46	allowed	allow	VERB
gsrj-29	167	47	for	for	ADP
gsrj-29	167	48	more	more	ADV
gsrj-29	167	49	efficient	efficient	ADJ
gsrj-29	167	50	development	development	NOUN
gsrj-29	167	51	and	and	CCONJ
gsrj-29	167	52	application	application	NOUN
gsrj-29	167	53	of	of	ADP
gsrj-29	167	54	crispr	crispr	NOUN
gsrj-29	167	55	.	.	PUNCT
gsrj-29	168	1	scientific	scientific	ADJ
gsrj-29	168	2	research	research	NOUN
gsrj-29	168	3	builds	build	VERB
gsrj-29	168	4	upon	upon	SCONJ
gsrj-29	168	5	other	other	ADJ
gsrj-29	168	6	scientific	scientific	ADJ
gsrj-29	168	7	research	research	NOUN
gsrj-29	168	8	,	,	PUNCT
gsrj-29	168	9	and	and	CCONJ
gsrj-29	168	10	with	with	ADP
gsrj-29	168	11	an	an	DET
gsrj-29	168	12	ever	ever	ADV
gsrj-29	168	13	-	-	PUNCT
gsrj-29	168	14	intensifying	intensify	VERB
gsrj-29	168	15	threat	threat	NOUN
gsrj-29	168	16	of	of	ADP
gsrj-29	168	17	infectious	infectious	ADJ
gsrj-29	168	18	disease	disease	NOUN
gsrj-29	168	19	,	,	PUNCT
gsrj-29	168	20	the	the	DET
gsrj-29	168	21	scientific	scientific	ADJ
gsrj-29	168	22	community	community	NOUN
gsrj-29	168	23	must	must	AUX
gsrj-29	168	24	accelerate	accelerate	VERB
gsrj-29	168	25	r&d	r&d	NOUN
gsrj-29	168	26	of	of	ADP
gsrj-29	168	27	crispr	crispr	NOUN
gsrj-29	168	28	for	for	ADP
gsrj-29	168	29	defense	defense	NOUN
gsrj-29	168	30	applications	application	NOUN
gsrj-29	168	31	.	.	PUNCT
gsrj-29	169	1	thus	thus	ADV
gsrj-29	169	2	,	,	PUNCT
gsrj-29	169	3	this	this	DET
gsrj-29	169	4	report	report	NOUN
gsrj-29	169	5	also	also	ADV
gsrj-29	169	6	recommends	recommend	VERB
gsrj-29	169	7	an	an	DET
gsrj-29	169	8	international	international	ADJ
gsrj-29	169	9	platform	platform	NOUN
gsrj-29	169	10	for	for	ADP
gsrj-29	169	11	information	information	NOUN
gsrj-29	169	12	sharing	share	VERB
gsrj-29	169	13	surrounding	surround	VERB
gsrj-29	169	14	altruistic	altruistic	ADJ
gsrj-29	169	15	crispr	crispr	ADJ
gsrj-29	169	16	research	research	NOUN
gsrj-29	169	17	efforts	effort	NOUN
gsrj-29	169	18	for	for	ADP
gsrj-29	169	19	biopreparedness	biopreparedness	NOUN
gsrj-29	169	20	,	,	PUNCT
gsrj-29	169	21	coordinated	coordinate	VERB
gsrj-29	169	22	by	by	ADP
gsrj-29	169	23	the	the	DET
gsrj-29	169	24	world	world	PROPN
gsrj-29	169	25	health	health	PROPN
gsrj-29	169	26	organization	organization	PROPN
gsrj-29	169	27	.	.	PUNCT
gsrj-29	170	1	a	a	DET
gsrj-29	170	2	primary	primary	ADJ
gsrj-29	170	3	intervention	intervention	NOUN
gsrj-29	170	4	for	for	ADP
gsrj-29	170	5	a	a	DET
gsrj-29	170	6	defender	defender	NOUN
gsrj-29	170	7	preventing	prevent	VERB
gsrj-29	170	8	a	a	DET
gsrj-29	170	9	widespread	widespread	ADJ
gsrj-29	170	10	outbreak	outbreak	NOUN
gsrj-29	170	11	of	of	ADP
gsrj-29	170	12	disease	disease	NOUN
gsrj-29	170	13	is	be	AUX
gsrj-29	170	14	diagnostic	diagnostic	ADJ
gsrj-29	170	15	testing	testing	NOUN
gsrj-29	170	16	to	to	PART
gsrj-29	170	17	support	support	VERB
gsrj-29	170	18	an	an	DET
gsrj-29	170	19	efficient	efficient	ADJ
gsrj-29	170	20	pathogenic	pathogenic	ADJ
gsrj-29	170	21	surveillance	surveillance	NOUN
gsrj-29	170	22	regime	regime	NOUN
gsrj-29	170	23	.	.	PUNCT
gsrj-29	171	1	this	this	DET
gsrj-29	171	2	report	report	NOUN
gsrj-29	171	3	therefore	therefore	ADV
gsrj-29	171	4	recommends	recommend	VERB
gsrj-29	171	5	incentivizing	incentivize	VERB
gsrj-29	171	6	national	national	ADJ
gsrj-29	171	7	private	private	ADJ
gsrj-29	171	8	sectors	sector	NOUN
gsrj-29	171	9	to	to	PART
gsrj-29	171	10	create	create	VERB
gsrj-29	171	11	new	new	ADJ
gsrj-29	171	12	manufacturing	manufacturing	NOUN
gsrj-29	171	13	capacity	capacity	NOUN
gsrj-29	171	14	for	for	ADP
gsrj-29	171	15	ready	ready	ADJ
gsrj-29	171	16	crispr	crispr	ADJ
gsrj-29	171	17	diagnostic	diagnostic	ADJ
gsrj-29	171	18	tests	test	NOUN
gsrj-29	171	19	for	for	ADP
gsrj-29	171	20	priority	priority	NOUN
gsrj-29	171	21	pathogens	pathogen	NOUN
gsrj-29	171	22	.	.	PUNCT
gsrj-29	172	1	furthermore	furthermore	ADV
gsrj-29	172	2	,	,	PUNCT
gsrj-29	172	3	this	this	DET
gsrj-29	172	4	report	report	NOUN
gsrj-29	172	5	recommends	recommend	VERB
gsrj-29	172	6	that	that	SCONJ
gsrj-29	172	7	nations	nation	NOUN
gsrj-29	172	8	deploy	deploy	VERB
gsrj-29	172	9	these	these	DET
gsrj-29	172	10	portable	portable	ADJ
gsrj-29	172	11	crispr	crispr	ADJ
gsrj-29	172	12	diagnostic	diagnostic	ADJ
gsrj-29	172	13	tests	test	NOUN
gsrj-29	172	14	to	to	ADP
gsrj-29	172	15	endemic	endemic	ADJ
gsrj-29	172	16	regions	region	NOUN
gsrj-29	172	17	upon	upon	SCONJ
gsrj-29	172	18	outbreak	outbreak	NOUN
gsrj-29	172	19	.	.	PUNCT
gsrj-29	173	1	covid-19	covid-19	PROPN
gsrj-29	173	2	has	have	AUX
gsrj-29	173	3	demonstrated	demonstrate	VERB
gsrj-29	173	4	that	that	SCONJ
gsrj-29	173	5	an	an	DET
gsrj-29	173	6	outbreak	outbreak	NOUN
gsrj-29	173	7	anywhere	anywhere	ADV
gsrj-29	173	8	is	be	AUX
gsrj-29	173	9	a	a	DET
gsrj-29	173	10	threat	threat	NOUN
gsrj-29	173	11	everywhere	everywhere	ADV
gsrj-29	173	12	,	,	PUNCT
gsrj-29	173	13	and	and	CCONJ
gsrj-29	173	14	the	the	DET
gsrj-29	173	15	low	low	ADJ
gsrj-29	173	16	-	-	PUNCT
gsrj-29	173	17	cost	cost	NOUN
gsrj-29	173	18	,	,	PUNCT
gsrj-29	173	19	portable	portable	ADJ
gsrj-29	173	20	,	,	PUNCT
gsrj-29	173	21	and	and	CCONJ
gsrj-29	173	22	easy	easy	ADJ
gsrj-29	173	23	-	-	PUNCT
gsrj-29	173	24	to	to	ADP
gsrj-29	173	25	-	-	PUNCT
gsrj-29	173	26	use	use	NOUN
gsrj-29	173	27	characteristics	characteristic	NOUN
gsrj-29	173	28	of	of	ADP
gsrj-29	173	29	crispr	crispr	ADJ
gsrj-29	173	30	diagnostic	diagnostic	ADJ
gsrj-29	173	31	tests	test	NOUN
gsrj-29	173	32	could	could	AUX
gsrj-29	173	33	be	be	AUX
gsrj-29	173	34	leveraged	leverage	VERB
gsrj-29	173	35	to	to	PART
gsrj-29	173	36	rapidly	rapidly	ADV
gsrj-29	173	37	contain	contain	VERB
gsrj-29	173	38	pathogens	pathogen	NOUN
gsrj-29	173	39	.	.	PUNCT
gsrj-29	174	1	6	6	NUM
gsrj-29	174	2	.	.	X
gsrj-29	174	3	conclusion	conclusion	NOUN
gsrj-29	174	4	the	the	DET
gsrj-29	174	5	strategic	strategic	ADJ
gsrj-29	174	6	environment	environment	NOUN
gsrj-29	174	7	for	for	ADP
gsrj-29	174	8	biosecurity	biosecurity	NOUN
gsrj-29	174	9	is	be	AUX
gsrj-29	174	10	more	more	ADV
gsrj-29	174	11	unstable	unstable	ADJ
gsrj-29	174	12	than	than	ADP
gsrj-29	174	13	ever	ever	ADV
gsrj-29	174	14	before	before	ADV
gsrj-29	174	15	.	.	PUNCT
gsrj-29	175	1	crispr	crispr	PROPN
gsrj-29	175	2	further	far	ADV
gsrj-29	175	3	exacerbates	exacerbate	VERB
gsrj-29	175	4	an	an	DET
gsrj-29	175	5	already	already	ADV
gsrj-29	175	6	heightened	heighten	VERB
gsrj-29	175	7	threat	threat	NOUN
gsrj-29	175	8	of	of	ADP
gsrj-29	175	9	infectious	infectious	ADJ
gsrj-29	175	10	disease	disease	NOUN
gsrj-29	175	11	by	by	ADP
gsrj-29	175	12	reducing	reduce	VERB
gsrj-29	175	13	barriers	barrier	NOUN
gsrj-29	175	14	to	to	ADP
gsrj-29	175	15	entry	entry	NOUN
gsrj-29	175	16	for	for	ADP
gsrj-29	175	17	genetically	genetically	ADV
gsrj-29	175	18	engineered	engineer	VERB
gsrj-29	175	19	pathogens	pathogen	NOUN
gsrj-29	175	20	.	.	PUNCT
gsrj-29	176	1	at	at	ADP
gsrj-29	176	2	the	the	DET
gsrj-29	176	3	same	same	ADJ
gsrj-29	176	4	time	time	NOUN
gsrj-29	176	5	,	,	PUNCT
gsrj-29	176	6	crispr	crispr	PROPN
gsrj-29	176	7	is	be	AUX
gsrj-29	176	8	a	a	DET
gsrj-29	176	9	remarkable	remarkable	ADJ
gsrj-29	176	10	tool	tool	NOUN
gsrj-29	176	11	for	for	ADP
gsrj-29	176	12	defense	defense	NOUN
gsrj-29	176	13	against	against	ADP
gsrj-29	176	14	either	either	CCONJ
gsrj-29	176	15	a	a	DET
gsrj-29	176	16	natural	natural	ADJ
gsrj-29	176	17	or	or	CCONJ
gsrj-29	176	18	deliberate	deliberate	ADJ
gsrj-29	176	19	biological	biological	ADJ
gsrj-29	176	20	event	event	NOUN
gsrj-29	176	21	.	.	PUNCT
gsrj-29	177	1	applied	apply	VERB
gsrj-29	177	2	use	use	NOUN
gsrj-29	177	3	in	in	ADP
gsrj-29	177	4	the	the	DET
gsrj-29	177	5	covid-19	covid-19	PROPN
gsrj-29	177	6	pandemic	pandemic	NOUN
gsrj-29	177	7	afforded	afford	VERB
gsrj-29	177	8	several	several	ADJ
gsrj-29	177	9	lessons	lesson	NOUN
gsrj-29	177	10	learned	learn	VERB
gsrj-29	177	11	for	for	ADP
gsrj-29	177	12	how	how	SCONJ
gsrj-29	177	13	crispr	crispr	NOUN
gsrj-29	177	14	can	can	AUX
gsrj-29	177	15	help	help	VERB
gsrj-29	177	16	support	support	VERB
gsrj-29	177	17	pathogenic	pathogenic	ADJ
gsrj-29	177	18	surveillance	surveillance	NOUN
gsrj-29	177	19	regimes	regime	NOUN
gsrj-29	177	20	,	,	PUNCT
gsrj-29	177	21	research	research	NOUN
gsrj-29	177	22	,	,	PUNCT
gsrj-29	177	23	and	and	CCONJ
gsrj-29	177	24	countermeasure	countermeasure	NOUN
gsrj-29	177	25	development	development	NOUN
gsrj-29	177	26	.	.	PUNCT
gsrj-29	178	1	crispr	crispr	PROPN
gsrj-29	178	2	must	must	AUX
gsrj-29	178	3	first	first	ADV
gsrj-29	178	4	overcome	overcome	VERB
gsrj-29	178	5	technical	technical	ADJ
gsrj-29	178	6	limitations	limitation	NOUN
gsrj-29	178	7	and	and	CCONJ
gsrj-29	178	8	social	social	ADJ
gsrj-29	178	9	hesitancy	hesitancy	NOUN
gsrj-29	178	10	,	,	PUNCT
gsrj-29	178	11	then	then	ADV
gsrj-29	178	12	be	be	AUX
gsrj-29	178	13	broadly	broadly	ADV
gsrj-29	178	14	applied	apply	VERB
gsrj-29	178	15	to	to	ADP
gsrj-29	178	16	biopreparedness	biopreparedness	NOUN
gsrj-29	178	17	strategies	strategy	NOUN
gsrj-29	178	18	like	like	ADP
gsrj-29	178	19	crispr	crispr	ADJ
gsrj-29	178	20	diagnostic	diagnostic	ADJ
gsrj-29	178	21	tests	test	NOUN
gsrj-29	178	22	on	on	ADP
gsrj-29	178	23	stand	stand	NOUN
gsrj-29	178	24	-	-	PUNCT
gsrj-29	178	25	by	by	NOUN
gsrj-29	178	26	.	.	PUNCT
gsrj-29	179	1	this	this	DET
gsrj-29	179	2	type	type	NOUN
gsrj-29	179	3	of	of	ADP
gsrj-29	179	4	rethought	rethought	NOUN
gsrj-29	179	5	approach	approach	NOUN
gsrj-29	179	6	is	be	AUX
gsrj-29	179	7	necessary	necessary	ADJ
gsrj-29	179	8	to	to	PART
gsrj-29	179	9	fully	fully	ADV
gsrj-29	179	10	leverage	leverage	VERB
gsrj-29	179	11	the	the	DET
gsrj-29	179	12	technology	technology	NOUN
gsrj-29	179	13	to	to	ADP
gsrj-29	179	14	the	the	DET
gsrj-29	179	15	advantage	advantage	NOUN
gsrj-29	179	16	of	of	ADP
gsrj-29	179	17	the	the	DET
gsrj-29	179	18	defender	defender	NOUN
gsrj-29	179	19	in	in	ADP
gsrj-29	179	20	a	a	DET
gsrj-29	179	21	transformed	transform	VERB
gsrj-29	179	22	biosecurity	biosecurity	NOUN
gsrj-29	179	23	strategic	strategic	ADJ
gsrj-29	179	24	environment	environment	NOUN
gsrj-29	179	25	.	.	PUNCT
gsrj-29	180	1	35	35	NUM
gsrj-29	180	2	georgetown	georgetown	PROPN
gsrj-29	180	3	scientific	scientific	PROPN
gsrj-29	180	4	research	research	NOUN
gsrj-29	180	5	journal	journal	PROPN
gsrj-29	180	6	before	before	ADP
gsrj-29	180	7	covid-19	covid-19	PROPN
gsrj-29	180	8	,	,	PUNCT
gsrj-29	180	9	commentators	commentator	NOUN
gsrj-29	180	10	warned	warn	VERB
gsrj-29	180	11	of	of	ADP
gsrj-29	180	12	the	the	DET
gsrj-29	180	13	emergence	emergence	NOUN
gsrj-29	180	14	of	of	ADP
gsrj-29	180	15	a	a	DET
gsrj-29	180	16	novel	novel	NOUN
gsrj-29	180	17	,	,	PUNCT
gsrj-29	180	18	pandemic	pandemic	ADJ
gsrj-29	180	19	-	-	PUNCT
gsrj-29	180	20	level	level	NOUN
gsrj-29	180	21	pathogen	pathogen	NOUN
gsrj-29	180	22	.	.	PUNCT
gsrj-29	181	1	when	when	SCONJ
gsrj-29	181	2	it	it	PRON
gsrj-29	181	3	arrived	arrive	VERB
gsrj-29	181	4	,	,	PUNCT
gsrj-29	181	5	we	we	PRON
gsrj-29	181	6	were	be	AUX
gsrj-29	181	7	not	not	PART
gsrj-29	181	8	prepared	prepared	ADJ
gsrj-29	181	9	to	to	PART
gsrj-29	181	10	contain	contain	VERB
gsrj-29	181	11	it	it	PRON
gsrj-29	181	12	.	.	PUNCT
gsrj-29	182	1	moreover	moreover	ADV
gsrj-29	182	2	,	,	PUNCT
gsrj-29	182	3	the	the	DET
gsrj-29	182	4	interplay	interplay	NOUN
gsrj-29	182	5	between	between	ADP
gsrj-29	182	6	an	an	DET
gsrj-29	182	7	attacker	attacker	NOUN
gsrj-29	182	8	,	,	PUNCT
gsrj-29	182	9	a	a	DET
gsrj-29	182	10	defender	defender	NOUN
gsrj-29	182	11	,	,	PUNCT
gsrj-29	182	12	and	and	CCONJ
gsrj-29	182	13	crispr	crispr	ADJ
gsrj-29	182	14	within	within	ADP
gsrj-29	182	15	the	the	DET
gsrj-29	182	16	contemporary	contemporary	ADJ
gsrj-29	182	17	strategic	strategic	ADJ
gsrj-29	182	18	environment	environment	NOUN
gsrj-29	182	19	does	do	AUX
gsrj-29	182	20	not	not	PART
gsrj-29	182	21	exist	exist	VERB
gsrj-29	182	22	in	in	ADP
gsrj-29	182	23	a	a	DET
gsrj-29	182	24	vacuum	vacuum	NOUN
gsrj-29	182	25	,	,	PUNCT
gsrj-29	182	26	and	and	CCONJ
gsrj-29	182	27	there	there	PRON
gsrj-29	182	28	are	be	VERB
gsrj-29	182	29	also	also	ADV
gsrj-29	182	30	several	several	ADJ
gsrj-29	182	31	concerning	concern	VERB
gsrj-29	182	32	humandriven	humandriven	NOUN
gsrj-29	182	33	trends	trend	NOUN
gsrj-29	182	34	that	that	PRON
gsrj-29	182	35	exacerbate	exacerbate	VERB
gsrj-29	182	36	risk	risk	NOUN
gsrj-29	182	37	:	:	PUNCT
gsrj-29	182	38	global	global	ADJ
gsrj-29	182	39	warming,81	warming,81	NOUN
gsrj-29	182	40	-	-	PUNCT
gsrj-29	182	41	84	84	NUM
gsrj-29	182	42	permafrost	permafrost	NOUN
gsrj-29	182	43	thaw,85,86	thaw,85,86	ADP
gsrj-29	182	44	climate	climate	NOUN
gsrj-29	182	45	-	-	PUNCT
gsrj-29	182	46	related	relate	VERB
gsrj-29	182	47	migration,87	migration,87	NOUN
gsrj-29	182	48	deforestation,88,89	deforestation,88,89	NOUN
gsrj-29	182	49	and	and	CCONJ
gsrj-29	182	50	loss	loss	NOUN
gsrj-29	182	51	of	of	ADP
gsrj-29	182	52	biodiversity.90	biodiversity.90	NOUN
gsrj-29	182	53	the	the	DET
gsrj-29	182	54	critical	critical	ADJ
gsrj-29	182	55	need	need	NOUN
gsrj-29	182	56	for	for	ADP
gsrj-29	182	57	biopreparedness	biopreparedness	NOUN
gsrj-29	182	58	strategies	strategy	NOUN
gsrj-29	182	59	to	to	PART
gsrj-29	182	60	counteract	counteract	VERB
gsrj-29	182	61	the	the	DET
gsrj-29	182	62	increased	increase	VERB
gsrj-29	182	63	risk	risk	NOUN
gsrj-29	182	64	of	of	ADP
gsrj-29	182	65	biological	biological	ADJ
gsrj-29	182	66	events	event	NOUN
gsrj-29	182	67	,	,	PUNCT
gsrj-29	182	68	whether	whether	SCONJ
gsrj-29	182	69	deliberate	deliberate	ADJ
gsrj-29	182	70	or	or	CCONJ
gsrj-29	182	71	natural	natural	ADJ
gsrj-29	182	72	,	,	PUNCT
gsrj-29	182	73	is	be	AUX
gsrj-29	182	74	greater	great	ADJ
gsrj-29	182	75	than	than	ADP
gsrj-29	182	76	ever	ever	ADV
gsrj-29	182	77	before	before	ADV
gsrj-29	182	78	.	.	PUNCT
gsrj-29	183	1	when	when	SCONJ
gsrj-29	183	2	the	the	DET
gsrj-29	183	3	next	next	ADJ
gsrj-29	183	4	pathogen	pathogen	NOUN
gsrj-29	183	5	arrives	arrive	VERB
gsrj-29	183	6	,	,	PUNCT
gsrj-29	183	7	will	will	AUX
gsrj-29	183	8	we	we	PRON
gsrj-29	183	9	have	have	AUX
gsrj-29	183	10	learned	learn	VERB
gsrj-29	183	11	to	to	PART
gsrj-29	183	12	leverage	leverage	VERB
gsrj-29	183	13	crispr	crispr	NOUN
gsrj-29	183	14	for	for	ADP
gsrj-29	183	15	a	a	DET
gsrj-29	183	16	prepared	prepared	ADJ
gsrj-29	183	17	and	and	CCONJ
gsrj-29	183	18	rapid	rapid	ADJ
gsrj-29	183	19	response	response	NOUN
gsrj-29	183	20	?	?	PUNCT
gsrj-29	184	1	our	our	PRON
gsrj-29	184	2	survival	survival	NOUN
gsrj-29	184	3	may	may	AUX
gsrj-29	184	4	depend	depend	VERB
gsrj-29	184	5	on	on	ADP
gsrj-29	184	6	it	it	PRON
gsrj-29	184	7	.	.	PUNCT
gsrj-29	185	1	acknowledgments	acknowledgment	NOUN
gsrj-29	185	2	this	this	DET
gsrj-29	185	3	report	report	NOUN
gsrj-29	185	4	is	be	AUX
gsrj-29	185	5	produced	produce	VERB
gsrj-29	185	6	as	as	ADP
gsrj-29	185	7	part	part	NOUN
gsrj-29	185	8	of	of	ADP
gsrj-29	185	9	the	the	DET
gsrj-29	185	10	2021	2021	NUM
gsrj-29	185	11	lisa	lisa	PROPN
gsrj-29	185	12	j.	j.	PROPN
gsrj-29	185	13	raines	raines	PROPN
gsrj-29	185	14	“	"	PUNCT
gsrj-29	185	15	grand	grand	ADJ
gsrj-29	185	16	challenge	challenge	NOUN
gsrj-29	185	17	”	"	PUNCT
gsrj-29	185	18	undergraduate	undergraduate	NOUN
gsrj-29	185	19	research	research	NOUN
gsrj-29	185	20	fellowship	fellowship	NOUN
gsrj-29	185	21	.	.	PUNCT
gsrj-29	186	1	throughout	throughout	ADP
gsrj-29	186	2	the	the	DET
gsrj-29	186	3	research	research	NOUN
gsrj-29	186	4	and	and	CCONJ
gsrj-29	186	5	writing	writing	NOUN
gsrj-29	186	6	of	of	ADP
gsrj-29	186	7	this	this	DET
gsrj-29	186	8	report	report	NOUN
gsrj-29	186	9	i	i	PRON
gsrj-29	186	10	have	have	AUX
gsrj-29	186	11	received	receive	VERB
gsrj-29	186	12	a	a	DET
gsrj-29	186	13	great	great	ADJ
gsrj-29	186	14	deal	deal	NOUN
gsrj-29	186	15	of	of	ADP
gsrj-29	186	16	support	support	NOUN
gsrj-29	186	17	and	and	CCONJ
gsrj-29	186	18	assistance	assistance	NOUN
gsrj-29	186	19	.	.	PUNCT
gsrj-29	187	1	i	i	PRON
gsrj-29	187	2	would	would	AUX
gsrj-29	187	3	first	first	ADV
gsrj-29	187	4	like	like	VERB
gsrj-29	187	5	to	to	PART
gsrj-29	187	6	thank	thank	VERB
gsrj-29	187	7	my	my	PRON
gsrj-29	187	8	faculty	faculty	NOUN
gsrj-29	187	9	sponsor	sponsor	NOUN
gsrj-29	187	10	,	,	PUNCT
gsrj-29	187	11	dr	dr	PROPN
gsrj-29	187	12	.	.	PROPN
gsrj-29	187	13	carol	carol	PROPN
gsrj-29	187	14	kuntz	kuntz	PROPN
gsrj-29	187	15	,	,	PUNCT
gsrj-29	187	16	whose	whose	DET
gsrj-29	187	17	guidance	guidance	NOUN
gsrj-29	187	18	was	be	AUX
gsrj-29	187	19	invaluable	invaluable	ADJ
gsrj-29	187	20	for	for	ADP
gsrj-29	187	21	integrating	integrate	VERB
gsrj-29	187	22	a	a	DET
gsrj-29	187	23	higher	high	ADJ
gsrj-29	187	24	degree	degree	NOUN
gsrj-29	187	25	of	of	ADP
gsrj-29	187	26	precision	precision	NOUN
gsrj-29	187	27	into	into	ADP
gsrj-29	187	28	my	my	PRON
gsrj-29	187	29	research	research	NOUN
gsrj-29	187	30	design	design	NOUN
gsrj-29	187	31	,	,	PUNCT
gsrj-29	187	32	overcoming	overcome	VERB
gsrj-29	187	33	research	research	NOUN
gsrj-29	187	34	barriers	barrier	NOUN
gsrj-29	187	35	,	,	PUNCT
gsrj-29	187	36	and	and	CCONJ
gsrj-29	187	37	writing	write	VERB
gsrj-29	187	38	the	the	DET
gsrj-29	187	39	report	report	NOUN
gsrj-29	187	40	for	for	ADP
gsrj-29	187	41	a	a	DET
gsrj-29	187	42	specified	specified	ADJ
gsrj-29	187	43	audience	audience	NOUN
gsrj-29	187	44	.	.	PUNCT
gsrj-29	188	1	our	our	PRON
gsrj-29	188	2	meetings	meeting	NOUN
gsrj-29	188	3	were	be	AUX
gsrj-29	188	4	refreshing	refreshing	ADJ
gsrj-29	188	5	,	,	PUNCT
gsrj-29	188	6	clarifying	clarify	VERB
gsrj-29	188	7	,	,	PUNCT
gsrj-29	188	8	and	and	CCONJ
gsrj-29	188	9	ultimately	ultimately	ADV
gsrj-29	188	10	brought	bring	VERB
gsrj-29	188	11	this	this	PRON
gsrj-29	188	12	and	and	CCONJ
gsrj-29	188	13	future	future	ADJ
gsrj-29	188	14	work	work	NOUN
gsrj-29	188	15	to	to	ADP
gsrj-29	188	16	a	a	DET
gsrj-29	188	17	higher	high	ADJ
gsrj-29	188	18	level	level	NOUN
gsrj-29	188	19	.	.	PUNCT
gsrj-29	189	1	i	i	PRON
gsrj-29	189	2	would	would	AUX
gsrj-29	189	3	also	also	ADV
gsrj-29	189	4	like	like	VERB
gsrj-29	189	5	to	to	PART
gsrj-29	189	6	thank	thank	VERB
gsrj-29	189	7	the	the	DET
gsrj-29	189	8	lisa	lisa	PROPN
gsrj-29	189	9	j.	j.	PROPN
gsrj-29	189	10	raines	raines	PROPN
gsrj-29	189	11	fellowship	fellowship	NOUN
gsrj-29	189	12	and	and	CCONJ
gsrj-29	189	13	georgetown	georgetown	PROPN
gsrj-29	189	14	university	university	PROPN
gsrj-29	189	15	’s	’s	PART
gsrj-29	189	16	center	center	NOUN
gsrj-29	189	17	for	for	ADP
gsrj-29	189	18	research	research	NOUN
gsrj-29	189	19	and	and	CCONJ
gsrj-29	189	20	fellowships	fellowship	NOUN
gsrj-29	189	21	for	for	ADP
gsrj-29	189	22	affording	afford	VERB
gsrj-29	189	23	me	i	PRON
gsrj-29	189	24	this	this	DET
gsrj-29	189	25	opportunity	opportunity	NOUN
gsrj-29	189	26	.	.	PUNCT
gsrj-29	190	1	the	the	PRON
gsrj-29	190	2	program	program	NOUN
gsrj-29	190	3	design	design	NOUN
gsrj-29	190	4	prioritized	prioritize	VERB
gsrj-29	190	5	interdisciplinary	interdisciplinary	ADJ
gsrj-29	190	6	collaboration	collaboration	NOUN
gsrj-29	190	7	between	between	ADP
gsrj-29	190	8	a	a	DET
gsrj-29	190	9	wide	wide	ADJ
gsrj-29	190	10	array	array	NOUN
gsrj-29	190	11	of	of	ADP
gsrj-29	190	12	peer	peer	NOUN
gsrj-29	190	13	-	-	PUNCT
gsrj-29	190	14	led	lead	VERB
gsrj-29	190	15	projects	project	NOUN
gsrj-29	190	16	,	,	PUNCT
gsrj-29	190	17	as	as	ADV
gsrj-29	190	18	well	well	ADV
gsrj-29	190	19	as	as	ADP
gsrj-29	190	20	provided	provide	VERB
gsrj-29	190	21	expert	expert	NOUN
gsrj-29	190	22	support	support	NOUN
gsrj-29	190	23	and	and	CCONJ
gsrj-29	190	24	insight	insight	NOUN
gsrj-29	190	25	.	.	PUNCT
gsrj-29	191	1	this	this	PRON
gsrj-29	191	2	was	be	AUX
gsrj-29	191	3	integral	integral	ADJ
gsrj-29	191	4	to	to	ADP
gsrj-29	191	5	success	success	NOUN
gsrj-29	191	6	in	in	ADP
gsrj-29	191	7	the	the	DET
gsrj-29	191	8	final	final	ADJ
gsrj-29	191	9	product	product	NOUN
gsrj-29	191	10	of	of	ADP
gsrj-29	191	11	my	my	PRON
gsrj-29	191	12	research	research	NOUN
gsrj-29	191	13	.	.	PUNCT
gsrj-29	192	1	references	reference	NOUN
gsrj-29	192	2	1	1	NUM
gsrj-29	192	3	.	.	PUNCT
gsrj-29	193	1	zhu	zhu	PROPN
gsrj-29	193	2	,	,	PUNCT
gsrj-29	193	3	h.	h.	PROPN
gsrj-29	193	4	,	,	PUNCT
gsrj-29	193	5	wei	wei	PROPN
gsrj-29	193	6	,	,	PUNCT
gsrj-29	193	7	l.	l.	PROPN
gsrj-29	193	8	&	&	CCONJ
gsrj-29	193	9	niu	niu	PROPN
gsrj-29	193	10	,	,	PUNCT
gsrj-29	193	11	p.	p.	NOUN
gsrj-29	193	12	the	the	DET
gsrj-29	193	13	novel	novel	ADJ
gsrj-29	193	14	coronavirus	coronavirus	NOUN
gsrj-29	193	15	outbreak	outbreak	NOUN
gsrj-29	193	16	in	in	ADP
gsrj-29	193	17	wuhan	wuhan	PROPN
gsrj-29	193	18	,	,	PUNCT
gsrj-29	193	19	china	china	PROPN
gsrj-29	193	20	.	.	PUNCT
gsrj-29	194	1	global	global	ADJ
gsrj-29	194	2	health	health	PROPN
gsrj-29	194	3	research	research	NOUN
gsrj-29	194	4	and	and	CCONJ
gsrj-29	194	5	policy	policy	NOUN
gsrj-29	194	6	.	.	PUNCT
gsrj-29	195	1	2020	2020	NUM
gsrj-29	195	2	;	;	PUNCT
gsrj-29	195	3	5	5	NUM
gsrj-29	195	4	(	(	PUNCT
gsrj-29	195	5	6	6	NUM
gsrj-29	195	6	)	)	PUNCT
gsrj-29	195	7	.	.	PUNCT
gsrj-29	196	1	https://doi.org/10.1186/s41256-020-00135-6	https://doi.org/10.1186/s41256-020-00135-6	PROPN
gsrj-29	197	1	2	2	NUM
gsrj-29	197	2	.	.	X
gsrj-29	198	1	who	who	PRON
gsrj-29	198	2	director	director	NOUN
gsrj-29	198	3	-	-	PUNCT
gsrj-29	198	4	general	general	NOUN
gsrj-29	198	5	's	's	PART
gsrj-29	198	6	opening	opening	NOUN
gsrj-29	198	7	remarks	remark	NOUN
gsrj-29	198	8	at	at	ADP
gsrj-29	198	9	the	the	DET
gsrj-29	198	10	media	medium	NOUN
gsrj-29	198	11	briefing	briefing	NOUN
gsrj-29	198	12	on	on	ADP
gsrj-29	198	13	covid-19	covid-19	PROPN
gsrj-29	198	14	11	11	NUM
gsrj-29	198	15	march	march	NOUN
gsrj-29	198	16	2020	2020	NUM
gsrj-29	198	17	.	.	PUNCT
gsrj-29	199	1	who.int	who.int	VERB
gsrj-29	199	2	.	.	PUNCT
gsrj-29	200	1	https://www.who.int/directorgeneral/speeches/detail/who-director-general-sopening-remarks-at-the-media-briefing-on-covid19---11-march-2020	https://www.who.int/directorgeneral/speeches/detail/who-director-general-sopening-remarks-at-the-media-briefing-on-covid19---11-march-2020	PROPN
gsrj-29	200	2	.	.	PROPN
gsrj-29	201	1	published	publish	VERB
gsrj-29	201	2	11	11	NUM
gsrj-29	201	3	march	march	NOUN
gsrj-29	201	4	2020	2020	NUM
gsrj-29	201	5	.	.	PUNCT
gsrj-29	202	1	accessed	access	VERB
gsrj-29	202	2	18	18	NUM
gsrj-29	202	3	august	august	PROPN
gsrj-29	202	4	2021	2021	NUM
gsrj-29	202	5	.	.	PUNCT
gsrj-29	203	1	3	3	X
gsrj-29	203	2	.	.	X
gsrj-29	203	3	who	who	PRON
gsrj-29	203	4	coronavirus	coronavirus	VERB
gsrj-29	203	5	(	(	PUNCT
gsrj-29	203	6	covid-19	covid-19	PROPN
gsrj-29	203	7	)	)	PUNCT
gsrj-29	203	8	dashboard	dashboard	NOUN
gsrj-29	203	9	.	.	PUNCT
gsrj-29	204	1	who.int	who.int	VERB
gsrj-29	204	2	.	.	PUNCT
gsrj-29	205	1	https://covid19.who.int/.	https://covid19.who.int/.	ADJ
gsrj-29	205	2	published	publish	VERB
gsrj-29	205	3	11	11	NUM
gsrj-29	205	4	march	march	NOUN
gsrj-29	205	5	2020	2020	NUM
gsrj-29	205	6	.	.	PUNCT
gsrj-29	206	1	updated	update	VERB
gsrj-29	206	2	20	20	NUM
gsrj-29	206	3	august	august	PROPN
gsrj-29	206	4	2021	2021	NUM
gsrj-29	206	5	.	.	PUNCT
gsrj-29	207	1	accessed	access	VERB
gsrj-29	207	2	20	20	NUM
gsrj-29	207	3	august	august	PROPN
gsrj-29	207	4	2021	2021	NUM
gsrj-29	207	5	.	.	PUNCT
gsrj-29	208	1	4	4	NUM
gsrj-29	208	2	.	.	X
gsrj-29	208	3	ledford	ledford	PROPN
gsrj-29	208	4	,	,	PUNCT
gsrj-29	208	5	h.	h.	PROPN
gsrj-29	208	6	,	,	PUNCT
gsrj-29	208	7	cyranoski	cyranoski	PROPN
gsrj-29	208	8	,	,	PUNCT
gsrj-29	208	9	d.	d.	PROPN
gsrj-29	208	10	&	&	CCONJ
gsrj-29	208	11	van	van	PROPN
gsrj-29	208	12	noorden	noorden	PROPN
gsrj-29	208	13	,	,	PUNCT
gsrj-29	208	14	r	r	NOUN
gsrj-29	208	15	..	..	X
gsrj-29	208	16	nature	nature	NOUN
gsrj-29	208	17	.	.	PUNCT
gsrj-29	209	1	2020	2020	NUM
gsrj-29	209	2	;	;	PUNCT
gsrj-29	209	3	588	588	NUM
gsrj-29	209	4	,	,	PUNCT
gsrj-29	209	5	205	205	NUM
gsrj-29	209	6	-	-	SYM
gsrj-29	209	7	206	206	NUM
gsrj-29	209	8	.	.	PUNCT
gsrj-29	210	1	doi	doi	NOUN
gsrj-29	210	2	:	:	PUNCT
gsrj-29	210	3	https://doi.org/10.1038/d41586-020-03441-8	https://doi.org/10.1038/d41586-020-03441-8	NUM
gsrj-29	210	4	5	5	NUM
gsrj-29	210	5	.	.	PUNCT
gsrj-29	211	1	covid-19	covid-19	PROPN
gsrj-29	211	2	dashboard	dashboard	NOUN
gsrj-29	211	3	by	by	ADP
gsrj-29	211	4	the	the	DET
gsrj-29	211	5	center	center	NOUN
gsrj-29	211	6	for	for	ADP
gsrj-29	211	7	systems	system	NOUN
gsrj-29	211	8	science	science	NOUN
gsrj-29	211	9	and	and	CCONJ
gsrj-29	211	10	engineering	engineering	NOUN
gsrj-29	211	11	(	(	PUNCT
gsrj-29	211	12	csse	csse	NOUN
gsrj-29	211	13	)	)	PUNCT
gsrj-29	211	14	at	at	ADP
gsrj-29	211	15	johns	johns	PROPN
gsrj-29	211	16	hopkins	hopkins	PROPN
gsrj-29	211	17	university	university	PROPN
gsrj-29	211	18	(	(	PUNCT
gsrj-29	211	19	jhu	jhu	PROPN
gsrj-29	211	20	)	)	PUNCT
gsrj-29	211	21	.	.	PUNCT
gsrj-29	212	1	coronavirus.jhu.edu	coronavirus.jhu.edu	PROPN
gsrj-29	212	2	.	.	PUNCT
gsrj-29	213	1	https://coronavirus.jhu.edu/map.html	https://coronavirus.jhu.edu/map.html	PROPN
gsrj-29	213	2	.	.	PUNCT
gsrj-29	214	1	published	publish	VERB
gsrj-29	214	2	11	11	NUM
gsrj-29	214	3	march	march	NOUN
gsrj-29	214	4	2020	2020	NUM
gsrj-29	214	5	.	.	PUNCT
gsrj-29	215	1	updated	update	VERB
gsrj-29	215	2	20	20	NUM
gsrj-29	215	3	august	august	PROPN
gsrj-29	215	4	2021	2021	NUM
gsrj-29	215	5	.	.	PUNCT
gsrj-29	216	1	accessed	access	VERB
gsrj-29	216	2	20	20	NUM
gsrj-29	216	3	august	august	PROPN
gsrj-29	216	4	2021	2021	NUM
gsrj-29	216	5	.	.	PUNCT
gsrj-29	217	1	6	6	NUM
gsrj-29	217	2	.	.	X
gsrj-29	217	3	mahase	mahase	NOUN
gsrj-29	217	4	,	,	PUNCT
gsrj-29	217	5	e	e	NOUN
gsrj-29	217	6	..	..	PUNCT
gsrj-29	217	7	delta	delta	NOUN
gsrj-29	217	8	variant	variant	NOUN
gsrj-29	217	9	:	:	PUNCT
gsrj-29	217	10	what	what	PRON
gsrj-29	217	11	is	be	AUX
gsrj-29	217	12	happening	happen	VERB
gsrj-29	217	13	with	with	ADP
gsrj-29	217	14	transmission	transmission	NOUN
gsrj-29	217	15	,	,	PUNCT
gsrj-29	217	16	hospital	hospital	NOUN
gsrj-29	217	17	admissions	admission	NOUN
gsrj-29	217	18	,	,	PUNCT
gsrj-29	217	19	and	and	CCONJ
gsrj-29	217	20	restrictions	restriction	NOUN
gsrj-29	217	21	?	?	PUNCT
gsrj-29	218	1	bmj	bmj	PROPN
gsrj-29	218	2	.	.	PUNCT
gsrj-29	218	3	2021	2021	NUM
gsrj-29	218	4	;	;	PUNCT
gsrj-29	218	5	373	373	NUM
gsrj-29	218	6	(	(	PUNCT
gsrj-29	218	7	1513	1513	NUM
gsrj-29	218	8	)	)	PUNCT
gsrj-29	218	9	.	.	PUNCT
gsrj-29	219	1	doi	doi	NOUN
gsrj-29	219	2	:	:	PUNCT
gsrj-29	219	3	https://doi.org/10.1136/bmj.n1513	https://doi.org/10.1136/bmj.n1513	PROPN
gsrj-29	219	4	7	7	NUM
gsrj-29	219	5	.	.	PUNCT
gsrj-29	220	1	cdc	cdc	PROPN
gsrj-29	220	2	covid-19	covid-19	PROPN
gsrj-29	220	3	vaccine	vaccine	NOUN
gsrj-29	220	4	breakthrough	breakthrough	NOUN
gsrj-29	220	5	case	case	NOUN
gsrj-29	220	6	investigations	investigation	NOUN
gsrj-29	220	7	team	team	NOUN
gsrj-29	220	8	.	.	PUNCT
gsrj-29	221	1	covid-19	covid-19	PROPN
gsrj-29	221	2	vaccine	vaccine	NOUN
gsrj-29	221	3	breakthrough	breakthrough	NOUN
gsrj-29	221	4	infections	infection	NOUN
gsrj-29	221	5	reported	report	VERB
gsrj-29	221	6	to	to	ADP
gsrj-29	221	7	cdc	cdc	PROPN
gsrj-29	221	8	united	united	PROPN
gsrj-29	221	9	states	states	PROPN
gsrj-29	221	10	,	,	PUNCT
gsrj-29	221	11	january	january	PROPN
gsrj-29	221	12	1	1	NUM
gsrj-29	221	13	-	-	SYM
gsrj-29	221	14	april	april	PROPN
gsrj-29	221	15	30	30	NUM
gsrj-29	221	16	,	,	PUNCT
gsrj-29	221	17	2021	2021	NUM
gsrj-29	221	18	.	.	PUNCT
gsrj-29	222	1	mmwr	mmwr	ADJ
gsrj-29	222	2	morb	morb	NOUN
gsrj-29	222	3	mortal	mortal	ADJ
gsrj-29	222	4	wkly	wkly	PROPN
gsrj-29	222	5	rep	rep	PROPN
gsrj-29	222	6	.	.	PROPN
gsrj-29	222	7	2021;70(21):792	2021;70(21):792	PROPN
gsrj-29	222	8	-	-	SYM
gsrj-29	222	9	793	793	NUM
gsrj-29	222	10	.	.	PUNCT
gsrj-29	223	1	published	publish	VERB
gsrj-29	223	2	2021	2021	NUM
gsrj-29	223	3	may	may	AUX
gsrj-29	223	4	28	28	NUM
gsrj-29	223	5	.	.	PUNCT
gsrj-29	223	6	doi:10.15585	doi:10.15585	PROPN
gsrj-29	223	7	/	/	SYM
gsrj-29	223	8	mmwr.mm7021e3	mmwr.mm7021e3	NOUN
gsrj-29	223	9	8	8	NUM
gsrj-29	223	10	.	.	NOUN
gsrj-29	223	11	asundi	asundi	PROPN
gsrj-29	223	12	,	,	PUNCT
gsrj-29	223	13	a.	a.	NOUN
gsrj-29	223	14	,	,	PUNCT
gsrj-29	223	15	o’leary	o’leary	PROPN
gsrj-29	223	16	,	,	PUNCT
gsrj-29	223	17	c.	c.	PROPN
gsrj-29	223	18	,	,	PUNCT
gsrj-29	223	19	bhadelia	bhadelia	PROPN
gsrj-29	223	20	,	,	PUNCT
gsrj-29	223	21	n	n	CCONJ
gsrj-29	223	22	..	..	PUNCT
gsrj-29	223	23	global	global	ADJ
gsrj-29	223	24	covid-19	covid-19	PROPN
gsrj-29	223	25	vaccine	vaccine	NOUN
gsrj-29	223	26	inequity	inequity	NOUN
gsrj-29	223	27	:	:	PUNCT
gsrj-29	223	28	the	the	DET
gsrj-29	223	29	scope	scope	NOUN
gsrj-29	223	30	,	,	PUNCT
gsrj-29	223	31	the	the	DET
gsrj-29	223	32	impact	impact	NOUN
gsrj-29	223	33	,	,	PUNCT
gsrj-29	223	34	and	and	CCONJ
gsrj-29	223	35	the	the	DET
gsrj-29	223	36	challenges	challenge	NOUN
gsrj-29	223	37	.	.	PUNCT
gsrj-29	224	1	cell	cell	NOUN
gsrj-29	224	2	host	host	NOUN
gsrj-29	224	3	&	&	CCONJ
gsrj-29	224	4	microbe	microbe	PROPN
gsrj-29	224	5	.	.	PUNCT
gsrj-29	225	1	2021	2021	NUM
gsrj-29	225	2	;	;	PUNCT
gsrj-29	225	3	29	29	NUM
gsrj-29	225	4	(	(	PUNCT
gsrj-29	225	5	7	7	NUM
gsrj-29	225	6	)	)	PUNCT
gsrj-29	225	7	,	,	PUNCT
gsrj-29	225	8	1036	1036	NUM
gsrj-29	225	9	-	-	SYM
gsrj-29	225	10	1039	1039	NUM
gsrj-29	225	11	.	.	PUNCT
gsrj-29	226	1	doi	doi	NOUN
gsrj-29	226	2	:	:	PUNCT
gsrj-29	226	3	https://doi.org/10.1016/j.chom.2021.06.007	https://doi.org/10.1016/j.chom.2021.06.007	PROPN
gsrj-29	226	4	9	9	NUM
gsrj-29	226	5	.	.	PUNCT
gsrj-29	226	6	ledford	ledford	PROPN
gsrj-29	226	7	,	,	PUNCT
gsrj-29	226	8	h.	h.	PROPN
gsrj-29	226	9	,	,	PUNCT
gsrj-29	226	10	&	&	CCONJ
gsrj-29	226	11	callaway	callaway	PROPN
gsrj-29	226	12	,	,	PUNCT
gsrj-29	226	13	e	e	PROPN
gsrj-29	226	14	..	..	PUNCT
gsrj-29	226	15	pioneers	pioneer	NOUN
gsrj-29	226	16	of	of	ADP
gsrj-29	226	17	revolutionary	revolutionary	ADJ
gsrj-29	226	18	crispr	crispr	ADJ
gsrj-29	226	19	gene	gene	NOUN
gsrj-29	226	20	editing	edit	VERB
gsrj-29	226	21	win	win	VERB
gsrj-29	226	22	chemistry	chemistry	NOUN
gsrj-29	226	23	nobel	nobel	NOUN
gsrj-29	226	24	.	.	PUNCT
gsrj-29	227	1	nature	nature	PROPN
gsrj-29	227	2	.	.	PUNCT
gsrj-29	228	1	2020	2020	NUM
gsrj-29	228	2	;	;	PUNCT
gsrj-29	228	3	586	586	NUM
gsrj-29	228	4	,	,	PUNCT
gsrj-29	228	5	346	346	NUM
gsrj-29	228	6	-	-	SYM
gsrj-29	228	7	347	347	NUM
gsrj-29	228	8	.	.	PUNCT
gsrj-29	229	1	doi	doi	NOUN
gsrj-29	229	2	:	:	PUNCT
gsrj-29	229	3	https://doi.org/10.1038/d41586-020-02765-9	https://doi.org/10.1038/d41586-020-02765-9	NUM
gsrj-29	229	4	36	36	NUM
gsrj-29	229	5	georgetown	georgetown	PROPN
gsrj-29	229	6	scientific	scientific	ADJ
gsrj-29	229	7	research	research	NOUN
gsrj-29	229	8	journal	journal	PROPN
gsrj-29	229	9	10	10	NUM
gsrj-29	229	10	.	.	PUNCT
gsrj-29	230	1	redman	redman	PROPN
gsrj-29	230	2	m	m	PROPN
gsrj-29	230	3	,	,	PUNCT
gsrj-29	230	4	king	king	PROPN
gsrj-29	230	5	a	a	X
gsrj-29	230	6	,	,	PUNCT
gsrj-29	230	7	watson	watson	PROPN
gsrj-29	230	8	c	c	PROPN
gsrj-29	230	9	,	,	PUNCT
gsrj-29	230	10	king	king	PROPN
gsrj-29	230	11	d.	d.	PROPN
gsrj-29	230	12	what	what	PRON
gsrj-29	230	13	is	be	AUX
gsrj-29	230	14	crispr	crispr	ADJ
gsrj-29	230	15	/	/	SYM
gsrj-29	230	16	cas9	cas9	NOUN
gsrj-29	230	17	?	?	PUNCT
gsrj-29	230	18	.	.	PUNCT
gsrj-29	231	1	arch	arch	PROPN
gsrj-29	231	2	dis	dis	PROPN
gsrj-29	231	3	child	child	PROPN
gsrj-29	231	4	educ	educ	VERB
gsrj-29	231	5	pract	pract	PROPN
gsrj-29	231	6	ed	ed	NOUN
gsrj-29	231	7	.	.	PUNCT
gsrj-29	232	1	2016;101(4):213	2016;101(4):213	NUM
gsrj-29	232	2	-	-	SYM
gsrj-29	232	3	215	215	NUM
gsrj-29	232	4	.	.	PUNCT
gsrj-29	232	5	doi	doi	NOUN
gsrj-29	232	6	:	:	PUNCT
gsrj-29	232	7	10.1136	10.1136	NUM
gsrj-29	232	8	/	/	SYM
gsrj-29	232	9	archdischild2016	archdischild2016	PROPN
gsrj-29	232	10	-	-	PUNCT
gsrj-29	232	11	310459	310459	NUM
gsrj-29	232	12	11	11	NUM
gsrj-29	232	13	.	.	PUNCT
gsrj-29	232	14	crispr	crispr	NOUN
gsrj-29	232	15	-	-	PUNCT
gsrj-29	232	16	based	base	VERB
gsrj-29	232	17	technologies	technology	NOUN
gsrj-29	232	18	for	for	ADP
gsrj-29	232	19	cell	cell	NOUN
gsrj-29	232	20	biology	biology	NOUN
gsrj-29	232	21	.	.	PUNCT
gsrj-29	233	1	nat	nat	NOUN
gsrj-29	233	2	cell	cell	NOUN
gsrj-29	233	3	biol	biol	PROPN
gsrj-29	233	4	.	.	PUNCT
gsrj-29	234	1	2019	2019	NUM
gsrj-29	234	2	;	;	PUNCT
gsrj-29	234	3	21	21	NUM
gsrj-29	234	4	,	,	PUNCT
gsrj-29	234	5	(	(	PUNCT
gsrj-29	234	6	1463	1463	NUM
gsrj-29	234	7	)	)	PUNCT
gsrj-29	234	8	.	.	PUNCT
gsrj-29	235	1	https://doi.org/10.1038/s41556-019-0434-y	https://doi.org/10.1038/s41556-019-0434-y	PROPN
gsrj-29	235	2	12	12	NUM
gsrj-29	235	3	.	.	PUNCT
gsrj-29	236	1	katz	katz	PROPN
gsrj-29	236	2	,	,	PUNCT
gsrj-29	236	3	r.	r.	PROPN
gsrj-29	236	4	,	,	PUNCT
gsrj-29	236	5	graeden	graeden	VERB
gsrj-29	236	6	,	,	PUNCT
gsrj-29	236	7	e.	e.	PROPN
gsrj-29	236	8	,	,	PUNCT
gsrj-29	236	9	kerr	kerr	PROPN
gsrj-29	236	10	,	,	PUNCT
gsrj-29	236	11	j.	j.	PROPN
gsrj-29	236	12	,	,	PUNCT
gsrj-29	236	13	the	the	DET
gsrj-29	236	14	complexity	complexity	NOUN
gsrj-29	236	15	of	of	ADP
gsrj-29	236	16	biological	biological	ADJ
gsrj-29	236	17	events	event	NOUN
gsrj-29	236	18	.	.	PUNCT
gsrj-29	237	1	the	the	DET
gsrj-29	237	2	lancet	lancet	NOUN
gsrj-29	237	3	.	.	PUNCT
gsrj-29	238	1	2018	2018	NUM
gsrj-29	238	2	;	;	PUNCT
gsrj-29	238	3	6	6	NUM
gsrj-29	238	4	(	(	PUNCT
gsrj-29	238	5	2	2	NUM
gsrj-29	238	6	)	)	PUNCT
gsrj-29	238	7	,	,	PUNCT
gsrj-29	238	8	136137	136137	NUM
gsrj-29	238	9	.	.	PUNCT
gsrj-29	239	1	doi	doi	NOUN
gsrj-29	239	2	:	:	PUNCT
gsrj-29	239	3	https://doi.org/10.1016/s2214109x(17)30494-1	https://doi.org/10.1016/s2214109x(17)30494-1	PROPN
gsrj-29	239	4	13	13	NUM
gsrj-29	239	5	.	.	PUNCT
gsrj-29	240	1	thompson	thompson	PROPN
gsrj-29	240	2	,	,	PUNCT
gsrj-29	240	3	t.	t.	PROPN
gsrj-29	240	4	l	l	PROPN
gsrj-29	240	5	..	..	PUNCT
gsrj-29	240	6	biopreparedness	biopreparedness	NOUN
gsrj-29	240	7	and	and	CCONJ
gsrj-29	240	8	biosecurity	biosecurity	NOUN
gsrj-29	240	9	.	.	PUNCT
gsrj-29	241	1	encyclopedia	encyclopedia	NOUN
gsrj-29	241	2	of	of	ADP
gsrj-29	241	3	health	health	NOUN
gsrj-29	241	4	communication	communication	NOUN
gsrj-29	241	5	,	,	PUNCT
gsrj-29	241	6	sage	sage	NOUN
gsrj-29	241	7	publications	publication	NOUN
gsrj-29	241	8	,	,	PUNCT
gsrj-29	241	9	inc	inc	PROPN
gsrj-29	241	10	..	..	PROPN
gsrj-29	241	11	2014	2014	NUM
gsrj-29	241	12	;	;	PUNCT
gsrj-29	241	13	1	1	NUM
gsrj-29	241	14	,	,	PUNCT
gsrj-29	241	15	114	114	NUM
gsrj-29	241	16	-	-	SYM
gsrj-29	241	17	116	116	NUM
gsrj-29	241	18	.	.	PUNCT
gsrj-29	242	1	https://www.doi.org/10.4135/9781483346427.n43	https://www.doi.org/10.4135/9781483346427.n43	PROPN
gsrj-29	242	2	14	14	NUM
gsrj-29	242	3	.	.	PUNCT
gsrj-29	243	1	u.s	u.s	PROPN
gsrj-29	243	2	.	.	PROPN
gsrj-29	243	3	department	department	PROPN
gsrj-29	243	4	of	of	ADP
gsrj-29	243	5	the	the	DET
gsrj-29	243	6	navy	navy	PROPN
gsrj-29	243	7	.	.	PUNCT
gsrj-29	244	1	chapter	chapter	NOUN
gsrj-29	244	2	1	1	NUM
gsrj-29	244	3	,	,	PUNCT
gsrj-29	244	4	the	the	DET
gsrj-29	244	5	strategic	strategic	ADJ
gsrj-29	244	6	environment	environment	NOUN
gsrj-29	244	7	in	in	ADP
gsrj-29	244	8	mcdp	mcdp	PROPN
gsrj-29	244	9	1	1	NUM
gsrj-29	244	10	-	-	SYM
gsrj-29	244	11	1	1	NUM
gsrj-29	244	12	.	.	PUNCT
gsrj-29	244	13	published	publish	VERB
gsrj-29	244	14	1997	1997	NUM
gsrj-29	244	15	.	.	PUNCT
gsrj-29	245	1	accessed	access	VERB
gsrj-29	245	2	august	august	PROPN
gsrj-29	245	3	18	18	NUM
gsrj-29	245	4	,	,	PUNCT
gsrj-29	245	5	2021	2021	NUM
gsrj-29	245	6	.	.	PUNCT
gsrj-29	246	1	https://www.globalsecurity.org/military/library/poli	https://www.globalsecurity.org/military/library/poli	VERB
gsrj-29	246	2	cy	cy	PROPN
gsrj-29	246	3	/	/	SYM
gsrj-29	246	4	usmc	usmc	PROPN
gsrj-29	246	5	/	/	SYM
gsrj-29	246	6	mcdp/1	mcdp/1	PROPN
gsrj-29	246	7	-	-	PUNCT
gsrj-29	246	8	1	1	NUM
gsrj-29	246	9	/	/	SYM
gsrj-29	246	10	mcdp1	mcdp1	NOUN
gsrj-29	246	11	-	-	PUNCT
gsrj-29	246	12	1_chap1.pdf	1_chap1.pdf	NUM
gsrj-29	246	13	15	15	NUM
gsrj-29	246	14	.	.	PUNCT
gsrj-29	247	1	ceasar	ceasar	NOUN
gsrj-29	247	2	,	,	PUNCT
gsrj-29	247	3	a.	a.	PROPN
gsrj-29	247	4	,	,	PUNCT
gsrj-29	247	5	rajan	rajan	PROPN
gsrj-29	247	6	,	,	PUNCT
gsrj-29	247	7	a.	a.	NOUN
gsrj-29	247	8	,	,	PUNCT
gsrj-29	247	9	prykhozhij	prykhozhij	NOUN
gsrj-29	247	10	,	,	PUNCT
gsrj-29	247	11	s.	s.	PROPN
gsrj-29	247	12	,	,	PUNCT
gsrj-29	247	13	berman	berman	PROPN
gsrj-29	247	14	,	,	PUNCT
gsrj-29	247	15	j.	j.	PROPN
gsrj-29	247	16	,	,	PUNCT
gsrj-29	247	17	ignacimuthu	ignacimuthu	PROPN
gsrj-29	247	18	.	.	PUNCT
gsrj-29	247	19	insert	insert	PROPN
gsrj-29	247	20	,	,	PUNCT
gsrj-29	247	21	remove	remove	VERB
gsrj-29	247	22	or	or	CCONJ
gsrj-29	247	23	replace	replace	VERB
gsrj-29	247	24	:	:	PUNCT
gsrj-29	247	25	a	a	DET
gsrj-29	247	26	highly	highly	ADV
gsrj-29	247	27	advanced	advanced	ADJ
gsrj-29	247	28	genome	genome	NOUN
gsrj-29	247	29	editing	editing	NOUN
gsrj-29	247	30	system	system	NOUN
gsrj-29	247	31	using	use	VERB
gsrj-29	247	32	crispr	crispr	ADJ
gsrj-29	247	33	/	/	SYM
gsrj-29	247	34	cas9	cas9	NOUN
gsrj-29	247	35	.	.	PUNCT
gsrj-29	248	1	biochimica	biochimica	PROPN
gsrj-29	248	2	et	et	PROPN
gsrj-29	248	3	biophysica	biophysica	PROPN
gsrj-29	248	4	acta	acta	PROPN
gsrj-29	248	5	(	(	PUNCT
gsrj-29	248	6	bba	bba	NOUN
gsrj-29	248	7	)	)	PUNCT
gsrj-29	248	8	molecular	molecular	ADJ
gsrj-29	248	9	cell	cell	NOUN
gsrj-29	248	10	research	research	NOUN
gsrj-29	248	11	.	.	PUNCT
gsrj-29	248	12	2016	2016	NUM
gsrj-29	248	13	;	;	PUNCT
gsrj-29	248	14	1863	1863	NUM
gsrj-29	248	15	(	(	PUNCT
gsrj-29	248	16	9	9	NUM
gsrj-29	248	17	)	)	PUNCT
gsrj-29	248	18	,	,	PUNCT
gsrj-29	248	19	23332344	23332344	NUM
gsrj-29	248	20	.	.	PUNCT
gsrj-29	249	1	doi	doi	NOUN
gsrj-29	249	2	:	:	PUNCT
gsrj-29	249	3	https://doi.org/10.1016/j.bbamcr.2016.06.009	https://doi.org/10.1016/j.bbamcr.2016.06.009	PROPN
gsrj-29	249	4	16	16	NUM
gsrj-29	249	5	.	.	PUNCT
gsrj-29	250	1	aken	aken	VERB
gsrj-29	250	2	,	,	PUNCT
gsrj-29	250	3	j.	j.	PROPN
gsrj-29	250	4	,	,	PUNCT
gsrj-29	250	5	and	and	CCONJ
gsrj-29	250	6	hammond	hammond	NOUN
gsrj-29	250	7	,	,	PUNCT
gsrj-29	250	8	e	e	X
gsrj-29	250	9	..	..	PUNCT
gsrj-29	250	10	genetic	genetic	ADJ
gsrj-29	250	11	engineering	engineering	NOUN
gsrj-29	250	12	and	and	CCONJ
gsrj-29	250	13	biological	biological	ADJ
gsrj-29	250	14	weapons	weapon	NOUN
gsrj-29	250	15	.	.	PUNCT
gsrj-29	251	1	science	science	NOUN
gsrj-29	251	2	and	and	CCONJ
gsrj-29	251	3	society	society	NOUN
gsrj-29	251	4	.	.	PUNCT
gsrj-29	252	1	2003	2003	NUM
gsrj-29	252	2	;	;	PUNCT
gsrj-29	252	3	4	4	NUM
gsrj-29	252	4	(	(	PUNCT
gsrj-29	252	5	special	special	ADJ
gsrj-29	252	6	issue	issue	NOUN
gsrj-29	252	7	)	)	PUNCT
gsrj-29	252	8	57–60	57–60	PROPN
gsrj-29	252	9	.	.	PROPN
gsrj-29	252	10	17	17	NUM
gsrj-29	252	11	.	.	PUNCT
gsrj-29	253	1	gaj	gaj	PROPN
gsrj-29	253	2	,	,	PUNCT
gsrj-29	253	3	t.	t.	PROPN
gsrj-29	253	4	,	,	PUNCT
gsrj-29	253	5	sirk	sirk	PROPN
gsrj-29	253	6	,	,	PUNCT
gsrj-29	253	7	s.	s.	PROPN
gsrj-29	253	8	j.	j.	PROPN
gsrj-29	253	9	,	,	PUNCT
gsrj-29	253	10	shui	shui	PROPN
gsrj-29	253	11	,	,	PUNCT
gsrj-29	253	12	s.	s.	PROPN
gsrj-29	253	13	,	,	PUNCT
gsrj-29	253	14	&	&	CCONJ
gsrj-29	253	15	liu	liu	PROPN
gsrj-29	253	16	,	,	PUNCT
gsrj-29	253	17	j.	j.	PROPN
gsrj-29	253	18	(	(	PUNCT
gsrj-29	253	19	2016	2016	NUM
gsrj-29	253	20	)	)	PUNCT
gsrj-29	253	21	.	.	PUNCT
gsrj-29	254	1	genome	genome	NOUN
gsrj-29	254	2	-	-	PUNCT
gsrj-29	254	3	editing	edit	VERB
gsrj-29	254	4	technologies	technology	NOUN
gsrj-29	254	5	:	:	PUNCT
gsrj-29	254	6	principles	principle	NOUN
gsrj-29	254	7	and	and	CCONJ
gsrj-29	254	8	applications	application	NOUN
gsrj-29	254	9	.	.	PUNCT
gsrj-29	255	1	cold	cold	ADJ
gsrj-29	255	2	spring	spring	NOUN
gsrj-29	255	3	harbor	harbor	NOUN
gsrj-29	255	4	perspectives	perspective	NOUN
gsrj-29	255	5	in	in	ADP
gsrj-29	255	6	biology	biology	NOUN
gsrj-29	255	7	,	,	PUNCT
gsrj-29	255	8	8(12	8(12	NUM
gsrj-29	255	9	)	)	PUNCT
gsrj-29	255	10	,	,	PUNCT
gsrj-29	255	11	a023754	a023754	PROPN
gsrj-29	255	12	.	.	PUNCT
gsrj-29	256	1	https://doi.org/10.1101/cshperspect.a023754	https://doi.org/10.1101/cshperspect.a023754	PROPN
gsrj-29	256	2	18	18	NUM
gsrj-29	256	3	.	.	PUNCT
gsrj-29	257	1	u.s	u.s	PROPN
gsrj-29	257	2	.	.	PROPN
gsrj-29	257	3	intelligence	intelligence	NOUN
gsrj-29	257	4	community	community	NOUN
gsrj-29	257	5	.	.	PUNCT
gsrj-29	258	1	worldwide	worldwide	ADJ
gsrj-29	258	2	threat	threat	NOUN
gsrj-29	258	3	assessment	assessment	NOUN
gsrj-29	258	4	of	of	ADP
gsrj-29	258	5	the	the	DET
gsrj-29	258	6	us	us	PROPN
gsrj-29	258	7	intelligence	intelligence	NOUN
gsrj-29	258	8	community	community	NOUN
gsrj-29	258	9	.	.	PUNCT
gsrj-29	259	1	published	publish	VERB
gsrj-29	259	2	2016	2016	NUM
gsrj-29	259	3	.	.	PUNCT
gsrj-29	260	1	accessed	access	VERB
gsrj-29	260	2	august	august	PROPN
gsrj-29	260	3	18	18	NUM
gsrj-29	260	4	,	,	PUNCT
gsrj-29	260	5	2021	2021	NUM
gsrj-29	260	6	.	.	PUNCT
gsrj-29	261	1	https://www.dni.gov/files/documents/sasc_uncl	https://www.dni.gov/files/documents/sasc_uncl	PROPN
gsrj-29	261	2	assified_2016_ata_sfr_final.pdf	assified_2016_ata_sfr_final.pdf	NOUN
gsrj-29	261	3	19	19	NUM
gsrj-29	261	4	.	.	PUNCT
gsrj-29	262	1	u.s	u.s	PROPN
gsrj-29	262	2	.	.	PROPN
gsrj-29	262	3	intelligence	intelligence	NOUN
gsrj-29	262	4	community	community	NOUN
gsrj-29	262	5	.	.	PUNCT
gsrj-29	263	1	worldwide	worldwide	ADJ
gsrj-29	263	2	threat	threat	NOUN
gsrj-29	263	3	assessment	assessment	NOUN
gsrj-29	263	4	of	of	ADP
gsrj-29	263	5	the	the	DET
gsrj-29	263	6	us	us	PROPN
gsrj-29	263	7	intelligence	intelligence	NOUN
gsrj-29	263	8	community	community	NOUN
gsrj-29	263	9	.	.	PUNCT
gsrj-29	264	1	published	publish	VERB
gsrj-29	264	2	2018	2018	NUM
gsrj-29	264	3	.	.	PUNCT
gsrj-29	265	1	accessed	access	VERB
gsrj-29	265	2	august	august	PROPN
gsrj-29	265	3	18	18	NUM
gsrj-29	265	4	,	,	PUNCT
gsrj-29	265	5	2021	2021	NUM
gsrj-29	265	6	.	.	PUNCT
gsrj-29	266	1	https://www.dni.gov/files/documents/newsroom/	https://www.dni.gov/files/documents/newsroom/	PROPN
gsrj-29	266	2	testimonies/2018	testimonies/2018	NOUN
gsrj-29	266	3	-	-	PUNCT
gsrj-29	266	4	ata	ata	ADJ
gsrj-29	266	5	---	---	PUNCT
gsrj-29	266	6	unclassified	unclassified	ADJ
gsrj-29	266	7	-	-	PUNCT
gsrj-29	266	8	ssci.pdf	ssci.pdf	NUM
gsrj-29	266	9	20	20	NUM
gsrj-29	266	10	.	.	PUNCT
gsrj-29	267	1	ryan	ryan	PROPN
gsrj-29	267	2	j.	j.	PROPN
gsrj-29	267	3	biosecurity	biosecurity	PROPN
gsrj-29	267	4	and	and	CCONJ
gsrj-29	267	5	bioterrorism	bioterrorism	NOUN
gsrj-29	267	6	.	.	PUNCT
gsrj-29	268	1	butterworthheinemann	butterworthheinemann	PROPN
gsrj-29	268	2	;	;	PUNCT
gsrj-29	268	3	2016	2016	NUM
gsrj-29	268	4	.	.	PUNCT
gsrj-29	269	1	21	21	NUM
gsrj-29	269	2	.	.	PUNCT
gsrj-29	270	1	katz	katz	PROPN
gsrj-29	270	2	r	r	PROPN
gsrj-29	270	3	,	,	PUNCT
gsrj-29	270	4	graeden	graeden	ADJ
gsrj-29	270	5	e	e	NOUN
gsrj-29	270	6	,	,	PUNCT
gsrj-29	270	7	abe	abe	PROPN
gsrj-29	270	8	k	k	PROPN
gsrj-29	270	9	,	,	PUNCT
gsrj-29	270	10	attal	attal	NOUN
gsrj-29	270	11	-	-	PUNCT
gsrj-29	270	12	juncqua	juncqua	NOUN
gsrj-29	270	13	a	a	X
gsrj-29	270	14	,	,	PUNCT
gsrj-29	270	15	boyce	boyce	PROPN
gsrj-29	270	16	mr	mr	PROPN
gsrj-29	270	17	,	,	PUNCT
gsrj-29	270	18	eaneff	eaneff	PROPN
gsrj-29	270	19	s.	s.	PROPN
gsrj-29	270	20	mapping	mapping	NOUN
gsrj-29	270	21	stakeholders	stakeholder	NOUN
gsrj-29	270	22	and	and	CCONJ
gsrj-29	270	23	policies	policy	NOUN
gsrj-29	270	24	in	in	ADP
gsrj-29	270	25	response	response	NOUN
gsrj-29	270	26	to	to	PART
gsrj-29	270	27	deliberate	deliberate	VERB
gsrj-29	270	28	biological	biological	ADJ
gsrj-29	270	29	events	event	NOUN
gsrj-29	270	30	.	.	PUNCT
gsrj-29	271	1	heliyon	heliyon	NOUN
gsrj-29	271	2	.	.	PUNCT
gsrj-29	272	1	2018	2018	NUM
gsrj-29	272	2	;	;	PUNCT
gsrj-29	272	3	4	4	NUM
gsrj-29	272	4	(	(	PUNCT
gsrj-29	272	5	12	12	NUM
gsrj-29	272	6	)	)	PUNCT
gsrj-29	272	7	.	.	PUNCT
gsrj-29	273	1	doi	doi	NOUN
gsrj-29	273	2	:	:	PUNCT
gsrj-29	273	3	10.1016	10.1016	NUM
gsrj-29	273	4	/	/	SYM
gsrj-29	273	5	j.heliyon.2018.e01091	j.heliyon.2018.e01091	NOUN
gsrj-29	273	6	22	22	NUM
gsrj-29	273	7	.	.	PUNCT
gsrj-29	274	1	grunow	grunow	PROPN
gsrj-29	274	2	,	,	PUNCT
gsrj-29	274	3	r.	r.	PROPN
gsrj-29	274	4	,	,	PUNCT
gsrj-29	274	5	finke	finke	PROPN
gsrj-29	274	6	,	,	PUNCT
gsrj-29	274	7	e.-j	e.-j	PROPN
gsrj-29	274	8	..	..	PUNCT
gsrj-29	274	9	a	a	DET
gsrj-29	274	10	procedure	procedure	NOUN
gsrj-29	274	11	for	for	ADP
gsrj-29	274	12	differentiating	differentiate	VERB
gsrj-29	274	13	between	between	ADP
gsrj-29	274	14	the	the	DET
gsrj-29	274	15	intentional	intentional	ADJ
gsrj-29	274	16	release	release	NOUN
gsrj-29	274	17	of	of	ADP
gsrj-29	274	18	biological	biological	ADJ
gsrj-29	274	19	warfare	warfare	NOUN
gsrj-29	274	20	agents	agent	NOUN
gsrj-29	274	21	and	and	CCONJ
gsrj-29	274	22	natural	natural	ADJ
gsrj-29	274	23	outbreaks	outbreak	NOUN
gsrj-29	274	24	of	of	ADP
gsrj-29	274	25	disease	disease	NOUN
gsrj-29	274	26	:	:	PUNCT
gsrj-29	274	27	its	its	PRON
gsrj-29	274	28	use	use	NOUN
gsrj-29	274	29	in	in	ADP
gsrj-29	274	30	analyzing	analyze	VERB
gsrj-29	274	31	the	the	DET
gsrj-29	274	32	tularemia	tularemia	NOUN
gsrj-29	274	33	outbreak	outbreak	NOUN
gsrj-29	274	34	in	in	ADP
gsrj-29	274	35	kosovo	kosovo	PROPN
gsrj-29	274	36	in	in	ADP
gsrj-29	274	37	1999	1999	NUM
gsrj-29	274	38	and	and	CCONJ
gsrj-29	274	39	2000	2000	NUM
gsrj-29	274	40	.	.	PUNCT
gsrj-29	275	1	clinical	clinical	ADJ
gsrj-29	275	2	microbiology	microbiology	NOUN
gsrj-29	275	3	and	and	CCONJ
gsrj-29	275	4	infection	infection	NOUN
gsrj-29	275	5	.	.	PUNCT
gsrj-29	276	1	2002	2002	NUM
gsrj-29	276	2	;	;	PUNCT
gsrj-29	276	3	8	8	NUM
gsrj-29	276	4	(	(	PUNCT
gsrj-29	276	5	8)	8)	NUM
gsrj-29	276	6	,	,	PUNCT
gsrj-29	276	7	510	510	NUM
gsrj-29	276	8	-	-	SYM
gsrj-29	276	9	521	521	NUM
gsrj-29	276	10	.	.	PUNCT
gsrj-29	277	1	doi	doi	PROPN
gsrj-29	277	2	:	:	PUNCT
gsrj-29	277	3	https://doi.org/10.1046/j.1469-0691.2002.00524.x	https://doi.org/10.1046/j.1469-0691.2002.00524.x	PROPN
gsrj-29	277	4	23	23	NUM
gsrj-29	277	5	.	.	PUNCT
gsrj-29	278	1	vogel	vogel	PROPN
gsrj-29	278	2	,	,	PUNCT
gsrj-29	278	3	k.	k.	PROPN
gsrj-29	278	4	m.	m.	PROPN
gsrj-29	278	5	,	,	PUNCT
gsrj-29	278	6	&	&	CCONJ
gsrj-29	278	7	ouagrham	ouagrham	PROPN
gsrj-29	278	8	-	-	PUNCT
gsrj-29	278	9	gormley	gormley	PROPN
gsrj-29	278	10	,	,	PUNCT
gsrj-29	278	11	s.	s.	PROPN
gsrj-29	278	12	b.	b.	PROPN
gsrj-29	278	13	(	(	PUNCT
gsrj-29	278	14	2018	2018	NUM
gsrj-29	278	15	)	)	PUNCT
gsrj-29	278	16	.	.	PUNCT
gsrj-29	279	1	anticipating	anticipate	VERB
gsrj-29	279	2	emerging	emerge	VERB
gsrj-29	279	3	biotechnology	biotechnology	NOUN
gsrj-29	279	4	threats	threat	NOUN
gsrj-29	279	5	:	:	PUNCT
gsrj-29	279	6	a	a	DET
gsrj-29	279	7	case	case	NOUN
gsrj-29	279	8	study	study	NOUN
gsrj-29	279	9	of	of	ADP
gsrj-29	279	10	crispr	crispr	NOUN
gsrj-29	279	11	.	.	PUNCT
gsrj-29	280	1	politics	politic	NOUN
gsrj-29	280	2	and	and	CCONJ
gsrj-29	280	3	the	the	DET
gsrj-29	280	4	life	life	NOUN
gsrj-29	280	5	sciences	sciences	PROPN
gsrj-29	280	6	,	,	PUNCT
gsrj-29	280	7	37(2	37(2	NOUN
gsrj-29	280	8	)	)	PUNCT
gsrj-29	280	9	,	,	PUNCT
gsrj-29	280	10	203–219	203–219	NUM
gsrj-29	280	11	.	.	PUNCT
gsrj-29	281	1	https://doi.org/10.1017/pls.2018.21	https://doi.org/10.1017/pls.2018.21	NOUN
gsrj-29	281	2	24	24	NUM
gsrj-29	281	3	.	.	PUNCT
gsrj-29	282	1	pope	pope	PROPN
gsrj-29	282	2	sm	sm	PROPN
gsrj-29	282	3	.	.	PROPN
gsrj-29	282	4	impact	impact	NOUN
gsrj-29	282	5	of	of	ADP
gsrj-29	282	6	gene	gene	NOUN
gsrj-29	282	7	editing	editing	NOUN
gsrj-29	282	8	tools	tool	NOUN
gsrj-29	282	9	,	,	PUNCT
gsrj-29	282	10	like	like	ADP
gsrj-29	282	11	crispr	crispr	NOUN
gsrj-29	282	12	/	/	SYM
gsrj-29	282	13	cas9	cas9	NOUN
gsrj-29	282	14	,	,	PUNCT
gsrj-29	282	15	on	on	ADP
gsrj-29	282	16	the	the	DET
gsrj-29	282	17	public	public	ADJ
gsrj-29	282	18	health	health	NOUN
gsrj-29	282	19	response	response	NOUN
gsrj-29	282	20	to	to	ADP
gsrj-29	282	21	disease	disease	NOUN
gsrj-29	282	22	outbreaks	outbreak	NOUN
gsrj-29	282	23	.	.	PUNCT
gsrj-29	283	1	disaster	disaster	NOUN
gsrj-29	283	2	medicine	medicine	NOUN
gsrj-29	283	3	and	and	CCONJ
gsrj-29	283	4	public	public	ADJ
gsrj-29	283	5	health	health	NOUN
gsrj-29	283	6	preparedness	preparedness	NOUN
gsrj-29	283	7	.	.	PUNCT
gsrj-29	284	1	2017	2017	NUM
gsrj-29	284	2	;	;	PUNCT
gsrj-29	284	3	11	11	NUM
gsrj-29	284	4	(	(	PUNCT
gsrj-29	284	5	2):155	2):155	NUM
gsrj-29	284	6	-	-	SYM
gsrj-29	284	7	159	159	NUM
gsrj-29	284	8	.	.	PUNCT
gsrj-29	285	1	doi	doi	NOUN
gsrj-29	285	2	:	:	PUNCT
gsrj-29	285	3	10.1017	10.1017	NUM
gsrj-29	285	4	/	/	SYM
gsrj-29	285	5	dmp.2016.123	dmp.2016.123	NOUN
gsrj-29	285	6	25	25	NUM
gsrj-29	285	7	.	.	PUNCT
gsrj-29	286	1	piret	piret	PROPN
gsrj-29	286	2	j	j	PROPN
gsrj-29	286	3	,	,	PUNCT
gsrj-29	286	4	boivin	boivin	PROPN
gsrj-29	286	5	g.	g.	PROPN
gsrj-29	286	6	pandemics	pandemic	NOUN
gsrj-29	286	7	throughout	throughout	ADP
gsrj-29	286	8	history	history	NOUN
gsrj-29	286	9	.	.	PUNCT
gsrj-29	287	1	front	front	ADJ
gsrj-29	287	2	microbiol	microbiol	PROPN
gsrj-29	287	3	.	.	PUNCT
gsrj-29	288	1	2021	2021	NUM
gsrj-29	288	2	;	;	PUNCT
gsrj-29	288	3	11	11	NUM
gsrj-29	288	4	.	.	X
gsrj-29	289	1	doi	doi	NOUN
gsrj-29	289	2	:	:	PUNCT
gsrj-29	289	3	10.3389	10.3389	NUM
gsrj-29	289	4	/	/	SYM
gsrj-29	289	5	fmicb.2020.631736	fmicb.2020.631736	PROPN
gsrj-29	289	6	26	26	NUM
gsrj-29	289	7	.	.	PUNCT
gsrj-29	290	1	hassell	hassell	PROPN
gsrj-29	290	2	,	,	PUNCT
gsrj-29	290	3	j	j	PROPN
gsrj-29	290	4	..	..	PUNCT
gsrj-29	290	5	testing	test	VERB
gsrj-29	290	6	early	early	ADV
gsrj-29	290	7	,	,	PUNCT
gsrj-29	290	8	testing	test	VERB
gsrj-29	290	9	late	late	ADV
gsrj-29	290	10	:	:	PUNCT
gsrj-29	290	11	four	four	NUM
gsrj-29	290	12	countries	country	NOUN
gsrj-29	290	13	’	'	PUNCT
gsrj-29	290	14	approaches	approach	NOUN
gsrj-29	290	15	to	to	ADP
gsrj-29	290	16	covid-19	covid-19	PROPN
gsrj-29	290	17	testing	testing	NOUN
gsrj-29	290	18	compared	compare	VERB
gsrj-29	290	19	.	.	PUNCT
gsrj-29	291	1	ourworldindata.org	ourworldindata.org	X
gsrj-29	291	2	.	.	PUNCT
gsrj-29	292	1	published	publish	VERB
gsrj-29	292	2	may	may	PROPN
gsrj-29	292	3	19	19	NUM
gsrj-29	292	4	,	,	PUNCT
gsrj-29	292	5	2020	2020	NUM
gsrj-29	292	6	.	.	PUNCT
gsrj-29	293	1	accessed	access	VERB
gsrj-29	293	2	august	august	PROPN
gsrj-29	293	3	18	18	NUM
gsrj-29	293	4	,	,	PUNCT
gsrj-29	293	5	2021	2021	NUM
gsrj-29	293	6	.	.	PUNCT
gsrj-29	294	1	https://ourworldindata.org/covid-testing-us-ukkorea-italy#licence	https://ourworldindata.org/covid-testing-us-ukkorea-italy#licence	NOUN
gsrj-29	294	2	27	27	NUM
gsrj-29	294	3	.	.	PUNCT
gsrj-29	295	1	botti	botti	NOUN
gsrj-29	295	2	-	-	PUNCT
gsrj-29	295	3	lodovico	lodovico	PROPN
gsrj-29	295	4	,	,	PUNCT
gsrj-29	295	5	y.	y.	NOUN
gsrj-29	295	6	,	,	PUNCT
gsrj-29	295	7	m.p.p	m.p.p	PROPN
gsrj-29	295	8	.	.	PROPN
gsrj-29	295	9	,	,	PUNCT
gsrj-29	295	10	rosenberg	rosenberg	PROPN
gsrj-29	295	11	,	,	PUNCT
gsrj-29	295	12	e.	e.	PROPN
gsrj-29	295	13	,	,	PUNCT
gsrj-29	295	14	m.d	m.d	PROPN
gsrj-29	295	15	.	.	PROPN
gsrj-29	295	16	,	,	PUNCT
gsrj-29	295	17	and	and	CCONJ
gsrj-29	295	18	sabeti	sabeti	NOUN
gsrj-29	295	19	,	,	PUNCT
gsrj-29	295	20	p.	p.	NOUN
gsrj-29	295	21	,	,	PUNCT
gsrj-29	295	22	d.phil	d.phil	PROPN
gsrj-29	295	23	.	.	PROPN
gsrj-29	295	24	,	,	PUNCT
gsrj-29	295	25	m.d	m.d	PROPN
gsrj-29	295	26	..	..	PUNCT
gsrj-29	295	27	testing	testing	NOUN
gsrj-29	295	28	in	in	ADP
gsrj-29	295	29	a	a	DET
gsrj-29	295	30	pandemic	pandemic	ADJ
gsrj-29	295	31	—	—	PUNCT
gsrj-29	295	32	improving	improve	VERB
gsrj-29	295	33	access	access	NOUN
gsrj-29	295	34	,	,	PUNCT
gsrj-29	295	35	coordination	coordination	NOUN
gsrj-29	295	36	,	,	PUNCT
gsrj-29	295	37	and	and	CCONJ
gsrj-29	295	38	prioritization	prioritization	NOUN
gsrj-29	295	39	.	.	PUNCT
gsrj-29	296	1	n	n	PROPN
gsrj-29	296	2	engl	engl	PROPN
gsrj-29	296	3	j	j	PROPN
gsrj-29	296	4	med	med	PROPN
gsrj-29	296	5	.	.	PROPN
gsrj-29	296	6	2021	2021	NUM
gsrj-29	296	7	;	;	PUNCT
gsrj-29	296	8	384	384	NUM
gsrj-29	296	9	,	,	PUNCT
gsrj-29	296	10	197	197	NUM
gsrj-29	296	11	-	-	SYM
gsrj-29	296	12	199	199	NUM
gsrj-29	296	13	.	.	PUNCT
gsrj-29	297	1	doi	doi	NOUN
gsrj-29	297	2	:	:	PUNCT
gsrj-29	297	3	10.1056	10.1056	NUM
gsrj-29	297	4	/	/	SYM
gsrj-29	297	5	nejmp2025173	nejmp2025173	PROPN
gsrj-29	297	6	28	28	NUM
gsrj-29	297	7	.	.	PUNCT
gsrj-29	298	1	larremore	larremore	PROPN
gsrj-29	298	2	,	,	PUNCT
gsrj-29	298	3	d.	d.	PROPN
gsrj-29	298	4	,	,	PUNCT
gsrj-29	298	5	wilder	wilder	PROPN
gsrj-29	298	6	,	,	PUNCT
gsrj-29	298	7	b.	b.	PROPN
gsrj-29	298	8	,	,	PUNCT
gsrj-29	298	9	lester	lester	PROPN
gsrj-29	298	10	,	,	PUNCT
gsrj-29	298	11	e.	e.	PROPN
gsrj-29	298	12	,	,	PUNCT
gsrj-29	298	13	shehata	shehata	PROPN
gsrj-29	298	14	,	,	PUNCT
gsrj-29	298	15	s.	s.	PROPN
gsrj-29	298	16	,	,	PUNCT
gsrj-29	298	17	burke	burke	PROPN
gsrj-29	298	18	,	,	PUNCT
gsrj-29	298	19	j.	j.	PROPN
gsrj-29	298	20	,	,	PUNCT
gsrj-29	298	21	hay	hay	PROPN
gsrj-29	298	22	,	,	PUNCT
gsrj-29	298	23	j.	j.	PROPN
gsrj-29	298	24	,	,	PUNCT
gsrj-29	298	25	tambe	tambe	NOUN
gsrj-29	298	26	,	,	PUNCT
gsrj-29	298	27	m.	m.	NOUN
gsrj-29	298	28	,	,	PUNCT
gsrj-29	298	29	mina	mina	PROPN
gsrj-29	298	30	,	,	PUNCT
gsrj-29	298	31	m.	m.	NOUN
gsrj-29	298	32	,	,	PUNCT
gsrj-29	298	33	parker	parker	PROPN
gsrj-29	298	34	,	,	PUNCT
gsrj-29	298	35	j	j	PROPN
gsrj-29	298	36	..	..	PUNCT
gsrj-29	298	37	test	test	NOUN
gsrj-29	298	38	sensitivity	sensitivity	NOUN
gsrj-29	298	39	is	be	AUX
gsrj-29	298	40	secondary	secondary	ADJ
gsrj-29	298	41	to	to	ADP
gsrj-29	298	42	frequency	frequency	NOUN
gsrj-29	298	43	and	and	CCONJ
gsrj-29	298	44	turnaround	turnaround	NOUN
gsrj-29	298	45	time	time	NOUN
gsrj-29	298	46	for	for	ADP
gsrj-29	298	47	covid-19	covid-19	PROPN
gsrj-29	298	48	surveillance	surveillance	NOUN
gsrj-29	298	49	.	.	PUNCT
gsrj-29	299	1	sci	sci	PROPN
gsrj-29	299	2	adv	adv	PROPN
gsrj-29	299	3	.	.	PROPN
gsrj-29	299	4	2021	2021	NUM
gsrj-29	299	5	;	;	PUNCT
gsrj-29	299	6	7	7	NUM
gsrj-29	299	7	(	(	PUNCT
gsrj-29	299	8	1	1	NUM
gsrj-29	299	9	)	)	PUNCT
gsrj-29	299	10	.	.	PUNCT
gsrj-29	300	1	doi	doi	NOUN
gsrj-29	300	2	:	:	PUNCT
gsrj-29	300	3	10.1126	10.1126	NUM
gsrj-29	300	4	/	/	SYM
gsrj-29	300	5	sciadv.abd5393	sciadv.abd5393	PROPN
gsrj-29	300	6	29	29	NUM
gsrj-29	300	7	.	.	PUNCT
gsrj-29	301	1	oliveira	oliveira	PROPN
gsrj-29	301	2	ba	ba	PROPN
gsrj-29	301	3	,	,	PUNCT
gsrj-29	301	4	oliveira	oliveira	PROPN
gsrj-29	301	5	lc	lc	PROPN
gsrj-29	301	6	,	,	PUNCT
gsrj-29	301	7	sabino	sabino	NOUN
gsrj-29	301	8	ec	ec	PROPN
gsrj-29	301	9	,	,	PUNCT
gsrj-29	301	10	okay	okay	INTJ
gsrj-29	301	11	ts	ts	PROPN
gsrj-29	301	12	.	.	PUNCT
gsrj-29	302	1	sars	sars	PROPN
gsrj-29	302	2	-	-	PUNCT
gsrj-29	302	3	cov-2	cov-2	PUNCT
gsrj-29	302	4	and	and	CCONJ
gsrj-29	302	5	the	the	DET
gsrj-29	302	6	covid-19	covid-19	PROPN
gsrj-29	302	7	disease	disease	NOUN
gsrj-29	302	8	:	:	PUNCT
gsrj-29	302	9	a	a	DET
gsrj-29	302	10	mini	mini	ADJ
gsrj-29	302	11	review	review	NOUN
gsrj-29	302	12	on	on	ADP
gsrj-29	302	13	diagnostic	diagnostic	ADJ
gsrj-29	302	14	methods	method	NOUN
gsrj-29	302	15	.	.	PUNCT
gsrj-29	303	1	rev	rev	PROPN
gsrj-29	303	2	inst	inst	PROPN
gsrj-29	303	3	med	med	PROPN
gsrj-29	303	4	trop	trop	X
gsrj-29	303	5	sao	sao	PROPN
gsrj-29	303	6	paulo	paulo	PROPN
gsrj-29	303	7	.	.	PUNCT
gsrj-29	304	1	2020	2020	NUM
gsrj-29	304	2	;	;	PUNCT
gsrj-29	304	3	62	62	NUM
gsrj-29	304	4	,	,	PUNCT
gsrj-29	304	5	44	44	NUM
gsrj-29	304	6	.	.	PUNCT
gsrj-29	305	1	doi:10.1590	doi:10.1590	PROPN
gsrj-29	305	2	/	/	SYM
gsrj-29	305	3	s16789946202062044	s16789946202062044	PROPN
gsrj-29	305	4	37	37	NUM
gsrj-29	305	5	georgetown	georgetown	PROPN
gsrj-29	305	6	scientific	scientific	PROPN
gsrj-29	305	7	research	research	NOUN
gsrj-29	305	8	journal	journal	NOUN
gsrj-29	305	9	30	30	NUM
gsrj-29	305	10	.	.	PUNCT
gsrj-29	306	1	rao	rao	PROPN
gsrj-29	306	2	,	,	PUNCT
gsrj-29	306	3	g.	g.	PROPN
gsrj-29	306	4	,	,	PUNCT
gsrj-29	306	5	agarwal	agarwal	PROPN
gsrj-29	306	6	,	,	PUNCT
gsrj-29	306	7	a.	a.	NOUN
gsrj-29	306	8	,	,	PUNCT
gsrj-29	306	9	and	and	CCONJ
gsrj-29	306	10	baturad	baturad	NOUN
gsrj-29	306	11	,	,	PUNCT
gsrj-29	306	12	d	d	NOUN
gsrj-29	306	13	..	..	PUNCT
gsrj-29	306	14	testing	test	VERB
gsrj-29	306	15	times	time	NOUN
gsrj-29	306	16	in	in	ADP
gsrj-29	306	17	coronavirus	coronavirus	NOUN
gsrj-29	306	18	disease	disease	NOUN
gsrj-29	306	19	(	(	PUNCT
gsrj-29	306	20	covid-19	covid-19	PROPN
gsrj-29	306	21	):	):	PUNCT
gsrj-29	306	22	a	a	DET
gsrj-29	306	23	tale	tale	NOUN
gsrj-29	306	24	of	of	ADP
gsrj-29	306	25	two	two	NUM
gsrj-29	306	26	nations	nation	NOUN
gsrj-29	306	27	.	.	PUNCT
gsrj-29	307	1	med	med	PROPN
gsrj-29	307	2	j	j	PROPN
gsrj-29	307	3	armed	armed	PROPN
gsrj-29	307	4	forces	forces	PROPN
gsrj-29	307	5	india	india	PROPN
gsrj-29	307	6	.	.	PUNCT
gsrj-29	307	7	2020	2020	NUM
gsrj-29	307	8	;	;	PUNCT
gsrj-29	307	9	76	76	NUM
gsrj-29	307	10	(	(	PUNCT
gsrj-29	307	11	3	3	NUM
gsrj-29	307	12	)	)	PUNCT
gsrj-29	307	13	,	,	PUNCT
gsrj-29	307	14	243–249	243–249	NUM
gsrj-29	307	15	.	.	PUNCT
gsrj-29	308	1	doi	doi	NOUN
gsrj-29	308	2	:	:	PUNCT
gsrj-29	308	3	10.1016	10.1016	NUM
gsrj-29	308	4	/	/	SYM
gsrj-29	308	5	j.mjafi.2020.05.014	j.mjafi.2020.05.014	PROPN
gsrj-29	308	6	31	31	NUM
gsrj-29	308	7	.	.	PUNCT
gsrj-29	309	1	du	du	PROPN
gsrj-29	309	2	,	,	PUNCT
gsrj-29	309	3	z.	z.	PROPN
gsrj-29	309	4	,	,	PUNCT
gsrj-29	309	5	phd	phd	PROPN
gsrj-29	309	6	,	,	PUNCT
gsrj-29	309	7	pandey	pandey	PROPN
gsrj-29	309	8	,	,	PUNCT
gsrj-29	309	9	a.	a.	PROPN
gsrj-29	309	10	,	,	PUNCT
gsrj-29	309	11	phd	phd	NOUN
gsrj-29	309	12	,	,	PUNCT
gsrj-29	309	13	bai	bai	PROPN
gsrj-29	309	14	,	,	PUNCT
gsrj-29	309	15	y.	y.	PROPN
gsrj-29	309	16	,	,	PUNCT
gsrj-29	309	17	phd	phd	PROPN
gsrj-29	309	18	,	,	PUNCT
gsrj-29	309	19	fitzpatrick	fitzpatrick	PROPN
gsrj-29	309	20	,	,	PUNCT
gsrj-29	309	21	m.	m.	NOUN
gsrj-29	309	22	,	,	PUNCT
gsrj-29	309	23	phd	phd	NOUN
gsrj-29	309	24	,	,	PUNCT
gsrj-29	309	25	chinazzi	chinazzi	ADJ
gsrj-29	309	26	,	,	PUNCT
gsrj-29	309	27	m.	m.	NOUN
gsrj-29	309	28	,	,	PUNCT
gsrj-29	309	29	phd	phd	NOUN
gsrj-29	309	30	,	,	PUNCT
gsrj-29	309	31	pastore	pastore	PROPN
gsrj-29	309	32	y	y	PROPN
gsrj-29	309	33	piontti	piontti	PROPN
gsrj-29	309	34	,	,	PUNCT
gsrj-29	309	35	a.	a.	PROPN
gsrj-29	309	36	,	,	PUNCT
gsrj-29	309	37	phd	phd	NOUN
gsrj-29	309	38	,	,	PUNCT
gsrj-29	309	39	et	et	PROPN
gsrj-29	309	40	al	al	PROPN
gsrj-29	309	41	.	.	PROPN
gsrj-29	309	42	comparative	comparative	ADJ
gsrj-29	309	43	costeffectiveness	costeffectiveness	NOUN
gsrj-29	309	44	of	of	ADP
gsrj-29	309	45	sars	sar	NOUN
gsrj-29	309	46	-	-	PUNCT
gsrj-29	309	47	cov-2	cov-2	NOUN
gsrj-29	309	48	testing	testing	NOUN
gsrj-29	309	49	strategies	strategy	NOUN
gsrj-29	309	50	in	in	ADP
gsrj-29	309	51	the	the	DET
gsrj-29	309	52	usa	usa	NOUN
gsrj-29	309	53	:	:	PUNCT
gsrj-29	309	54	a	a	DET
gsrj-29	309	55	modelling	model	VERB
gsrj-29	309	56	study	study	NOUN
gsrj-29	309	57	.	.	PUNCT
gsrj-29	310	1	the	the	DET
gsrj-29	310	2	lancet	lancet	PROPN
gsrj-29	310	3	.	.	PUNCT
gsrj-29	311	1	2021	2021	NUM
gsrj-29	311	2	;	;	PUNCT
gsrj-29	311	3	6	6	NUM
gsrj-29	311	4	(	(	PUNCT
gsrj-29	311	5	3	3	NUM
gsrj-29	311	6	)	)	PUNCT
gsrj-29	311	7	184	184	NUM
gsrj-29	311	8	-	-	SYM
gsrj-29	311	9	191	191	NUM
gsrj-29	311	10	.	.	PUNCT
gsrj-29	312	1	doi	doi	NOUN
gsrj-29	312	2	:	:	PUNCT
gsrj-29	312	3	https://doi.org/10.1016/s24682667(21)00002-5	https://doi.org/10.1016/s24682667(21)00002-5	NOUN
gsrj-29	312	4	32	32	NUM
gsrj-29	312	5	.	.	PUNCT
gsrj-29	313	1	chen	chen	PROPN
gsrj-29	313	2	z	z	PROPN
gsrj-29	313	3	,	,	PUNCT
gsrj-29	313	4	li	li	PROPN
gsrj-29	313	5	y	y	PROPN
gsrj-29	313	6	,	,	PUNCT
gsrj-29	313	7	wu	wu	PROPN
gsrj-29	313	8	b	b	PROPN
gsrj-29	313	9	,	,	PUNCT
gsrj-29	313	10	hou	hou	PROPN
gsrj-29	313	11	y	y	PROPN
gsrj-29	313	12	,	,	PUNCT
gsrj-29	313	13	bao	bao	PROPN
gsrj-29	313	14	j	j	PROPN
gsrj-29	313	15	,	,	PUNCT
gsrj-29	313	16	deng	deng	PROPN
gsrj-29	313	17	x.	x.	PROPN
gsrj-29	313	18	a	a	DET
gsrj-29	313	19	patient	patient	NOUN
gsrj-29	313	20	with	with	ADP
gsrj-29	313	21	covid-19	covid-19	PROPN
gsrj-29	313	22	presenting	present	VERB
gsrj-29	313	23	a	a	DET
gsrj-29	313	24	falsenegative	falsenegative	ADJ
gsrj-29	313	25	reverse	reverse	NOUN
gsrj-29	313	26	transcriptase	transcriptase	NOUN
gsrj-29	313	27	polymerase	polymerase	NOUN
gsrj-29	313	28	chain	chain	NOUN
gsrj-29	313	29	reaction	reaction	NOUN
gsrj-29	313	30	result	result	NOUN
gsrj-29	313	31	.	.	PUNCT
gsrj-29	314	1	korean	korean	PROPN
gsrj-29	314	2	j	j	PROPN
gsrj-29	314	3	radiol	radiol	PROPN
gsrj-29	314	4	.	.	PUNCT
gsrj-29	315	1	2020	2020	NUM
gsrj-29	315	2	;	;	PUNCT
gsrj-29	315	3	21	21	NUM
gsrj-29	315	4	(	(	PUNCT
gsrj-29	315	5	5	5	NUM
gsrj-29	315	6	)	)	PUNCT
gsrj-29	315	7	,	,	PUNCT
gsrj-29	315	8	623	623	NUM
gsrj-29	315	9	-	-	SYM
gsrj-29	315	10	624	624	NUM
gsrj-29	315	11	.	.	PUNCT
gsrj-29	316	1	doi	doi	NOUN
gsrj-29	316	2	:	:	PUNCT
gsrj-29	316	3	https://doi.org/10.3348/kjr.2020.0195	https://doi.org/10.3348/kjr.2020.0195	PROPN
gsrj-29	316	4	33	33	NUM
gsrj-29	316	5	.	.	PUNCT
gsrj-29	317	1	kucirka	kucirka	PROPN
gsrj-29	317	2	,	,	PUNCT
gsrj-29	317	3	l.	l.	PROPN
gsrj-29	317	4	,	,	PUNCT
gsrj-29	317	5	md	md	PROPN
gsrj-29	317	6	,	,	PUNCT
gsrj-29	317	7	phd	phd	NOUN
gsrj-29	317	8	,	,	PUNCT
gsrj-29	317	9	lauer	lauer	PROPN
gsrj-29	317	10	,	,	PUNCT
gsrj-29	317	11	s.	s.	PROPN
gsrj-29	317	12	,	,	PUNCT
gsrj-29	317	13	phd	phd	NOUN
gsrj-29	317	14	*	*	PROPN
gsrj-29	317	15	,	,	PUNCT
gsrj-29	317	16	laeyendecker	laeyendecker	PROPN
gsrj-29	317	17	,	,	PUNCT
gsrj-29	317	18	o.	o.	PROPN
gsrj-29	317	19	,	,	PUNCT
gsrj-29	317	20	phd	phd	NOUN
gsrj-29	317	21	,	,	PUNCT
gsrj-29	317	22	mba	mba	NOUN
gsrj-29	317	23	,	,	PUNCT
gsrj-29	317	24	boon	boon	NOUN
gsrj-29	317	25	,	,	PUNCT
gsrj-29	317	26	d.	d.	PROPN
gsrj-29	317	27	,	,	PUNCT
gsrj-29	317	28	phd	phd	NOUN
gsrj-29	317	29	,	,	PUNCT
gsrj-29	317	30	lessler	lessler	PROPN
gsrj-29	317	31	,	,	PUNCT
gsrj-29	317	32	j.	j.	PROPN
gsrj-29	317	33	,	,	PUNCT
gsrj-29	317	34	phd	phd	PROPN
gsrj-29	317	35	.	.	PROPN
gsrj-29	317	36	variation	variation	NOUN
gsrj-29	317	37	in	in	ADP
gsrj-29	317	38	false	false	ADJ
gsrj-29	317	39	-	-	PUNCT
gsrj-29	317	40	negative	negative	ADJ
gsrj-29	317	41	rate	rate	NOUN
gsrj-29	317	42	of	of	ADP
gsrj-29	317	43	reverse	reverse	ADJ
gsrj-29	317	44	transcriptase	transcriptase	NOUN
gsrj-29	317	45	polymerase	polymerase	NOUN
gsrj-29	317	46	chain	chain	NOUN
gsrj-29	317	47	reaction	reaction	NOUN
gsrj-29	317	48	–	–	PUNCT
gsrj-29	317	49	based	base	VERB
gsrj-29	317	50	sars	sar	NOUN
gsrj-29	317	51	-	-	PUNCT
gsrj-29	317	52	cov-2	cov-2	NOUN
gsrj-29	317	53	tests	test	NOUN
gsrj-29	317	54	by	by	ADP
gsrj-29	317	55	time	time	NOUN
gsrj-29	317	56	since	since	SCONJ
gsrj-29	317	57	exposure	exposure	NOUN
gsrj-29	317	58	.	.	PUNCT
gsrj-29	318	1	annals	annal	NOUN
gsrj-29	318	2	of	of	ADP
gsrj-29	318	3	internal	internal	ADJ
gsrj-29	318	4	medicine	medicine	NOUN
gsrj-29	318	5	.	.	PUNCT
gsrj-29	319	1	2020	2020	NUM
gsrj-29	319	2	;	;	PUNCT
gsrj-29	319	3	173	173	NUM
gsrj-29	319	4	,	,	PUNCT
gsrj-29	319	5	262	262	NUM
gsrj-29	319	6	-	-	SYM
gsrj-29	319	7	267	267	NUM
gsrj-29	319	8	.	.	PUNCT
gsrj-29	320	1	doi	doi	NOUN
gsrj-29	320	2	:	:	PUNCT
gsrj-29	320	3	https://doi.org/10.7326/m20-1495	https://doi.org/10.7326/m20-1495	PROPN
gsrj-29	320	4	34	34	NUM
gsrj-29	320	5	.	.	PUNCT
gsrj-29	321	1	hernández	hernández	PROPN
gsrj-29	321	2	-	-	PUNCT
gsrj-29	321	3	péreza	péreza	PROPN
gsrj-29	321	4	,	,	PUNCT
gsrj-29	321	5	j	j	PROPN
gsrj-29	321	6	-	-	PUNCT
gsrj-29	321	7	m.	m.	NOUN
gsrj-29	321	8	,	,	PUNCT
gsrj-29	321	9	martín	martín	NOUN
gsrj-29	321	10	-	-	PUNCT
gsrj-29	321	11	gonzálezb	gonzálezb	NOUN
gsrj-29	321	12	,	,	PUNCT
gsrj-29	321	13	e.	e.	PROPN
gsrj-29	321	14	,	,	PUNCT
gsrj-29	321	15	pino	pino	NOUN
gsrj-29	321	16	-	-	PUNCT
gsrj-29	321	17	yanesb	yanesb	NOUN
gsrj-29	321	18	,	,	PUNCT
gsrj-29	321	19	m	m	PROPN
gsrj-29	321	20	..	..	PUNCT
gsrj-29	321	21	strengths	strength	NOUN
gsrj-29	321	22	and	and	CCONJ
gsrj-29	321	23	weaknesses	weakness	NOUN
gsrj-29	321	24	of	of	ADP
gsrj-29	321	25	the	the	DET
gsrj-29	321	26	diagnostic	diagnostic	ADJ
gsrj-29	321	27	tests	test	NOUN
gsrj-29	321	28	for	for	ADP
gsrj-29	321	29	sars	sar	NOUN
gsrj-29	321	30	-	-	PUNCT
gsrj-29	321	31	cov-2	cov-2	PART
gsrj-29	321	32	infection	infection	NOUN
gsrj-29	321	33	.	.	PUNCT
gsrj-29	322	1	medicina	medicina	PROPN
gsrj-29	322	2	clínica	clínica	PROPN
gsrj-29	322	3	(	(	PUNCT
gsrj-29	322	4	english	english	PROPN
gsrj-29	322	5	edition	edition	PROPN
gsrj-29	322	6	)	)	PUNCT
gsrj-29	322	7	.	.	PUNCT
gsrj-29	323	1	2020	2020	NUM
gsrj-29	323	2	;	;	PUNCT
gsrj-29	323	3	155	155	NUM
gsrj-29	323	4	(	(	PUNCT
gsrj-29	323	5	10	10	NUM
gsrj-29	323	6	):	):	PUNCT
gsrj-29	323	7	464	464	NUM
gsrj-29	323	8	-	-	SYM
gsrj-29	323	9	465	465	NUM
gsrj-29	323	10	.	.	PUNCT
gsrj-29	324	1	doi	doi	NOUN
gsrj-29	324	2	:	:	PUNCT
gsrj-29	324	3	10.1016	10.1016	NUM
gsrj-29	324	4	/	/	SYM
gsrj-29	324	5	j.medcle.2020.05.025	j.medcle.2020.05.025	PRON
gsrj-29	324	6	35	35	NUM
gsrj-29	324	7	.	.	PUNCT
gsrj-29	325	1	hernández	hernández	PROPN
gsrj-29	325	2	-	-	PUNCT
gsrj-29	325	3	pérez	pérez	NOUN
gsrj-29	325	4	,	,	PUNCT
gsrj-29	325	5	j.	j.	PROPN
gsrj-29	325	6	m.	m.	PROPN
gsrj-29	325	7	,	,	PUNCT
gsrj-29	325	8	martín	martín	NOUN
gsrj-29	325	9	-	-	PUNCT
gsrj-29	325	10	gonzález	gonzález	PROPN
gsrj-29	325	11	,	,	PUNCT
gsrj-29	325	12	e.	e.	PROPN
gsrj-29	325	13	,	,	PUNCT
gsrj-29	325	14	&	&	CCONJ
gsrj-29	325	15	pino	pino	NOUN
gsrj-29	325	16	-	-	PUNCT
gsrj-29	325	17	yanes	yane	NOUN
gsrj-29	325	18	,	,	PUNCT
gsrj-29	325	19	m.	m.	NOUN
gsrj-29	325	20	(	(	PUNCT
gsrj-29	325	21	2020	2020	NUM
gsrj-29	325	22	)	)	PUNCT
gsrj-29	325	23	.	.	PUNCT
gsrj-29	326	1	strengths	strength	NOUN
gsrj-29	326	2	and	and	CCONJ
gsrj-29	326	3	weaknesses	weakness	NOUN
gsrj-29	326	4	of	of	ADP
gsrj-29	326	5	the	the	DET
gsrj-29	326	6	diagnostic	diagnostic	ADJ
gsrj-29	326	7	tests	test	NOUN
gsrj-29	326	8	for	for	ADP
gsrj-29	326	9	sars	sar	NOUN
gsrj-29	326	10	-	-	PUNCT
gsrj-29	326	11	cov-2	cov-2	PART
gsrj-29	326	12	infection	infection	NOUN
gsrj-29	326	13	.	.	PUNCT
gsrj-29	327	1	medicina	medicina	PROPN
gsrj-29	327	2	clínica	clínica	PROPN
gsrj-29	327	3	(	(	PUNCT
gsrj-29	327	4	english	english	PROPN
gsrj-29	327	5	edition	edition	PROPN
gsrj-29	327	6	)	)	PUNCT
gsrj-29	327	7	,	,	PUNCT
gsrj-29	327	8	155(10	155(10	NUM
gsrj-29	327	9	)	)	PUNCT
gsrj-29	327	10	,	,	PUNCT
gsrj-29	327	11	464	464	NUM
gsrj-29	327	12	–	–	PUNCT
gsrj-29	327	13	465	465	NUM
gsrj-29	327	14	.	.	PUNCT
gsrj-29	328	1	https://doi.org/10.1016/j.medcle.2020.05.025	https://doi.org/10.1016/j.medcle.2020.05.025	NUM
gsrj-29	328	2	36	36	NUM
gsrj-29	328	3	.	.	PUNCT
gsrj-29	329	1	lambert	lambert	PROPN
gsrj-29	329	2	-	-	PUNCT
gsrj-29	329	3	niclot	niclot	PROPN
gsrj-29	329	4	,	,	PUNCT
gsrj-29	329	5	s.	s.	PROPN
gsrj-29	329	6	,	,	PUNCT
gsrj-29	329	7	cuffel	cuffel	ADJ
gsrj-29	329	8	,	,	PUNCT
gsrj-29	329	9	a.	a.	NOUN
gsrj-29	329	10	,	,	PUNCT
gsrj-29	329	11	pape	pape	NOUN
gsrj-29	329	12	,	,	PUNCT
gsrj-29	329	13	s.	s.	PROPN
gsrj-29	329	14	l.	l.	PROPN
gsrj-29	329	15	,	,	PUNCT
gsrj-29	329	16	vauloup	vauloup	NOUN
gsrj-29	329	17	-	-	PUNCT
gsrj-29	329	18	fellous	fellous	ADJ
gsrj-29	329	19	,	,	PUNCT
gsrj-29	329	20	c.	c.	NOUN
gsrj-29	329	21	,	,	PUNCT
gsrj-29	329	22	morand	morand	NOUN
gsrj-29	329	23	-	-	PUNCT
gsrj-29	329	24	joubert	joubert	PROPN
gsrj-29	329	25	,	,	PUNCT
gsrj-29	329	26	l.	l.	PROPN
gsrj-29	329	27	,	,	PUNCT
gsrj-29	329	28	roqueafonso	roqueafonso	PROPN
gsrj-29	329	29	,	,	PUNCT
gsrj-29	329	30	a.-m	a.-m	ADV
gsrj-29	329	31	.	.	PUNCT
gsrj-29	329	32	,	,	PUNCT
gsrj-29	329	33	goff	goff	PROPN
gsrj-29	329	34	,	,	PUNCT
gsrj-29	329	35	j.	j.	PROPN
gsrj-29	329	36	l.	l.	PROPN
gsrj-29	329	37	,	,	PUNCT
gsrj-29	329	38	&	&	CCONJ
gsrj-29	329	39	delaugerre	delaugerre	PROPN
gsrj-29	329	40	,	,	PUNCT
gsrj-29	329	41	c.	c.	PROPN
gsrj-29	329	42	(	(	PUNCT
gsrj-29	329	43	2020	2020	NUM
gsrj-29	329	44	)	)	PUNCT
gsrj-29	329	45	.	.	PUNCT
gsrj-29	330	1	evaluation	evaluation	NOUN
gsrj-29	330	2	of	of	ADP
gsrj-29	330	3	a	a	DET
gsrj-29	330	4	rapid	rapid	ADJ
gsrj-29	330	5	diagnostic	diagnostic	ADJ
gsrj-29	330	6	assay	assay	NOUN
gsrj-29	330	7	for	for	ADP
gsrj-29	330	8	detection	detection	NOUN
gsrj-29	330	9	of	of	ADP
gsrj-29	330	10	sars	sar	NOUN
gsrj-29	330	11	-	-	PUNCT
gsrj-29	330	12	cov-2	cov-2	NOUN
gsrj-29	330	13	antigen	antigen	NOUN
gsrj-29	330	14	in	in	ADP
gsrj-29	330	15	nasopharyngeal	nasopharyngeal	ADJ
gsrj-29	330	16	swabs	swab	NOUN
gsrj-29	330	17	.	.	PUNCT
gsrj-29	331	1	journal	journal	NOUN
gsrj-29	331	2	of	of	ADP
gsrj-29	331	3	clinical	clinical	ADJ
gsrj-29	331	4	microbiology	microbiology	NOUN
gsrj-29	331	5	.	.	PUNCT
gsrj-29	332	1	https://doi.org/10.1128/jcm.0097720	https://doi.org/10.1128/jcm.0097720	PROPN
gsrj-29	332	2	37	37	NUM
gsrj-29	332	3	.	.	PUNCT
gsrj-29	333	1	barra	barra	PROPN
gsrj-29	333	2	gb	gb	PROPN
gsrj-29	333	3	,	,	PUNCT
gsrj-29	333	4	santa	santa	PROPN
gsrj-29	333	5	rita	rita	PROPN
gsrj-29	333	6	th	th	PROPN
gsrj-29	333	7	,	,	PUNCT
gsrj-29	333	8	mesquita	mesquita	PROPN
gsrj-29	333	9	pg	pg	PROPN
gsrj-29	333	10	,	,	PUNCT
gsrj-29	333	11	jácomo	jácomo	PROPN
gsrj-29	333	12	rh	rh	PROPN
gsrj-29	333	13	,	,	PUNCT
gsrj-29	333	14	nery	nery	PROPN
gsrj-29	333	15	lfa	lfa	PROPN
gsrj-29	333	16	.	.	PUNCT
gsrj-29	334	1	overcoming	overcome	VERB
gsrj-29	334	2	supply	supply	NOUN
gsrj-29	334	3	shortage	shortage	NOUN
gsrj-29	334	4	for	for	ADP
gsrj-29	334	5	sars	sar	NOUN
gsrj-29	334	6	-	-	PUNCT
gsrj-29	334	7	cov-2	cov-2	PART
gsrj-29	334	8	detection	detection	NOUN
gsrj-29	334	9	by	by	ADP
gsrj-29	334	10	rt	rt	NOUN
gsrj-29	334	11	-	-	PUNCT
gsrj-29	334	12	qpcr	qpcr	ADJ
gsrj-29	334	13	.	.	PUNCT
gsrj-29	335	1	genes	gene	NOUN
gsrj-29	335	2	(	(	PUNCT
gsrj-29	335	3	basel	basel	PROPN
gsrj-29	335	4	)	)	PUNCT
gsrj-29	335	5	.	.	PUNCT
gsrj-29	336	1	2021;12	2021;12	NUM
gsrj-29	336	2	(	(	PUNCT
gsrj-29	336	3	1	1	NUM
gsrj-29	336	4	):	):	PUNCT
gsrj-29	336	5	90	90	NUM
gsrj-29	337	1	.	.	PUNCT
gsrj-29	337	2	doi	doi	NOUN
gsrj-29	337	3	:	:	PUNCT
gsrj-29	337	4	10.3390	10.3390	NUM
gsrj-29	337	5	/	/	SYM
gsrj-29	337	6	genes12010090	genes12010090	PROPN
gsrj-29	337	7	38	38	NUM
gsrj-29	337	8	.	.	PUNCT
gsrj-29	338	1	caliendo	caliendo	PROPN
gsrj-29	338	2	,	,	PUNCT
gsrj-29	338	3	a.	a.	PROPN
gsrj-29	338	4	,	,	PUNCT
gsrj-29	338	5	gilbert	gilbert	PROPN
gsrj-29	338	6	,	,	PUNCT
gsrj-29	338	7	d.	d.	PROPN
gsrj-29	338	8	,	,	PUNCT
gsrj-29	338	9	ginocchio	ginocchio	PROPN
gsrj-29	338	10	,	,	PUNCT
gsrj-29	338	11	c.	c.	PROPN
gsrj-29	338	12	,	,	PUNCT
gsrj-29	338	13	hanson	hanson	PROPN
gsrj-29	338	14	,	,	PUNCT
gsrj-29	338	15	k.	k.	PROPN
gsrj-29	338	16	,	,	PUNCT
gsrj-29	338	17	may	may	AUX
gsrj-29	338	18	,	,	PUNCT
gsrj-29	338	19	l.	l.	PROPN
gsrj-29	338	20	,	,	PUNCT
gsrj-29	338	21	quinn	quinn	PROPN
gsrj-29	338	22	,	,	PUNCT
gsrj-29	338	23	t.	t.	PROPN
gsrj-29	338	24	,	,	PUNCT
gsrj-29	338	25	tenover	tenover	PROPN
gsrj-29	338	26	,	,	PUNCT
gsrj-29	338	27	f.	f.	PROPN
gsrj-29	338	28	,	,	PUNCT
gsrj-29	338	29	alland	alland	PROPN
gsrj-29	338	30	,	,	PUNCT
gsrj-29	338	31	d.	d.	PROPN
gsrj-29	338	32	,	,	PUNCT
gsrj-29	338	33	blaschke	blaschke	PROPN
gsrj-29	338	34	,	,	PUNCT
gsrj-29	338	35	a.	a.	NOUN
gsrj-29	338	36	,	,	PUNCT
gsrj-29	338	37	bonomo	bonomo	NOUN
gsrj-29	338	38	,	,	PUNCT
gsrj-29	338	39	r.	r.	PROPN
gsrj-29	338	40	,	,	PUNCT
gsrj-29	338	41	carroll	carroll	PROPN
gsrj-29	338	42	,	,	PUNCT
gsrj-29	338	43	k.	k.	PROPN
gsrj-29	338	44	,	,	PUNCT
gsrj-29	338	45	ferraro	ferraro	PROPN
gsrj-29	338	46	,	,	PUNCT
gsrj-29	338	47	m	m	PROPN
gsrj-29	338	48	-	-	PUNCT
gsrj-29	338	49	j.	j.	PROPN
gsrj-29	338	50	,	,	PUNCT
gsrj-29	338	51	hirschhorn	hirschhorn	ADJ
gsrj-29	338	52	,	,	PUNCT
gsrj-29	338	53	l.	l.	PROPN
gsrj-29	338	54	,	,	PUNCT
gsrj-29	338	55	joseph	joseph	PROPN
gsrj-29	338	56	,	,	PUNCT
gsrj-29	338	57	w.p	w.p	PROPN
gsrj-29	338	58	.	.	PROPN
gsrj-29	338	59	,	,	PUNCT
gsrj-29	338	60	karchmer	karchmer	PROPN
gsrj-29	338	61	,	,	PUNCT
gsrj-29	338	62	t.	t.	PROPN
gsrj-29	338	63	,	,	PUNCT
gsrj-29	338	64	macintyre	macintyre	PROPN
gsrj-29	338	65	,	,	PUNCT
gsrj-29	338	66	a.	a.	NOUN
gsrj-29	338	67	,	,	PUNCT
gsrj-29	338	68	reller	reller	NOUN
gsrj-29	338	69	,	,	PUNCT
gsrj-29	338	70	l.	l.	PROPN
gsrj-29	338	71	,	,	PUNCT
gsrj-29	338	72	jackson	jackson	PROPN
gsrj-29	338	73	,	,	PUNCT
gsrj-29	338	74	a.	a.	PROPN
gsrj-29	338	75	,	,	PUNCT
gsrj-29	338	76	clinical	clinical	ADJ
gsrj-29	338	77	infectious	infectious	ADJ
gsrj-29	338	78	diseases	disease	NOUN
gsrj-29	338	79	.	.	PUNCT
gsrj-29	339	1	2013	2013	NUM
gsrj-29	339	2	;	;	PUNCT
gsrj-29	339	3	57	57	NUM
gsrj-29	339	4	(	(	PUNCT
gsrj-29	339	5	3	3	NUM
gsrj-29	339	6	):	):	PUNCT
gsrj-29	339	7	139–170	139–170	NUM
gsrj-29	339	8	.	.	PUNCT
gsrj-29	340	1	doi	doi	NOUN
gsrj-29	340	2	:	:	PUNCT
gsrj-29	340	3	https://doi.org/10.1093/cid/cit578	https://doi.org/10.1093/cid/cit578	PROPN
gsrj-29	340	4	39	39	NUM
gsrj-29	340	5	.	.	PUNCT
gsrj-29	341	1	kelly	kelly	PROPN
gsrj-29	341	2	-	-	PUNCT
gsrj-29	341	3	cirino	cirino	PROPN
gsrj-29	341	4	cd	cd	PROPN
gsrj-29	341	5	,	,	PUNCT
gsrj-29	341	6	nkengasong	nkengasong	PROPN
gsrj-29	341	7	j	j	PROPN
gsrj-29	341	8	,	,	PUNCT
gsrj-29	341	9	kettler	kettler	PROPN
gsrj-29	341	10	h	h	PROPN
gsrj-29	341	11	,	,	PUNCT
gsrj-29	341	12	et	et	PROPN
gsrj-29	341	13	al	al	PROPN
gsrj-29	341	14	.	.	PUNCT
gsrj-29	341	15	importance	importance	NOUN
gsrj-29	341	16	of	of	ADP
gsrj-29	341	17	diagnostics	diagnostic	NOUN
gsrj-29	341	18	in	in	ADP
gsrj-29	341	19	epidemic	epidemic	NOUN
gsrj-29	341	20	and	and	CCONJ
gsrj-29	341	21	pandemic	pandemic	ADJ
gsrj-29	341	22	preparedness	preparedness	NOUN
gsrj-29	341	23	.	.	PUNCT
gsrj-29	342	1	bmj	bmj	PROPN
gsrj-29	342	2	global	global	ADJ
gsrj-29	342	3	health	health	NOUN
gsrj-29	342	4	.	.	PUNCT
gsrj-29	343	1	2019	2019	NUM
gsrj-29	343	2	;	;	PUNCT
gsrj-29	343	3	4	4	X
gsrj-29	343	4	.	.	X
gsrj-29	343	5	doi	doi	NOUN
gsrj-29	343	6	:	:	PUNCT
gsrj-29	343	7	http://dx.doi.org/10.1136/bmjgh-2018001179	http://dx.doi.org/10.1136/bmjgh-2018001179	NOUN
gsrj-29	343	8	.	.	PUNCT
gsrj-29	344	1	40	40	NUM
gsrj-29	344	2	.	.	PUNCT
gsrj-29	345	1	engel	engel	PROPN
gsrj-29	345	2	n	n	PROPN
gsrj-29	345	3	,	,	PUNCT
gsrj-29	345	4	wachter	wachter	NOUN
gsrj-29	345	5	k	k	PROPN
gsrj-29	345	6	,	,	PUNCT
gsrj-29	345	7	pai	pai	PROPN
gsrj-29	345	8	m	m	PROPN
gsrj-29	345	9	,	,	PUNCT
gsrj-29	345	10	et	et	PROPN
gsrj-29	345	11	al	al	PROPN
gsrj-29	345	12	.	.	PUNCT
gsrj-29	346	1	addressing	address	VERB
gsrj-29	346	2	the	the	DET
gsrj-29	346	3	challenges	challenge	NOUN
gsrj-29	346	4	of	of	ADP
gsrj-29	346	5	diagnostics	diagnostic	NOUN
gsrj-29	346	6	demand	demand	NOUN
gsrj-29	346	7	and	and	CCONJ
gsrj-29	346	8	supply	supply	NOUN
gsrj-29	346	9	:	:	PUNCT
gsrj-29	346	10	insights	insight	NOUN
gsrj-29	346	11	from	from	ADP
gsrj-29	346	12	an	an	DET
gsrj-29	346	13	online	online	ADJ
gsrj-29	346	14	global	global	ADJ
gsrj-29	346	15	health	health	NOUN
gsrj-29	346	16	discussion	discussion	NOUN
gsrj-29	346	17	platform	platform	NOUN
gsrj-29	346	18	.	.	PUNCT
gsrj-29	347	1	bmj	bmj	PROPN
gsrj-29	347	2	global	global	ADJ
gsrj-29	347	3	health	health	NOUN
gsrj-29	347	4	.	.	PUNCT
gsrj-29	348	1	2016	2016	NUM
gsrj-29	348	2	;	;	PUNCT
gsrj-29	348	3	1	1	X
gsrj-29	348	4	.	.	X
gsrj-29	348	5	doi	doi	NOUN
gsrj-29	348	6	:	:	PUNCT
gsrj-29	348	7	http://dx.doi.org/10.1136/bmjgh-2016-000132	http://dx.doi.org/10.1136/bmjgh-2016-000132	NOUN
gsrj-29	348	8	41	41	NUM
gsrj-29	348	9	.	.	PUNCT
gsrj-29	349	1	j.	j.	PROPN
gsrj-29	349	2	s.	s.	PROPN
gsrj-29	349	3	gootenberg	gootenberg	PROPN
gsrj-29	349	4	,	,	PUNCT
gsrj-29	349	5	o.	o.	PROPN
gsrj-29	349	6	o.	o.	PROPN
gsrj-29	349	7	abudayyeh	abudayyeh	PROPN
gsrj-29	349	8	,	,	PUNCT
gsrj-29	349	9	j.	j.	PROPN
gsrj-29	349	10	w.	w.	PROPN
gsrj-29	349	11	lee	lee	PROPN
gsrj-29	349	12	,	,	PUNCT
gsrj-29	349	13	p.	p.	PROPN
gsrj-29	349	14	essletzbichler	essletzbichler	NOUN
gsrj-29	349	15	,	,	PUNCT
gsrj-29	349	16	a.	a.	PROPN
gsrj-29	349	17	j.	j.	PROPN
gsrj-29	349	18	dy	dy	PROPN
gsrj-29	349	19	,	,	PUNCT
gsrj-29	349	20	j.	j.	PROPN
gsrj-29	349	21	joung	joung	PROPN
gsrj-29	349	22	,	,	PUNCT
gsrj-29	349	23	v.	v.	PROPN
gsrj-29	349	24	verdine	verdine	NOUN
gsrj-29	349	25	,	,	PUNCT
gsrj-29	349	26	n.	n.	NOUN
gsrj-29	349	27	donghia	donghia	PROPN
gsrj-29	349	28	,	,	PUNCT
gsrj-29	349	29	n.	n.	PROPN
gsrj-29	349	30	m.	m.	NOUN
gsrj-29	349	31	daringer	daringer	PROPN
gsrj-29	349	32	,	,	PUNCT
gsrj-29	349	33	c.	c.	PROPN
gsrj-29	349	34	a.	a.	NOUN
gsrj-29	349	35	freije	freije	PROPN
gsrj-29	349	36	,	,	PUNCT
gsrj-29	349	37	c.	c.	PROPN
gsrj-29	349	38	myhrvold	myhrvold	PROPN
gsrj-29	349	39	,	,	PUNCT
gsrj-29	349	40	r.	r.	PROPN
gsrj-29	349	41	p.	p.	PROPN
gsrj-29	349	42	bhattacharyya	bhattacharyya	PROPN
gsrj-29	349	43	,	,	PUNCT
gsrj-29	349	44	j.	j.	PROPN
gsrj-29	349	45	livny	livny	PROPN
gsrj-29	349	46	,	,	PUNCT
gsrj-29	349	47	a.	a.	NOUN
gsrj-29	349	48	regev	regev	PROPN
gsrj-29	349	49	,	,	PUNCT
gsrj-29	349	50	e.	e.	PROPN
gsrj-29	349	51	v.	v.	PROPN
gsrj-29	349	52	koonin	koonin	PROPN
gsrj-29	349	53	,	,	PUNCT
gsrj-29	349	54	d.	d.	PROPN
gsrj-29	349	55	t.	t.	PROPN
gsrj-29	349	56	hung	hung	PROPN
gsrj-29	349	57	,	,	PUNCT
gsrj-29	349	58	p.	p.	PROPN
gsrj-29	349	59	c.	c.	PROPN
gsrj-29	349	60	sabeti	sabeti	PROPN
gsrj-29	349	61	,	,	PUNCT
gsrj-29	349	62	j.	j.	PROPN
gsrj-29	349	63	j.	j.	PROPN
gsrj-29	349	64	collins	collins	PROPN
gsrj-29	349	65	,	,	PUNCT
gsrj-29	349	66	f.	f.	PROPN
gsrj-29	349	67	zhang	zhang	PROPN
gsrj-29	349	68	,	,	PUNCT
gsrj-29	349	69	nucleic	nucleic	ADJ
gsrj-29	349	70	acid	acid	NOUN
gsrj-29	349	71	detection	detection	NOUN
gsrj-29	349	72	with	with	ADP
gsrj-29	349	73	crispr	crispr	NOUN
gsrj-29	349	74	-	-	PUNCT
gsrj-29	349	75	cas13a	cas13a	NOUN
gsrj-29	349	76	/	/	SYM
gsrj-29	349	77	c2c2	c2c2	NOUN
gsrj-29	349	78	.	.	PUNCT
gsrj-29	349	79	science	science	NOUN
gsrj-29	349	80	.	.	PUNCT
gsrj-29	350	1	2017	2017	NUM
gsrj-29	350	2	;	;	PUNCT
gsrj-29	350	3	356	356	NUM
gsrj-29	350	4	,	,	PUNCT
gsrj-29	350	5	(	(	PUNCT
gsrj-29	350	6	3663	3663	NUM
gsrj-29	350	7	):	):	PUNCT
gsrj-29	351	1	438–442	438–442	NUM
gsrj-29	351	2	.	.	PUNCT
gsrj-29	352	1	doi	doi	NOUN
gsrj-29	352	2	:	:	PUNCT
gsrj-29	352	3	10.1126	10.1126	NUM
gsrj-29	352	4	/	/	SYM
gsrj-29	352	5	science.aam9321	science.aam9321	PROPN
gsrj-29	352	6	42	42	NUM
gsrj-29	352	7	.	.	PUNCT
gsrj-29	353	1	garcia	garcia	PROPN
gsrj-29	353	2	-	-	PUNCT
gsrj-29	353	3	venzor	venzor	PROPN
gsrj-29	353	4	a	a	PRON
gsrj-29	353	5	,	,	PUNCT
gsrj-29	353	6	rueda	rueda	X
gsrj-29	353	7	-	-	ADJ
gsrj-29	353	8	zarazua	zarazua	ADJ
gsrj-29	353	9	b	b	NOUN
gsrj-29	353	10	,	,	PUNCT
gsrj-29	353	11	marquezgarcia	marquezgarcia	PROPN
gsrj-29	353	12	e	e	NOUN
gsrj-29	353	13	,	,	PUNCT
gsrj-29	353	14	maldonado	maldonado	PROPN
gsrj-29	353	15	v	v	PROPN
gsrj-29	353	16	,	,	PUNCT
gsrj-29	353	17	moncada	moncada	NOUN
gsrj-29	353	18	-	-	PUNCT
gsrj-29	353	19	morales	morales	PROPN
gsrj-29	353	20	a	a	DET
gsrj-29	353	21	,	,	PUNCT
gsrj-29	353	22	olivera	olivera	PROPN
gsrj-29	353	23	h	h	NOUN
gsrj-29	353	24	,	,	PUNCT
gsrj-29	353	25	lopez	lopez	PROPN
gsrj-29	353	26	i	i	PROPN
gsrj-29	353	27	,	,	PUNCT
gsrj-29	353	28	zuñiga	zuñiga	PROPN
gsrj-29	353	29	j	j	PROPN
gsrj-29	353	30	and	and	CCONJ
gsrj-29	353	31	melendezzajgla	melendezzajgla	PROPN
gsrj-29	353	32	j.	j.	PROPN
gsrj-29	353	33	sars	sars	PROPN
gsrj-29	353	34	-	-	PUNCT
gsrj-29	353	35	cov-2	cov-2	NOUN
gsrj-29	353	36	direct	direct	ADJ
gsrj-29	353	37	detection	detection	NOUN
gsrj-29	353	38	without	without	ADP
gsrj-29	353	39	rna	rna	NOUN
gsrj-29	353	40	isolation	isolation	NOUN
gsrj-29	353	41	with	with	ADP
gsrj-29	353	42	loop	loop	NOUN
gsrj-29	353	43	-	-	PUNCT
gsrj-29	353	44	mediated	mediate	VERB
gsrj-29	353	45	isothermal	isothermal	ADJ
gsrj-29	353	46	amplification	amplification	NOUN
gsrj-29	353	47	(	(	PUNCT
gsrj-29	353	48	lamp	lamp	NOUN
gsrj-29	353	49	)	)	PUNCT
gsrj-29	353	50	and	and	CCONJ
gsrj-29	353	51	crispr	crispr	ADJ
gsrj-29	353	52	-	-	PUNCT
gsrj-29	353	53	cas12	cas12	NOUN
gsrj-29	353	54	.	.	PUNCT
gsrj-29	354	1	front	front	NOUN
gsrj-29	354	2	.	.	PUNCT
gsrj-29	355	1	med	med	PROPN
gsrj-29	355	2	.	.	PROPN
gsrj-29	355	3	2021	2021	NUM
gsrj-29	355	4	;	;	PUNCT
gsrj-29	356	1	8	8	NUM
gsrj-29	356	2	.	.	X
gsrj-29	356	3	doi	doi	NOUN
gsrj-29	356	4	:	:	PUNCT
gsrj-29	356	5	10.3389	10.3389	NUM
gsrj-29	356	6	/	/	SYM
gsrj-29	356	7	fmed.2021.627679	fmed.2021.627679	PROPN
gsrj-29	356	8	43	43	NUM
gsrj-29	356	9	.	.	PUNCT
gsrj-29	357	1	gootenberg	gootenberg	PROPN
gsrj-29	357	2	,	,	PUNCT
gsrj-29	357	3	j.	j.	PROPN
gsrj-29	357	4	,	,	PUNCT
gsrj-29	357	5	abudayyeh	abudayyeh	PROPN
gsrj-29	357	6	,	,	PUNCT
gsrj-29	357	7	o.	o.	PROPN
gsrj-29	357	8	,	,	PUNCT
gsrj-29	357	9	kellner	kellner	PROPN
gsrj-29	357	10	,	,	PUNCT
gsrj-29	357	11	m.	m.	NOUN
gsrj-29	357	12	,	,	PUNCT
gsrj-29	357	13	joung	joung	PROPN
gsrj-29	357	14	,	,	PUNCT
gsrj-29	357	15	j.	j.	PROPN
gsrj-29	357	16	,	,	PUNCT
gsrj-29	357	17	collins	collins	PROPN
gsrj-29	357	18	,	,	PUNCT
gsrj-29	357	19	j.	j.	PROPN
gsrj-29	357	20	,	,	PUNCT
gsrj-29	357	21	zhang	zhang	PROPN
gsrj-29	357	22	,	,	PUNCT
gsrj-29	357	23	f	f	PROPN
gsrj-29	357	24	..	..	PUNCT
gsrj-29	357	25	multiplexed	multiplexed	ADJ
gsrj-29	357	26	and	and	CCONJ
gsrj-29	357	27	portable	portable	ADJ
gsrj-29	357	28	nucleic	nucleic	ADJ
gsrj-29	357	29	acid	acid	NOUN
gsrj-29	357	30	detection	detection	NOUN
gsrj-29	357	31	platform	platform	NOUN
gsrj-29	357	32	with	with	ADP
gsrj-29	357	33	cas13	cas13	PROPN
gsrj-29	357	34	,	,	PUNCT
gsrj-29	357	35	cas12a	cas12a	NOUN
gsrj-29	357	36	,	,	PUNCT
gsrj-29	357	37	and	and	CCONJ
gsrj-29	357	38	csm6	csm6	PROPN
gsrj-29	357	39	.	.	PUNCT
gsrj-29	358	1	science	science	NOUN
gsrj-29	358	2	.	.	PUNCT
gsrj-29	359	1	2018	2018	NUM
gsrj-29	359	2	;	;	PUNCT
gsrj-29	359	3	360	360	NUM
gsrj-29	359	4	(	(	PUNCT
gsrj-29	359	5	6387	6387	NUM
gsrj-29	359	6	):	):	PUNCT
gsrj-29	359	7	439	439	NUM
gsrj-29	359	8	-	-	SYM
gsrj-29	359	9	444	444	NUM
gsrj-29	359	10	.	.	PUNCT
gsrj-29	360	1	doi	doi	NOUN
gsrj-29	360	2	:	:	PUNCT
gsrj-29	360	3	10.1126	10.1126	NUM
gsrj-29	360	4	/	/	SYM
gsrj-29	360	5	science.aaq0179	science.aaq0179	NUM
gsrj-29	360	6	44	44	NUM
gsrj-29	360	7	.	.	PUNCT
gsrj-29	361	1	chen	chen	PROPN
gsrj-29	361	2	,	,	PUNCT
gsrj-29	361	3	j.	j.	PROPN
gsrj-29	361	4	,	,	PUNCT
gsrj-29	361	5	ma	ma	PROPN
gsrj-29	361	6	,	,	PUNCT
gsrj-29	361	7	e.	e.	PROPN
gsrj-29	361	8	,	,	PUNCT
gsrj-29	361	9	harrington	harrington	PROPN
gsrj-29	361	10	,	,	PUNCT
gsrj-29	361	11	l.	l.	PROPN
gsrj-29	361	12	,	,	PUNCT
gsrj-29	361	13	da	da	PROPN
gsrj-29	361	14	costa	costa	PROPN
gsrj-29	361	15	,	,	PUNCT
gsrj-29	361	16	m.	m.	NOUN
gsrj-29	361	17	,	,	PUNCT
gsrj-29	361	18	tian	tian	PROPN
gsrj-29	361	19	,	,	PUNCT
gsrj-29	361	20	x.	x.	NOUN
gsrj-29	361	21	,	,	PUNCT
gsrj-29	361	22	palefsky	palefsky	PROPN
gsrj-29	361	23	,	,	PUNCT
gsrj-29	361	24	j.	j.	PROPN
gsrj-29	361	25	,	,	PUNCT
gsrj-29	361	26	doudna	doudna	PROPN
gsrj-29	361	27	,	,	PUNCT
gsrj-29	361	28	j	j	PROPN
gsrj-29	361	29	..	..	PUNCT
gsrj-29	361	30	crisprcas12a	crisprcas12a	ADJ
gsrj-29	361	31	target	target	NOUN
gsrj-29	361	32	binding	bind	VERB
gsrj-29	361	33	unleashes	unleash	VERB
gsrj-29	361	34	indiscriminate	indiscriminate	ADJ
gsrj-29	361	35	single	single	ADJ
gsrj-29	361	36	-	-	PUNCT
gsrj-29	361	37	stranded	strand	VERB
gsrj-29	361	38	dnase	dnase	NOUN
gsrj-29	361	39	activity	activity	NOUN
gsrj-29	361	40	.	.	PUNCT
gsrj-29	362	1	science	science	NOUN
gsrj-29	362	2	.	.	PUNCT
gsrj-29	363	1	2018	2018	NUM
gsrj-29	363	2	;	;	PUNCT
gsrj-29	363	3	360	360	NUM
gsrj-29	363	4	,	,	PUNCT
gsrj-29	363	5	(	(	PUNCT
gsrj-29	363	6	6387	6387	NUM
gsrj-29	363	7	):	):	PUNCT
gsrj-29	363	8	436	436	NUM
gsrj-29	363	9	-	-	SYM
gsrj-29	363	10	439	439	NUM
gsrj-29	363	11	.	.	PUNCT
gsrj-29	363	12	doi	doi	NOUN
gsrj-29	363	13	:	:	PUNCT
gsrj-29	363	14	10.1126	10.1126	NUM
gsrj-29	363	15	/	/	SYM
gsrj-29	363	16	science.aar6245	science.aar6245	NUM
gsrj-29	363	17	38	38	NUM
gsrj-29	363	18	georgetown	georgetown	PROPN
gsrj-29	363	19	scientific	scientific	PROPN
gsrj-29	363	20	research	research	NOUN
gsrj-29	363	21	journal	journal	PROPN
gsrj-29	363	22	45	45	NUM
gsrj-29	363	23	.	.	PUNCT
gsrj-29	364	1	chertow	chertow	NOUN
gsrj-29	364	2	,	,	PUNCT
gsrj-29	364	3	d	d	X
gsrj-29	364	4	..	..	PUNCT
gsrj-29	364	5	next	next	ADJ
gsrj-29	364	6	-	-	PUNCT
gsrj-29	364	7	generation	generation	NOUN
gsrj-29	364	8	diagnostics	diagnostic	NOUN
gsrj-29	364	9	with	with	ADP
gsrj-29	364	10	crispr	crispr	NOUN
gsrj-29	364	11	.	.	PUNCT
gsrj-29	365	1	science	science	NOUN
gsrj-29	365	2	.	.	PUNCT
gsrj-29	366	1	2018	2018	NUM
gsrj-29	366	2	;	;	PUNCT
gsrj-29	366	3	360	360	NUM
gsrj-29	366	4	(	(	PUNCT
gsrj-29	366	5	6387	6387	NUM
gsrj-29	366	6	):	):	PUNCT
gsrj-29	366	7	381	381	NUM
gsrj-29	366	8	-	-	SYM
gsrj-29	366	9	382	382	NUM
gsrj-29	366	10	.	.	PUNCT
gsrj-29	367	1	doi	doi	NOUN
gsrj-29	367	2	:	:	PUNCT
gsrj-29	367	3	10.1126	10.1126	NUM
gsrj-29	367	4	/	/	SYM
gsrj-29	367	5	science.aat4982	science.aat4982	NUM
gsrj-29	367	6	46	46	NUM
gsrj-29	367	7	.	.	PUNCT
gsrj-29	368	1	isaacson	isaacson	PROPN
gsrj-29	368	2	,	,	PUNCT
gsrj-29	368	3	w	w	PROPN
gsrj-29	368	4	..	..	PUNCT
gsrj-29	368	5	crispr	crispr	ADJ
gsrj-29	368	6	rivals	rival	NOUN
gsrj-29	368	7	put	put	VERB
gsrj-29	368	8	patents	patent	NOUN
gsrj-29	368	9	aside	aside	ADV
gsrj-29	368	10	to	to	PART
gsrj-29	368	11	help	help	VERB
gsrj-29	368	12	in	in	ADP
gsrj-29	368	13	fight	fight	NOUN
gsrj-29	368	14	against	against	ADP
gsrj-29	368	15	covid-19	covid-19	PROPN
gsrj-29	368	16	.	.	PUNCT
gsrj-29	369	1	stat	stat	PROPN
gsrj-29	369	2	news	news	PROPN
gsrj-29	369	3	.	.	PUNCT
gsrj-29	370	1	published	publish	VERB
gsrj-29	370	2	march	march	PROPN
gsrj-29	370	3	3	3	NUM
gsrj-29	370	4	,	,	PUNCT
gsrj-29	370	5	2021	2021	NUM
gsrj-29	370	6	.	.	PUNCT
gsrj-29	371	1	accessed	access	VERB
gsrj-29	371	2	august	august	PROPN
gsrj-29	371	3	19	19	NUM
gsrj-29	371	4	,	,	PUNCT
gsrj-29	371	5	2021	2021	NUM
gsrj-29	371	6	.	.	PUNCT
gsrj-29	372	1	https://www.statnews.com/2021/03/03/crisprrivals-put-patents-aside-fight-against-covid-19/	https://www.statnews.com/2021/03/03/crisprrivals-put-patents-aside-fight-against-covid-19/	PROPN
gsrj-29	372	2	47	47	NUM
gsrj-29	372	3	.	.	PUNCT
gsrj-29	373	1	joung	joung	PROPN
gsrj-29	373	2	j	j	PROPN
gsrj-29	373	3	,	,	PUNCT
gsrj-29	373	4	ladha	ladha	PROPN
gsrj-29	373	5	a	a	PRON
gsrj-29	373	6	,	,	PUNCT
gsrj-29	373	7	saito	saito	PROPN
gsrj-29	373	8	m	m	PROPN
gsrj-29	373	9	,	,	PUNCT
gsrj-29	373	10	et	et	PROPN
gsrj-29	373	11	al	al	PROPN
gsrj-29	373	12	.	.	PUNCT
gsrj-29	373	13	point	point	PROPN
gsrj-29	373	14	-	-	PUNCT
gsrj-29	373	15	of	of	ADP
gsrj-29	373	16	-	-	PUNCT
gsrj-29	373	17	care	care	NOUN
gsrj-29	373	18	testing	testing	NOUN
gsrj-29	373	19	for	for	ADP
gsrj-29	373	20	covid-19	covid-19	PROPN
gsrj-29	373	21	using	use	VERB
gsrj-29	373	22	sherlock	sherlock	NOUN
gsrj-29	373	23	diagnostics	diagnostic	NOUN
gsrj-29	373	24	.	.	PUNCT
gsrj-29	374	1	preprint	preprint	NOUN
gsrj-29	374	2	.	.	PUNCT
gsrj-29	375	1	medrxiv	medrxiv	PROPN
gsrj-29	375	2	.	.	PUNCT
gsrj-29	376	1	2020	2020	NUM
gsrj-29	376	2	;	;	PUNCT
gsrj-29	377	1	2020.05.04.20091231	2020.05.04.20091231	X
gsrj-29	377	2	.	.	PUNCT
gsrj-29	378	1	doi	doi	NOUN
gsrj-29	378	2	:	:	PUNCT
gsrj-29	378	3	10.1101/2020.05.04.20091231	10.1101/2020.05.04.20091231	NUM
gsrj-29	378	4	48	48	NUM
gsrj-29	378	5	.	.	PUNCT
gsrj-29	379	1	broughton	broughton	PROPN
gsrj-29	379	2	,	,	PUNCT
gsrj-29	379	3	j.p	j.p	PROPN
gsrj-29	379	4	.	.	PROPN
gsrj-29	379	5	,	,	PUNCT
gsrj-29	379	6	deng	deng	PROPN
gsrj-29	379	7	,	,	PUNCT
gsrj-29	379	8	x.	x.	PROPN
gsrj-29	379	9	,	,	PUNCT
gsrj-29	379	10	yu	yu	PROPN
gsrj-29	379	11	,	,	PUNCT
gsrj-29	379	12	g.	g.	PROPN
gsrj-29	379	13	et	et	PROPN
gsrj-29	379	14	al	al	PROPN
gsrj-29	379	15	.	.	PROPN
gsrj-29	379	16	crispr	crispr	PROPN
gsrj-29	379	17	–	–	PUNCT
gsrj-29	379	18	cas12	cas12	NOUN
gsrj-29	379	19	-	-	PUNCT
gsrj-29	379	20	based	base	VERB
gsrj-29	379	21	detection	detection	NOUN
gsrj-29	379	22	of	of	ADP
gsrj-29	379	23	sars	sar	NOUN
gsrj-29	379	24	-	-	PUNCT
gsrj-29	379	25	cov-2	cov-2	NOUN
gsrj-29	379	26	.	.	PUNCT
gsrj-29	380	1	nat	nat	PROPN
gsrj-29	380	2	biotechnol	biotechnol	NOUN
gsrj-29	380	3	.	.	PUNCT
gsrj-29	381	1	2020	2020	NUM
gsrj-29	381	2	;	;	PUNCT
gsrj-29	382	1	38	38	NUM
gsrj-29	382	2	:	:	PUNCT
gsrj-29	382	3	870–874	870–874	NUM
gsrj-29	382	4	.	.	PUNCT
gsrj-29	383	1	doi	doi	NOUN
gsrj-29	383	2	:	:	PUNCT
gsrj-29	383	3	https://doi.org/10.1038/s41587-020-0513-4	https://doi.org/10.1038/s41587-020-0513-4	NUM
gsrj-29	383	4	49	49	NUM
gsrj-29	383	5	.	.	PUNCT
gsrj-29	384	1	guglielmi	guglielmi	PROPN
gsrj-29	384	2	,	,	PUNCT
gsrj-29	384	3	g	g	PROPN
gsrj-29	384	4	..	..	PUNCT
gsrj-29	384	5	first	first	ADJ
gsrj-29	384	6	crispr	crispr	ADJ
gsrj-29	384	7	test	test	NOUN
gsrj-29	384	8	for	for	ADP
gsrj-29	384	9	the	the	DET
gsrj-29	384	10	coronavirus	coronavirus	NOUN
gsrj-29	384	11	approved	approve	VERB
gsrj-29	384	12	in	in	ADP
gsrj-29	384	13	the	the	DET
gsrj-29	384	14	united	united	PROPN
gsrj-29	384	15	states	states	PROPN
gsrj-29	384	16	.	.	PUNCT
gsrj-29	385	1	nature	nature	NOUN
gsrj-29	385	2	.	.	PUNCT
gsrj-29	386	1	2020	2020	NUM
gsrj-29	386	2	.	.	PUNCT
gsrj-29	387	1	doi	doi	NOUN
gsrj-29	387	2	:	:	PUNCT
gsrj-29	387	3	https://doi.org/10.1038/d41586-02001402-9	https://doi.org/10.1038/d41586-02001402-9	NOUN
gsrj-29	387	4	50	50	NUM
gsrj-29	387	5	.	.	PUNCT
gsrj-29	388	1	u.s	u.s	PROPN
gsrj-29	388	2	.	.	PROPN
gsrj-29	388	3	food	food	PROPN
gsrj-29	388	4	and	and	CCONJ
gsrj-29	388	5	drug	drug	PROPN
gsrj-29	388	6	administration	administration	NOUN
gsrj-29	388	7	.	.	PUNCT
gsrj-29	389	1	accelerated	accelerate	VERB
gsrj-29	389	2	emergency	emergency	NOUN
gsrj-29	389	3	use	use	NOUN
gsrj-29	389	4	authorization	authorization	NOUN
gsrj-29	389	5	(	(	PUNCT
gsrj-29	389	6	eua	eua	PROPN
gsrj-29	389	7	)	)	PUNCT
gsrj-29	389	8	summary	summary	NOUN
gsrj-29	389	9	sars	sar	NOUN
gsrj-29	389	10	-	-	PUNCT
gsrj-29	389	11	cov-2	cov-2	NOUN
gsrj-29	389	12	rna	rna	NOUN
gsrj-29	389	13	detectr	detectr	PROPN
gsrj-29	389	14	assay	assay	PROPN
gsrj-29	389	15	.	.	PUNCT
gsrj-29	390	1	published	publish	VERB
gsrj-29	390	2	2020	2020	NUM
gsrj-29	390	3	.	.	PUNCT
gsrj-29	391	1	accessed	access	VERB
gsrj-29	391	2	august	august	PROPN
gsrj-29	391	3	18	18	NUM
gsrj-29	391	4	,	,	PUNCT
gsrj-29	391	5	2021	2021	NUM
gsrj-29	391	6	.	.	PUNCT
gsrj-29	392	1	https://www.fda.gov/media/139937/download	https://www.fda.gov/media/139937/download	ADP
gsrj-29	392	2	51	51	NUM
gsrj-29	392	3	.	.	PUNCT
gsrj-29	393	1	khan	khan	PROPN
gsrj-29	393	2	,	,	PUNCT
gsrj-29	393	3	w.	w.	PROPN
gsrj-29	393	4	,	,	PUNCT
gsrj-29	393	5	barney	barney	PROPN
gsrj-29	393	6	,	,	PUNCT
gsrj-29	393	7	r.	r.	PROPN
gsrj-29	393	8	,	,	PUNCT
gsrj-29	393	9	tsongalis	tsongalis	PROPN
gsrj-29	393	10	,	,	PUNCT
gsrj-29	393	11	g	g	NOUN
gsrj-29	393	12	..	..	PUNCT
gsrj-29	393	13	crisprcas13	crisprcas13	ADJ
gsrj-29	393	14	enzymology	enzymology	NOUN
gsrj-29	393	15	rapidly	rapidly	ADV
gsrj-29	393	16	detects	detect	VERB
gsrj-29	393	17	sars	sar	NOUN
gsrj-29	393	18	-	-	PUNCT
gsrj-29	393	19	cov-2	cov-2	NOUN
gsrj-29	393	20	fragments	fragment	NOUN
gsrj-29	393	21	in	in	ADP
gsrj-29	393	22	a	a	DET
gsrj-29	393	23	clinical	clinical	ADJ
gsrj-29	393	24	setting	setting	NOUN
gsrj-29	393	25	.	.	PUNCT
gsrj-29	394	1	preprint	preprint	NOUN
gsrj-29	394	2	.	.	PUNCT
gsrj-29	395	1	medrxiv	medrxiv	PROPN
gsrj-29	395	2	.	.	PUNCT
gsrj-29	396	1	2020	2020	NUM
gsrj-29	396	2	.	.	PUNCT
gsrj-29	397	1	doi	doi	NOUN
gsrj-29	397	2	:	:	PUNCT
gsrj-29	397	3	https://doi.org/10.1101/2020.12.17.20228593	https://doi.org/10.1101/2020.12.17.20228593	PROPN
gsrj-29	397	4	52	52	NUM
gsrj-29	397	5	.	.	PUNCT
gsrj-29	398	1	sherlock	sherlock	PROPN
gsrj-29	398	2	biosciences	biosciences	PROPN
gsrj-29	398	3	.	.	PUNCT
gsrj-29	399	1	high	high	ADJ
gsrj-29	399	2	throughput	throughput	NOUN
gsrj-29	399	3	sherlock	sherlock	PROPN
gsrj-29	399	4	crispr	crispr	PROPN
gsrj-29	399	5	sars	sars	PROPN
gsrj-29	399	6	-	-	PUNCT
gsrj-29	399	7	cov-2	cov-2	PART
gsrj-29	399	8	test	test	NOUN
gsrj-29	399	9	.	.	PUNCT
gsrj-29	400	1	white	white	ADJ
gsrj-29	400	2	paper	paper	PROPN
gsrj-29	400	3	.	.	PUNCT
gsrj-29	401	1	biorxiv	biorxiv	NOUN
gsrj-29	401	2	.	.	PUNCT
gsrj-29	402	1	2020	2020	NUM
gsrj-29	402	2	.	.	PUNCT
gsrj-29	403	1	https://sherlock.bio/wpcontent/uploads/2021/01/high_througput_she	https://sherlock.bio/wpcontent/uploads/2021/01/high_througput_she	PRON
gsrj-29	403	2	rlock_sars_cov2_test_jan2021.pdf	rlock_sars_cov2_test_jan2021.pdf	PROPN
gsrj-29	403	3	53	53	NUM
gsrj-29	403	4	.	.	PUNCT
gsrj-29	404	1	tsang	tsang	PROPN
gsrj-29	404	2	,	,	PUNCT
gsrj-29	404	3	j.	j.	PROPN
gsrj-29	404	4	and	and	CCONJ
gsrj-29	404	5	lamanna	lamanna	PROPN
gsrj-29	404	6	,	,	PUNCT
gsrj-29	404	7	c.	c.	PROPN
gsrj-29	404	8	open	open	ADJ
gsrj-29	404	9	sharing	sharing	NOUN
gsrj-29	404	10	during	during	ADP
gsrj-29	404	11	covid-19	covid-19	PROPN
gsrj-29	404	12	:	:	PUNCT
gsrj-29	404	13	crispr	crispr	NOUN
gsrj-29	404	14	-	-	PUNCT
gsrj-29	404	15	based	base	VERB
gsrj-29	404	16	detection	detection	NOUN
gsrj-29	404	17	tools	tool	NOUN
gsrj-29	404	18	.	.	PUNCT
gsrj-29	405	1	the	the	DET
gsrj-29	405	2	crispr	crispr	ADJ
gsrj-29	405	3	journal	journal	NOUN
gsrj-29	405	4	.	.	PUNCT
gsrj-29	406	1	2020	2020	NUM
gsrj-29	406	2	;	;	PUNCT
gsrj-29	406	3	3	3	NUM
gsrj-29	406	4	(	(	PUNCT
gsrj-29	406	5	3	3	NUM
gsrj-29	406	6	)	)	PUNCT
gsrj-29	406	7	.	.	PUNCT
gsrj-29	407	1	doi	doi	NOUN
gsrj-29	407	2	:	:	PUNCT
gsrj-29	407	3	https://doi.org/10.1089/crispr.2020.0030	https://doi.org/10.1089/crispr.2020.0030	PROPN
gsrj-29	407	4	54	54	NUM
gsrj-29	407	5	.	.	PUNCT
gsrj-29	408	1	u.s	u.s	PROPN
gsrj-29	408	2	.	.	PROPN
gsrj-29	408	3	food	food	PROPN
gsrj-29	408	4	and	and	CCONJ
gsrj-29	408	5	drug	drug	NOUN
gsrj-29	408	6	administration	administration	NOUN
gsrj-29	408	7	.	.	PUNCT
gsrj-29	409	1	fact	fact	NOUN
gsrj-29	409	2	sheet	sheet	NOUN
gsrj-29	409	3	for	for	ADP
gsrj-29	409	4	healthcare	healthcare	NOUN
gsrj-29	409	5	providers	provider	NOUN
gsrj-29	409	6	:	:	PUNCT
gsrj-29	409	7	sherlock	sherlock	NOUN
gsrj-29	409	8	™	™	PROPN
gsrj-29	409	9	crispr	crispr	ADJ
gsrj-29	409	10	sars	sar	NOUN
gsrj-29	409	11	-	-	PUNCT
gsrj-29	409	12	cov-2	cov-2	PART
gsrj-29	409	13	kit	kit	NOUN
gsrj-29	409	14	.	.	PROPN
gsrj-29	410	1	published	publish	VERB
gsrj-29	410	2	january	january	PROPN
gsrj-29	410	3	14	14	NUM
gsrj-29	410	4	2021	2021	NUM
gsrj-29	410	5	.	.	PUNCT
gsrj-29	411	1	accessed	access	VERB
gsrj-29	411	2	august	august	PROPN
gsrj-29	411	3	18	18	NUM
gsrj-29	411	4	,	,	PUNCT
gsrj-29	411	5	2021	2021	NUM
gsrj-29	411	6	.	.	PUNCT
gsrj-29	412	1	https://www.fda.gov/media/137745/download	https://www.fda.gov/media/137745/download	ADP
gsrj-29	412	2	55	55	NUM
gsrj-29	412	3	.	.	PUNCT
gsrj-29	413	1	fozouni	fozouni	PROPN
gsrj-29	413	2	,	,	PUNCT
gsrj-29	413	3	p.	p.	PROPN
gsrj-29	413	4	,	,	PUNCT
gsrj-29	413	5	son	son	PROPN
gsrj-29	413	6	,	,	PUNCT
gsrj-29	413	7	s.	s.	PROPN
gsrj-29	413	8	,	,	PUNCT
gsrj-29	413	9	de	de	PROPN
gsrj-29	413	10	león	león	PROPN
gsrj-29	413	11	derby	derby	PROPN
gsrj-29	413	12	,	,	PUNCT
gsrj-29	413	13	m.	m.	NOUN
gsrj-29	413	14	,	,	PUNCT
gsrj-29	413	15	knott	knott	PROPN
gsrj-29	413	16	,	,	PUNCT
gsrj-29	413	17	g.	g.	PROPN
gsrj-29	413	18	,	,	PUNCT
gsrj-29	413	19	gray	gray	ADJ
gsrj-29	413	20	,	,	PUNCT
gsrj-29	413	21	c.	c.	NOUN
gsrj-29	413	22	,	,	PUNCT
gsrj-29	413	23	d’ambrosio	d’ambrosio	PROPN
gsrj-29	413	24	,	,	PUNCT
gsrj-29	413	25	m.	m.	NOUN
gsrj-29	413	26	,	,	PUNCT
gsrj-29	413	27	zhao	zhao	PROPN
gsrj-29	413	28	,	,	PUNCT
gsrj-29	413	29	c.	c.	PROPN
gsrj-29	413	30	,	,	PUNCT
gsrj-29	413	31	switz	switz	PROPN
gsrj-29	413	32	,	,	PUNCT
gsrj-29	413	33	n.	n.	PROPN
gsrj-29	413	34	,	,	PUNCT
gsrj-29	413	35	renuka	renuka	PROPN
gsrj-29	413	36	kumar	kumar	PROPN
gsrj-29	413	37	,	,	PUNCT
gsrj-29	413	38	g.	g.	PROPN
gsrj-29	413	39	,	,	PUNCT
gsrj-29	413	40	stephens	stephens	PROPN
gsrj-29	413	41	,	,	PUNCT
gsrj-29	413	42	s.	s.	PROPN
gsrj-29	413	43	,	,	PUNCT
gsrj-29	413	44	boehm	boehm	PROPN
gsrj-29	413	45	,	,	PUNCT
gsrj-29	413	46	d.	d.	PROPN
gsrj-29	413	47	,	,	PUNCT
gsrj-29	413	48	tsou	tsou	PROPN
gsrj-29	413	49	,	,	PUNCT
gsrj-29	413	50	c	c	PROPN
gsrj-29	413	51	-	-	PUNCT
gsrj-29	413	52	l.	l.	PROPN
gsrj-29	413	53	,	,	PUNCT
gsrj-29	413	54	shu	shu	PROPN
gsrj-29	413	55	,	,	PUNCT
gsrj-29	413	56	j.	j.	PROPN
gsrj-29	413	57	,	,	PUNCT
gsrj-29	413	58	bhuiya	bhuiya	PROPN
gsrj-29	413	59	,	,	PUNCT
gsrj-29	413	60	a.	a.	PROPN
gsrj-29	413	61	,	,	PUNCT
gsrj-29	413	62	armstrong	armstrong	PROPN
gsrj-29	413	63	,	,	PUNCT
gsrj-29	413	64	m.	m.	NOUN
gsrj-29	413	65	,	,	PUNCT
gsrj-29	413	66	harris	harris	PROPN
gsrj-29	413	67	,	,	PUNCT
gsrj-29	413	68	a.	a.	PROPN
gsrj-29	413	69	,	,	PUNCT
gsrj-29	413	70	chen	chen	PROPN
gsrj-29	413	71	,	,	PUNCT
gsrj-29	413	72	p	p	PROPN
gsrj-29	413	73	-	-	PUNCT
gsrj-29	413	74	y.	y.	NOUN
gsrj-29	413	75	,	,	PUNCT
gsrj-29	413	76	osterloh	osterloh	PROPN
gsrj-29	413	77	,	,	PUNCT
gsrj-29	413	78	j.	j.	PROPN
gsrj-29	413	79	,	,	PUNCT
gsrj-29	413	80	meyerfranke	meyerfranke	PROPN
gsrj-29	413	81	,	,	PUNCT
gsrj-29	413	82	a.	a.	NOUN
gsrj-29	413	83	,	,	PUNCT
gsrj-29	413	84	joehnk	joehnk	PROPN
gsrj-29	413	85	,	,	PUNCT
gsrj-29	413	86	b.	b.	PROPN
gsrj-29	413	87	,	,	PUNCT
gsrj-29	413	88	walcott	walcott	PROPN
gsrj-29	413	89	,	,	PUNCT
gsrj-29	413	90	k.	k.	PROPN
gsrj-29	413	91	,	,	PUNCT
gsrj-29	413	92	sil	sil	PROPN
gsrj-29	413	93	,	,	PUNCT
gsrj-29	413	94	a.	a.	NOUN
gsrj-29	413	95	,	,	PUNCT
gsrj-29	413	96	langelier	langelier	NOUN
gsrj-29	413	97	,	,	PUNCT
gsrj-29	413	98	c.	c.	PROPN
gsrj-29	413	99	,	,	PUNCT
gsrj-29	413	100	pollard	pollard	PROPN
gsrj-29	413	101	,	,	PUNCT
gsrj-29	413	102	k.	k.	PROPN
gsrj-29	413	103	,	,	PUNCT
gsrj-29	413	104	crawford	crawford	PROPN
gsrj-29	413	105	,	,	PUNCT
gsrj-29	413	106	e.	e.	PROPN
gsrj-29	413	107	,	,	PUNCT
gsrj-29	413	108	puschnik	puschnik	X
gsrj-29	413	109	,	,	PUNCT
gsrj-29	413	110	a.	a.	PROPN
gsrj-29	413	111	,	,	PUNCT
gsrj-29	413	112	phelps	phelps	PROPN
gsrj-29	413	113	,	,	PUNCT
gsrj-29	413	114	m.	m.	NOUN
gsrj-29	413	115	,	,	PUNCT
gsrj-29	413	116	kistler	kistler	NOUN
gsrj-29	413	117	,	,	PUNCT
gsrj-29	413	118	a.	a.	PROPN
gsrj-29	413	119	,	,	PUNCT
gsrj-29	413	120	derisi	derisi	VERB
gsrj-29	413	121	,	,	PUNCT
gsrj-29	413	122	j.	j.	PROPN
gsrj-29	413	123	,	,	PUNCT
gsrj-29	413	124	doudna	doudna	PROPN
gsrj-29	413	125	,	,	PUNCT
gsrj-29	413	126	j.	j.	PROPN
gsrj-29	413	127	,	,	PUNCT
gsrj-29	413	128	fletcher	fletcher	PROPN
gsrj-29	413	129	,	,	PUNCT
gsrj-29	413	130	d.	d.	PROPN
gsrj-29	413	131	,	,	PUNCT
gsrj-29	413	132	ott	ott	PROPN
gsrj-29	413	133	,	,	PUNCT
gsrj-29	413	134	m	m	PROPN
gsrj-29	413	135	..	..	PUNCT
gsrj-29	413	136	amplification	amplification	NOUN
gsrj-29	413	137	-	-	PUNCT
gsrj-29	413	138	free	free	ADJ
gsrj-29	413	139	detection	detection	NOUN
gsrj-29	413	140	of	of	ADP
gsrj-29	413	141	sars	sar	NOUN
gsrj-29	413	142	-	-	PUNCT
gsrj-29	413	143	cov-2	cov-2	NOUN
gsrj-29	413	144	with	with	ADP
gsrj-29	413	145	crispr	crispr	NOUN
gsrj-29	413	146	-	-	PUNCT
gsrj-29	413	147	cas13a	cas13a	NOUN
gsrj-29	413	148	and	and	CCONJ
gsrj-29	413	149	mobile	mobile	ADJ
gsrj-29	413	150	phone	phone	NOUN
gsrj-29	413	151	microscopy	microscopy	NOUN
gsrj-29	413	152	.	.	PUNCT
gsrj-29	414	1	cell	cell	NOUN
gsrj-29	414	2	.	.	PUNCT
gsrj-29	415	1	2020	2020	NUM
gsrj-29	415	2	;	;	PUNCT
gsrj-29	415	3	184	184	NUM
gsrj-29	415	4	(	(	PUNCT
gsrj-29	415	5	2	2	NUM
gsrj-29	415	6	)	)	PUNCT
gsrj-29	415	7	.	.	PUNCT
gsrj-29	416	1	doi	doi	NOUN
gsrj-29	416	2	:	:	PUNCT
gsrj-29	416	3	https://doi.org/10.1016/j.cell.2020.12.001	https://doi.org/10.1016/j.cell.2020.12.001	PROPN
gsrj-29	416	4	56	56	NUM
gsrj-29	416	5	.	.	PUNCT
gsrj-29	417	1	ning	ning	PROPN
gsrj-29	417	2	,	,	PUNCT
gsrj-29	417	3	b.	b.	PROPN
gsrj-29	417	4	,	,	PUNCT
gsrj-29	417	5	yu	yu	PROPN
gsrj-29	417	6	,	,	PUNCT
gsrj-29	417	7	t.	t.	PROPN
gsrj-29	417	8	,	,	PUNCT
gsrj-29	417	9	zhang	zhang	PROPN
gsrj-29	417	10	,	,	PUNCT
gsrj-29	417	11	s.	s.	PROPN
gsrj-29	417	12	,	,	PUNCT
gsrj-29	417	13	huang	huang	PROPN
gsrj-29	417	14	,	,	PUNCT
gsrj-29	417	15	z.	z.	PROPN
gsrj-29	417	16	,	,	PUNCT
gsrj-29	417	17	tian	tian	PROPN
gsrj-29	417	18	,	,	PUNCT
gsrj-29	417	19	d.	d.	PROPN
gsrj-29	417	20	,	,	PUNCT
gsrj-29	417	21	lin	lin	PROPN
gsrj-29	417	22	,	,	PUNCT
gsrj-29	417	23	z.	z.	PROPN
gsrj-29	417	24	,	,	PUNCT
gsrj-29	417	25	niu	niu	PROPN
gsrj-29	417	26	,	,	PUNCT
gsrj-29	417	27	a.	a.	NOUN
gsrj-29	417	28	,	,	PUNCT
gsrj-29	417	29	golden	golden	ADJ
gsrj-29	417	30	,	,	PUNCT
gsrj-29	417	31	n.	n.	NOUN
gsrj-29	417	32	,	,	PUNCT
gsrj-29	417	33	hensley	hensley	NOUN
gsrj-29	417	34	,	,	PUNCT
gsrj-29	417	35	k.	k.	PROPN
gsrj-29	417	36	,	,	PUNCT
gsrj-29	417	37	threeton	threeton	PROPN
gsrj-29	417	38	,	,	PUNCT
gsrj-29	417	39	b.	b.	PROPN
gsrj-29	417	40	,	,	PUNCT
gsrj-29	417	41	lyon	lyon	PROPN
gsrj-29	417	42	,	,	PUNCT
gsrj-29	417	43	c.	c.	PROPN
gsrj-29	417	44	,	,	PUNCT
gsrj-29	417	45	yin	yin	PROPN
gsrj-29	417	46	,	,	PUNCT
gsrj-29	417	47	x	x	NOUN
gsrj-29	417	48	-	-	NOUN
gsrj-29	417	49	m.	m.	NOUN
gsrj-29	417	50	,	,	PUNCT
gsrj-29	417	51	roy	roy	PROPN
gsrj-29	417	52	,	,	PUNCT
gsrj-29	417	53	c.	c.	PROPN
gsrj-29	417	54	,	,	PUNCT
gsrj-29	417	55	saba	saba	PROPN
gsrj-29	417	56	n.	n.	PROPN
gsrj-29	417	57	,	,	PUNCT
gsrj-29	417	58	rappaport	rappaport	PROPN
gsrj-29	417	59	,	,	PUNCT
gsrj-29	417	60	j.	j.	PROPN
gsrj-29	417	61	,	,	PUNCT
gsrj-29	417	62	wei	wei	PROPN
gsrj-29	417	63	,	,	PUNCT
gsrj-29	417	64	q.	q.	PROPN
gsrj-29	417	65	,	,	PUNCT
gsrj-29	417	66	and	and	CCONJ
gsrj-29	417	67	hul	hul	PROPN
gsrj-29	417	68	,	,	PUNCT
gsrj-29	417	69	t	t	PROPN
gsrj-29	417	70	..	..	PUNCT
gsrj-29	417	71	a	a	DET
gsrj-29	417	72	smartphone	smartphone	NOUN
gsrj-29	417	73	-	-	PUNCT
gsrj-29	417	74	read	read	NOUN
gsrj-29	417	75	ultrasensitive	ultrasensitive	NOUN
gsrj-29	417	76	and	and	CCONJ
gsrj-29	417	77	quantitative	quantitative	ADJ
gsrj-29	417	78	saliva	saliva	NOUN
gsrj-29	417	79	test	test	NOUN
gsrj-29	417	80	for	for	ADP
gsrj-29	417	81	covid-19	covid-19	PROPN
gsrj-29	417	82	.	.	PUNCT
gsrj-29	418	1	science	science	NOUN
gsrj-29	418	2	advances	advance	NOUN
gsrj-29	418	3	.	.	PUNCT
gsrj-29	419	1	2021	2021	NUM
gsrj-29	419	2	;	;	PUNCT
gsrj-29	419	3	7	7	NUM
gsrj-29	419	4	,	,	PUNCT
gsrj-29	419	5	(	(	PUNCT
gsrj-29	419	6	2	2	NUM
gsrj-29	419	7	)	)	PUNCT
gsrj-29	419	8	.	.	PUNCT
gsrj-29	420	1	doi	doi	NOUN
gsrj-29	420	2	:	:	PUNCT
gsrj-29	420	3	10.1126	10.1126	NUM
gsrj-29	420	4	/	/	SYM
gsrj-29	420	5	sciadv.abe3703	sciadv.abe3703	PROPN
gsrj-29	420	6	57	57	NUM
gsrj-29	420	7	.	.	PUNCT
gsrj-29	421	1	manke	manke	ADJ
gsrj-29	421	2	,	,	PUNCT
gsrj-29	421	3	k	k	X
gsrj-29	421	4	..	..	PUNCT
gsrj-29	421	5	new	new	ADJ
gsrj-29	421	6	crispr	crispr	NOUN
gsrj-29	421	7	-	-	PUNCT
gsrj-29	421	8	based	base	VERB
gsrj-29	421	9	covid-19	covid-19	PROPN
gsrj-29	421	10	test	test	NOUN
gsrj-29	421	11	uses	use	VERB
gsrj-29	421	12	smartphone	smartphone	NOUN
gsrj-29	421	13	cameras	camera	NOUN
gsrj-29	421	14	to	to	PART
gsrj-29	421	15	spot	spot	VERB
gsrj-29	421	16	virus	virus	PROPN
gsrj-29	421	17	rna	rna	PROPN
gsrj-29	421	18	.	.	PUNCT
gsrj-29	422	1	berkeley	berkeley	PROPN
gsrj-29	422	2	news	news	PROPN
gsrj-29	422	3	.	.	PUNCT
gsrj-29	423	1	2020	2020	NUM
gsrj-29	423	2	.	.	PUNCT
gsrj-29	424	1	https://news.berkeley.edu/story_jump/new-crisprbased-covid-19-test-uses-smartphone-cameras-tospot-virus-rna/	https://news.berkeley.edu/story_jump/new-crisprbased-covid-19-test-uses-smartphone-cameras-tospot-virus-rna/	NOUN
gsrj-29	424	2	58	58	NUM
gsrj-29	424	3	.	.	PUNCT
gsrj-29	425	1	béchard	béchard	NOUN
gsrj-29	425	2	,	,	PUNCT
gsrj-29	425	3	d	d	PROPN
gsrj-29	425	4	..	..	PUNCT
gsrj-29	425	5	over	over	ADP
gsrj-29	425	6	-	-	PUNCT
gsrj-29	425	7	the	the	DET
gsrj-29	425	8	-	-	PUNCT
gsrj-29	425	9	counter	counter	NOUN
gsrj-29	425	10	cancer	cancer	NOUN
gsrj-29	425	11	tests	test	NOUN
gsrj-29	425	12	?	?	PUNCT
gsrj-29	426	1	stanford	stanford	PROPN
gsrj-29	426	2	magazine	magazine	PROPN
gsrj-29	426	3	.	.	PUNCT
gsrj-29	427	1	2019	2019	NUM
gsrj-29	427	2	.	.	PUNCT
gsrj-29	428	1	https://stanfordmag.org/contents/over-thecounter-cancer-tests-mammoth-biosciences	https://stanfordmag.org/contents/over-thecounter-cancer-tests-mammoth-bioscience	NOUN
gsrj-29	428	2	59	59	NUM
gsrj-29	428	3	.	.	PUNCT
gsrj-29	429	1	harmon	harmon	PROPN
gsrj-29	429	2	courage	courage	PROPN
gsrj-29	429	3	,	,	PUNCT
gsrj-29	429	4	k	k	PROPN
gsrj-29	429	5	..	..	PUNCT
gsrj-29	429	6	the	the	DET
gsrj-29	429	7	race	race	NOUN
gsrj-29	429	8	to	to	PART
gsrj-29	429	9	make	make	VERB
gsrj-29	429	10	coronavirus	coronavirus	NOUN
gsrj-29	429	11	testing	testing	NOUN
gsrj-29	429	12	as	as	ADV
gsrj-29	429	13	easy	easy	ADJ
gsrj-29	429	14	as	as	ADP
gsrj-29	429	15	a	a	DET
gsrj-29	429	16	pregnancy	pregnancy	NOUN
gsrj-29	429	17	test	test	NOUN
gsrj-29	429	18	.	.	PUNCT
gsrj-29	430	1	vox	vox	PROPN
gsrj-29	430	2	magazine	magazine	PROPN
gsrj-29	430	3	.	.	PUNCT
gsrj-29	431	1	2020	2020	NUM
gsrj-29	431	2	.	.	PUNCT
gsrj-29	432	1	https://www.vox.com/2020/6/3/21277347/covid19-testing-at-home-accuracy	https://www.vox.com/2020/6/3/21277347/covid19-testing-at-home-accuracy	NOUN
gsrj-29	432	2	60	60	NUM
gsrj-29	432	3	.	.	PUNCT
gsrj-29	433	1	ackerman	ackerman	PROPN
gsrj-29	433	2	,	,	PUNCT
gsrj-29	433	3	c.m	c.m	PROPN
gsrj-29	433	4	.	.	PROPN
gsrj-29	433	5	,	,	PUNCT
gsrj-29	433	6	myhrvold	myhrvold	PROPN
gsrj-29	433	7	,	,	PUNCT
gsrj-29	433	8	c.	c.	PROPN
gsrj-29	433	9	,	,	PUNCT
gsrj-29	433	10	thakku	thakku	PROPN
gsrj-29	433	11	,	,	PUNCT
gsrj-29	433	12	s.g	s.g	PROPN
gsrj-29	433	13	.	.	PROPN
gsrj-29	433	14	et	et	PROPN
gsrj-29	433	15	al	al	PROPN
gsrj-29	433	16	.	.	PROPN
gsrj-29	433	17	massively	massively	ADV
gsrj-29	433	18	multiplexed	multiplexed	ADJ
gsrj-29	433	19	nucleic	nucleic	ADJ
gsrj-29	433	20	acid	acid	NOUN
gsrj-29	433	21	detection	detection	NOUN
gsrj-29	433	22	with	with	ADP
gsrj-29	433	23	cas13	cas13	PROPN
gsrj-29	433	24	.	.	PUNCT
gsrj-29	434	1	nature	nature	NOUN
gsrj-29	434	2	.	.	PUNCT
gsrj-29	435	1	2020	2020	NUM
gsrj-29	435	2	;	;	PUNCT
gsrj-29	436	1	582	582	NUM
gsrj-29	436	2	:	:	PUNCT
gsrj-29	436	3	277–282	277–282	NUM
gsrj-29	436	4	.	.	PUNCT
gsrj-29	436	5	doi	doi	NOUN
gsrj-29	436	6	:	:	PUNCT
gsrj-29	436	7	https://doi.org/10.1038/s41586-020-2279-8	https://doi.org/10.1038/s41586-020-2279-8	NUM
gsrj-29	436	8	61	61	NUM
gsrj-29	436	9	.	.	PUNCT
gsrj-29	437	1	lucia	lucia	PROPN
gsrj-29	437	2	,	,	PUNCT
gsrj-29	437	3	c.	c.	PROPN
gsrj-29	437	4	,	,	PUNCT
gsrj-29	437	5	federico	federico	PROPN
gsrj-29	437	6	,	,	PUNCT
gsrj-29	437	7	p.-b	p.-b	PROPN
gsrj-29	437	8	.	.	PROPN
gsrj-29	437	9	,	,	PUNCT
gsrj-29	437	10	carla	carla	PROPN
gsrj-29	437	11	alejandra	alejandra	PROPN
gsrj-29	437	12	,	,	PUNCT
gsrj-29	437	13	g	g	PROPN
gsrj-29	437	14	..	..	PUNCT
gsrj-29	437	15	an	an	DET
gsrj-29	437	16	ultrasensitive	ultrasensitive	NOUN
gsrj-29	437	17	,	,	PUNCT
gsrj-29	437	18	rapid	rapid	ADJ
gsrj-29	437	19	,	,	PUNCT
gsrj-29	437	20	and	and	CCONJ
gsrj-29	437	21	portable	portable	ADJ
gsrj-29	437	22	coronavirus	coronavirus	NOUN
gsrj-29	437	23	sars	sar	NOUN
gsrj-29	437	24	-	-	PUNCT
gsrj-29	437	25	cov-2	cov-2	NOUN
gsrj-29	437	26	sequence	sequence	NOUN
gsrj-29	437	27	detection	detection	NOUN
gsrj-29	437	28	method	method	NOUN
gsrj-29	437	29	based	base	VERB
gsrj-29	437	30	on	on	ADP
gsrj-29	437	31	crispr	crispr	NOUN
gsrj-29	437	32	-	-	PUNCT
gsrj-29	437	33	cas12	cas12	NOUN
gsrj-29	437	34	.	.	PUNCT
gsrj-29	438	1	biorxiv	biorxiv	PROPN
gsrj-29	438	2	.	.	PUNCT
gsrj-29	439	1	preprint	preprint	NOUN
gsrj-29	439	2	.	.	PUNCT
gsrj-29	440	1	2020	2020	NUM
gsrj-29	440	2	.	.	PUNCT
gsrj-29	441	1	doi	doi	NOUN
gsrj-29	441	2	:	:	PUNCT
gsrj-29	441	3	https://doi.org/10.1101/2020.02.29.971127	https://doi.org/10.1101/2020.02.29.971127	NOUN
gsrj-29	441	4	62	62	NUM
gsrj-29	441	5	.	.	PUNCT
gsrj-29	442	1	yaron	yaron	PROPN
gsrj-29	442	2	,	,	PUNCT
gsrj-29	442	3	t.	t.	PROPN
gsrj-29	442	4	,	,	PUNCT
gsrj-29	442	5	heaton	heaton	PROPN
gsrj-29	442	6	,	,	PUNCT
gsrj-29	442	7	b.	b.	PROPN
gsrj-29	442	8	,	,	PUNCT
gsrj-29	442	9	levy	levy	NOUN
gsrj-29	442	10	,	,	PUNCT
gsrj-29	442	11	t.	t.	PROPN
gsrj-29	442	12	,	,	PUNCT
gsrj-29	442	13	johnson	johnson	PROPN
gsrj-29	442	14	,	,	PUNCT
gsrj-29	442	15	j.	j.	PROPN
gsrj-29	442	16	,	,	PUNCT
gsrj-29	442	17	jordan	jordan	PROPN
gsrj-29	442	18	,	,	PUNCT
gsrj-29	442	19	t.	t.	PROPN
gsrj-29	442	20	,	,	PUNCT
gsrj-29	442	21	cohen	cohen	PROPN
gsrj-29	442	22	,	,	PUNCT
gsrj-29	442	23	b.	b.	PROPN
gsrj-29	442	24	,	,	PUNCT
gsrj-29	442	25	kerelsky	kerelsky	PROPN
gsrj-29	442	26	,	,	PUNCT
gsrj-29	442	27	a.	a.	PROPN
gsrj-29	442	28	,	,	PUNCT
gsrj-29	442	29	lin	lin	PROPN
gsrj-29	442	30	,	,	PUNCT
gsrj-29	442	31	t	t	PROPN
gsrj-29	442	32	-	-	PUNCT
gsrj-29	442	33	y.	y.	PROPN
gsrj-29	442	34	,	,	PUNCT
gsrj-29	442	35	liberatore	liberatore	PROPN
gsrj-29	442	36	,	,	PUNCT
gsrj-29	442	37	k.	k.	PROPN
gsrj-29	442	38	,	,	PUNCT
gsrj-29	442	39	bulaon	bulaon	PROPN
gsrj-29	442	40	,	,	PUNCT
gsrj-29	442	41	d.	d.	PROPN
gsrj-29	442	42	,	,	PUNCT
gsrj-29	442	43	kastenhuber	kastenhuber	PROPN
gsrj-29	442	44	,	,	PUNCT
gsrj-29	442	45	e.	e.	PROPN
gsrj-29	442	46	,	,	PUNCT
gsrj-29	442	47	mercadante	mercadante	PROPN
gsrj-29	442	48	,	,	PUNCT
gsrj-29	442	49	m.	m.	NOUN
gsrj-29	442	50	,	,	PUNCT
gsrj-29	442	51	et	et	PROPN
gsrj-29	442	52	al	al	PROPN
gsrj-29	442	53	.	.	PUNCT
gsrj-29	443	1	the	the	DET
gsrj-29	443	2	fda	fda	PROPN
gsrj-29	443	3	-	-	PUNCT
gsrj-29	443	4	approved	approve	VERB
gsrj-29	443	5	drug	drug	NOUN
gsrj-29	443	6	39	39	NUM
gsrj-29	443	7	georgetown	georgetown	PROPN
gsrj-29	443	8	scientific	scientific	PROPN
gsrj-29	443	9	research	research	PROPN
gsrj-29	443	10	journal	journal	PROPN
gsrj-29	443	11	alectinib	alectinib	PROPN
gsrj-29	443	12	compromises	compromise	VERB
gsrj-29	443	13	sars	sar	NOUN
gsrj-29	443	14	-	-	PUNCT
gsrj-29	443	15	cov-2	cov-2	ADV
gsrj-29	443	16	nucleocapsid	nucleocapsid	ADJ
gsrj-29	443	17	phosphorylation	phosphorylation	NOUN
gsrj-29	443	18	and	and	CCONJ
gsrj-29	443	19	inhibits	inhibit	VERB
gsrj-29	443	20	viral	viral	ADJ
gsrj-29	443	21	infection	infection	NOUN
gsrj-29	443	22	in	in	ADP
gsrj-29	443	23	vitro	vitro	X
gsrj-29	443	24	.	.	PUNCT
gsrj-29	444	1	biorxiv	biorxiv	NOUN
gsrj-29	444	2	.	.	PUNCT
gsrj-29	445	1	preprint	preprint	NOUN
gsrj-29	445	2	.	.	PUNCT
gsrj-29	446	1	2020.08.14.251207	2020.08.14.251207	NOUN
gsrj-29	446	2	.	.	PUNCT
gsrj-29	447	1	doi	doi	NOUN
gsrj-29	447	2	:	:	PUNCT
gsrj-29	447	3	https://doi.org/10.1101/2020.08.14.251207	https://doi.org/10.1101/2020.08.14.251207	NOUN
gsrj-29	447	4	63	63	NUM
gsrj-29	447	5	.	.	PUNCT
gsrj-29	448	1	hoffmann	hoffmann	PROPN
gsrj-29	448	2	,	,	PUNCT
gsrj-29	448	3	h.	h.	PROPN
gsrj-29	448	4	,	,	PUNCT
gsrj-29	448	5	sánchez	sánchez	NOUN
gsrj-29	448	6	-	-	PUNCT
gsrj-29	448	7	rivera	rivera	PROPN
gsrj-29	448	8	,	,	PUNCT
gsrj-29	448	9	f.	f.	PROPN
gsrj-29	448	10	,	,	PUNCT
gsrj-29	448	11	schneider	schneider	PROPN
gsrj-29	448	12	,	,	PUNCT
gsrj-29	448	13	w.	w.	PROPN
gsrj-29	448	14	,	,	PUNCT
gsrj-29	448	15	luna	luna	PROPN
gsrj-29	448	16	,	,	PUNCT
gsrj-29	448	17	j.	j.	PROPN
gsrj-29	448	18	,	,	PUNCT
gsrj-29	448	19	soto	soto	PROPN
gsrj-29	448	20	-	-	PUNCT
gsrj-29	448	21	feliciano	feliciano	NOUN
gsrj-29	448	22	,	,	PUNCT
gsrj-29	448	23	y.	y.	PROPN
gsrj-29	448	24	,	,	PUNCT
gsrj-29	448	25	ashbrook	ashbrook	PROPN
gsrj-29	448	26	,	,	PUNCT
gsrj-29	448	27	a.	a.	PROPN
gsrj-29	448	28	,	,	PUNCT
gsrj-29	448	29	le	le	X
gsrj-29	448	30	pen	pen	PROPN
gsrj-29	448	31	,	,	PUNCT
gsrj-29	448	32	j.	j.	PROPN
gsrj-29	448	33	,	,	PUNCT
gsrj-29	448	34	leal	leal	PROPN
gsrj-29	448	35	,	,	PUNCT
gsrj-29	448	36	a.	a.	NOUN
gsrj-29	448	37	,	,	PUNCT
gsrj-29	448	38	ricardo	ricardo	NOUN
gsrj-29	448	39	-	-	PUNCT
gsrj-29	448	40	lax	lax	PROPN
gsrj-29	448	41	,	,	PUNCT
gsrj-29	448	42	i.	i.	NOUN
gsrj-29	448	43	,	,	PUNCT
gsrj-29	448	44	michailidis	michailidis	PROPN
gsrj-29	448	45	,	,	PUNCT
gsrj-29	448	46	e.	e.	PROPN
gsrj-29	448	47	,	,	PUNCT
gsrj-29	448	48	hao	hao	PROPN
gsrj-29	448	49	,	,	PUNCT
gsrj-29	448	50	y.	y.	PROPN
gsrj-29	448	51	,	,	PUNCT
gsrj-29	448	52	stenzel	stenzel	PROPN
gsrj-29	448	53	,	,	PUNCT
gsrj-29	448	54	a.	a.	NOUN
gsrj-29	448	55	,	,	PUNCT
gsrj-29	448	56	peace	peace	NOUN
gsrj-29	448	57	,	,	PUNCT
gsrj-29	448	58	a.	a.	NOUN
gsrj-29	448	59	,	,	PUNCT
gsrj-29	448	60	zuber	zuber	PROPN
gsrj-29	448	61	,	,	PUNCT
gsrj-29	448	62	j.	j.	PROPN
gsrj-29	448	63	,	,	PUNCT
gsrj-29	448	64	allis	allis	PROPN
gsrj-29	448	65	,	,	PUNCT
gsrj-29	448	66	c.	c.	PROPN
gsrj-29	448	67	,	,	PUNCT
gsrj-29	448	68	lowe	lowe	PROPN
gsrj-29	448	69	,	,	PUNCT
gsrj-29	448	70	s.	s.	PROPN
gsrj-29	448	71	,	,	PUNCT
gsrj-29	448	72	macdonald	macdonald	PROPN
gsrj-29	448	73	,	,	PUNCT
gsrj-29	448	74	m.	m.	NOUN
gsrj-29	448	75	,	,	PUNCT
gsrj-29	448	76	poirier	poirier	PROPN
gsrj-29	448	77	,	,	PUNCT
gsrj-29	448	78	j.	j.	PROPN
gsrj-29	448	79	,	,	PUNCT
gsrj-29	448	80	rice	rice	PROPN
gsrj-29	448	81	,	,	PUNCT
gsrj-29	448	82	c.	c.	PROPN
gsrj-29	448	83	cell	cell	NOUN
gsrj-29	448	84	host	host	PROPN
gsrj-29	448	85	&	&	CCONJ
gsrj-29	448	86	microbe	microbe	PROPN
gsrj-29	448	87	.	.	PUNCT
gsrj-29	449	1	2021	2021	NUM
gsrj-29	449	2	;	;	PUNCT
gsrj-29	449	3	29	29	NUM
gsrj-29	449	4	(	(	PUNCT
gsrj-29	449	5	2	2	NUM
gsrj-29	449	6	):	):	PUNCT
gsrj-29	449	7	267	267	NUM
gsrj-29	449	8	-	-	SYM
gsrj-29	449	9	280	280	NUM
gsrj-29	449	10	.	.	PUNCT
gsrj-29	450	1	doi	doi	NOUN
gsrj-29	450	2	:	:	PUNCT
gsrj-29	450	3	https://doi.org/10.1016/j.chom.2020.12.009	https://doi.org/10.1016/j.chom.2020.12.009	PROPN
gsrj-29	450	4	64	64	NUM
gsrj-29	450	5	.	.	PUNCT
gsrj-29	451	1	baggen	baggen	PROPN
gsrj-29	451	2	,	,	PUNCT
gsrj-29	451	3	j.	j.	PROPN
gsrj-29	451	4	,	,	PUNCT
gsrj-29	451	5	persoons	persoon	NOUN
gsrj-29	451	6	,	,	PUNCT
gsrj-29	451	7	l.	l.	PROPN
gsrj-29	451	8	,	,	PUNCT
gsrj-29	451	9	vanstreels	vanstreel	NOUN
gsrj-29	451	10	,	,	PUNCT
gsrj-29	451	11	e.	e.	PROPN
gsrj-29	451	12	et	et	PROPN
gsrj-29	451	13	al	al	PROPN
gsrj-29	451	14	.	.	PUNCT
gsrj-29	451	15	genome	genome	NOUN
gsrj-29	451	16	-	-	PUNCT
gsrj-29	451	17	wide	wide	ADJ
gsrj-29	451	18	crispr	crispr	NOUN
gsrj-29	451	19	screening	screening	NOUN
gsrj-29	451	20	identifies	identify	VERB
gsrj-29	451	21	tmem106b	tmem106b	PROPN
gsrj-29	451	22	as	as	ADP
gsrj-29	451	23	a	a	DET
gsrj-29	451	24	proviral	proviral	ADJ
gsrj-29	451	25	host	host	NOUN
gsrj-29	451	26	factor	factor	NOUN
gsrj-29	451	27	for	for	ADP
gsrj-29	451	28	sarscov-2	sarscov-2	PROPN
gsrj-29	451	29	.	.	PUNCT
gsrj-29	452	1	nat	nat	PROPN
gsrj-29	452	2	genet	genet	PROPN
gsrj-29	452	3	.	.	PUNCT
gsrj-29	453	1	2021	2021	NUM
gsrj-29	453	2	;	;	PUNCT
gsrj-29	454	1	53	53	NUM
gsrj-29	454	2	:	:	PUNCT
gsrj-29	454	3	435–444	435–444	NUM
gsrj-29	454	4	.	.	PUNCT
gsrj-29	454	5	doi	doi	NOUN
gsrj-29	454	6	:	:	PUNCT
gsrj-29	454	7	https://doi.org/10.1038/s41588-021-00805-2	https://doi.org/10.1038/s41588-021-00805-2	NUM
gsrj-29	454	8	65	65	NUM
gsrj-29	454	9	.	.	PUNCT
gsrj-29	455	1	zhu	zhu	PROPN
gsrj-29	455	2	,	,	PUNCT
gsrj-29	455	3	y.	y.	PROPN
gsrj-29	455	4	,	,	PUNCT
gsrj-29	455	5	feng	feng	PROPN
gsrj-29	455	6	,	,	PUNCT
gsrj-29	455	7	f.	f.	PROPN
gsrj-29	455	8	,	,	PUNCT
gsrj-29	455	9	hu	hu	PROPN
gsrj-29	455	10	,	,	PUNCT
gsrj-29	455	11	g.	g.	PROPN
gsrj-29	455	12	et	et	PROPN
gsrj-29	455	13	al	al	PROPN
gsrj-29	455	14	.	.	PUNCT
gsrj-29	456	1	a	a	DET
gsrj-29	456	2	genome	genome	NOUN
gsrj-29	456	3	-	-	PUNCT
gsrj-29	456	4	wide	wide	ADJ
gsrj-29	456	5	crispr	crispr	ADJ
gsrj-29	456	6	screen	screen	NOUN
gsrj-29	456	7	identifies	identify	VERB
gsrj-29	456	8	host	host	NOUN
gsrj-29	456	9	factors	factor	NOUN
gsrj-29	456	10	that	that	PRON
gsrj-29	456	11	regulate	regulate	VERB
gsrj-29	456	12	sars	sar	NOUN
gsrj-29	456	13	-	-	PUNCT
gsrj-29	456	14	cov-2	cov-2	PART
gsrj-29	456	15	entry	entry	NOUN
gsrj-29	456	16	.	.	PUNCT
gsrj-29	457	1	nat	nat	PROPN
gsrj-29	457	2	commun	commun	PROPN
gsrj-29	457	3	.	.	PUNCT
gsrj-29	457	4	2021	2021	NUM
gsrj-29	457	5	;	;	PUNCT
gsrj-29	457	6	12	12	NUM
gsrj-29	457	7	:	:	SYM
gsrj-29	457	8	961	961	NUM
gsrj-29	457	9	.	.	PUNCT
gsrj-29	457	10	doi	doi	NOUN
gsrj-29	457	11	:	:	PUNCT
gsrj-29	457	12	https://doi.org/10.1038/s41467-021-21213-4	https://doi.org/10.1038/s41467-021-21213-4	NUM
gsrj-29	457	13	66	66	NUM
gsrj-29	457	14	.	.	PUNCT
gsrj-29	458	1	sun	sun	PROPN
gsrj-29	458	2	sh	sh	PROPN
gsrj-29	458	3	,	,	PUNCT
gsrj-29	458	4	chen	chen	PROPN
gsrj-29	458	5	q	q	PROPN
gsrj-29	458	6	,	,	PUNCT
gsrj-29	458	7	gu	gu	PROPN
gsrj-29	458	8	hj	hj	PROPN
gsrj-29	458	9	,	,	PUNCT
gsrj-29	458	10	yang	yang	PROPN
gsrj-29	458	11	g	g	PROPN
gsrj-29	458	12	,	,	PUNCT
gsrj-29	458	13	wang	wang	PROPN
gsrj-29	458	14	yx	yx	PROPN
gsrj-29	458	15	,	,	PUNCT
gsrj-29	458	16	huang	huang	PROPN
gsrj-29	458	17	xy	xy	PROPN
gsrj-29	458	18	,	,	PUNCT
gsrj-29	458	19	liu	liu	PROPN
gsrj-29	458	20	ss	ss	PROPN
gsrj-29	458	21	,	,	PUNCT
gsrj-29	458	22	zhang	zhang	PROPN
gsrj-29	458	23	nn	nn	PROPN
gsrj-29	458	24	,	,	PUNCT
gsrj-29	458	25	li	li	PROPN
gsrj-29	458	26	xf	xf	PROPN
gsrj-29	458	27	,	,	PUNCT
gsrj-29	458	28	xiong	xiong	PROPN
gsrj-29	458	29	r	r	PROPN
gsrj-29	458	30	,	,	PUNCT
gsrj-29	458	31	guo	guo	PROPN
gsrj-29	458	32	y	y	PROPN
gsrj-29	458	33	,	,	PUNCT
gsrj-29	458	34	deng	deng	PROPN
gsrj-29	458	35	yq	yq	PROPN
gsrj-29	458	36	,	,	PUNCT
gsrj-29	458	37	huang	huang	PROPN
gsrj-29	458	38	wj	wj	PROPN
gsrj-29	458	39	,	,	PUNCT
gsrj-29	458	40	liu	liu	PROPN
gsrj-29	458	41	q	q	PROPN
gsrj-29	458	42	,	,	PUNCT
gsrj-29	458	43	liu	liu	PROPN
gsrj-29	458	44	qm	qm	PROPN
gsrj-29	458	45	,	,	PUNCT
gsrj-29	458	46	shen	shen	PROPN
gsrj-29	458	47	yl	yl	PROPN
gsrj-29	458	48	,	,	PUNCT
gsrj-29	458	49	zhou	zhou	PROPN
gsrj-29	458	50	y	y	PROPN
gsrj-29	458	51	,	,	PUNCT
gsrj-29	458	52	yang	yang	PROPN
gsrj-29	458	53	x	x	PROPN
gsrj-29	458	54	,	,	PUNCT
gsrj-29	458	55	zhao	zhao	PROPN
gsrj-29	458	56	ty	ty	PROPN
gsrj-29	458	57	,	,	PUNCT
gsrj-29	458	58	fan	fan	NOUN
gsrj-29	458	59	cf	cf	NOUN
gsrj-29	458	60	,	,	PUNCT
gsrj-29	458	61	zhou	zhou	PROPN
gsrj-29	458	62	ys	ys	PROPN
gsrj-29	458	63	,	,	PUNCT
gsrj-29	458	64	qin	qin	PROPN
gsrj-29	458	65	cf	cf	PROPN
gsrj-29	458	66	,	,	PUNCT
gsrj-29	458	67	wang	wang	PROPN
gsrj-29	458	68	yc	yc	PROPN
gsrj-29	458	69	.	.	PUNCT
gsrj-29	459	1	a	a	DET
gsrj-29	459	2	mouse	mouse	NOUN
gsrj-29	459	3	model	model	NOUN
gsrj-29	459	4	of	of	ADP
gsrj-29	459	5	sars	sar	NOUN
gsrj-29	459	6	-	-	PUNCT
gsrj-29	459	7	cov-2	cov-2	NOUN
gsrj-29	459	8	infection	infection	NOUN
gsrj-29	459	9	and	and	CCONJ
gsrj-29	459	10	pathogenesis	pathogenesis	NOUN
gsrj-29	459	11	.	.	PUNCT
gsrj-29	460	1	cell	cell	NOUN
gsrj-29	460	2	host	host	NOUN
gsrj-29	460	3	microbe	microbe	NOUN
gsrj-29	460	4	.	.	PUNCT
gsrj-29	461	1	2020	2020	NUM
gsrj-29	461	2	;	;	PUNCT
gsrj-29	461	3	28	28	NUM
gsrj-29	461	4	(	(	PUNCT
gsrj-29	461	5	1	1	NUM
gsrj-29	461	6	):	):	PUNCT
gsrj-29	461	7	124	124	NUM
gsrj-29	461	8	-	-	SYM
gsrj-29	461	9	133	133	NUM
gsrj-29	461	10	.	.	PUNCT
gsrj-29	462	1	doi	doi	NOUN
gsrj-29	462	2	:	:	PUNCT
gsrj-29	462	3	10.1016	10.1016	NUM
gsrj-29	462	4	/	/	SYM
gsrj-29	462	5	j.chom.2020.05.020	j.chom.2020.05.020	PROPN
gsrj-29	462	6	67	67	NUM
gsrj-29	462	7	.	.	PUNCT
gsrj-29	463	1	krasnopolsky	krasnopolsky	PROPN
gsrj-29	463	2	,	,	PUNCT
gsrj-29	463	3	s.	s.	PROPN
gsrj-29	463	4	,	,	PUNCT
gsrj-29	463	5	kuzmina	kuzmina	PROPN
gsrj-29	463	6	,	,	PUNCT
gsrj-29	463	7	a.	a.	NOUN
gsrj-29	463	8	,	,	PUNCT
gsrj-29	463	9	taube	taube	PROPN
gsrj-29	463	10	,	,	PUNCT
gsrj-29	463	11	r.	r.	NOUN
gsrj-29	463	12	genome	genome	NOUN
gsrj-29	463	13	-	-	PUNCT
gsrj-29	463	14	wide	wide	ADJ
gsrj-29	463	15	crispr	crispr	ADJ
gsrj-29	463	16	knockout	knockout	NOUN
gsrj-29	463	17	screen	screen	NOUN
gsrj-29	463	18	identifies	identify	VERB
gsrj-29	463	19	znf304	znf304	PROPN
gsrj-29	463	20	as	as	ADP
gsrj-29	463	21	a	a	DET
gsrj-29	463	22	silencer	silencer	NOUN
gsrj-29	463	23	of	of	ADP
gsrj-29	463	24	hiv	hiv	PROPN
gsrj-29	463	25	transcription	transcription	NOUN
gsrj-29	463	26	that	that	PRON
gsrj-29	463	27	promotes	promote	VERB
gsrj-29	463	28	viral	viral	ADJ
gsrj-29	463	29	latency	latency	NOUN
gsrj-29	463	30	.	.	PUNCT
gsrj-29	464	1	plos	plos	PROPN
gsrj-29	464	2	pathogens	pathogen	NOUN
gsrj-29	464	3	.	.	PUNCT
gsrj-29	465	1	2020	2020	NUM
gsrj-29	465	2	.	.	PUNCT
gsrj-29	466	1	doi	doi	NOUN
gsrj-29	466	2	:	:	PUNCT
gsrj-29	466	3	https://doi.org/10.1371/journal.ppat.1008834	https://doi.org/10.1371/journal.ppat.1008834	PROPN
gsrj-29	466	4	68	68	NUM
gsrj-29	466	5	.	.	PUNCT
gsrj-29	467	1	vijayan	vijayan	PROPN
gsrj-29	467	2	,	,	PUNCT
gsrj-29	467	3	k.	k.	PROPN
gsrj-29	467	4	,	,	PUNCT
gsrj-29	467	5	arang	arang	PROPN
gsrj-29	467	6	,	,	PUNCT
gsrj-29	467	7	n.	n.	PROPN
gsrj-29	467	8	,	,	PUNCT
gsrj-29	467	9	wei	wei	PROPN
gsrj-29	467	10	,	,	PUNCT
gsrj-29	467	11	l.	l.	PROPN
gsrj-29	467	12	,	,	PUNCT
gsrj-29	467	13	morrison	morrison	PROPN
gsrj-29	467	14	,	,	PUNCT
gsrj-29	467	15	r.	r.	PROPN
gsrj-29	467	16	,	,	PUNCT
gsrj-29	467	17	geiger	geiger	PROPN
gsrj-29	467	18	,	,	PUNCT
gsrj-29	467	19	r.	r.	PROPN
gsrj-29	467	20	,	,	PUNCT
gsrj-29	467	21	parks	park	NOUN
gsrj-29	467	22	,	,	PUNCT
gsrj-29	467	23	k.	k.	PROPN
gsrj-29	467	24	,	,	PUNCT
gsrj-29	467	25	lewis	lewis	PROPN
gsrj-29	467	26	,	,	PUNCT
gsrj-29	467	27	a.	a.	NOUN
gsrj-29	467	28	,	,	PUNCT
gsrj-29	467	29	mast	mast	NOUN
gsrj-29	467	30	,	,	PUNCT
gsrj-29	467	31	f.	f.	PROPN
gsrj-29	467	32	,	,	PUNCT
gsrj-29	467	33	douglass	douglass	PROPN
gsrj-29	467	34	,	,	PUNCT
gsrj-29	467	35	a.	a.	PROPN
gsrj-29	467	36	,	,	PUNCT
gsrj-29	467	37	kain	kain	PROPN
gsrj-29	467	38	,	,	PUNCT
gsrj-29	467	39	h.	h.	PROPN
gsrj-29	467	40	,	,	PUNCT
gsrj-29	467	41	aitchison	aitchison	PROPN
gsrj-29	467	42	,	,	PUNCT
gsrj-29	467	43	j.	j.	PROPN
gsrj-29	467	44	,	,	PUNCT
gsrj-29	467	45	johnson	johnson	PROPN
gsrj-29	467	46	,	,	PUNCT
gsrj-29	467	47	j.	j.	PROPN
gsrj-29	467	48	,	,	PUNCT
gsrj-29	467	49	aderem	aderem	PROPN
gsrj-29	467	50	,	,	PUNCT
gsrj-29	467	51	a.	a.	NOUN
gsrj-29	467	52	,	,	PUNCT
gsrj-29	467	53	kaushansky	kaushansky	PROPN
gsrj-29	467	54	,	,	PUNCT
gsrj-29	467	55	a	a	PRON
gsrj-29	467	56	..	..	PUNCT
gsrj-29	467	57	a	a	DET
gsrj-29	467	58	genome	genome	NOUN
gsrj-29	467	59	-	-	PUNCT
gsrj-29	467	60	wide	wide	ADJ
gsrj-29	467	61	crispr	crispr	ADJ
gsrj-29	467	62	-	-	PUNCT
gsrj-29	467	63	cas9	cas9	NOUN
gsrj-29	467	64	screen	screen	NOUN
gsrj-29	467	65	identifies	identify	VERB
gsrj-29	467	66	cenpj	cenpj	PROPN
gsrj-29	467	67	as	as	ADP
gsrj-29	467	68	a	a	DET
gsrj-29	467	69	host	host	NOUN
gsrj-29	467	70	regulator	regulator	NOUN
gsrj-29	467	71	of	of	ADP
gsrj-29	467	72	altered	altered	ADJ
gsrj-29	467	73	microtubule	microtubule	NOUN
gsrj-29	467	74	organization	organization	NOUN
gsrj-29	467	75	during	during	ADP
gsrj-29	467	76	plasmodium	plasmodium	NOUN
gsrj-29	467	77	liver	liver	NOUN
gsrj-29	467	78	infection	infection	NOUN
gsrj-29	467	79	.	.	PUNCT
gsrj-29	468	1	preprint	preprint	NOUN
gsrj-29	468	2	.	.	PUNCT
gsrj-29	469	1	biorxiv	biorxiv	NOUN
gsrj-29	469	2	.	.	PUNCT
gsrj-29	470	1	2021	2021	NUM
gsrj-29	470	2	;	;	PUNCT
gsrj-29	470	3	doi	doi	NOUN
gsrj-29	470	4	:	:	PUNCT
gsrj-29	470	5	https://doi.org/10.1101/2020.08.31.275867	https://doi.org/10.1101/2020.08.31.275867	PROPN
gsrj-29	470	6	69	69	NUM
gsrj-29	470	7	.	.	PUNCT
gsrj-29	471	1	tregoning	tregone	VERB
gsrj-29	471	2	,	,	PUNCT
gsrj-29	471	3	j.s	j.s	PROPN
gsrj-29	471	4	.	.	PROPN
gsrj-29	471	5	,	,	PUNCT
gsrj-29	471	6	flight	flight	NOUN
gsrj-29	471	7	,	,	PUNCT
gsrj-29	471	8	k.e	k.e	PROPN
gsrj-29	471	9	.	.	PROPN
gsrj-29	471	10	,	,	PUNCT
gsrj-29	471	11	higham	higham	PROPN
gsrj-29	471	12	,	,	PUNCT
gsrj-29	471	13	s.l	s.l	PROPN
gsrj-29	471	14	.	.	PROPN
gsrj-29	471	15	et	et	PROPN
gsrj-29	471	16	al	al	PROPN
gsrj-29	471	17	.	.	PUNCT
gsrj-29	471	18	progress	progress	NOUN
gsrj-29	471	19	of	of	ADP
gsrj-29	471	20	the	the	DET
gsrj-29	471	21	covid-19	covid-19	PROPN
gsrj-29	471	22	vaccine	vaccine	NOUN
gsrj-29	471	23	effort	effort	NOUN
gsrj-29	471	24	:	:	PUNCT
gsrj-29	471	25	viruses	virus	NOUN
gsrj-29	471	26	,	,	PUNCT
gsrj-29	471	27	vaccines	vaccine	NOUN
gsrj-29	471	28	and	and	CCONJ
gsrj-29	471	29	variants	variant	NOUN
gsrj-29	471	30	versus	versus	ADP
gsrj-29	471	31	efficacy	efficacy	NOUN
gsrj-29	471	32	,	,	PUNCT
gsrj-29	471	33	effectiveness	effectiveness	NOUN
gsrj-29	471	34	and	and	CCONJ
gsrj-29	471	35	escape	escape	NOUN
gsrj-29	471	36	.	.	PUNCT
gsrj-29	472	1	nat	nat	PROPN
gsrj-29	472	2	rev	rev	PROPN
gsrj-29	472	3	immunol	immunol	NOUN
gsrj-29	472	4	.	.	PUNCT
gsrj-29	472	5	2021	2021	NUM
gsrj-29	472	6	.	.	PUNCT
gsrj-29	473	1	doi	doi	NOUN
gsrj-29	473	2	:	:	PUNCT
gsrj-29	473	3	https://doi.org/10.1038/s41577-021-00592-1	https://doi.org/10.1038/s41577-021-00592-1	NUM
gsrj-29	473	4	70	70	NUM
gsrj-29	473	5	.	.	PUNCT
gsrj-29	474	1	shah	shah	NOUN
gsrj-29	474	2	,	,	PUNCT
gsrj-29	474	3	h	h	NOUN
gsrj-29	474	4	..	..	PUNCT
gsrj-29	474	5	covid-19	covid-19	PROPN
gsrj-29	474	6	recovery	recovery	NOUN
gsrj-29	474	7	:	:	PUNCT
gsrj-29	474	8	science	science	NOUN
gsrj-29	474	9	is	be	AUX
gsrj-29	474	10	n’t	not	PART
gsrj-29	474	11	enough	enough	ADV
gsrj-29	474	12	to	to	PART
gsrj-29	474	13	save	save	VERB
gsrj-29	474	14	us	we	PRON
gsrj-29	474	15	.	.	PUNCT
gsrj-29	475	1	nature	nature	NOUN
gsrj-29	475	2	.	.	PUNCT
gsrj-29	476	1	2021	2021	NUM
gsrj-29	476	2	;	;	PUNCT
gsrj-29	476	3	591	591	NUM
gsrj-29	476	4	:	:	PUNCT
gsrj-29	477	1	503	503	NUM
gsrj-29	477	2	.	.	PUNCT
gsrj-29	478	1	doi	doi	NOUN
gsrj-29	478	2	:	:	PUNCT
gsrj-29	478	3	https://doi.org/10.1038/d41586-021-00731-7	https://doi.org/10.1038/d41586-021-00731-7	NUM
gsrj-29	478	4	71	71	NUM
gsrj-29	478	5	.	.	PUNCT
gsrj-29	479	1	griffin	griffin	PROPN
gsrj-29	479	2	,	,	PUNCT
gsrj-29	479	3	s.	s.	PROPN
gsrj-29	479	4	(	(	PUNCT
gsrj-29	479	5	2021	2021	NUM
gsrj-29	479	6	)	)	PUNCT
gsrj-29	479	7	.	.	PUNCT
gsrj-29	480	1	covid-19	covid-19	PROPN
gsrj-29	480	2	:	:	PUNCT
gsrj-29	480	3	fully	fully	ADV
gsrj-29	480	4	vaccinated	vaccinate	VERB
gsrj-29	480	5	people	people	NOUN
gsrj-29	480	6	can	can	AUX
gsrj-29	480	7	carry	carry	VERB
gsrj-29	480	8	as	as	ADV
gsrj-29	480	9	much	much	ADJ
gsrj-29	480	10	delta	delta	NOUN
gsrj-29	480	11	virus	virus	NOUN
gsrj-29	480	12	as	as	ADP
gsrj-29	480	13	unvaccinated	unvaccinated	ADJ
gsrj-29	480	14	people	people	NOUN
gsrj-29	480	15	,	,	PUNCT
gsrj-29	480	16	data	datum	NOUN
gsrj-29	480	17	indicate	indicate	VERB
gsrj-29	480	18	.	.	PUNCT
gsrj-29	481	1	bmj	bmj	PROPN
gsrj-29	481	2	,	,	PUNCT
gsrj-29	481	3	374	374	NUM
gsrj-29	481	4	,	,	PUNCT
gsrj-29	481	5	n2074	n2074	PROPN
gsrj-29	481	6	.	.	PUNCT
gsrj-29	481	7	https://doi.org/10.1136/bmj.n2074	https://doi.org/10.1136/bmj.n2074	PROPN
gsrj-29	481	8	72	72	NUM
gsrj-29	481	9	.	.	PUNCT
gsrj-29	481	10	lotfi	lotfi	PROPN
gsrj-29	481	11	,	,	PUNCT
gsrj-29	481	12	m.	m.	NOUN
gsrj-29	481	13	and	and	CCONJ
gsrj-29	481	14	rezaei	rezaei	PROPN
gsrj-29	481	15	,	,	PUNCT
gsrj-29	481	16	n.	n.	PROPN
gsrj-29	481	17	crispr	crispr	PROPN
gsrj-29	481	18	/	/	SYM
gsrj-29	481	19	cas13	cas13	PROPN
gsrj-29	481	20	:	:	PUNCT
gsrj-29	481	21	a	a	DET
gsrj-29	481	22	potential	potential	ADJ
gsrj-29	481	23	therapeutic	therapeutic	ADJ
gsrj-29	481	24	option	option	NOUN
gsrj-29	481	25	of	of	ADP
gsrj-29	481	26	covid-19	covid-19	PROPN
gsrj-29	481	27	.	.	PUNCT
gsrj-29	481	28	biomedicine	biomedicine	PROPN
gsrj-29	481	29	&	&	CCONJ
gsrj-29	481	30	pharmacotherapy	pharmacotherapy	NOUN
gsrj-29	481	31	.	.	PUNCT
gsrj-29	482	1	2020	2020	NUM
gsrj-29	482	2	;	;	PUNCT
gsrj-29	482	3	131	131	NUM
gsrj-29	482	4	.	.	X
gsrj-29	483	1	doi	doi	NOUN
gsrj-29	483	2	:	:	PUNCT
gsrj-29	483	3	https://doi.org/10.1016/j.biopha.2020.110738	https://doi.org/10.1016/j.biopha.2020.110738	PROPN
gsrj-29	483	4	73	73	NUM
gsrj-29	483	5	.	.	PUNCT
gsrj-29	484	1	abbott	abbott	PROPN
gsrj-29	484	2	tr	tr	VERB
gsrj-29	484	3	,	,	PUNCT
gsrj-29	484	4	dhamdhere	dhamdhere	VERB
gsrj-29	484	5	g	g	PROPN
gsrj-29	484	6	,	,	PUNCT
gsrj-29	484	7	liu	liu	PROPN
gsrj-29	484	8	y	y	PROPN
gsrj-29	484	9	,	,	PUNCT
gsrj-29	484	10	et	et	PROPN
gsrj-29	484	11	al	al	PROPN
gsrj-29	484	12	.	.	PROPN
gsrj-29	484	13	development	development	NOUN
gsrj-29	484	14	of	of	ADP
gsrj-29	484	15	crispr	crispr	NOUN
gsrj-29	484	16	as	as	ADP
gsrj-29	484	17	an	an	DET
gsrj-29	484	18	antiviral	antiviral	ADJ
gsrj-29	484	19	strategy	strategy	NOUN
gsrj-29	484	20	to	to	PART
gsrj-29	484	21	combat	combat	VERB
gsrj-29	484	22	sars	sar	NOUN
gsrj-29	484	23	-	-	PUNCT
gsrj-29	484	24	cov-2	cov-2	PUNCT
gsrj-29	484	25	and	and	CCONJ
gsrj-29	484	26	influenza	influenza	NOUN
gsrj-29	484	27	.	.	PUNCT
gsrj-29	485	1	cell	cell	NOUN
gsrj-29	485	2	.	.	PUNCT
gsrj-29	486	1	2020	2020	NUM
gsrj-29	486	2	;	;	PUNCT
gsrj-29	486	3	181	181	NUM
gsrj-29	486	4	(	(	PUNCT
gsrj-29	486	5	4	4	NUM
gsrj-29	486	6	):	):	PUNCT
gsrj-29	486	7	865	865	NUM
gsrj-29	486	8	-	-	SYM
gsrj-29	486	9	876	876	NUM
gsrj-29	486	10	.	.	PUNCT
gsrj-29	487	1	doi	doi	NOUN
gsrj-29	487	2	:	:	PUNCT
gsrj-29	487	3	10.1016	10.1016	NUM
gsrj-29	487	4	/	/	SYM
gsrj-29	487	5	j.cell.2020.04.020	j.cell.2020.04.020	VERB
gsrj-29	487	6	74	74	NUM
gsrj-29	487	7	.	.	PUNCT
gsrj-29	488	1	fareh	fareh	NOUN
gsrj-29	488	2	,	,	PUNCT
gsrj-29	488	3	m.	m.	NOUN
gsrj-29	488	4	,	,	PUNCT
gsrj-29	488	5	zhao	zhao	PROPN
gsrj-29	488	6	,	,	PUNCT
gsrj-29	488	7	w.	w.	PROPN
gsrj-29	488	8	,	,	PUNCT
gsrj-29	488	9	hu	hu	PROPN
gsrj-29	488	10	,	,	PUNCT
gsrj-29	488	11	w.	w.	PROPN
gsrj-29	488	12	et	et	PROPN
gsrj-29	488	13	al	al	PROPN
gsrj-29	488	14	.	.	PROPN
gsrj-29	489	1	reprogrammed	reprogramme	VERB
gsrj-29	489	2	crispr	crispr	ADJ
gsrj-29	489	3	-	-	PUNCT
gsrj-29	489	4	cas13b	cas13b	NOUN
gsrj-29	489	5	suppresses	suppress	VERB
gsrj-29	489	6	sars	sar	NOUN
gsrj-29	489	7	-	-	PUNCT
gsrj-29	489	8	cov-2	cov-2	NOUN
gsrj-29	489	9	replication	replication	NOUN
gsrj-29	489	10	and	and	CCONJ
gsrj-29	489	11	circumvents	circumvent	VERB
gsrj-29	489	12	its	its	PRON
gsrj-29	489	13	mutational	mutational	ADJ
gsrj-29	489	14	escape	escape	NOUN
gsrj-29	489	15	through	through	ADP
gsrj-29	489	16	mismatch	mismatch	ADJ
gsrj-29	489	17	tolerance	tolerance	NOUN
gsrj-29	489	18	.	.	PUNCT
gsrj-29	490	1	nat	nat	PROPN
gsrj-29	490	2	commun	commun	PROPN
gsrj-29	490	3	.	.	PUNCT
gsrj-29	490	4	2021	2021	NUM
gsrj-29	490	5	;	;	PUNCT
gsrj-29	490	6	12	12	NUM
gsrj-29	490	7	:	:	SYM
gsrj-29	490	8	4270	4270	NUM
gsrj-29	490	9	.	.	PUNCT
gsrj-29	491	1	doi	doi	NOUN
gsrj-29	491	2	:	:	PUNCT
gsrj-29	491	3	https://doi.org/10.1038/s41467-021-24577-9	https://doi.org/10.1038/s41467-021-24577-9	NUM
gsrj-29	491	4	75	75	NUM
gsrj-29	491	5	.	.	PUNCT
gsrj-29	492	1	sibbald	sibbald	PROPN
gsrj-29	492	2	b.	b.	PROPN
gsrj-29	492	3	death	death	NOUN
gsrj-29	492	4	but	but	CCONJ
gsrj-29	492	5	one	one	NUM
gsrj-29	492	6	unintended	unintended	ADJ
gsrj-29	492	7	consequence	consequence	NOUN
gsrj-29	492	8	of	of	ADP
gsrj-29	492	9	gene	gene	NOUN
gsrj-29	492	10	-	-	PUNCT
gsrj-29	492	11	therapy	therapy	NOUN
gsrj-29	492	12	trial	trial	NOUN
gsrj-29	492	13	.	.	PUNCT
gsrj-29	493	1	cmaj	cmaj	PROPN
gsrj-29	493	2	.	.	PROPN
gsrj-29	494	1	2001	2001	NUM
gsrj-29	494	2	;	;	PUNCT
gsrj-29	494	3	164	164	NUM
gsrj-29	494	4	(	(	PUNCT
gsrj-29	494	5	11	11	NUM
gsrj-29	494	6	):	):	PUNCT
gsrj-29	494	7	1612	1612	NUM
gsrj-29	494	8	.	.	PUNCT
gsrj-29	495	1	76	76	NUM
gsrj-29	495	2	.	.	PUNCT
gsrj-29	496	1	johnston	johnston	PROPN
gsrj-29	496	2	,	,	PUNCT
gsrj-29	496	3	j.	j.	PROPN
gsrj-29	496	4	(	(	PUNCT
gsrj-29	496	5	2020	2020	NUM
gsrj-29	496	6	)	)	PUNCT
gsrj-29	496	7	.	.	PUNCT
gsrj-29	497	1	shaping	shape	VERB
gsrj-29	497	2	the	the	DET
gsrj-29	497	3	crispr	crispr	NOUN
gsrj-29	497	4	geneediting	geneedite	VERB
gsrj-29	497	5	debate	debate	NOUN
gsrj-29	497	6	:	:	PUNCT
gsrj-29	497	7	questions	question	NOUN
gsrj-29	497	8	about	about	ADP
gsrj-29	497	9	enhancement	enhancement	NOUN
gsrj-29	497	10	and	and	CCONJ
gsrj-29	497	11	germline	germline	NOUN
gsrj-29	497	12	modification	modification	NOUN
gsrj-29	497	13	.	.	PUNCT
gsrj-29	498	1	perspectives	perspective	NOUN
gsrj-29	498	2	in	in	ADP
gsrj-29	498	3	biology	biology	NOUN
gsrj-29	498	4	and	and	CCONJ
gsrj-29	498	5	medicine	medicine	NOUN
gsrj-29	498	6	,	,	PUNCT
gsrj-29	498	7	63(1	63(1	NUM
gsrj-29	498	8	)	)	PUNCT
gsrj-29	498	9	,	,	PUNCT
gsrj-29	498	10	141–154	141–154	NUM
gsrj-29	498	11	.	.	PUNCT
gsrj-29	499	1	https://doi.org/10.1353/pbm.2020.0011	https://doi.org/10.1353/pbm.2020.0011	ADJ
gsrj-29	499	2	77	77	NUM
gsrj-29	499	3	.	.	PUNCT
gsrj-29	500	1	sherkow	sherkow	PROPN
gsrj-29	500	2	js	js	PROPN
gsrj-29	500	3	.	.	PROPN
gsrj-29	501	1	crispr	crispr	PROPN
gsrj-29	501	2	,	,	PUNCT
gsrj-29	501	3	patents	patent	NOUN
gsrj-29	501	4	,	,	PUNCT
gsrj-29	501	5	and	and	CCONJ
gsrj-29	501	6	the	the	DET
gsrj-29	501	7	public	public	ADJ
gsrj-29	501	8	health	health	NOUN
gsrj-29	501	9	.	.	PUNCT
gsrj-29	502	1	yale	yale	PROPN
gsrj-29	502	2	j	j	PROPN
gsrj-29	502	3	biol	biol	PROPN
gsrj-29	502	4	med	me	VERB
gsrj-29	502	5	.	.	PUNCT
gsrj-29	503	1	2017	2017	NUM
gsrj-29	503	2	;	;	PUNCT
gsrj-29	503	3	90	90	NUM
gsrj-29	503	4	(	(	PUNCT
gsrj-29	503	5	4	4	NUM
gsrj-29	503	6	):	):	PUNCT
gsrj-29	503	7	667	667	NUM
gsrj-29	503	8	-	-	SYM
gsrj-29	503	9	672	672	NUM
gsrj-29	503	10	.	.	PUNCT
gsrj-29	504	1	78	78	NUM
gsrj-29	504	2	.	.	PUNCT
gsrj-29	505	1	uddin	uddin	PROPN
gsrj-29	505	2	f	f	PROPN
gsrj-29	505	3	,	,	PUNCT
gsrj-29	505	4	rudin	rudin	PROPN
gsrj-29	505	5	cm	cm	PROPN
gsrj-29	505	6	,	,	PUNCT
gsrj-29	505	7	sen	sen	PROPN
gsrj-29	505	8	t.	t.	PROPN
gsrj-29	505	9	crispr	crispr	PROPN
gsrj-29	505	10	gene	gene	NOUN
gsrj-29	505	11	therapy	therapy	NOUN
gsrj-29	505	12	:	:	PUNCT
gsrj-29	505	13	applications	application	NOUN
gsrj-29	505	14	,	,	PUNCT
gsrj-29	505	15	limitations	limitation	NOUN
gsrj-29	505	16	,	,	PUNCT
gsrj-29	505	17	and	and	CCONJ
gsrj-29	505	18	implications	implication	NOUN
gsrj-29	505	19	for	for	ADP
gsrj-29	505	20	the	the	DET
gsrj-29	505	21	future	future	NOUN
gsrj-29	505	22	.	.	PUNCT
gsrj-29	506	1	front	front	ADJ
gsrj-29	506	2	oncol	oncol	ADJ
gsrj-29	506	3	.	.	PUNCT
gsrj-29	507	1	2020	2020	NUM
gsrj-29	507	2	;	;	PUNCT
gsrj-29	507	3	10	10	NUM
gsrj-29	507	4	:	:	SYM
gsrj-29	507	5	1387	1387	NUM
gsrj-29	507	6	.	.	PUNCT
gsrj-29	508	1	doi:10.3389	doi:10.3389	PROPN
gsrj-29	508	2	/	/	SYM
gsrj-29	508	3	fonc.2020.01387	fonc.2020.01387	PROPN
gsrj-29	508	4	79	79	NUM
gsrj-29	508	5	.	.	PUNCT
gsrj-29	509	1	panfil	panfil	PROPN
gsrj-29	509	2	,	,	PUNCT
gsrj-29	509	3	a.	a.	NOUN
gsrj-29	509	4	,	,	PUNCT
gsrj-29	509	5	green	green	ADJ
gsrj-29	509	6	,	,	PUNCT
gsrj-29	509	7	p.	p.	NOUN
gsrj-29	509	8	,	,	PUNCT
gsrj-29	509	9	and	and	CCONJ
gsrj-29	509	10	yoder	yoder	PROPN
gsrj-29	509	11	,	,	PUNCT
gsrj-29	509	12	k	k	PROPN
gsrj-29	509	13	..	..	PUNCT
gsrj-29	509	14	crispr	crispr	ADJ
gsrj-29	509	15	genome	genome	NOUN
gsrj-29	509	16	editing	editing	NOUN
gsrj-29	509	17	applied	apply	VERB
gsrj-29	509	18	to	to	ADP
gsrj-29	509	19	the	the	DET
gsrj-29	509	20	pathogenic	pathogenic	ADJ
gsrj-29	509	21	retrovirus	retrovirus	NOUN
gsrj-29	509	22	htlv-1	htlv-1	PROPN
gsrj-29	509	23	.	.	NOUN
gsrj-29	509	24	front	front	NOUN
gsrj-29	509	25	.	.	PUNCT
gsrj-29	510	1	cell	cell	NOUN
gsrj-29	510	2	.	.	PUNCT
gsrj-29	511	1	infect	infect	VERB
gsrj-29	511	2	.	.	PUNCT
gsrj-29	512	1	microbiol	microbiol	PROPN
gsrj-29	512	2	.	.	PUNCT
gsrj-29	513	1	2020	2020	NUM
gsrj-29	513	2	.	.	PUNCT
gsrj-29	514	1	doi	doi	NOUN
gsrj-29	514	2	:	:	PUNCT
gsrj-29	514	3	https://doi.org/10.3389/fcimb.2020.580371	https://doi.org/10.3389/fcimb.2020.580371	PROPN
gsrj-29	514	4	80	80	NUM
gsrj-29	514	5	.	.	PUNCT
gsrj-29	515	1	kumar	kumar	PROPN
gsrj-29	515	2	,	,	PUNCT
gsrj-29	515	3	p.	p.	PROPN
gsrj-29	515	4	,	,	PUNCT
gsrj-29	515	5	malik	malik	PROPN
gsrj-29	515	6	,	,	PUNCT
gsrj-29	515	7	y.	y.	PROPN
gsrj-29	515	8	s.	s.	PROPN
gsrj-29	515	9	,	,	PUNCT
gsrj-29	515	10	ganesh	ganesh	PROPN
gsrj-29	515	11	,	,	PUNCT
gsrj-29	515	12	b.	b.	PROPN
gsrj-29	515	13	,	,	PUNCT
gsrj-29	515	14	rahangdale	rahangdale	PROPN
gsrj-29	515	15	,	,	PUNCT
gsrj-29	515	16	s.	s.	PROPN
gsrj-29	515	17	,	,	PUNCT
gsrj-29	515	18	saurabh	saurabh	PROPN
gsrj-29	515	19	,	,	PUNCT
gsrj-29	515	20	s.	s.	PROPN
gsrj-29	515	21	,	,	PUNCT
gsrj-29	515	22	natesan	natesan	PROPN
gsrj-29	515	23	,	,	PUNCT
gsrj-29	515	24	s.	s.	PROPN
gsrj-29	515	25	,	,	PUNCT
gsrj-29	515	26	srivastava	srivastava	PROPN
gsrj-29	515	27	,	,	PUNCT
gsrj-29	515	28	a.	a.	NOUN
gsrj-29	515	29	,	,	PUNCT
gsrj-29	515	30	sharun	sharun	NOUN
gsrj-29	515	31	,	,	PUNCT
gsrj-29	515	32	k.	k.	PROPN
gsrj-29	515	33	,	,	PUNCT
gsrj-29	515	34	yatoo	yatoo	NOUN
gsrj-29	515	35	,	,	PUNCT
gsrj-29	515	36	mohd	mohd	PROPN
gsrj-29	515	37	.	.	PROPN
gsrj-29	515	38	i.	i.	PROPN
gsrj-29	515	39	,	,	PUNCT
gsrj-29	515	40	tiwari	tiwari	PROPN
gsrj-29	515	41	,	,	PUNCT
gsrj-29	515	42	r.	r.	PROPN
gsrj-29	515	43	,	,	PUNCT
gsrj-29	515	44	singh	singh	PROPN
gsrj-29	515	45	,	,	PUNCT
gsrj-29	515	46	r.	r.	PROPN
gsrj-29	515	47	k.	k.	PROPN
gsrj-29	515	48	,	,	PUNCT
gsrj-29	515	49	&	&	CCONJ
gsrj-29	515	50	dhama	dhama	PROPN
gsrj-29	515	51	,	,	PUNCT
gsrj-29	515	52	k.	k.	PROPN
gsrj-29	515	53	(	(	PUNCT
gsrj-29	515	54	2020	2020	NUM
gsrj-29	515	55	)	)	PUNCT
gsrj-29	515	56	.	.	PUNCT
gsrj-29	516	1	crispr	crispr	ADJ
gsrj-29	516	2	-	-	PUNCT
gsrj-29	516	3	cas	cas	NOUN
gsrj-29	516	4	system	system	NOUN
gsrj-29	516	5	:	:	PUNCT
gsrj-29	516	6	an	an	DET
gsrj-29	516	7	approach	approach	NOUN
gsrj-29	516	8	with	with	ADP
gsrj-29	516	9	potentials	potential	NOUN
gsrj-29	516	10	for	for	ADP
gsrj-29	516	11	covid-19	covid-19	PROPN
gsrj-29	516	12	40	40	NUM
gsrj-29	516	13	georgetown	georgetown	PROPN
gsrj-29	516	14	scientific	scientific	ADJ
gsrj-29	516	15	research	research	NOUN
gsrj-29	516	16	journal	journal	NOUN
gsrj-29	516	17	diagnosis	diagnosis	NOUN
gsrj-29	516	18	and	and	CCONJ
gsrj-29	516	19	therapeutics	therapeutic	NOUN
gsrj-29	516	20	.	.	PUNCT
gsrj-29	517	1	frontiers	frontier	NOUN
gsrj-29	517	2	in	in	ADP
gsrj-29	517	3	cellular	cellular	ADJ
gsrj-29	517	4	and	and	CCONJ
gsrj-29	517	5	infection	infection	NOUN
gsrj-29	517	6	microbiology	microbiology	NOUN
gsrj-29	517	7	,	,	PUNCT
gsrj-29	517	8	10	10	NUM
gsrj-29	517	9	,	,	PUNCT
gsrj-29	517	10	639	639	NUM
gsrj-29	517	11	.	.	PUNCT
gsrj-29	518	1	https://doi.org/10.3389/fcimb.2020.576875	https://doi.org/10.3389/fcimb.2020.576875	PROPN
gsrj-29	518	2	81	81	NUM
gsrj-29	518	3	.	.	PUNCT
gsrj-29	519	1	curseu	curseu	PROPN
gsrj-29	519	2	,	,	PUNCT
gsrj-29	519	3	d.	d.	PROPN
gsrj-29	519	4	,	,	PUNCT
gsrj-29	519	5	popa	popa	NOUN
gsrj-29	519	6	,	,	PUNCT
gsrj-29	519	7	m.	m.	NOUN
gsrj-29	519	8	,	,	PUNCT
gsrj-29	519	9	sirbuioan	sirbuioan	NOUN
gsrj-29	519	10	stoian	stoian	PROPN
gsrj-29	519	11	,	,	PUNCT
gsrj-29	519	12	d	d	NOUN
gsrj-29	519	13	..	..	PUNCT
gsrj-29	519	14	potential	potential	ADJ
gsrj-29	519	15	impact	impact	NOUN
gsrj-29	519	16	of	of	ADP
gsrj-29	519	17	climate	climate	NOUN
gsrj-29	519	18	change	change	NOUN
gsrj-29	519	19	on	on	ADP
gsrj-29	519	20	pandemic	pandemic	ADJ
gsrj-29	519	21	influenza	influenza	NOUN
gsrj-29	519	22	risk	risk	NOUN
gsrj-29	519	23	.	.	PUNCT
gsrj-29	520	1	global	global	ADJ
gsrj-29	520	2	warming	warming	NOUN
gsrj-29	520	3	.	.	PUNCT
gsrj-29	521	1	2010	2010	NUM
gsrj-29	521	2	;	;	PUNCT
gsrj-29	521	3	643	643	NUM
gsrj-29	521	4	-	-	SYM
gsrj-29	521	5	657	657	NUM
gsrj-29	521	6	.	.	PUNCT
gsrj-29	522	1	doi	doi	NOUN
gsrj-29	522	2	:	:	PUNCT
gsrj-29	522	3	https://doi.org/10.1007/978-1-4419-10172_45	https://doi.org/10.1007/978-1-4419-10172_45	PROPN
gsrj-29	522	4	82	82	NUM
gsrj-29	522	5	.	.	PUNCT
gsrj-29	523	1	thomas	thomas	PROPN
gsrj-29	523	2	,	,	PUNCT
gsrj-29	523	3	mb	mb	PROPN
gsrj-29	523	4	.	.	PUNCT
gsrj-29	523	5	epidemics	epidemic	NOUN
gsrj-29	523	6	on	on	ADP
gsrj-29	523	7	the	the	DET
gsrj-29	523	8	move	move	NOUN
gsrj-29	523	9	:	:	PUNCT
gsrj-29	523	10	climate	climate	NOUN
gsrj-29	523	11	change	change	NOUN
gsrj-29	523	12	and	and	CCONJ
gsrj-29	523	13	infectious	infectious	ADJ
gsrj-29	523	14	disease	disease	NOUN
gsrj-29	523	15	.	.	PUNCT
gsrj-29	524	1	plos	plos	PROPN
gsrj-29	524	2	biol	biol	PROPN
gsrj-29	524	3	.	.	PUNCT
gsrj-29	525	1	2020	2020	NUM
gsrj-29	525	2	;	;	PUNCT
gsrj-29	525	3	18	18	NUM
gsrj-29	525	4	(	(	PUNCT
gsrj-29	525	5	11	11	NUM
gsrj-29	525	6	)	)	PUNCT
gsrj-29	525	7	.	.	PUNCT
gsrj-29	526	1	doi	doi	NOUN
gsrj-29	526	2	:	:	PUNCT
gsrj-29	526	3	https://doi.org/10.1371/journal.pbio.3001013	https://doi.org/10.1371/journal.pbio.3001013	PROPN
gsrj-29	526	4	83	83	NUM
gsrj-29	526	5	.	.	PUNCT
gsrj-29	527	1	patz	patz	PROPN
gsrj-29	527	2	,	,	PUNCT
gsrj-29	527	3	j.	j.	PROPN
gsrj-29	527	4	a.	a.	PROPN
gsrj-29	527	5	,	,	PUNCT
gsrj-29	527	6	githeko	githeko	NOUN
gsrj-29	527	7	,	,	PUNCT
gsrj-29	527	8	a.	a.	PROPN
gsrj-29	527	9	k.	k.	PROPN
gsrj-29	527	10	,	,	PUNCT
gsrj-29	527	11	mccarty	mccarty	PROPN
gsrj-29	527	12	,	,	PUNCT
gsrj-29	527	13	j.	j.	PROPN
gsrj-29	527	14	p.	p.	PROPN
gsrj-29	527	15	,	,	PUNCT
gsrj-29	527	16	hussein	hussein	PROPN
gsrj-29	527	17	,	,	PUNCT
gsrj-29	527	18	s.	s.	PROPN
gsrj-29	527	19	,	,	PUNCT
gsrj-29	527	20	confalonieri	confalonieri	NOUN
gsrj-29	527	21	,	,	PUNCT
gsrj-29	527	22	u.	u.	PROPN
gsrj-29	527	23	,	,	PUNCT
gsrj-29	527	24	de	de	ADP
gsrj-29	527	25	wet	wet	NOUN
gsrj-29	527	26	,	,	PUNCT
gsrj-29	527	27	n	n	CCONJ
gsrj-29	527	28	..	..	PUNCT
gsrj-29	527	29	climate	climate	NOUN
gsrj-29	527	30	change	change	NOUN
gsrj-29	527	31	and	and	CCONJ
gsrj-29	527	32	infectious	infectious	ADJ
gsrj-29	527	33	diseases	disease	NOUN
gsrj-29	527	34	in	in	ADP
gsrj-29	527	35	climate	climate	NOUN
gsrj-29	527	36	change	change	NOUN
gsrj-29	527	37	and	and	CCONJ
gsrj-29	527	38	human	human	ADJ
gsrj-29	527	39	health	health	NOUN
gsrj-29	527	40	:	:	PUNCT
gsrj-29	527	41	risks	risk	NOUN
gsrj-29	527	42	and	and	CCONJ
gsrj-29	527	43	responses	response	NOUN
gsrj-29	527	44	.	.	PUNCT
gsrj-29	527	45	2003	2003	NUM
gsrj-29	527	46	;	;	PUNCT
gsrj-29	527	47	103	103	NUM
gsrj-29	527	48	-	-	SYM
gsrj-29	527	49	132	132	NUM
gsrj-29	527	50	.	.	PUNCT
gsrj-29	527	51	https://citeseerx.ist.psu.edu/viewdoc/download?doi	https://citeseerx.ist.psu.edu/viewdoc/download?doi	X
gsrj-29	528	1	=	=	SYM
gsrj-29	528	2	10.1.1.1054.1929&rep	10.1.1.1054.1929&rep	NUM
gsrj-29	528	3	=	=	NOUN
gsrj-29	528	4	rep1&type	rep1&type	NOUN
gsrj-29	528	5	=	=	SYM
gsrj-29	528	6	pdf	pdf	NOUN
gsrj-29	528	7	84	84	NUM
gsrj-29	528	8	.	.	PUNCT
gsrj-29	529	1	martens	martens	PROPN
gsrj-29	529	2	wj	wj	PROPN
gsrj-29	529	3	,	,	PUNCT
gsrj-29	529	4	niessen	niessen	NOUN
gsrj-29	529	5	lw	lw	PROPN
gsrj-29	529	6	,	,	PUNCT
gsrj-29	529	7	rotmans	rotmans	PROPN
gsrj-29	529	8	j	j	PROPN
gsrj-29	529	9	,	,	PUNCT
gsrj-29	529	10	jetten	jetten	PROPN
gsrj-29	529	11	th	th	PROPN
gsrj-29	529	12	,	,	PUNCT
gsrj-29	529	13	mcmichael	mcmichael	PROPN
gsrj-29	529	14	aj	aj	PROPN
gsrj-29	529	15	.	.	PROPN
gsrj-29	529	16	potential	potential	ADJ
gsrj-29	529	17	impact	impact	NOUN
gsrj-29	529	18	of	of	ADP
gsrj-29	529	19	global	global	ADJ
gsrj-29	529	20	climate	climate	NOUN
gsrj-29	529	21	change	change	NOUN
gsrj-29	529	22	on	on	ADP
gsrj-29	529	23	malaria	malaria	ADJ
gsrj-29	529	24	risk	risk	NOUN
gsrj-29	529	25	.	.	PUNCT
gsrj-29	530	1	environ	environ	PROPN
gsrj-29	530	2	health	health	NOUN
gsrj-29	530	3	perspect	perspect	NOUN
gsrj-29	530	4	.	.	PUNCT
gsrj-29	531	1	1995	1995	NUM
gsrj-29	531	2	;	;	PUNCT
gsrj-29	531	3	103	103	NUM
gsrj-29	531	4	(	(	PUNCT
gsrj-29	531	5	5	5	NUM
gsrj-29	531	6	):	):	PUNCT
gsrj-29	531	7	458	458	NUM
gsrj-29	531	8	-	-	SYM
gsrj-29	531	9	464	464	NUM
gsrj-29	531	10	.	.	PUNCT
gsrj-29	532	1	doi	doi	NOUN
gsrj-29	532	2	:	:	PUNCT
gsrj-29	532	3	10.1289	10.1289	NUM
gsrj-29	532	4	/	/	SYM
gsrj-29	532	5	ehp.95103458	ehp.95103458	NUM
gsrj-29	532	6	85	85	NUM
gsrj-29	532	7	.	.	PUNCT
gsrj-29	533	1	gross	gross	ADJ
gsrj-29	533	2	,	,	PUNCT
gsrj-29	533	3	m	m	PROPN
gsrj-29	533	4	..	..	X
gsrj-29	533	5	permafrost	permafrost	NOUN
gsrj-29	533	6	thaw	thaw	NOUN
gsrj-29	533	7	releases	release	NOUN
gsrj-29	533	8	problems	problem	NOUN
gsrj-29	533	9	.	.	PUNCT
gsrj-29	534	1	current	current	ADJ
gsrj-29	534	2	biology	biology	NOUN
gsrj-29	534	3	.	.	PUNCT
gsrj-29	535	1	2019	2019	NUM
gsrj-29	535	2	;	;	PUNCT
gsrj-29	535	3	29	29	NUM
gsrj-29	535	4	(	(	PUNCT
gsrj-29	535	5	2	2	NUM
gsrj-29	535	6	)	)	PUNCT
gsrj-29	535	7	,	,	PUNCT
gsrj-29	535	8	39	39	NUM
gsrj-29	535	9	-	-	SYM
gsrj-29	535	10	41	41	NUM
gsrj-29	535	11	.	.	PUNCT
gsrj-29	536	1	https://doi.org/10.1016/j.cub.2018.12.045	https://doi.org/10.1016/j.cub.2018.12.045	ADV
gsrj-29	536	2	86	86	NUM
gsrj-29	536	3	.	.	PUNCT
gsrj-29	536	4	stella	stella	PROPN
gsrj-29	536	5	,	,	PUNCT
gsrj-29	536	6	e.	e.	PROPN
gsrj-29	536	7	,	,	PUNCT
gsrj-29	536	8	mari	mari	PROPN
gsrj-29	536	9	,	,	PUNCT
gsrj-29	536	10	l.	l.	PROPN
gsrj-29	536	11	,	,	PUNCT
gsrj-29	536	12	gabrieli	gabrieli	PROPN
gsrj-29	536	13	,	,	PUNCT
gsrj-29	536	14	j.	j.	PROPN
gsrj-29	536	15	et	et	PROPN
gsrj-29	536	16	al	al	PROPN
gsrj-29	536	17	.	.	PROPN
gsrj-29	536	18	permafrost	permafrost	PROPN
gsrj-29	536	19	dynamics	dynamic	NOUN
gsrj-29	536	20	and	and	CCONJ
gsrj-29	536	21	the	the	DET
gsrj-29	536	22	risk	risk	NOUN
gsrj-29	536	23	of	of	ADP
gsrj-29	536	24	anthrax	anthrax	NOUN
gsrj-29	536	25	transmission	transmission	NOUN
gsrj-29	536	26	:	:	PUNCT
gsrj-29	536	27	a	a	DET
gsrj-29	536	28	modelling	model	VERB
gsrj-29	536	29	study	study	NOUN
gsrj-29	536	30	.	.	PUNCT
gsrj-29	537	1	sci	sci	PROPN
gsrj-29	537	2	rep	rep	PROPN
gsrj-29	537	3	.	.	PROPN
gsrj-29	537	4	2020	2020	NUM
gsrj-29	537	5	;	;	PUNCT
gsrj-29	537	6	10	10	NUM
gsrj-29	537	7	.	.	PUNCT
gsrj-29	537	8	https://doi.org/10.1038/s41598-020-72440-6	https://doi.org/10.1038/s41598-020-72440-6	NOUN
gsrj-29	537	9	87	87	NUM
gsrj-29	537	10	.	.	PUNCT
gsrj-29	538	1	mcmichael	mcmichael	PROPN
gsrj-29	538	2	,	,	PUNCT
gsrj-29	538	3	c	c	X
gsrj-29	538	4	..	..	PUNCT
gsrj-29	538	5	climate	climate	NOUN
gsrj-29	538	6	change	change	NOUN
gsrj-29	538	7	-	-	PUNCT
gsrj-29	538	8	related	relate	VERB
gsrj-29	538	9	migration	migration	NOUN
gsrj-29	538	10	and	and	CCONJ
gsrj-29	538	11	infectious	infectious	ADJ
gsrj-29	538	12	disease	disease	NOUN
gsrj-29	538	13	.	.	PUNCT
gsrj-29	539	1	virulence	virulence	NOUN
gsrj-29	539	2	.	.	PUNCT
gsrj-29	540	1	2015	2015	NUM
gsrj-29	540	2	;	;	PUNCT
gsrj-29	540	3	6	6	NUM
gsrj-29	540	4	(	(	PUNCT
gsrj-29	540	5	6	6	NUM
gsrj-29	540	6	)	)	PUNCT
gsrj-29	540	7	.	.	PUNCT
gsrj-29	541	1	https://doi.org/10.1080/21505594.2015.1021539	https://doi.org/10.1080/21505594.2015.1021539	X
gsrj-29	542	1	88	88	NUM
gsrj-29	542	2	.	.	PUNCT
gsrj-29	543	1	morris	morris	PROPN
gsrj-29	543	2	,	,	PUNCT
gsrj-29	543	3	a.	a.	NOUN
gsrj-29	543	4	,	,	PUNCT
gsrj-29	543	5	guégan	guégan	NOUN
gsrj-29	543	6	,	,	PUNCT
gsrj-29	543	7	j	j	PROPN
gsrj-29	543	8	-	-	PROPN
gsrj-29	543	9	f.	f.	PROPN
gsrj-29	543	10	,	,	PUNCT
gsrj-29	543	11	andreou	andreou	PROPN
gsrj-29	543	12	,	,	PUNCT
gsrj-29	543	13	d.	d.	PROPN
gsrj-29	543	14	,	,	PUNCT
gsrj-29	543	15	marsollier	marsollier	NOUN
gsrj-29	543	16	,	,	PUNCT
gsrj-29	543	17	l.	l.	PROPN
gsrj-29	543	18	,	,	PUNCT
gsrj-29	543	19	carolan	carolan	PROPN
gsrj-29	543	20	,	,	PUNCT
gsrj-29	543	21	k.	k.	PROPN
gsrj-29	543	22	,	,	PUNCT
gsrj-29	543	23	le	le	PROPN
gsrj-29	543	24	croller	croller	NOUN
gsrj-29	543	25	,	,	PUNCT
gsrj-29	543	26	m.	m.	NOUN
gsrj-29	543	27	,	,	PUNCT
gsrj-29	543	28	sanhueza	sanhueza	PROPN
gsrj-29	543	29	,	,	PUNCT
gsrj-29	543	30	d.	d.	PROPN
gsrj-29	543	31	,	,	PUNCT
gsrj-29	543	32	gozlan	gozlan	PROPN
gsrj-29	543	33	,	,	PUNCT
gsrj-29	543	34	r	r	NOUN
gsrj-29	543	35	..	..	PUNCT
gsrj-29	543	36	deforestation	deforestation	NOUN
gsrj-29	543	37	-	-	PUNCT
gsrj-29	543	38	driven	drive	VERB
gsrj-29	543	39	food	food	NOUN
gsrj-29	543	40	-	-	PUNCT
gsrj-29	543	41	web	web	NOUN
gsrj-29	543	42	collapse	collapse	NOUN
gsrj-29	543	43	linked	link	VERB
gsrj-29	543	44	to	to	ADP
gsrj-29	543	45	emerging	emerge	VERB
gsrj-29	543	46	tropical	tropical	ADJ
gsrj-29	543	47	infectious	infectious	ADJ
gsrj-29	543	48	disease	disease	NOUN
gsrj-29	543	49	,	,	PUNCT
gsrj-29	543	50	mycobacterium	mycobacterium	NOUN
gsrj-29	543	51	ulcerans	ulceran	NOUN
gsrj-29	543	52	.	.	PUNCT
gsrj-29	544	1	science	science	NOUN
gsrj-29	544	2	advances	advance	NOUN
gsrj-29	544	3	.	.	PUNCT
gsrj-29	545	1	2016	2016	NUM
gsrj-29	545	2	;	;	PUNCT
gsrj-29	545	3	2	2	NUM
gsrj-29	545	4	(	(	PUNCT
gsrj-29	545	5	12	12	NUM
gsrj-29	545	6	)	)	PUNCT
gsrj-29	545	7	.	.	PUNCT
gsrj-29	546	1	doi	doi	NOUN
gsrj-29	546	2	:	:	PUNCT
gsrj-29	546	3	10.1126	10.1126	NUM
gsrj-29	546	4	/	/	SYM
gsrj-29	546	5	sciadv.1600387	sciadv.1600387	PROPN
gsrj-29	546	6	89	89	NUM
gsrj-29	546	7	.	.	PUNCT
gsrj-29	547	1	henrique	henrique	PROPN
gsrj-29	547	2	ellwanger	ellwanger	PROPN
gsrj-29	547	3	,	,	PUNCT
gsrj-29	547	4	j.	j.	PROPN
gsrj-29	547	5	and	and	CCONJ
gsrj-29	547	6	artur	artur	PROPN
gsrj-29	547	7	b.	b.	PROPN
gsrj-29	547	8	chies	chies	PROPN
gsrj-29	547	9	,	,	PUNCT
gsrj-29	547	10	j	j	PROPN
gsrj-29	547	11	..	..	PUNCT
gsrj-29	547	12	beyond	beyond	ADP
gsrj-29	547	13	diversity	diversity	NOUN
gsrj-29	547	14	loss	loss	NOUN
gsrj-29	547	15	and	and	CCONJ
gsrj-29	547	16	climate	climate	NOUN
gsrj-29	547	17	change	change	NOUN
gsrj-29	547	18	:	:	PUNCT
gsrj-29	547	19	impacts	impact	NOUN
gsrj-29	547	20	of	of	ADP
gsrj-29	547	21	amazon	amazon	NOUN
gsrj-29	547	22	deforestation	deforestation	NOUN
gsrj-29	547	23	on	on	ADP
gsrj-29	547	24	infectious	infectious	ADJ
gsrj-29	547	25	diseases	disease	NOUN
gsrj-29	547	26	and	and	CCONJ
gsrj-29	547	27	public	public	ADJ
gsrj-29	547	28	health	health	NOUN
gsrj-29	547	29	.	.	PUNCT
gsrj-29	548	1	an	an	PRON
gsrj-29	548	2	.	.	PUNCT
gsrj-29	548	3	acad	acad	PROPN
gsrj-29	548	4	.	.	PUNCT
gsrj-29	549	1	bras	bras	PROPN
gsrj-29	549	2	.	.	PUNCT
gsrj-29	550	1	ciênc	ciênc	PROPN
gsrj-29	550	2	.	.	PUNCT
gsrj-29	551	1	2020	2020	NUM
gsrj-29	551	2	;	;	PUNCT
gsrj-29	551	3	92	92	NUM
gsrj-29	551	4	(	(	PUNCT
gsrj-29	551	5	01	01	NUM
gsrj-29	551	6	)	)	PUNCT
gsrj-29	551	7	.	.	PUNCT
gsrj-29	552	1	doi	doi	NOUN
gsrj-29	552	2	:	:	PUNCT
gsrj-29	552	3	https://doi.org/10.1590/00013765202020191375	https://doi.org/10.1590/00013765202020191375	PROPN
gsrj-29	552	4	90	90	NUM
gsrj-29	552	5	.	.	PUNCT
gsrj-29	553	1	wood	wood	PROPN
gsrj-29	553	2	,	,	PUNCT
gsrj-29	553	3	c.	c.	NOUN
gsrj-29	553	4	,	,	PUNCT
gsrj-29	553	5	lafferty	lafferty	PROPN
gsrj-29	553	6	,	,	PUNCT
gsrj-29	553	7	k.	k.	PROPN
gsrj-29	553	8	,	,	PUNCT
gsrj-29	553	9	deleo	deleo	PROPN
gsrj-29	553	10	,	,	PUNCT
gsrj-29	553	11	g.	g.	PROPN
gsrj-29	553	12	,	,	PUNCT
gsrj-29	553	13	young	young	ADJ
gsrj-29	553	14	,	,	PUNCT
gsrj-29	553	15	h.	h.	PROPN
gsrj-29	553	16	,	,	PUNCT
gsrj-29	553	17	hudson	hudson	PROPN
gsrj-29	553	18	,	,	PUNCT
gsrj-29	553	19	p.	p.	PROPN
gsrj-29	553	20	,	,	PUNCT
gsrj-29	553	21	kuris	kuris	PROPN
gsrj-29	553	22	,	,	PUNCT
gsrj-29	553	23	a	a	PRON
gsrj-29	553	24	..	..	PUNCT
gsrj-29	553	25	does	do	AUX
gsrj-29	553	26	biodiversity	biodiversity	NOUN
gsrj-29	553	27	protect	protect	VERB
gsrj-29	553	28	humans	human	NOUN
gsrj-29	553	29	against	against	ADP
gsrj-29	553	30	infectious	infectious	ADJ
gsrj-29	553	31	disease	disease	NOUN
gsrj-29	553	32	?	?	PUNCT
gsrj-29	554	1	ecology	ecology	NOUN
gsrj-29	554	2	.	.	PUNCT
gsrj-29	555	1	2014	2014	NUM
gsrj-29	555	2	;	;	PUNCT
gsrj-29	555	3	95	95	NUM
gsrj-29	555	4	(	(	PUNCT
gsrj-29	555	5	4	4	NUM
gsrj-29	555	6	)	)	PUNCT
gsrj-29	555	7	,	,	PUNCT
gsrj-29	555	8	817	817	NUM
gsrj-29	555	9	-	-	SYM
gsrj-29	555	10	832	832	NUM
gsrj-29	555	11	.	.	PUNCT
gsrj-29	556	1	doi	doi	NOUN
gsrj-29	556	2	:	:	PUNCT
gsrj-29	556	3	https://doi.org/10.1890/131041.1	https://doi.org/10.1890/131041.1	NOUN
gsrj-29	556	4	41	41	NUM
gsrj-29	556	5	table	table	NOUN
gsrj-29	556	6	of	of	ADP
gsrj-29	556	7	contents	content	NOUN
gsrj-29	556	8	letter	letter	NOUN
gsrj-29	556	9	from	from	ADP
gsrj-29	556	10	the	the	DET
gsrj-29	556	11	editors	editor	NOUN
gsrj-29	556	12	letter	letter	NOUN
gsrj-29	556	13	from	from	ADP
gsrj-29	556	14	the	the	DET
gsrj-29	556	15	editor	editor	NOUN
gsrj-29	556	16	-	-	PUNCT
gsrj-29	556	17	in	in	ADP
gsrj-29	556	18	-	-	PUNCT
gsrj-29	556	19	chief	chief	ADJ
gsrj-29	556	20	emerita	emerita	X
gsrj-29	556	21	energy	energy	NOUN
gsrj-29	556	22	security	security	NOUN
gsrj-29	556	23	in	in	ADP
gsrj-29	556	24	poland	poland	PROPN
gsrj-29	556	25	:	:	PUNCT
gsrj-29	556	26	where	where	SCONJ
gsrj-29	556	27	the	the	DET
gsrj-29	556	28	energy	energy	NOUN
gsrj-29	556	29	sector	sector	NOUN
gsrj-29	556	30	falls	fall	VERB
gsrj-29	556	31	short	short	ADJ
gsrj-29	556	32	and	and	CCONJ
gsrj-29	556	33	where	where	SCONJ
gsrj-29	556	34	it	it	PRON
gsrj-29	556	35	can	can	AUX
gsrj-29	556	36	go	go	VERB
gsrj-29	556	37	impacts	impact	NOUN
gsrj-29	556	38	of	of	ADP
gsrj-29	556	39	climate	climate	NOUN
gsrj-29	556	40	change	change	NOUN
gsrj-29	556	41	on	on	ADP
gsrj-29	556	42	mycorrhizal	mycorrhizal	NOUN
gsrj-29	556	43	fungi	fungus	NOUN
gsrj-29	556	44	in	in	ADP
gsrj-29	556	45	salt	salt	NOUN
gsrj-29	556	46	marsh	marsh	ADJ
gsrj-29	556	47	habitats	habitat	NOUN
gsrj-29	556	48	crispr	crispr	ADJ
gsrj-29	556	49	and	and	CCONJ
gsrj-29	556	50	covid-19	covid-19	PROPN
gsrj-29	556	51	:	:	PUNCT
gsrj-29	556	52	lessons	lesson	NOUN
gsrj-29	556	53	learned	learn	VERB
gsrj-29	556	54	to	to	PART
gsrj-29	556	55	prepare	prepare	VERB
gsrj-29	556	56	for	for	ADP
gsrj-29	556	57	the	the	DET
gsrj-29	556	58	next	next	ADJ
gsrj-29	556	59	pathogen	pathogen	NOUN
gsrj-29	556	60	the	the	DET
gsrj-29	556	61	impacts	impact	NOUN
gsrj-29	556	62	on	on	ADP
gsrj-29	556	63	well	well	ADV
gsrj-29	556	64	-	-	PUNCT
gsrj-29	556	65	being	being	NOUN
gsrj-29	556	66	of	of	ADP
gsrj-29	556	67	undergraduate	undergraduate	ADJ
gsrj-29	556	68	college	college	NOUN
gsrj-29	556	69	students	student	NOUN
gsrj-29	556	70	serving	serve	VERB
gsrj-29	556	71	in	in	ADP
gsrj-29	556	72	a	a	DET
gsrj-29	556	73	resident	resident	ADJ
gsrj-29	556	74	assistant	assistant	ADJ
gsrj-29	556	75	role	role	NOUN
gsrj-29	556	76	about	about	ADP
gsrj-29	556	77	the	the	DET
gsrj-29	556	78	authors	author	NOUN
gsrj-29	556	79	acknowledgements	acknowledgement	VERB